
<html lang="en"     class="pb-page"  data-request-id="736c32d9-aea8-4bad-aa56-0cbad1911a58"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2014.57.issue-1;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/jm4014696;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel S1P1 Receptor Agonists − Part 3: From Thiophenes to Pyridines" /></meta><meta name="dc.Creator" content="Martin H.  Bolli" /></meta><meta name="dc.Creator" content="Stefan  Abele" /></meta><meta name="dc.Creator" content="Magdalena  Birker" /></meta><meta name="dc.Creator" content="Roberto  Bravo" /></meta><meta name="dc.Creator" content="Daniel  Bur" /></meta><meta name="dc.Creator" content="Ruben  de Kanter" /></meta><meta name="dc.Creator" content="Christopher  Kohl" /></meta><meta name="dc.Creator" content="Julien  Grimont" /></meta><meta name="dc.Creator" content="Patrick  Hess" /></meta><meta name="dc.Creator" content="Cyrille  Lescop" /></meta><meta name="dc.Creator" content="Boris  Mathys" /></meta><meta name="dc.Creator" content="Claus  Müller" /></meta><meta name="dc.Creator" content="Oliver  Nayler" /></meta><meta name="dc.Creator" content="Markus  Rey" /></meta><meta name="dc.Creator" content="Michael  Scherz" /></meta><meta name="dc.Creator" content="Gunther  Schmidt" /></meta><meta name="dc.Creator" content="Jürgen  Seifert" /></meta><meta name="dc.Creator" content="Beat  Steiner" /></meta><meta name="dc.Creator" content="Jörg  Velker" /></meta><meta name="dc.Creator" content="Thomas  Weller" /></meta><meta name="dc.Description" content="In preceding communications we summarized our medicinal chemistry efforts leading to the identification of potent, selective, and orally active S1P1 agonists such as the thiophene derivative 1. As ..." /></meta><meta name="Description" content="In preceding communications we summarized our medicinal chemistry efforts leading to the identification of potent, selective, and orally active S1P1 agonists such as the thiophene derivative 1. As ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 24, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm4014696" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm4014696" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm4014696" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm4014696" /></link>
        
    
    

<title>Novel S1P1 Receptor Agonists − Part 3: From Thiophenes to Pyridines | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm4014696" /></meta><meta property="og:title" content="Novel S1P1 Receptor Agonists − Part 3: From Thiophenes to Pyridines" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0017.jpeg" /></meta><meta property="og:description" content="In preceding communications we summarized our medicinal chemistry efforts leading to the identification of potent, selective, and orally active S1P1 agonists such as the thiophene derivative 1. As a continuation of these efforts, we replaced the thiophene in 1 by a 2-, 3-, or 4-pyridine and obtained less lipophilic, potent, and selective S1P1 agonists (e.g., 2) efficiently reducing blood lymphocyte count in the rat. Structural features influencing the compounds’ receptor affinity profile and pharmacokinetics are discussed. In addition, the ability to penetrate brain tissue has been studied for several compounds. As a typical example for these pyridine based S1P1 agonists, compound 53 showed EC50 values of 0.6 and 352 nM for the S1P1 and S1P3 receptor, respectively, displayed favorable PK properties, and penetrated well into brain tissue. In the rat, compound 53 maximally reduced the blood lymphocyte count for at least 24 h after oral dosing of 3 mg/kg." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm4014696"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm4014696">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm4014696&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm4014696&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm4014696&amp;href=/doi/10.1021/jm4014696" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 110-130</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401457n" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm4015263" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel S1P<sub>1</sub> Receptor Agonists − Part 3: From Thiophenes to Pyridines</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin+H.++Bolli">Martin H. Bolli</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++Abele">Stefan Abele</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Magdalena++Birker">Magdalena Birker</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roberto++Bravo">Roberto Bravo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Bur">Daniel Bur</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ruben++de+Kanter">Ruben de Kanter</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Kohl">Christopher Kohl</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julien++Grimont">Julien Grimont</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Hess">Patrick Hess</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cyrille++Lescop">Cyrille Lescop</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Boris++Mathys">Boris Mathys</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claus++M%C3%BCller">Claus Müller</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Oliver++Nayler">Oliver Nayler</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Markus++Rey">Markus Rey</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Scherz">Michael Scherz</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gunther++Schmidt">Gunther Schmidt</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%BCrgen++Seifert">Jürgen Seifert</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Beat++Steiner">Beat Steiner</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%B6rg++Velker">Jörg Velker</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Weller">Thomas Weller</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Drug Discovery Chemistry, Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div><div class="corresp-info"><strong>*</strong>Phone: +41 61 565 65 65. Fax: +41 61 565 65 00. E-mail: <a href="/cdn-cgi/l/email-protection#4924283b3d2027672b2625252009282a3d2c25202627672a2624"><span class="__cf_email__" data-cfemail="412c203335282f6f232e2d2d2801202235242d282e2f6f222e2c">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm4014696&amp;href=/doi/10.1021%2Fjm4014696" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 110–130</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 24, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 September 2013</li><li><span class="item_label"><b>Published</b> online</span>24 December 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 January 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm4014696" title="DOI URL">https://doi.org/10.1021/jm4014696</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D110%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMartin%2BH.%2BBolli%252C%2BStefan%2BAbele%252C%2BMagdalena%2BBirker%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D1%26contentID%3Djm4014696%26title%3DNovel%2BS1P1%2BReceptor%2BAgonists%2B%25E2%2588%2592%2BPart%2B3%253A%2BFrom%2BThiophenes%2Bto%2BPyridines%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D130%26publicationDate%3DJanuary%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm4014696"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2849</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">14</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm4014696" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel S1P1 Receptor Agonists − Part 3: From Thiophenes to Pyridines&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;H. Bolli&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;Abele&quot;},{&quot;first_name&quot;:&quot;Magdalena&quot;,&quot;last_name&quot;:&quot;Birker&quot;},{&quot;first_name&quot;:&quot;Roberto&quot;,&quot;last_name&quot;:&quot;Bravo&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Bur&quot;},{&quot;first_name&quot;:&quot;Ruben&quot;,&quot;last_name&quot;:&quot;de Kanter&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Kohl&quot;},{&quot;first_name&quot;:&quot;Julien&quot;,&quot;last_name&quot;:&quot;Grimont&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Hess&quot;},{&quot;first_name&quot;:&quot;Cyrille&quot;,&quot;last_name&quot;:&quot;Lescop&quot;},{&quot;first_name&quot;:&quot;Boris&quot;,&quot;last_name&quot;:&quot;Mathys&quot;},{&quot;first_name&quot;:&quot;Claus&quot;,&quot;last_name&quot;:&quot;Müller&quot;},{&quot;first_name&quot;:&quot;Oliver&quot;,&quot;last_name&quot;:&quot;Nayler&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;Rey&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Scherz&quot;},{&quot;first_name&quot;:&quot;Gunther&quot;,&quot;last_name&quot;:&quot;Schmidt&quot;},{&quot;first_name&quot;:&quot;Jürgen&quot;,&quot;last_name&quot;:&quot;Seifert&quot;},{&quot;first_name&quot;:&quot;Beat&quot;,&quot;last_name&quot;:&quot;Steiner&quot;},{&quot;first_name&quot;:&quot;Jörg&quot;,&quot;last_name&quot;:&quot;Velker&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Weller&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;110-130&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm4014696&quot;},&quot;abstract&quot;:&quot;In preceding communications we summarized our medicinal chemistry efforts leading to the identification of potent, selective, and orally active S1P1 agonists such as the thiophene derivative 1. As a continuation of these efforts, we replaced the thiophene in 1 by a 2-, 3-, or 4-pyridine and obtained less lipophilic, potent, and selective S1P1 agonists (e.g., 2) efficiently reducing blood lymphocyte count in the rat. Structural features influencing the compounds’ receptor affinity profile and pharmacokinetics are discussed. In addition, the ability to penetrate brain tissue has been studied for several compounds. As a typical example for these pyridine based S1P1 agonists, compound 53 showed EC50 values of 0.6 and 352 nM for the S1P1 and S1P3 receptor, respectively, displayed favorable PK properties, and penetrated well into brain tissue. In the rat, compound 53 maximally reduced the blood lymphocyte count for at least 24 h after oral dosing of 3 mg/kg.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4014696&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4014696" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4014696&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4014696" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4014696&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4014696" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm4014696&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4014696&amp;href=/doi/10.1021/jm4014696" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm4014696" /></input><a href="/doi/pdf/10.1021/jm4014696" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm4014696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm4014696%26sid%3Dliteratum%253Aachs%26pmid%3D24367923%26genre%3Darticle%26aulast%3DBolli%26date%3D2014%26atitle%3DNovel%2BS1P1%2BReceptor%2BAgonists%2B%25E2%2588%2592%2BPart%2B3%253A%2BFrom%2BThiophenes%2Bto%2BPyridines%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D1%26spage%3D110%26epage%3D130%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a>,</li><li><a href="/action/doSearch?ConceptID=292234" title="Chromatography">Chromatography</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jmcmar.2014.57.issue-1/production/jmcmar.2014.57.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014696&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In preceding communications we summarized our medicinal chemistry efforts leading to the identification of potent, selective, and orally active S1P<sub>1</sub> agonists such as the thiophene derivative <b>1</b>. As a continuation of these efforts, we replaced the thiophene in <b>1</b> by a 2-, 3-, or 4-pyridine and obtained less lipophilic, potent, and selective S1P<sub>1</sub> agonists (e.g., <b>2</b>) efficiently reducing blood lymphocyte count in the rat. Structural features influencing the compounds’ receptor affinity profile and pharmacokinetics are discussed. In addition, the ability to penetrate brain tissue has been studied for several compounds. As a typical example for these pyridine based S1P<sub>1</sub> agonists, compound <b>53</b> showed EC<sub>50</sub> values of 0.6 and 352 nM for the S1P<sub>1</sub> and S1P<sub>3</sub> receptor, respectively, displayed favorable PK properties, and penetrated well into brain tissue. In the rat, compound <b>53</b> maximally reduced the blood lymphocyte count for at least 24 h after oral dosing of 3 mg/kg.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53113" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53113" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Synthetic sphingosine 1-phosphate 1 (S1P<sub>1</sub>) receptor agonists hold great promise for treating inflammatory disorders and autoimmune diseases,<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> and the number of clinical trials investigating their safety and efficacy is growing rapidly. While fingolimod<a onclick="showRef(event, 'ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7">(4-7)</a> has approval to treat relapsing multiple sclerosis, siponimod,<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a> ponesimod,<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> and ONO-4641 (structure undisclosed)<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> successfully completed phase II and RPC-1063 (structure undisclosed)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and MT-1303 (structure undisclosed)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> recently entered phase II clinical trials for this debilitating disease. The last two compounds are also evaluated in patients suffering from ulcerative colitis<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and inflammatory bowel disease,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> respectively. Results of an open-label phase I study in MS patients treated with CS-0777 have been published recently.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> In addition, siponimod is currently studied in patients suffering from secondary progressive multiple sclerosis<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> as well as in patients with polymyositis and dermatomyositis.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Ponesimod, on the other hand, successfully completed a phase II trial for chronic plaque psoriasis.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> Furthermore, fingolimod’s ability to reduce graft rejection has been studied in renal transplant patients,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and KRP-203<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> was investigated in patients with subacute cutaneous lupus erythematosus<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and refractory ulcerative colitis.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> APD334 (structure undisclosed)<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> recently entered phase I clinial trials. Additional molecules emerged from discovery programs at Almirall,<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> Glaxo,<a onclick="showRef(event, 'ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35">(33-35)</a> Bristol-Myers Squibb,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a><sup>e.g.</sup><a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and other companies,<a onclick="showRef(event, 'ref38 ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref40 ref41">(38-41)</a> but it is not known whether they entered clinical development yet.</div><div class="NLM_p">The lysophospholipid sphingosine 1-phosphate (S1P) is the natural ligand of five G-protein-coupled receptors named S1P<sub>1</sub>–S1P<sub>5</sub>.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> S1P–S1P receptor signaling is involved in many cellular responses including survival, proliferation, differentiation, adhesion, migration, and chemotaxis<a onclick="showRef(event, 'ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45">(43-45)</a> and leads to angiogenesis, endothelial barrier enhancement, airway and blood vessel constriction, alveolar epithelial barrier disruption, heart rate modulation, neurite extension, and bone homeostasis.<a onclick="showRef(event, 'ref46 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48 ref49">(46-49)</a> The physiological role of S1P receptor signaling has been studied in several organs and tissues such as the nervous system,<a onclick="showRef(event, 'ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref50 ref51 ref52">(50-52)</a> the lung,<a onclick="showRef(event, 'ref46 ref53'); return false;" href="javascript:void(0);" class="ref ref46 ref53">(46, 53)</a> the cardiovascular system,<a onclick="showRef(event, 'ref54 ref55 ref56 ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56 ref57 ref58">(54-58)</a> the cells of the immune system,<a onclick="showRef(event, 'ref59 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref59 ref60 ref61">(59-61)</a> and bone tissue,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> and S1P receptor activation has been implicated in many pathological situations such as autoimmunity, inflammation, cardiovascular disorders, and cancer.<a onclick="showRef(event, 'ref3 ref60 ref61 ref63 ref64 ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref3 ref60 ref61 ref63 ref64 ref65 ref66">(3, 60, 61, 63-66)</a></div><div class="NLM_p">S1P plays an important role in the motility of various cell types,<a onclick="showRef(event, 'ref62 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref62 ref67 ref68">(62, 67, 68)</a> in particular of the immune system.<a onclick="showRef(event, 'ref69 ref70 ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref69 ref70 ref71 ref72">(69-72)</a> Lymphocytes continuously circulate through the body, thereby monitoring the body for microbial intruders or aberrant cells and home to lymph nodes and Peyer’s patches.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> In order to leave these secondary lymphoid organs and return to circulation, lymphocytes follow the gradient of S1P that exists between lymph and blood. This chemotactic event is driven by the S1P/S1P<sub>1</sub> receptor signaling axis.<a onclick="showRef(event, 'ref69 ref74 ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref69 ref74 ref75 ref76">(69, 74-76)</a> Synthetic S1P<sub>1</sub> agonists have been shown to trigger internalization of the S1P<sub>1</sub> receptor, thereby abolishing the lymphocyte’s ability to sense the S1P gradient.<a onclick="showRef(event, 'ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref76 ref77">(76, 77)</a> As a consequence, lymphocytes are sequestered to lymph nodes and no longer migrate to other organs. Interfering with lymphocyte trafficking by S1P<sub>1</sub> receptor modulation represents an attractive approach to treat a variety of lymphocyte dependent autoimmune diseases, as demonstrated in several clinical trials. In contrast, activation of the S1P<sub>3</sub> receptor is deemed undesirable, as it has been associated with effects on heart rate,<a onclick="showRef(event, 'ref78 ref79 ref80 ref81 ref82 ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref78 ref79 ref80 ref81 ref82 ref83 ref84">(78-84)</a> vaso- and bronchoconstriction,<a onclick="showRef(event, 'ref82 ref85'); return false;" href="javascript:void(0);" class="ref ref82 ref85">(82, 85)</a> hypertension,<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> and enhancement of fibrosis<a onclick="showRef(event, 'ref86 ref87 ref88'); return false;" href="javascript:void(0);" class="ref ref86 ref87 ref88">(86-88)</a> in animal studies.</div><div class="NLM_p">In addition to the peripheral immunomodulatory action of S1P<sub>1</sub> receptor agonists, more recent studies identified modulation of the S1P<sub>1</sub>, S1P<sub>3</sub>, or S1P<sub>5</sub> receptors on neural cells like astrocytes and oligodendrocytes as a nonimmunologic central nervous system (CNS) effect possibly contributing to the efficacy of synthetic S1P receptor agonists in multiple sclerosis.<a onclick="showRef(event, 'ref6 ref89 ref90 ref91 ref92 ref93 ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref6 ref89 ref90 ref91 ref92 ref93 ref94 ref95">(6, 89-95)</a> Following these arguments, brain penetration of a synthetic S1P<sub>1</sub> receptor agonist may be beneficial for a compound’s efficacy in CNS related diseases such as multiple sclerosis. On the other hand, for the treatment of peripheral diseases such as psoriasis or Crohn’s disease, CNS penetration of a S1P receptor agonist is not needed or may even be undesired. Hence, the utility of a compound for different diseases may depend on its ability to penetrate brain tissue, and we therefore characterized some of our most advanced compounds with respect to their potential to penetrate the brain.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of thiophene based S1P<sub>1</sub> receptor agonist <b>1</b> and a first 3-pyridine analogue <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014696&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Previously we described the discovery of a novel series of selective S1P<sub>1</sub> receptor agonists incorporating a 5-isobutyl substituted thiophene.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> A prototypical example, compound <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), had EC<sub>50</sub> values of 0.7 and 320 nM in a GTPγS assay for S1P<sub>1</sub> and S1P<sub>3</sub>, respectively. With a clogP value of 3.97 this thiophene derivative is rather lipophilic. As high lipophilicity has been shown to be associated with compound liabilities such as target promiscuity, hERG inhibition, poor aqueous solubility, metabolic instability, or high protein binding,<a onclick="showRef(event, 'ref97 ref98 ref99 ref100 ref101'); return false;" href="javascript:void(0);" class="ref ref97 ref98 ref99 ref100 ref101">(97-101)</a> we embarked on a program in which the thiophene head of our S1P<sub>1</sub> receptor agonists was replaced by a pyridine. A first such analogue, pyridine derivative <b>2</b>, has a clogP of 2.74 and showed an EC<sub>50</sub> value of 5.7 nM for S1P<sub>1</sub>, making the pyridine an attractive alternative to the thiophene in <b>1</b>. In the following sections we describe our detailed studies aiming at the discovery of pyridine containing S1P<sub>1</sub> receptor agonists meeting the following requirements: the compound has a lower clogP than thiophene <b>1</b> (ideally <3), is highly potent on S1P<sub>1</sub> (EC<sub>50</sub> < 5 nM) with an affinity of >250 nM for S1P<sub>3</sub> and a more than 100-fold selectivity against this receptor, and shows maximal lymphocyte count reduction for at least 24 h when administered at a dose of 10 mg/kg to Wistar rats. For compounds fulfilling these criteria the ability to penetrate the brain would then be measured to assess their utility in different diseases.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05486" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05486" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis</h3><div class="NLM_p">The target compounds <b>2</b>–<b>54</b> for this study were usually prepared by coupling each of the pyridine carboxylic acids <b>59</b>–<b>79</b> with <i>N</i>-hydroxybenzamidine <b>80</b> followed by cyclizing the hydroxyamidine ester intermediate to the desired oxadiazole (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). <i>N</i>-Hydroxybenzamidine <b>80</b> was prepared by formylating phenol <b>81</b> in a Duff reaction to give benzaldehyde <b>82</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Reacting <b>82</b> with hydroxylamine hydrochloride in NMP under microwave irradiation furnished benzonitrile <b>83</b> which was then alkylated with (<i>R</i>)-glycidol under Mitsunobu conditions. Epoxide <b>84</b> was reacted with ammonia in methanol to give amino alcohol <b>85</b>. Coupling of <b>85</b> with glycolic acid to give <b>86</b> established the side chain attached to the benzene ring. Finally, nitrile <b>86</b> was reacted with hydroxylamine hydrochloride to afford the desired building block <b>80</b>. In some cases the polar side chain attached to the para position of the phenyl moiety was introduced after the oxadiazole ring had been established. In this case, the appropriate pyridine carboxylic acid was reacted with 3-ethyl-<i>N</i>,4-dihydroxy-5-methylbenzamidine and the side chain was established in analogy to the steps outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> (for details see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). For details on the synthesis of compounds <b>55</b>–<b>58</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>) see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Assembling the Central Oxadiazole Ring<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014696&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HOBt, EDC HCl, THF, rt, 18 h; or TBTU, Hünig’s base, DMF, rt, 1 h; (b) dioxane, 80 °C, 18 h, 6–76% (two steps).</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of the <i>N</i>-Hydroxybenzamidine Building Block <b>80</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014696&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) hexamethylenetetraamine, HOAc, H<sub>2</sub>O, 120 °C, Dean–Stark 2–3 h, 53–97%; (b) HONH<sub>2</sub> HCl, NMP, microwave 80–100 °C, 0.5–3 h; 86–95%; (c) (<i>R</i>)-glycidol, PPh<sub>3</sub>, DEAD, THF, 0–20 °C, 18 h, 72–86%; (d) 7 N NH<sub>3</sub> in MeOH, 65 °C, 18 h (sealed vessel), quantitative (crude); (e) glycolic acid, EDC HCl, HOBt, rt, 18 h, 51–90%; (f) HONH<sub>2</sub> HCl, NaHCO<sub>3</sub> or Et<sub>3</sub>N, MeOH or EtOH 60–80 °C, 18 h, 60–87%.</p></p></figure><div class="NLM_p">Prototypical syntheses of the various pyridinecarboxylic acids are exemplified in Schemes <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, <a class="ref internalNav" href="#sch5" aria-label="5">5</a>, and <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. Alkyl groups could be introduced to the pyridines by making use of transition metal catalyzed cross-coupling reactions developed by Suzuki,<a onclick="showRef(event, 'ref102 ref103 ref104'); return false;" href="javascript:void(0);" class="ref ref102 ref103 ref104">(102-104)</a> Negishi,<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> and Fürstner.<a onclick="showRef(event, 'ref105 ref106'); return false;" href="javascript:void(0);" class="ref ref105 ref106">(105, 106)</a> The choice of the reaction type was generally driven by the availability of the corresponding alkyl electrophile. Alkylamines were introduced either by simple thermal displacement or by a Pd-catalyzed Buchwald–Hartwig reaction.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> For more details see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> illustrates the synthesis of some nicotinic acids. 6-Alkylnicotinic acid esters <b>88a</b>–<b>e</b> were obtained by reacting ethyl 6-chloronicotinate <b>87</b> either with the appropriate alkenyl boronic ester under Suzuki conditions followed by catalytic hydrogenation or with the appropriate Grignard reagent under Fürstner conditions. Ester cleavage under acidic conditions afforded the 6-alkylnicotinic acid building blocks <b>59a</b>–<b>e</b>. 6-Alkyl-5-methylnicotinic acids (e.g., <b>60</b>) were prepared in a similar fashion starting from ethyl 5-methyl-6-chloronicotinate <b>90</b> employing 2,4,6-tri-(2-alkenyl)cyclotriboroxanepyridine complexes or alkenylboronic acid pinacol esters under Suzuki conditions.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> Catalytic hydrogenation of the ethyl 6-alkenylnicotinate intermediate furnished the corresponding ethyl 6-alkyl-5-methylnicotinate (e.g., <b>91</b>) which upon acidic ester cleavage afforded the desired nicotinic acid building block (e.g., <b>60</b>). Ethyl nicotinate <b>90</b> was prepared by oxidizing aldehyde <b>89</b><a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> with hydrogen peroxide and subsequent esterification of the resulting nicotinic acid carboxylic acid. In an alternative approach, isopropyl 5,6-dichloronicotinate <b>92</b> was first reacted with cyclopentylmagnesium bromide at room temperature in the presence of Fe(acac)<sub>3</sub> to give isopropyl 5-chloro-6-cyclopentylnicotinate <b>93</b> which was then converted to nicotinate <b>94</b> using dimethylzinc at 75–85 °C. Saponification yielded nicotinic acid <b>61</b>. Reacting ethyl 5,6-dichloronicotinate <b>95</b> with 2,4,6-tri(2-methylprop-1-en-1-yl)cyclotriboroxanepyridine complex under aqueous Suzuki conditions furnished 5-chloronicotinate <b>96</b> which was then subjected to anhydrous Suzuki conditions in the presence of 2,4,6-trivinylcyclotriboroxanepyridine complex to afford 5,6-dialkenylnicotinate <b>97</b>. Hydrogenation and ester cleavage furnished 5-ethyl-6-isobutylnicotinic acid <b>62</b>.</div><div class="NLM_p">In the case of the 3-pentyl derivative <b>63</b> the above approaches were unsuccessful. We therefore followed an alternative strategy. Thus, 2,5-dibromo-3-methylpyridine <b>98</b> was lithiated using 1.1 equiv of <i>n</i>-butyllithium and then reacted with 3-pentanone to form 5-bromopyridine <b>99</b>, which was converted to vinylpyridine <b>100</b> using trivinylcyclotriboroxanepyridine complex under Suzuki conditions. The olefin in <b>100</b> was cleaved by KMnO<sub>4</sub>, and the resulting acid was esterified to give nicotinate <b>101</b>. Treating <b>101</b> with Burgess reagent under microwave irradiation effected dehydration, and the corresponding unsaturated product was hydrogenated using H<sub>2</sub> on Pd/C. Saponification of this material finally furnished the desired 6-(3-pentyl)nicotinic acid derivative <b>63</b>.</div><div class="NLM_p">6-Aminonicotinic acids <b>64a</b>,<b>b</b> were obtained from their esters <b>102a</b>,<b>b</b> which were prepared by heating 6-chloronicotinate <b>90</b> in a sealed vessel with a large excess of the corresponding amine (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Alternatively, 5,6-dichloronicotinate <b>95</b> was reacted with diethylamine to form ethyl 5-chloro-6-aminonicotinate <b>103a</b>. When pyrrolidine was used as the amine component, the ester in <b>95</b> was transformed to the corresponding pyrrolidine amide <b>103b</b>. Pd-catalyzed Negishi coupling of <b>103a</b>,<b>b</b> with diethylzinc and subsequent ester hydrolysis afforded the 6-amino-5-ethylnicotinic acids <b>65a</b>,<b>b</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of 6-Alkylnicotinic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014696&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-alkenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, Pd(PPh<sub>3</sub>)<sub>4</sub>, PPh<sub>3</sub>, 2 M aq K<sub>2</sub>CO<sub>3</sub>, 80 °C, 18 h, 66%, then 5 bar of H<sub>2</sub>, Pd/C, methanol, 18 h, 46%; (b) alkylmagnesium bromide, Fe(acac)<sub>3</sub>, THF, NMP, −75 °C, 1–4 h, 47–93% (c) 4–7 N aq HCl, 65–80 °C, 18–24 h, 91–97%; (d) 50% H<sub>2</sub>O<sub>2</sub>, HCOOH, 0 °C, 15 h, 47–87%; (e) EtOH, H<sub>2</sub>SO<sub>4</sub>, or TMSCl, reflux 18–42 h, 65–92%; (f) 2,4,6-tri(2-methylpropenyl)cyclotriboroxanepyridine complex or alkenylboronic acid pinacol ester, Ph<sub>3</sub>P, Pd(PPh<sub>3</sub>)<sub>4</sub>, DME or dioxane, 2 M aq K<sub>2</sub>CO<sub>3</sub>, 90 °C, 20 h, 71–73%; (g) Pd/C, H<sub>2</sub>, MeOH, THF, rt, 15 h, 61–99%; (h) cyclopentylmagnesium bromide, Fe(acac)<sub>3</sub>, THF, NMP, 0 °C, 1 h, rt, 18 h, 78%; (i) Me<sub>2</sub>Zn, Pd(dppf)Cl<sub>2</sub>, dioxane, 75–85 °C, 3–18 h, 36–58%; (j) 2 M aq LiOH, MeOH or EtOH, rt, 1–2 h, 83–88%; (k) 2,4,6-tri(2-methylpropenyl)cyclotriboroxanepyridine complex, Ph<sub>3</sub>P, Pd(PPh<sub>3</sub>)<sub>4</sub>, DME, 2 M aq K<sub>2</sub>CO<sub>3</sub>, 100 °C, 4.5 h, 92%; (l) 2,4,6-trivinylcyclotriboroxanepyridine complex, Cs<sub>2</sub>CO<sub>3</sub>, tri-<i>tert</i>-butylphosphine, Pd<sub>2</sub>(dba)<sub>3</sub>, or PPh<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, 100 °C, 16–40 h, 59–67%; (m) <i>n</i>-BuLi, 3-pentanone, THF, −70 °C, 2 h, 37%; (n) KMnO<sub>4</sub>, acetone, rt, 24 h, quantitative crude; (o) Burgess reagent, dioxane, 80 °C, 1 h microwave, 76%; (p) 1 bar of H<sub>2</sub>, Pd/C, THF/methanol 1:1, rt, 4 h, 80%.</p></p></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of 6-Aminonicotinic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014696&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>1</sub>R<sub>2</sub>NH, 80–100 °C, 1 day to 3 weeks, 85–99%; (b) 4–7 N aq HCl, 65–80 °C, 18–24 h, quantitative; (c) Et<sub>2</sub>Zn, Pd(dppf)Cl<sub>2</sub>, dioxane, 75 °C, 18–24 h, 84% to quantitative; (d) 3 N aq NaOH, MeOH, 75 °C, 18 h, 79%.</p></p></figure><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Picolinic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014696&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2,4,6-trivinylcyclotriboroxanepyridine complex, 2 M aq K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DME, 80 °C, 15 h, 49–99%; (b) KMnO<sub>4</sub>, acetone, water, rt, 3 days, quantitative crude; (c) EtOH, H<sub>2</sub>SO<sub>4</sub> or TMSCl, 70 °C, 18 h, 40–95%; (d) 2,4,6-tri(2-methylpropenyl)cycloboroxanepyridine complex, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M aq K<sub>2</sub>CO<sub>3</sub>, DME, 80 °C, 6 h, 37–68%; (e) H<sub>2</sub>, Pd/C, THF, EtOH, rt, 15 h, 95%; (f) 6–7 N aq HCl, 65 °C, 48 h, 64–94%; (g) cyclopentylzinc bromide, Pd(dppf)Cl<sub>2</sub>, dioxane, 65 °C, 18 h, 28–70% (h) 2 M aq LiOH, dioxane, 75 °C, 5 h, 15–88%; (i) Et<sub>2</sub>NH, Pd(OAc)<sub>2</sub>, xanthphos, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 90–110 °C, 18–24 h, 1–9%; (j) MeOH, H<sub>2</sub>SO<sub>4</sub>, ammonium peroxydisulfate, 75 °C, 2 h, 19–28%; (k) Et<sub>2</sub>NH, BuOH, reflux 16 h; EtOH, H<sub>2</sub>SO<sub>4</sub>, 70 °C, 18 h; 6 N aq HCl, 65 °C, 18 h, 40% (three steps).</p></p></figure><div class="NLM_p">The synthesis of prototypical 4,5-, 5,6-, and 4,6-disubstituted picolinic acids is outlined in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. Reacting 2,5-dibromopyridine <b>104</b> or <b>108</b> with trivinylcyclotriboroxanepyridine complex selectively furnished the corresponding 2-vinylpyridines <b>105</b> and <b>109</b> in good yields. Potassium permanganate mediated oxidation established the carboxylic acids which were esterified to deliver <b>106</b> and <b>110</b>. A second Suzuki reaction using 2,4,6-tri(2-methylpropenyl)cyclotriboroxanepyridine complex produced the 5-alkenylpicolinic acid derivatives <b>107</b> and <b>111</b>. Catalytic hydrogenation and subsequent ester cleavage completed the synthesis of the two picolinic acids <b>66</b> and <b>67</b>. Negishi coupling of 5-bromo-4-methylpicolinate <b>106</b> with cyclopentylzinc bromide furnished ester <b>112</b> which was cleaved under basic conditions to give cyclopentyl-4-methylpicolinic acid <b>68</b>. 5-Diethylaminopicolinic acids <b>69</b> and <b>70</b> were prepared by reacting 5-bromopicolinates <b>113</b> and <b>114</b>, respectively, with diethylamine under Buchwald–Hartwig conditions and subsequent ester hydrolysis. Although the yields of these cross-coupling reactions were rather low, sufficient material could be isolated for the purpose of our studies. The preparation of 4,6-disubstituted picolinic acids followed a strategy similar to the one pursued for the 3,4- and 2,3-disubstituted picolinic acids <b>66</b> and <b>67</b>. Hence, 2,6-dichloro-4-methylpyridine <b>115</b> was first converted to 2-chloro-4-methyl-6-vinylpyridine <b>116</b> and then oxidized and esterified to give 2-chloropicolinate <b>117</b>. Suzuki cross-coupling of this material with 2,4,6-tri(2-methylpropenyl)cyclotriboroxanepyridine complex furnished the 6-isobutenylpicolinate <b>118</b> which, after hydrogenation and ester hydrolysis, produced picolinic acid <b>71</b>. The isomeric picolinic acid <b>72</b> was prepared following the same strategy starting from 2,4-dibromopicoline <b>119</b>. Thus, a vinyl group was introduced to position 6 of <b>119</b> via Suzuki reaction to give <b>120</b> which was then oxidized and esterified to form picolinate <b>121</b>. Suzuki reaction using 2,4,6-tri(2-methylpropenyl)cyclotriboroxanepyridine complex, catalytic hydrogenation, and saponification furnished the desired compound <b>72</b>. Ethyl 4-bromo-6-methylpicolinate <b>121</b> could also be prepared via an alternative route making use of the Minisci reaction.<a onclick="showRef(event, 'ref110 ref111 ref112'); return false;" href="javascript:void(0);" class="ref ref110 ref111 ref112">(110-112)</a> To this end, 4-bromopicoline <b>123</b> was treated with ammonium peroxydisulfate in methanol containing a small amount of sulfuric acid to give hydroxymethylpyridine <b>124</b> in moderate yield. Oxidation of the primary alcohol with KMnO<sub>4</sub> and esterification of the resulting acid gave picolinate <b>121</b>. The 6-diethylaminopicolinic acid <b>73</b> was obtained by Buchwald reaction of 6-chloropicolinate <b>125</b> and subsequent saponification. The isomeric acid <b>74</b> was obtained by thermal displacement of the 4-bromo substituent of acid <b>126</b>. To enhance purification, the acid was temporarily transformed to its ethyl ester.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of Pyridine-4-carboxylic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014696&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) alkylzinc bromide or chloride, or dialkylzinc, Pd(dppf)Cl<sub>2</sub>, dioxane, 75–80 °C, 2–24 h, 21–84%; (b) alkylmagnesium bromide or chloride, Fe(acac)<sub>3</sub>, THF, NMP, −75 °C, 1 h, rt, 1 h, 26–40%; (c) 6–7 M aq HCl, 60–95 °C, 3–20 h, 37% to quantitative; (d) 2,4,6-trialkenylcycloboroxanepyridine complex, PPh<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M aq K<sub>2</sub>CO<sub>3</sub>, DME, 75–90 °C, 6–20 h, 50–95%; (e) H<sub>2</sub>, Pd/C, THF, MeOH, rt, 5–16 h, 98%; (f) Et<sub>2</sub>Zn, Pd(dppf)Cl<sub>2</sub>, dioxane, 75–80 °C, 1–2 h, 79–82%; (g) diethylamine, 70–100 °C, 2–72 h, 95% to quantitative; (h) ethylamine, Cs<sub>2</sub>CO<sub>3</sub>, Pd(OAc)<sub>2</sub>, Xanthphos, dioxane, 90 °C, 15 h, 44–47%; (i) 3 N aq NaOH, EtOH, 60 °C, 72 h; 87%.</p></p></figure><div class="NLM_p">Finally, Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a> illustrates the synthesis of 2-substituted and 2,6-disubstituted isonicotinic acids. The preparation of the 2-substituted representatives <b>75a</b>–<b>h</b> started from 2-haloisonicotinic ester <b>127</b> and involved a Negishi or a Fürstner type cross-coupling reaction with the appropriate alkylzinc or alkylmagnesium halide, respectively, and subsequent ester cleavage. The 6-methylisonicotinic acids <b>76a</b>–<b>g</b> were prepared in a similar fashion via Negishi or Suzuki reaction of the 2-halo-6-methylisonicotinate <b>129</b>. 2-Alkyl-6-ethylisonicotinic acids <b>77a</b>–<b>d</b> were prepared starting from ethyl 2,6-dichloroisonicotinate <b>131</b> by two consecutive Negishi couplings. Although the bulkier alkyl group was introduced first, the monochloroisonicotinates <b>132a</b>–<b>d</b> were usually contaminated with 10–25% of the corresponding double alkylation product. In the case of Negishi reactions employing 3-pentylzinc bromide, formation of a significant amount of the isomeric 2-(pentan-2-yl)isonicotinates clearly hampered the purification of the reaction products. Hence, Suzuki reaction and subsequent catalytic hydrogenation as employed to prepare 6-methyl isonicotinic esters <b>130a</b>–<b>e</b> often gave better results when compared to a Negishi or Fürstner cross-coupling approach.</div><div class="NLM_p last">2-Amino-6-methylisonicotinic acids <b>78a</b>,<b>b</b> and <b>79</b> were prepared starting from 2-chloro-6-methyl- or 2,6-dichloroisonicotinic acid ester <b>134</b> or <b>136</b>, respectively. A large excess of the amine was usually employed when 2-chloro-6-methyl isonicotinate <b>134</b> was reacted under thermal, noncatalyzed conditions. However, the use of a large excess of pyrrolidine led to the formation of the corresponding amide (e.g., <b>135b</b>) which then had to be cleaved under basic conditions to give the desired acid (<b>78b</b>). A much smaller excess of the amine could be used if the reaction was carried out under Pd-catalyzed Buchwald conditions (e.g., <b>135a</b>). In addition, 1 equiv of diethylamine was sufficient to efficiently convert <i>tert</i>-butyl 2,6-dichloroisonicotinate <b>136</b> to the corresponding monochloride <b>137</b>. 6-Chloropicolinate <b>137</b> was then treated with dimethylzinc to afford the 6-methyl substituted isonicotinate <b>138</b> which upon ester cleavage delivered the isonicotinic acid <b>79</b>.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> In Vitro SAR Discussion</h3><div class="NLM_p">As mentioned in the <a class="ref internalNav" href="#sec1" aria-label="introduction">introduction</a>, we wanted to reduce the overall lipophilicity and amphiphilic nature of our S1P<sub>1</sub> agonists such as <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). In our previous studies,<a onclick="showRef(event, 'ref113 ref96'); return false;" href="javascript:void(0);" class="ref ref113 ref96">(113, 96)</a> we learned that a large variety of polar side chains are tolerated in the 4-position of the phenyl ring of <b>1</b>. This offered a starting point to improve the compounds’ physicochemical properties. In a next step, we explored whether polar groups were also tolerated in the headgroup. In this account, we focus our discussion on the replacement of the thiophene by a pyridine. For the following SAR discussion the (<i>S</i>)-3-(3-ethyl-4-(2-hydroxy-3-(2-hydroxyacetamido)propoxy)-5-methylphenyl)-1,2,4-oxadiazole part was kept constant, as this moiety reliably brought about high affinity and selectivity for S1P<sub>1</sub> and high in vivo efficacy.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of 3-Pyridines (Nicotinic Acid Derivatives)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0010.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">EC<sub>50</sub> [nM]<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">clogP</th><th class="colsep0 rowsep0" align="center">S1P<sub>1</sub></th><th class="colsep0 rowsep0" align="center">S1P<sub>3</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3.97</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">320</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">isobutyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.75</td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left">1710</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">isobutyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.75</td><td class="colsep0 rowsep0" align="left">89</td><td class="colsep0 rowsep0" align="left">5740</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-propyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.41</td><td class="colsep0 rowsep0" align="left">4.6</td><td class="colsep0 rowsep0" align="left">1770</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">isopropyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.37</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">2900</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">ethyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.94</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.59</td><td class="colsep0 rowsep0" align="left">248</td><td class="colsep0 rowsep0" align="left">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">isobutyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3.06</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">318</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">isobutyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3.06</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">519</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">isopropyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">2.68</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">429</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">pent-3-yl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3.61</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">2630</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">cyclopentyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3.20</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">isobutyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">3.42</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">cyclopentyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">3.56</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">diethylamino</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">2.83</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">616</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">diethylamino</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">3.18</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left"><i>N</i>-pyrrolidine</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">2.24</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">1230</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left"><i>N</i>-pyrrolidine</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">2.59</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">176</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values as determined in a GTPγS assay using membranes of CHO cells expressing either S1P<sub>1</sub> or S1P<sub>3</sub>.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> EC<sub>50</sub> values represent the geometric mean of at least three independent measurements.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">For structure, see Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">(<i>R</i>)-Enantiomer.</p></div></div></div><div class="NLM_p">A set of 3-pyridines representing close analogues of compound <b>1</b> is compiled in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. As evident from the clogP values listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, even pyridines bearing large and lipophilic substituents such as the 3-pentyl derivative <b>11</b> or the cyclopentylpyridines <b>12</b> and <b>14</b> are less liphophilic than thiophene <b>1</b>. The closest analogue of thiophene <b>1</b>, the isobutylpyridine <b>2</b>, had a lower clogP (2.75 vs 3.97) and showed an EC<sub>50</sub> of 5.7 nM for S1P<sub>1</sub>, demonstrating that replacing the thiophene in <b>1</b> by a pyridine reduces the compound’s lipophilicity while retaining its affinity for the S1P<sub>1</sub> receptor. The S1P<sub>1/3</sub> selectivity ratio is comparable for the two compounds <b>1</b> and <b>2</b>. The potency on S1P<sub>1</sub> and S1P<sub>3</sub> remained unaffected when the isobutyl chain in <b>2</b> was replaced by an <i>n</i>-propyl (<b>4</b>) or isopropyl (<b>5</b>) group. However, when the alkyl group was further shortened to an ethyl (<b>6</b>) or a methyl (<b>7</b>) group, a significant potency loss was observed. As shown with compounds <b>8</b> and <b>10</b>, introducing a methyl group to position 5 of the pyridine clearly enhanced the compound’s affinity for S1P<sub>1</sub> and S1P<sub>3</sub>. An ethyl group in position 5 brought a further potency gain on both receptors, and several compounds (e.g., <b>13</b>, <b>14</b>, <b>16</b>) reached EC<sub>50</sub> values close to 0.1 nM for S1P<sub>1</sub> and about 25 nM for S1P<sub>3</sub>. While the (<i>R</i>)-enantiomer of <b>2</b>, compound <b>3</b>, was significantly less potent in particular on S1P<sub>1</sub>, the two enantiomers <b>8</b> and <b>9</b> showed an almost identical affinity profile. As shown with compound <b>11</b>, replacing the isobutyl chain in <b>8</b> by a 3-pentyl group had no significant effect on S1P<sub>1</sub> but significantly increased the compound’s selectivity against S1P<sub>3</sub>. Interestingly, the cyclopentyl derivative <b>12</b> was clearly less selective against S1P<sub>3</sub> when compared to its open chain analogue <b>11</b>. Replacing the 3-pentyl group in <b>11</b> by diethylamine to give aminopyridine <b>15</b> was well tolerated by S1P<sub>1</sub> and slightly improved the compound’s affinity for S1P<sub>3</sub>. Conversely, exchanging the cyclopentyl group in <b>12</b> by a pyrrolidine to give <b>17</b> resulted in a marked affinity loss on both receptors. As observed with the alkyl substituted pyridines, the 5-ethyl analogues <b>16</b> and <b>18</b> were clearly more potent on S1P<sub>1</sub> and S1P<sub>3</sub> when compared to their 5-methyl analogues <b>15</b> and <b>17</b>, respectively.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of 4,5- and 5,6-Disubstituted Pyridin-2-yl Derivatives (Picolinic Acid Derivatives)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0011.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">EC<sub>50</sub> [nM]<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">clogP</th><th class="colsep0 rowsep0" align="center">S1P<sub>1</sub></th><th class="colsep0 rowsep0" align="center">S1P<sub>3</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">isobutyl</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">3.02</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">154</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">isobutyl</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">3.12</td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">3080</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">cyclopentyl</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">3.15</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">106</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">cyclopentyl</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">3.26</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">860</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">diethylamino</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">2.41</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">617</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">diethylamino</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">2.52</td><td class="colsep0 rowsep0" align="left">9.5</td><td class="colsep0 rowsep0" align="left">5960</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values as determined in a GTPγS assay using membranes of CHO cells expressing either S1P<sub>1</sub> or S1P<sub>3</sub>.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> EC<sub>50</sub> values represent the geometric mean of at least three independent measurements.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of 4,6-Disubstituted Pyridin-2-yl Derivatives (Picolinic Acid Derivatives)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0012.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">EC<sub>50</sub> [nM]<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">clogP</th><th class="colsep0 rowsep0" align="center">S1P<sub>1</sub></th><th class="colsep0 rowsep0" align="center">S1P<sub>3</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">isobutyl</td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">3.12</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">125</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">isobutyl</td><td class="colsep0 rowsep0" align="left">3.12</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">139</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">cyclopentyl</td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">3.26</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">866</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">cyclopentyl</td><td class="colsep0 rowsep0" align="left">3.26</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">258</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">diethylamino</td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">2.89</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">429</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">diethylamino</td><td class="colsep0 rowsep0" align="left">2.52</td><td class="colsep0 rowsep0" align="left">54</td><td class="colsep0 rowsep0" align="left">5240</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values as determined in a GTPγS assay using membranes of CHO cells expressing either S1P<sub>1</sub> or S1P<sub>3</sub>.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> EC<sub>50</sub> values represent the geometric mean of at least three independent measurements.</p></div></div></div><div class="NLM_p">In a next step we turned our attention to replacing the thiophene in <b>1</b> by a number of substituted 2-pyridines bearing two substituents in either an ortho or a meta relationship. A few examples illustrating their SAR are listed in Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. As judged by their clogP values, the most lipophilic 2-pyridines in Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> (e.g., <b>22</b> and <b>28</b>) are less lipophilic than thiophene <b>1</b>. The 4,5-disubstituted 2-pyridines <b>19</b>, <b>21</b>, and <b>23</b> are all highly potent S1P<sub>1</sub> agonists with affinities and selectivity profiles very close to those of their 3-pyridine analogues <b>8</b>, <b>12</b>, and <b>15</b>, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compound <b>21</b> appears to be somewhat more selective against S1P<sub>3</sub> when compared to its analogue <b>12</b>. The 5,6-disubstituted 2-pyridines <b>20</b>, <b>22</b>, and in particular <b>24</b> were less potent on both S1P receptors when compared to the corresponding 3-pyridine analogues <b>8</b>, <b>12</b>, and <b>15</b>, respectively. In the series of the 4,6-disubstituted 2-pyridines, compounds <b>25</b>–<b>28</b> were highly potent S1P<sub>1</sub> agonists, and no relevant difference in the affinity profile was seen between isomers (i.e., <b>25</b> vs <b>26</b>, <b>27</b> vs <b>28</b>). This is in contrast to diethylaminopyridines <b>29</b> and <b>30</b> where the 6-methyl substitued isomer <b>30</b> was significantly less potent than 4-methyl isomer <b>29</b>. A similar trend was observed between compounds <b>23</b> and <b>24</b>.</div><div class="NLM_p">The observation that incorporation of 4,6-disubstituted 2-pyridines led to potent and selective S1P<sub>1</sub> agonists prompted us to extend our study to 4-pyridine derivatives. Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> compiles some prototypical examples illustrating their SAR. As observed with the 2- and the 3-pyridine derivatives, the 4-pyridines were generally less lipophilic when compared to thiophene <b>1</b> and only examples incorporating rather large lipophilic substituents (e.g., as in <b>48</b>, <b>51</b>) showed a clogP as high as the one of thiophene <b>1</b>. The least lipophilic compound of this series, the unsubstituted 4-pyridine <b>31</b>, gave only weak activity on the S1P<sub>1</sub> receptor. However, the compound’s affinity for S1P<sub>1</sub> very rapidly improved with increasing length of a 2-alkyl substituent, and the 2-ethylpyridine <b>33</b> already represented a highly potent and selective S1P<sub>1</sub> agonist. A further increase in the length of the alkyl group brought a less profound gain in S1P<sub>1</sub> affinity. The <i>n</i>-butyl (<b>36</b>) and in particular the isopentyl (<b>38</b>) derivative were in fact less potent when compared to their isomers <b>37</b> and <b>39</b>, indicating that the ideal alkyl substituent may be branched but should not exceed more than three consecutive carbons in the chain. In general, there is a trend for compounds <b>32</b>–<b>40</b> to become more potent on S1P<sub>3</sub> with increasing size of the alkyl substituent. As for S1P<sub>1</sub>, the isopentylpyridine <b>38</b> appears to mark the turn of this trend.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of 2- and 2,6-(Di)Substituted Pyridin-4-yl Derivatives (Isonicotinic Acid Derivatives)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0013.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">EC<sub>50</sub> [nM]<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">clogP</th><th class="colsep0 rowsep0" align="center">S1P<sub>1</sub></th><th class="colsep0 rowsep0" align="center">S1P<sub>3</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.17</td><td class="colsep0 rowsep0" align="left">1110</td><td class="colsep0 rowsep0" align="left">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">methyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.59</td><td class="colsep0 rowsep0" align="left">86</td><td class="colsep0 rowsep0" align="left">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">ethyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.94</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">9950</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-propyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.41</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">1120</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">isopropyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.37</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">3940</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-butyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.87</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">700</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">isobutyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.75</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">757</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">isopentyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3.21</td><td class="colsep0 rowsep0" align="left">8.4</td><td class="colsep0 rowsep0" align="left">3730</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">pent-3-yl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3.30</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">1340</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">cyclopentyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.88</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">736</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">ethyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">2.36</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">1532</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-propyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">2.83</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">310</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">isobutyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3.17</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">pent-3-yl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3.71</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">cyclobutyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">2.98</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">cyclopentyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3.30</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">cyclohexyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3.62</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">149</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">pent-3-yl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">4.07</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">cyclobutyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">3.34</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">5.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">cyclopentyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">3.65</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">cyclohexyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">3.98</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">ethylamino</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">2.07</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">868</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">diethylamino</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">2.93</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">352</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left"><i>N</i>-pyrrolidinyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">2.34</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">307</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values as determined in a GTPγS assay using membranes of CHO cells expressing either S1P<sub>1</sub> or S1P<sub>3</sub>.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> EC<sub>50</sub> values represent the geometric mean of at least three independent measurements.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Racemate.</p></div></div></div><div class="NLM_p">Compounds <b>41</b>–<b>47</b> bearing an additional 6-methyl substituent were all highly potent S1P<sub>1</sub> agonists, indicating that the additional methyl group was well tolerated by this receptor. The 2-ethyl-6-methyl derivative <b>41</b> appears to be slightly more potent when compared to the corresponding des-methyl analogue <b>33</b>. In the case of the <i>n</i>-propylpyridine <b>42</b>, the affinity gain on S1P<sub>1</sub> was not significant. The additional 6-methyl group markedly increased the activity of compounds <b>41</b>–<b>47</b> on S1P<sub>3</sub> (compare <b>44</b> with <b>39</b>, <b>46</b> with <b>40</b>). A further gain in potency on S1P<sub>3</sub> was observed when the 6-methyl group was replaced by an ethyl group. As a consequence, compounds <b>48</b>–<b>51</b> were almost equipotent on both S1P receptors.</div><div class="NLM_p">The activity of the alkylaminopyridines <b>52</b> and <b>53</b> on S1P<sub>1</sub> was nearly identical to the one of the corresponding alkylpyridine analogues <b>42</b> and <b>44</b>, while the pyrrolidine derivative <b>54</b> was less potent than its cyclopentane analogue <b>46</b>. On the other hand, the aminopyridines had lower clogP values and showed a clearly reduced affinity for S1P<sub>3</sub> when compared to the corresponding alkylpyridines (compare <b>53</b> with <b>44</b> or <b>54</b> with <b>46</b>), making them a particularly attractive subclass of compounds.</div><div class="NLM_p">In brief, all substituted pyridine isomers constituted potent S1P<sub>1</sub> agonists. More specifically, we have seen that in the 3-pyridine series potent S1P<sub>1</sub> agonists were obtained if the substituent at position 6 of the pyridine consisted of at least three carbon atoms. An additional substituent in position 5 improved the affinity for both S1P<sub>1</sub> and S1P<sub>3</sub> at least 5-fold. In the series of the 2-pyridine derivatives, compounds incorporating a 4,5-, a 5,6-, or a 4,6-substitution pattern have been studied. While the 4,5- and the 4,6-disubstituted 2-pyridine compounds led to highly potent S1P<sub>1</sub> agonists, compounds with a 5,6-disubstitution pattern were slightly less active. In the 4-pyridines, an ethyl substituent in position 2 was sufficient to obtain highly potent S1P<sub>1</sub> agonists. A larger substituent in postion 2 and/or an additional substituent in position 6 mainly improved the compound’s affinity for S1P<sub>3</sub>. The amino-4-pyridine derivatives had lower clogP values and were usually more selective against S1P<sub>3</sub> when compared to the corresponding alkylpyridine analogues.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Effect on Blood LC after Oral Administration of 10 mg/kg to Wistar Rats and in Vitro Intrinsic Clearance Measured in Rat Liver Microsomes</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">% LC after dose</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">type</th><th class="colsep0 rowsep0" align="center">3 h</th><th class="colsep0 rowsep0" align="center">6 h</th><th class="colsep0 rowsep0" align="center">24 h</th><th class="colsep0 rowsep0" align="center">CL<sub>int</sub> in RLM<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> [(μL/min)/mg protein]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">3-pyridine</td><td class="colsep0 rowsep0" align="left">–68</td><td class="colsep0 rowsep0" align="left">–61</td><td class="colsep0 rowsep0" align="left">–69</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">3-pyridine</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">253</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">3-pyridine</td><td class="colsep0 rowsep0" align="left">–75</td><td class="colsep0 rowsep0" align="left">–81</td><td class="colsep0 rowsep0" align="left">–85</td><td class="colsep0 rowsep0" align="left">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">3-pyridine</td><td class="colsep0 rowsep0" align="left">–55</td><td class="colsep0 rowsep0" align="left">–61</td><td class="colsep0 rowsep0" align="left">–66</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">3-pyridine</td><td class="colsep0 rowsep0" align="left">–59</td><td class="colsep0 rowsep0" align="left">–61</td><td class="colsep0 rowsep0" align="left">–67</td><td class="colsep0 rowsep0" align="left">56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">2-pyridine</td><td class="colsep0 rowsep0" align="left">–70</td><td class="colsep0 rowsep0" align="left">–74</td><td class="colsep0 rowsep0" align="left">–65</td><td class="colsep0 rowsep0" align="left">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">2-pyridine</td><td class="colsep0 rowsep0" align="left">–68</td><td class="colsep0 rowsep0" align="left">–68</td><td class="colsep0 rowsep0" align="left">–71</td><td class="colsep0 rowsep0" align="left">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">2-pyridine</td><td class="colsep0 rowsep0" align="left">–69</td><td class="colsep0 rowsep0" align="left">–74</td><td class="colsep0 rowsep0" align="left">–61</td><td class="colsep0 rowsep0" align="left">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">2-pyridine</td><td class="colsep0 rowsep0" align="left">–64</td><td class="colsep0 rowsep0" align="left">–67</td><td class="colsep0 rowsep0" align="left">–20</td><td class="colsep0 rowsep0" align="left">48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">2-pyridine</td><td class="colsep0 rowsep0" align="left">–67</td><td class="colsep0 rowsep0" align="left">–69</td><td class="colsep0 rowsep0" align="left">–50</td><td class="colsep0 rowsep0" align="left">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">2-pyridine</td><td class="colsep0 rowsep0" align="left">–67</td><td class="colsep0 rowsep0" align="left">–63</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">4-pyridine</td><td class="colsep0 rowsep0" align="left">–71</td><td class="colsep0 rowsep0" align="left">–71</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">112</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">4-pyridine</td><td class="colsep0 rowsep0" align="left">–70</td><td class="colsep0 rowsep0" align="left">–73</td><td class="colsep0 rowsep0" align="left">–71</td><td class="colsep0 rowsep0" align="left">40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">4-pyridine</td><td class="colsep0 rowsep0" align="left">–67</td><td class="colsep0 rowsep0" align="left">–74</td><td class="colsep0 rowsep0" align="left">–81</td><td class="colsep0 rowsep0" align="left">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">4-pyridine</td><td class="colsep0 rowsep0" align="left">–61</td><td class="colsep0 rowsep0" align="left">–67</td><td class="colsep0 rowsep0" align="left">–73</td><td class="colsep0 rowsep0" align="left">5.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">4-pyridine</td><td class="colsep0 rowsep0" align="left">–62</td><td class="colsep0 rowsep0" align="left">–65</td><td class="colsep0 rowsep0" align="left">–71</td><td class="colsep0 rowsep0" align="left">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">4-pyridine</td><td class="colsep0 rowsep0" align="left">–59</td><td class="colsep0 rowsep0" align="left">–63</td><td class="colsep0 rowsep0" align="left">–53</td><td class="colsep0 rowsep0" align="left">65<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">4-pyridine</td><td class="colsep0 rowsep0" align="left">–67</td><td class="colsep0 rowsep0" align="left">–73</td><td class="colsep0 rowsep0" align="left">–76</td><td class="colsep0 rowsep0" align="left">17<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">4-pyridine</td><td class="colsep0 rowsep0" align="left">–57</td><td class="colsep0 rowsep0" align="left">–59</td><td class="colsep0 rowsep0" align="left">–67</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">4-pyridine</td><td class="colsep0 rowsep0" align="left">–62</td><td class="colsep0 rowsep0" align="left">–67</td><td class="colsep0 rowsep0" align="left">–68</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">4-pyridine</td><td class="colsep0 rowsep0" align="left">–66</td><td class="colsep0 rowsep0" align="left">–65</td><td class="colsep0 rowsep0" align="left">–70</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">4-pyridine</td><td class="colsep0 rowsep0" align="left">–64</td><td class="colsep0 rowsep0" align="left">–64</td><td class="colsep0 rowsep0" align="left">–70</td><td class="colsep0 rowsep0" align="left">1.0<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">4-pyridine</td><td class="colsep0 rowsep0" align="left">–73</td><td class="colsep0 rowsep0" align="left">–76</td><td class="colsep0 rowsep0" align="left">–82</td><td class="colsep0 rowsep0" align="left">nd</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Intrinsic clearance in the presence of rat liver microsomes (RLM) at 1 μM compound concentration.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Compound tested as racemate.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Intrinsic clearance at 0.5 and 0.1 μM <b>44</b> was 107 and 233 μL/(min mg), respectively.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Intrinsic clearance at 0.5 and 0.1 μM <b>46</b> was 20 and 12 μL/(min mg), respectively.</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">Intrinsic clearance at 0.5 and 0.1 μM <b>53</b> was 5 and 13 μL/(min mg), respectively.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Pharmacokinetics and Pharmacodynamics</h3><div class="NLM_p">In the body, S1P<sub>1</sub> agonists lead to sequestration of circulating lymphocytes to lymph nodes and lymphoid tissue. Blood lymphocyte numbers can be measured easily by means of hemocytometry and therefore represent an attractive biomarker to assess a compound’s in vivo activity. Hence, the ability to reduce the blood lymphocyte count (LC) was studied with several of the highly potent S1P<sub>1</sub> agonists discussed above. While a high potency on S1P<sub>1</sub> was required for a compound to be included in the pharmacodynamic experiment, we did not restrict these studies to highly selective compounds only in order to obtain a representative data set for each pyridine isomer subseries. The compounds were administered orally at a dose of 10 mg/kg to Wistar rats and the blood LC was measured shortly before and 3, 6, and 24 h after compound administration. A LC reduction of ≥60% was considered to be the maximal effect observable under the experimental conditions. A sustained 24 h plasma exposure resulting in sustained maximal LC reduction appeared desirable from a compound efficacy and safety perspective. In humans, a transient heart rate reduction after oral dosing of (selective) S1P<sub>1</sub> receptor agonists has been observed.<a onclick="showRef(event, 'ref8 ref114 ref115 ref116'); return false;" href="javascript:void(0);" class="ref ref8 ref114 ref115 ref116">(8, 114-116)</a> Model studies in guinea pigs suggested that the S1P<sub>1</sub> receptor is rapidly desensitized upon activation by a S1P<sub>1</sub> receptor agonist and sustained plasma concentrations of the agonist protect the animal from second dose effects on heart rate.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> summarizes our results.</div><div class="NLM_p">At 3 h all compounds tested displayed maximal LC reduction, indicating a rapid onset of action irrespective of the pyridine isomer series the compound belongs to. In general, maximal LC reduction was maintained for 24 h. Notable exceptions were the two closely related 2-pyridines <b>26</b> and <b>28</b> and the 4-pyridine <b>39</b>. Although these three compounds were highly potent on S1P<sub>1</sub>, they did not significantly lower LC at 24 h.</div><div class="NLM_p">In the LC experiments with the cyclopentyl substituted 2-pyridines <b>21</b> and <b>28</b>, compound concentrations were determined in plasma (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). The data show a good PK–PD correlation. In line with its long duration of action, compound <b>21</b> still showed nearly micromolar plasma concentrations at 24 h. On the other hand, compound <b>28</b> reached micromolar concentrations 3 and 6 h after administration but was more rapidly cleared and almost completely removed from circulation at 24 h. Metabolic stability testing using rat liver microsomes (RLM) revealed that compound <b>28</b> is less stable when compared to the corresponding isomer <b>21</b> (Tables <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> and <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>), explaining its shorter duration of action in vivo. Similar differences observed between the microsomal stability of the two isobutyl-2-pyridines <b>19</b> and <b>26</b> may also explain the corresponding differences in the compounds’ PD profiles. Rat microsomal stability data revealed that the pent-3-ylpyridine <b>39</b> is less stable than its cyclopentyl analogue <b>40</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), offering an explanation of why compound <b>39</b> showed a shorter duration of action relative to analogue <b>40</b>. A similar difference in microsomal stability between pent-3-ylpyridines <b>11</b> and <b>44</b> and their cyclopentyl analogues <b>12</b> and <b>46</b>, respectively, indicated that the pent-3-yl residue in general leads to metabolically less stable compounds than the cyclopentyl analogues (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Effect on Lymphocyte Count (LC) and Plasma Concentration after Oral Administration of 10 mg/kg Compounds <b>21</b> and <b>28</b> to Wistar Rats (<i>n</i> = 6)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">3 h</th><th class="rowsep1 colsep0" colspan="2" align="center">6 h</th><th class="rowsep1 colsep0" colspan="2" align="center">24 h</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">plasma concn [nM]</th><th class="colsep0 rowsep0" align="center">LC [%]</th><th class="colsep0 rowsep0" align="center">plasma concn [nM]</th><th class="colsep0 rowsep0" align="center">LC [%]</th><th class="colsep0 rowsep0" align="center">plasma concn [nM]</th><th class="colsep0 rowsep0" align="center">LC [%]</th><th class="colsep0 rowsep0" align="center">CL<sub>int</sub> in RLM<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> [(μL/min)/mg protein]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">4910</td><td class="colsep0 rowsep0" align="left">–68</td><td class="colsep0 rowsep0" align="left">3690</td><td class="colsep0 rowsep0" align="left">–68</td><td class="colsep0 rowsep0" align="left">800</td><td class="colsep0 rowsep0" align="left">–71</td><td class="colsep0 rowsep0" align="left">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">1890</td><td class="colsep0 rowsep0" align="left">–67</td><td class="colsep0 rowsep0" align="left">1070</td><td class="colsep0 rowsep0" align="left">–63</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">85</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Intrinsic clearance determined in rat liver microsomes at 1 μM compound concentration. Experiments at 0.5 and 0.1 μM gave comparable results indicating that metabolic processes are not saturated under the assay conditions.</p></div></div></div><div class="NLM_p">Interestingly, the enhanced in vitro clearance of 65 (μL/min)/mg of the pent-3-yl derivative <b>44</b> was not clearly reflected in a significantly shorter duration of action in vivo. Pharmacokinetic assessment of <b>44</b> revealed that this compound was indeed cleared very rapidly from the body with a clearance value in the range of liver blood flow (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). When the compound was administered orally at a dose of 1 mg/kg, no significant exposure in the plasma was detected. At a dose of 10 mg/kg, however, plasma concentrations reached 804 ng/mL and therefore clearly exceeded dose proportionality, suggesting possible saturation of compound metabolism. A closer inspection of the in vitro clearance revealed that the intrinsic clearance of compound <b>44</b> was already saturated under the assay conditions chosen (1 μM compound concentration). Repeating the microsomal stability assay at lower concentrations of <b>44</b> showed that the unsaturated in vitro clearance is >250 (μL/min)/mg (see Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). From substrate depletion studies using RLM the Michaelis constant (<i>K</i><sub>M</sub>) was estimated to be <0.5 μM (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Pent-3-ylpyridine <b>44</b> therefore is best characterized as a high clearance compound for which the metabolic process is saturated at relatively low concentrations. The pharmacokinetic behavior of the pent-3-yl derivative <b>44</b> is in clear contrast to the one of its close analogues <b>46</b> and <b>53</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Cyclopentyl analogue <b>46</b> not only had a lower in vitro and in vivo clearance than <b>44</b> but also showed no sign of blocking its own metabolism in vitro at concentrations up to 1 μM (Tables <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> and <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Interestingly, replacing the pent-3-yl group in <b>44</b> by a diethylamino moiety to give <b>53</b> completely abolished the metabolic instability of <b>44</b>. RLM data of <b>53</b> indicated very low intrinsic clearance (<i>K</i><sub>M</sub> = 0.06 μM), although saturation was occurring at 1 μM (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). A PK experiment in the rat revealed that compound <b>53</b> was rapidly and well absorbed, slowly cleared, and easily distributed into tissue (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>).</div><div class="NLM_p">In brief, several compounds listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> meet the requirements we set forth for a compound to qualify for more detailed studies. For instance, compounds <b>15</b>, <b>40</b>, <b>41</b>, <b>42</b>, <b>53</b> were all highly potent on S1P<sub>1</sub>, displayed an EC<sub>50</sub> of >250 nM on S1P<sub>3</sub>, and were >100-fold selective against this receptor. In particular, the last three compounds were further characterized by a very low in vitro clearance and produced a maximal LC reduction in the rat lasting for at least 24 h. In the following paragraphs we chose compound <b>53</b> to illustrate the additional experiments that were carried out to assess the compounds’ viability as candidates for preclinical development.</div><figure id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. LC (A) and plasma concentrations (B) of a dose response experiment with amino pyridine <b>53</b> in Wistar rats: □, vehicle (<i>n</i> = 5); ●, 0.1 mg/kg (<i>n</i> = 5); ▲, 0.3 mg/kg (<i>n</i> = 5); ▼, 1 mg/kg (<i>n</i> = 5); ◆, 3 mg/kg (<i>n</i> = 5); ■, 10 mg/kg (<i>n</i> = 5). (A) LC fully recovered 96 h after administration of all doses tested (data not shown). (B) 24 h after administration of 0.1 mg/kg and 96 h after administration of 0.3, 1, 3, and 10 mg/kg plasma concentrations were below the limit of quantification (BLQ) of 1.5 ng/mL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014696&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">First, a clear dose response of compound <b>53</b> on LC could be established in the rat (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). At a dose of 0.1 mg/kg, aminopyridine <b>53</b> showed a substantial reduction of LC at 3 and 6 h. Maximal LC count reduction was achieved for 6 h with a dose of 0.3 mg, and a dose of 3 mg/kg maximally reduced LC for at least 24 h. At all doses studied, LC completely recovered within 96 h after compound administration. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B, plasma concentrations were dose proportional over the dose range of 0.1–10 mg/kg at each time point measured. The exposure data further suggest that a plasma concentration of about 12 ng/mL (25 nM) pyridine <b>53</b> is sufficient to induce maximal reduction of the number of circulating lymphocytes.</div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Plasma concentrations (A) and blood LC (B) at days 1 and 7 after repeated daily dosing of 3 (mg/kg)/day compound <b>53</b> to Wistar rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014696&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A dose of 3 mg/kg was then selected for a multiple dose experiment with aminopyridine <b>53</b>. The compound was administered once daily (<i>t</i> = 0 h) on 7 consecutive days to Wistar rats, and plasma concentrations of <b>53</b> and LC were measured (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). At corresponding time points, plasma concentrations of <b>53</b> were nearly identical on days 1 and 7 and were in good agreement with the concentrations found in the single dose experiment, indicating that the compound did not accumulate upon repeated daily dosing of 3 mg/kg. Sustained maximal LC reduction was observed between 6 h after the first dose (day 1) and 24 h after the last dose (day 7) with no sign of tachyphylaxis.</div><div class="NLM_p">In a next step, pharmacokinetic studies with compound <b>53</b> were extended to the Beagle dog and the cynomolgus monkey (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Peak plasma concentrations (<i>C</i><sub>max</sub>) and total plasma exposure (AUC) were comparable for all three species when corrected for the dose. As in the rat, low clearance was observed in the dog and the monkey. However, the half-life of <b>53</b> in the dog and the monkey was shorter than in the rat because of a smaller volume of distribution, and bioavailability indicated less efficient absorption in these two species.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Pharmacokinetic Data of Compounds <b>44</b>, <b>46</b> and <b>53</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="9" align="center">pharmacokinetic parameters<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">oral dosing</th><th class="rowsep1 colsep0" colspan="5" align="center">intravenous dosing</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">species<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">dose [mg/kg]</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> [ng/mL] (<i>t</i><sub>max</sub>, [h])</th><th class="colsep0 rowsep0" align="center">AUC<sub>0–24h</sub> [ng h/mL]</th><th class="colsep0 rowsep0" align="center"><i>F</i> [%]</th><th class="colsep0 rowsep0" align="center">dose [mg/kg]</th><th class="colsep0 rowsep0" align="center">AUC<sub>0–inf</sub> [ng h/mL]</th><th class="colsep0 rowsep0" align="center">Cl [(mL/min)/kg]</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> [L/kg]</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> [h]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">804 (0.5)</td><td class="colsep0 rowsep0" align="left">1760</td><td class="colsep0 rowsep0" align="left">126<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">69.9</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">3.4</td><td class="colsep0 rowsep0" align="left">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">BLQ</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">49 (3.0)</td><td class="colsep0 rowsep0" align="left">436</td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">566</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">7.3</td><td class="colsep0 rowsep0" align="left">5.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">1090 (2.0)</td><td class="colsep0 rowsep0" align="left">16500<a class="ref internalNav" href="#t7fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">52</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">3200</td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">8.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">546 (1.0)</td><td class="colsep0 rowsep0" align="left">3250</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">3350</td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">cynomolgus</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">97 (2.0)</td><td class="colsep0 rowsep0" align="left">866</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">5450</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">4.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last"><i>F</i> = bioavailability; <i>C</i><sub>max</sub> = maximal concentration reached in plasma; <i>t</i><sub>max</sub> = time at which <i>C</i><sub>max</sub> was reached, <i>t</i><sub>1/2</sub> = half-life determined with iv experiment, Cl = clearance, <i>V</i><sub>ss</sub> = volume of distribution.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Oral dosing in three Wistar rats, two Beagle dogs, or three cynomolgus monkeys; iv dosing in two Wistar rats, two Beagle dogs, or three cynomolgus monkeys; for experimental details, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">Bioavailability exceeds 100% because of saturation of the metabolism of compound <b>44</b> in the 10 mg/kg oral dose experiment.</p></div><div class="footnote" id="t7fn4"><sup>d</sup><p class="last">AUC<sub>0–32h</sub>.</p></div></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Plasma and Brain Concentrations of Compounds <b>53</b>, <b>55</b>, <b>56</b>, <b>57</b>, and <b>58</b> after Oral Administration to Wistar Rats<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0014.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0015.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>Table a</sup><p class="last">10 mg/kg administered orally as a suspension in 7.5% aqueous gelatin.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Brain Penetration</h3><div class="NLM_p last">Several research groups reported beneficial effects of S1P<sub>1</sub> receptor agonism in brain tissue, in particular in animal models of multiple sclerosis.<a onclick="showRef(event, 'ref6 ref89 ref90 ref91 ref92 ref93 ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref6 ref89 ref90 ref91 ref92 ref93 ref94 ref95">(6, 89-95)</a> For the treatment of CNS related autoimmune diseases, it thus appears advantageous for a synthetic S1P receptor agonists to be able to penetrate the brain. On the other hand, CNS penetration of a S1P receptor agonist is not needed or may even be undesired when treating peripheral diseases such as psoriasis or Crohn’s disease. To support the decision on the utility of our most interesting compounds in different diseases, their ability to penetrate the brain was studied. For the following discussion, we selected the aminopyridine <b>53</b> and a few close analogues to illustrate how compound permeability and plasma exposure influence brain exposure. Similar observations were made with compound <b>41</b> and the corresponding analogues (data not shown). A number of physicochemical parameters, biochemical assays, and computational models have been proposed to predict a compound’s ability to pass the blood–brain barrier (BBB).<a onclick="showRef(event, 'ref118 ref119 ref120 ref121 ref122 ref123 ref124'); return false;" href="javascript:void(0);" class="ref ref118 ref119 ref120 ref121 ref122 ref123 ref124">(118-124)</a> For example, Wager et al. recently proposed the central nervous system multiparameter optimization (CNS MPO) tool.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> The clogP, clogD, PSA, <i>M</i><sub>w</sub>, the number of hydrogen bond donors, and the p<i>K</i><sub>a</sub> values of known CNS drugs were analyzed to design a scoring algorithm to classify the compounds according to their potential to cross the BBB. Wager et al. reported that 90% of CNS drugs show a PSA of <86 Å<sup>2</sup> and a <i>M</i><sub>w</sub> of <427 and incorporate one hydrogen bond donor only.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Other groups proposed similar values to be optimal for brain penetration.<a onclick="showRef(event, 'ref120 ref122'); return false;" href="javascript:void(0);" class="ref ref120 ref122">(120, 122)</a> In view of these observations, aminopyridine <b>53</b> clearly classified as a compound with a low potential to cross the BBB, as it has a PSA of 134 Å<sup>2</sup>, a <i>M</i><sub>w</sub> of 497, and three hydrogen bond donors and scored only 2.9 out of 6 points using the CNS MPO tool. On the other hand, the smallest cross section of the aminopyridine <b>53</b> as calculated according to Seelig et al.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> is 56 Å<sup>2</sup> and thus is clearly below the proposed maximal projection area of 80 Å<sup>2</sup> still allowing good permeability.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Plasma and brain concentrations of <b>53</b> were then measured after oral administration of 10 mg/kg to Wistar rats (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). In line with the previous PK experiment, plasma concentration of <b>53</b> reached a <i>C</i><sub>max</sub> of 2170 ng/mL very rapidly and was still about 400 ng/mL at 24 h. Interestingly, high concentrations of <b>53</b> were also found in brain tissue. At first sight, this result appeared to contradict the above predictions. In the brain, however, <i>C</i><sub>max</sub> was reached much later (<i>t</i><sub>max</sub> ≈ 6 h) than in plasma (<i>t</i><sub>max</sub> = 2 h). At 24 h brain concentrations were even slightly higher than in plasma, indicating that for compound <b>53</b> crossing the BBB is a rather slow process in both directions. Hence, the predictions were indeed correct in the sense that <b>53</b> crosses the BBB only slowly. The high and sustained plasma exposure of <b>53</b> compensated for the low permeability, i.e., the slow BBB passage of the compound. A similar result was obtained with the [1,2,4]oxadiazole isomer <b>55</b>. As with <b>53</b>, sustained high plasma concentrations allowed reaching significant brain concentrations despite slow permeation across the BBB. In contrast, the [1,3,4]oxadiazole <b>56</b> showed a more rapid decline of the plasma concentrations which clearly hampered building up of significant brain concentrations. (For a detailed discussion of property differencies between oxadiazole isomers see Boström et al.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a>) Compared to <b>53</b>, the two glycerol derivatives <b>57</b> and <b>58</b> are characterized by a reduced molecular weight (440) and PSA (105 Å<sup>2</sup>) and a smaller number of hydrogen bond donors. With a CNS MPO score of 3.2 and 3.6 the glycerol derivatives <b>57</b> and <b>58</b> respectively show a more desirable property profile for brain penetration. Indeed, brain concentrations of the two glycerol derivatives <b>57</b> and <b>58</b> followed plasma concentrations very closely confirming a more rapid crossing of the BBB of these two compounds. As a consequence of the enhanced permeability of <b>57</b> and <b>58</b>, significant brain concentrations were observed at 2 and 6 h after compound administration but no sustained 24 h brain exposure was achieved. The different behavior of compounds <b>53</b> and <b>56</b> with respect to brain penetration makes them interesting tools to assess the contribution of S1P<sub>1</sub> agonism to the treatment efficiency in diseases affecting the brain. In particular, the above studies suggest that compound <b>53</b> might be well suited for the treatment of diseases for which brain penetration is important, while compound <b>56</b> may be useful for diseases for which brain penetration is not necessary or even undesirable.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56157" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56157" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Aiming at reducing the lipophilicity of thiophene based S1P<sub>1</sub> agonists such as compound <b>1</b>, we replaced the thiophene in <b>1</b> by a 2-, 3-, or 4-pyridine. This led to the discovery of a new series of less lipophilic S1P<sub>1</sub> receptor agonists with all three pyridine isomers furnishing potent compounds. Increasing the size of a first alkyl or alkylamino substituent in the para- or meta-position to the oxadiazole improved the compound’s affinity rapidly for the S1P<sub>1</sub> and to a lesser extent for the S1P<sub>3</sub> receptor. When a second alkyl group was attached to the pyridine, the compound’s potency on S1P<sub>1</sub> and S1P<sub>3</sub> was further enhanced. This time, the affinity gain was more pronounced on S1P<sub>3</sub>. Representatives from all three pyridine isomer series maximally reduced blood LC for at least 24 h when administered at a dose of 10 mg/kg to Wistar rats. Enhanced in vitro clearance in rat liver microsomes may explain the shorter duration of action observed for compounds <b>26</b>, <b>28</b>, and <b>39</b>. Compound <b>44</b> showed a high clearance in vitro and in vivo. However, the metabolism was saturated at relatively low compound concentrations, explaining why at a dose of 10 mg/kg this compound was still able to maximally reduce LC for almost 24 h. From the above studies several compounds appeared interesting for further characterization, as they were less lipophilic than thiophene <b>1</b>, displayed high affinity and selectivity for S1P<sub>1</sub>, and sustained maximal reduction of blood LC in the rat. As an example, aminopyridine <b>53</b> has a clogP which is 1 log unit lower than the one of thiophene <b>1</b>, showed an EC<sub>50</sub> of 0.6 nM on S1P<sub>1</sub>, and was more than 500-fold selective against S1P<sub>3</sub>. In addition, this compound was highly efficacious in reducing blood LC in Wistar rats. In the following, the aminopyridine <b>53</b> was chosen to illustrate the more detailed charaterization process. A dose response experiment revealed that for <b>53</b> the ED<sub>50</sub> for maximal LC reduction at 24 h after administration is about 0.5 mg/kg in the rat. Furthermore, compound <b>53</b> showed favorable PK properties in the Wistar rat and Beagle dog, showed acceptable PK behavior in the cynomolgus monkey, and is considered suitable for once daily dosing in humans. High concentrations of <b>53</b> were found in rat brain tissue after oral administration, making this compound an interesting candidate for further studies in particular in CNS related diseases or disorders.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41056" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41056" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Chemistry</h3><div class="NLM_p">All reagents and solvents were used as purchased from commercial sources (Sigma-Aldrich, Switzerland; Lancaster Synthesis GmbH, Germany; Acros Organics, USA). Moisture sensitive reactions were carried out under an argon atmosphere. Progress of the reactions was followed either by thin-layer chromatography (TLC) analysis (Merck, 0.2 mm silica gel 60 F<sub>254</sub> on glass plates) or by LC–MS.</div><div class="NLM_p">LC–MS parameters were the following: Finnigan MSQ plus or MSQ surveyor (Dionex, Switzerland), with HP 1100 binary pump and DAD (Agilent, Switzerland), column Zorbax SB-AQ, 3.5 μm, 120 Å, 4.6 mm × 50 mm (Agilent), gradient 5–95% acetonitrile in water containing 0.04% of trifluoroacetic acid within 1 min, flow of 4.5 mL/min. <i>t</i><sub>R</sub> is given in min. The asterisk (∗) denotes basic conditions: gradient 5–95% acetonitrile in water containing 0.04% of ammonium hydroxide within 1 min, flow of 4.5 mL/min; 40 °C. <i>t</i><sub>R</sub> is given in min. UV detection was at at 230, 254, and 280 nm.</div><div class="NLM_p">Purity of all final compounds was checked by an additional LC–MS analysis on a Waters Acquity UPLC system equipped with an ACQ-PDA detector, an ACQ-ESL detector, and an ACQ-SQ detector: column ACQUITY UPLC BEH C18 1.7 μm, 2.1 mm × 50 mm; gradient 2–98% acetonitrile containing 0.045% formic acid in water containing 0.05% formic acid over 1.8 min; flow of 1.2 mL/min; 60 °C. According to these LC–MS analyses, final compounds showed a purity of >95% (UV at 230 and at 214 nm).</div><div class="NLM_p">Chiral integrity was proven by HPLC (chiral stationary phase). Hardware was from UltiMate instrument series (Dionex): HPG-3200SD binary pump, WPS-3000 autosampler, TCC-3200 thermostated column compartment, DAD-3000 detector, SRD-3400 degasser, ValveMate 2 (Gilson) solvent valves. Column, solvent, and retention time (<i>t</i><sub>R</sub>) are as indicated, DEA = diethylamine, TFA = trifluoroacetic acid, at 25 °C, flow 1 mL/min. No racemization was observed during the synthesis of the target compounds.</div><div class="NLM_p">LC–HRMS parameters were the following: analytical pump Waters Acquity binary, Solvent Manager, MS, SYNAPT G2 MS, source temperature of 150 °C, desolvatation temperature of 400 °C, desolvatation gas flow of 400 L/h; cone gas flow of 10 L/h, extraction cone of 4 RF; lens 0.1 V; sampling cone 30; capillary 1.5 kV; high resolution mode; gain of 1.0, MS function of 0.2 s per scan, 120–1000 amu in full scan, centroid mode. Lock spray: keucine enkephalin, 2 ng/mL (556.2771 Da), scan time of 0.2 s with interval of 10 s and average of 5 scans; DAD: Acquity UPLC PDA detector. Column was an Acquity UPLC BEH C18 1.7 μm, 2.1 mm × 50 mm from Waters, thermostated in the Acquity UPLC column manager at 60 °C. Eluents were the following: water + 0.05% formic acid; B, acetonitrile + 0.05% formic acid. Gradient was 2–98% B over 3.0 min. Flow was 0.6 mL/min. Detection was at UV 214 nm. For MS, <i>t</i><sub>R</sub> is given in min.</div><div class="NLM_p">Purity of all target compounds was assessed using the two independent LC–MS methods described above: (1) a Zorbax SB-AQ, 5 μm, 120 Å, 4.6 mm × 50 mm (Agilent) column, eluting with a gradient of 5–95% acetonitrile in water containing 0.04% of trifluoroacetic acid, within 1 min, flow of 4.5 mL/min; (2) an ACQUITY UPLC BEH C18 1.7 μm, 2.1 mm × 50 mm column, eluting with a gradient of 2–98% acetonitrile containing 0.045% formic acid in water containing 0.05% formic acid over 1.8 min; flow of 1.2 mL/min. In addition, important compounds were analyzed by LC–HRMS as described above. Purity and identity of the target compounds were further corroborated by NMR spectroscopy, and chiral integrity was proven by HPLC using chiral stationary phases. No racemization/epimerization was observed during the synthesis of the target compounds. According to these LC–MS analyses, final compounds showed a purity of ≥95% (UV at 230 and at 214 nm).</div><div class="NLM_p">For NMR spectroscopy, instruments used were the following: Varian Oxford, <sup>1</sup>H (300 MHz) or <sup>13</sup>C (75 MHz); Bruker Avance II, 400 MHz UltraShield, <sup>1</sup>H (400 MHz), <sup>13</sup>C (100 MHz). Chemical shifts are reported in parts per million (ppm) relative to tetramethylsilane (TMS), and multiplicities are given as s (singlet), d (doublet), t (triplet), q (quartet), quint (quintuplet), h (hextet), hept (heptuplet), or m (multiplet). br = broad, and coupling constants are given in Hz. Several compounds have been prepared in a combinatorial library format on a 15–50 mmol scale. For those compounds <sup>1</sup>H NMR spectra were acquired using nondeuterated 10 mM DMSO stock solutions submitted for biological testing.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> The solvent and water signals were suppressed by irradiation at 2.54 and 3.54 ppm, respectively. As a consequence, signal integrals close to those frequencies are not always accurate. The numbers of protons given in the description represent observed values.</div><div class="NLM_p">Compounds were purified by flash column chromatography (CC) on silica gel 60 (Fluka Sigma-Aldrich, Switzerland), by preparative TLC glass plates coated with silica gel 60 F<sub>254</sub> (0.5 mm), by preparative HPLC (Waters XBridge Prep C18, 5 μm, OBD, 19 mm × 50 mm, or Waters X-terra RP18, 19 mm × 50 mm, 5 μm, gradient of acetonitrile in water containing 0.4% of formic acid, flow of 75 mL/min), or by MPLC (Labomatic MD-80-100 pump, linear UVIS-201 detector, column 350 mm × 18 mm, Labogel-RP-18-5s-100, gradient 10% methanol in water to 100% methanol).</div><div class="NLM_p last">clogP values were calculated using an algorithm developed in-house and published online at openmolecules.org.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> In Vitro Potency Assessment</h3><div class="NLM_p">Data (EC<sub>50</sub>) are given as geometric mean values (<i>X</i><sub>geo</sub>) with geometric standard deviation (σ<sub>g</sub>). The upper and lower 95% confidence limits are calculated as X<sub>geo</sub>σ<sub>g</sub><sup>2</sup> and X<sub>geo</sub>/σ<sub>g</sub><sup>2</sup>, respectively (results not shown).</div><div class="NLM_p">GTPγS binding assays were performed in 96-well polypropylene microtiter plates in a final volume of 200 μL. Membrane preparations of CHO cells expressing recombinant human S1P<sub>1</sub> or S1P<sub>3</sub> receptors were used. Assay conditions were 20 mM Hepes, pH 7.4, 100 mM NaCl, 5 mM MgCl<sub>2</sub>, 0.1% fatty acid free BSA, 1 or 3 μM GDP (for S1P<sub>1</sub> or S1P<sub>3</sub>, respectively), 2.5% DMSO, and 50 pM <sup>35</sup>S-GTPγS. Test compounds were dissolved and diluted and preincubated with the membranes, in the absence of <sup>35</sup>S-GTPγS, in 150 μL of assay buffer at room temperature for 30 min. After addition of 50 μL of <sup>35</sup>S-GTPγS in assay buffer, the reaction mixture was incubated for 1 h at room temperature. The assay was terminated by filtration of the reaction mixture through a Multiscreen GF/C plate, prewetted with ice-cold 50 mM Hepes, pH 7.4, 100 mM NaCl, 5 mM MgCl<sub>2</sub>, 0.4% fatty acid free BSA, using a cell harvester. The filter plates were then washed with ice-cold 10 mM Na<sub>2</sub>HPO<sub>4</sub>/NaH<sub>2</sub>PO<sub>4</sub> (70%/30%, w/w) containing 0.1% fatty acid free BSA. Then the plates were dried at 50 °C and sealed, 25 μL of MicroScint20 was added, and membrane-bound <sup>35</sup>S-GTPγS was determined on the TopCount. Specific <sup>35</sup>S-GTPγS binding was determined by subtracting nonspecific binding (the signal obtained in the absence of agonist) from maximal binding (the signal obtained with 10 μM S1P). The EC<sub>50</sub> of a test compound is the concentration of a compound inducing 50% of specific binding.</div><div class="NLM_p">Intrinsic metabolic clearance (CL<sub>int</sub>) was determined by substrate depletion experiments, with a default starting concentration of 1 μM in the presence of 0.5 mg/mL rat liver microsomes (RLM) in 100 mM sodium phosphate buffer at pH 7.4. Incubations were initated by the addition of an NADPH regenerating system containing <span class="smallcaps smallerCapital">d</span>-glucose 6-phosphate, NADPH, and glucose 6-phosphate dehydrogenase. All incubations were conducted by shaking reaction mixtures under air at 37 °C. Aliquots (0.1 mL) were removed at 0, 2.5, 5, 10, and 15 min and terminated by addition to 0.1 mL of methanol on ice. After protein precipitation by centrifugation, the remaining concentrations were analyzed by liquid chromatography coupled to mass spectrometry (LC–MS/MS). CL<sub>int</sub> was calculated from the concentration remaining versus time, fitted to a first order decay constant versus time. <i>K</i><sub>M</sub> values from substrate consumption experiments were determined by plotting the first order decay constants versus the substrate concentration on a linear–log plot and fitting the following equation:<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a><span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/jm-2013-014696_m001.gif" alt="" /></img></span>Male Wistar rats (RccHan:WIST) were obtained from Harlan (Venray, The Netherlands) and used for pharmacokinetic experiments after an acclimatization period of at least 7 days. The body weight of the rats was about 250 g at the day of the experiment. Two days prior to dosing, rats were anesthetized via inhalation of the gas anesthetic isoflurane (4–5% for induction and 1.5–3% for maintenance) in 100% O<sub>2</sub>. Buprenorphine was dosed as analgesic at 0.03 mg/kg sc half an hour before the operation. Catheters were implanted into jugular vein and carotid artery under aseptic conditions to allow for multiple serial blood sampling. Animals foreseen for oral dosing did not undergo surgery, but blood samples were taken sublingually under light anesthesia with isoflurane. Compounds were administered intravenously via the tail vein at doses of 1 mg/kg body weight formulated as solutions in an aqueous mixed micellar vehicle based on phospholipids and bile acids (mixed micelles). Oral administration at doses of 10 mg/kg was performed by gavage. Oral formulations were dispersions prepared by addition of a DMSO stock solution of the compounds to succinylated gelatin (7.5% w/v) in water.</div><div class="NLM_p">For pharmacokinetics in the dog, the pharmacokinetic profile of compound <b>53</b> was determined in the fasted male Beagle dog (<i>n</i> = 2 dogs). The compound was administered iv at a dose of 1 mg/kg as a solution in mixed micelles and orally at a dose of 3 mg/kg as a dispersion in succinylated gelatin (7.5% w/v) in water.</div><div class="NLM_p">For pharmacokinetics in the monkey, the pharmacokinetic profile of compound <b>53</b> was determined in the male cynomolgus monkey (<i>n</i> = 3). The compound was administered iv as a short infusion at a dose of 1 mg/kg as a solution in mixed micelles and orally at a dose of 1 mg/kg as a dispersion in 0.25% methyl cellulose in water with 0.05% Tween 80.</div><div class="NLM_p">For bioanalysis and pharmacokinetics, serial blood samples of 0.25 mL each were taken from each individual animal to obtain a complete concentration vs time profile per animal. Blood samples were taken predose and at 30 min and 1, 2, 3, 4, 6, 8, and 24 h postdose into vials containing EDTA as anticoagulant. For the iv applications, additional samples were obtained 2, 10, and 20 min after dosing. Plasma was prepared from blood samples by centrifugation and stored at −20 °C and analyzed for drug concentrations using LC–MS/MS after protein precipitation. Pharmacokinetic parameters were estimated with the WinNonlin software (Pharsight Corporation, Mountain View, CA, USA) using noncompartmental analysis.</div><div class="NLM_p">For brain penetration in the rat, at 2, 6, and 24 h after dosing, male Wistar rats (<i>n</i> = 2) were anaesthetized with 5% isoflurane and sacrificed by opening the diaphragm. A blood sample was taken. Plasma was prepared, and the brain was slowly perfused with 10 mL of 0.9% NaCl through the carotid. The whole brain was then removed and homogenized in an equal volume of ice-cold 0.1 M Na phosphate buffer, pH 7.4, using a IKA-WERKE Ultra-Turrax T25 tissue homogenizer for 10 s, and the brain homogenate was snap frozen in liquid nitrogen. Drug concentrations were then determined as described for plasma, using a calibration curve from blanco brain homogenate.</div><div class="NLM_p last">The in vivo efficacy of the target compounds was assessed by measuring the circulating lymphocytes after oral administration of 3–100 mg/kg of a target compound to normotensive male Wistar rats. The animals were housed in climate-controlled conditions with a 12 h light/dark cycle and had free access to normal rat chow and drinking water. Blood was collected before and 3, 6, and 24 h after drug administration. Full blood was subjected to hematology using Beckman Coulter Ac·T 5diff CP (Beckman Coulter International SA, Nyon, Switzerland). The effect on lymphocyte count (% LC) was calculated for each animal as the difference between LC at a given time point and the predose value (=100%). All data are presented as the mean ± SEM. Statistical analyses were performed by analysis of variance (ANOVA) using Statistica (StatSoft) and the Student–Newman–Keuls procedure for multiple comparisons. The null hypothesis was rejected when <i>p</i> < 0.05. Because of interindividual variability and the circadian rhythm of the number of circulating lymphocytes, a compound showing relative changes in the range of −20% to +40% is considered inactive. A lymphocyte count (LC) reduction in the range of −60% to −75% represents the maximal effect to be observed under the conditions of the experiment. For formulation, the compounds were dissolved in DMSO. This solution was added to a stirred solution of succinylated gelatin (7.5% w/v) in water. The resulting milky suspension containing a final concentration of 5% of DMSO was administred to the animals by gavage. A mixture of 95% of succinylated gelatin (7.5% w/v) in water and 5% of DMSO served as vehicle.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 6-Isobutyl-5-methylnicotinic Acid (<b>60</b>)</h3><div class="NLM_p">(a) Phosphoroxychloride (183 mL, 2 mol) was heated at 90 °C, and a mixture of commercially available 2-methyl-2-butenenitrile (73 g, 0.9 mol) and DMF (154 mL, 2 mol) was added slowly while keeping the temperature at 100–110 °C. The mixture was stirred at 110 °C for 15 h, cooled to room temperature, and diluted with DCM (500 mL). The mixture was cooled at 0 °C and carefully quenched with water (500 mL). The phases were separated, and the aqueous phase was extracted with DCM (total of 800 mL). The combined organic extracts were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated. The residue was crystallized from cyclohexane to provide 6-chloro-3-formyl-5-methylpyridine <b>89</b><a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> (28.3 g, 20%) as slightly yellow crystals. LC–MS: <i>t</i><sub>R</sub> = 0.76 min, [M + 1]<sup>+</sup> = 156.14. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 10.09 (s, 1 H), 8.78 (s, 1 H), 8.24 (s, 1 H), 2.43 (s, 3 H).</div><div class="NLM_p">(b) A solution of <b>89</b> (10 g, 64 mmol) in formic acid (200 mL) was cooled at 0 °C, and an aqueous 50 wt % solution of H<sub>2</sub>O<sub>2</sub> in water (9.6 mL, 360 mmol) was added at this temperature. The mixture was stirred at 0 °C for 15 h, carefully diluted with water (200 mL), and extracted with DCM (8 × 100 mL). The combined organic extracts were washed with 1 M aqueous HCl (100 mL) (checked for remaining peroxide), dried (MgSO<sub>4</sub>), filtered, and evaporated. The residue was dried to give 6-chloro-5-methylnicotinic acid (9.56 g, 87%). LC–MS: <i>t</i><sub>R</sub> = 0.72 min, [M + 1]<sup>+</sup> = 172.0. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.94 (d, <i>J</i> = 2.0 Hz, 1 H), 8.23 (d, <i>J</i> = 2.3 Hz, 1 H), 2.49 (s, 3 H).</div><div class="NLM_p">(c) A solution of 6-chloro-5-methylnicotinic acid (13.85 g, 80.75 mmol) in dry EtOH (200 mL) containing some drops of concentrated H<sub>2</sub>SO<sub>4</sub> was stirred at reflux for 2 days. The solution was cooled to room temperature, the solvent evaporated, the residue dissolved in EA (200 mL) and washed with a solution of saturated aqueous Na<sub>2</sub>CO<sub>3</sub> (2 × 80 mL), 1 M aqueous KHSO<sub>4</sub> (2 × 80 mL), and brine (50 mL). The organic phase was dried over MgSO<sub>4</sub>, filtered, and evaporated to give 6-chloro-5-methylnicotinic acid ethyl ester <b>90</b> (12.65 g, 79%) as a solid. LC–MS: <i>t</i><sub>R</sub> = 0.92 min, [M + 1]<sup>+</sup> = 200.10. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.43 (t, <i>J</i> = 7.0 Hz, 3 H), 2.46 (s, 3 H), 4.43 (q, <i>J</i> = 7.3 Hz, 2 H), 8.16 (m, 1 H), 8.84 (d, <i>J</i> = 2.0 Hz, 1 H).</div><div class="NLM_p">(d) To a solution of <b>90</b> (4.98 g, 24.9 mmol), 2,4,6-tri(2-methylpropenyl)cyclotriboroxanepyridine complex (5.74 g, 17.7 mmol, prepared in analogy to a procedure given by F. Kerins and D. F. O’Shea<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a>), and PPh<sub>3</sub> (1.15 g, 4.4 mmol) in DME (60 mL), a solution of 2 M aqueous K<sub>2</sub>CO<sub>3</sub> (20 mL) was added. The mixture was degassed and flushed with N<sub>2</sub> before Pd(PPh<sub>3</sub>)<sub>4</sub> (460 mg, 0.4 mmol) was added. The mixture was stirred at 90 °C for 20 h before it was cooled to room temperature, diluted with EA (150 mL), and washed with saturated aqueous NaHCO<sub>3</sub> (2 × 50 mL). The organic extract was dried over MgSO<sub>4</sub>, filtered, and evaporated. The crude product was purified by FC (SiO<sub>2</sub>, heptane–EA) to give 5-methyl-6-(2-methylpropenyl)nicotinic acid ethyl ester (3.98 g, 73%) as an orange oil. LC–MS: <i>t</i><sub>R</sub> = 0.72 min, [M + 1]<sup>+</sup> = 220.15. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.04 (d, <i>J</i> = 1.9 Hz, 1 H), 8.04 (d, <i>J</i> = 1.6 Hz, 1 H), 6.37 (s, 1 H), 4.41 (q, <i>J</i> = 7.1 Hz, 2 H), 2.34 (s, 3 H), 2.008 (s, 3 H), 2.006 (s, 3 H), 1.42 (t, <i>J</i> = 7.1 Hz, 3 H).</div><div class="NLM_p">(e) 5-Methyl-6-(2-methylpropenyl)nicotinic acid ethyl ester (3.98 g, 18.2 mmol) was dissolved in THF (100 mL) and MeOH (100 mL). Pd/C (500 mg, 10% Pd) was added as a slurry in THF (5 mL), and the mixture was stirred under 1 atm of H<sub>2</sub> at room temperature for 15 h. The catalyst was filtered off and the filtrate was evaporated to give 6-isobutyl-5-methylnicotinic acid ethyl ester <b>91</b> (3.76 g, 93%) as a colorless oil. LC–MS: <i>t</i><sub>R</sub> = 0.75 min, [M + 1]<sup>+</sup> = 222.15. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.97 (d, <i>J</i> = 6.8 Hz, 6 H), 1.42 (t, <i>J</i> = 7.3 Hz, 3 H), 2.20 (hept, <i>J</i> = 6.8 Hz, 1H), 2.38 (s, 3 H), 2.75 (d, <i>J</i> = 7.0 Hz, 2 H), 4.41 (q, <i>J</i> = 7.3 Hz, 2 H), 8.03 (d, <i>J</i> = 1.8 Hz, 1 H), 9.00 (d, <i>J</i> = 2.0 Hz, 1 H).</div><div class="NLM_p last">(f) A solution of <b>91</b> (3.75 g, 16.95 mmol) in 12.5% aqueous HCl (50 mL) was stirred at 65 °C for 24 h before the solvent was evaporated. The residue was dried under high vacuum to give 6-isobutyl-5-methylnicotinic acid hydrochloride <b>60</b> (3.55 g, 91%) as a white powder. LC–MS: <i>t</i><sub>R</sub> = 0.57 min, [M + 1]<sup>+</sup> = 194.25. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.23 (s, 1 H), 8.77 (s, 1 H), 3.17 (d, <i>J</i> = 7.5 Hz, 2 H), 2.62 (s, 3 H), 2.35 (hept, <i>J</i> = 6.3 Hz, 1 H), 1.09 (d, <i>J</i> = 6.6 Hz, 6 H).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 6-Cyclopentyl-5-methylnicotinic Acid (<b>61</b>)</h3><div class="NLM_p">(a) A solution of 5,6-dichloronicotinic acid (50 g, 260 mmol) and TMSCl (8.49 g, 781 mmol) in isopropanol (500 mL) was stirred at 60 °C for 18 h. The mixture was concentrated, and the residue was partitioned between EA and saturated aqueous NaHCO<sub>3</sub> solution. The organic extract was separated, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified on silica gel, eluting with heptane/EA 9:1 to give 5,6-dichloronicotinic acid isopropyl ester <b>92</b> (56.2 g, 92%) as a white solid. LC–MS: <i>t</i><sub>R</sub> = 1.01 min, [M + 1]<sup>+</sup> = 233.89. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.85 (d, <i>J</i> = 2.0 Hz, 1 H), 8.49 (d, <i>J</i> = 2.0 Hz, 1 H), 5.18 (hept, <i>J</i> = 6.3 Hz, 1 H), 1.35 (d, <i>J</i> = 6.3 Hz, 6 H).</div><div class="NLM_p">(b) To a solution of <b>92</b> (2.15 g, 9.19 mmol) in THF (30 mL) were added NMP (3 mL) and Fe(acac)<sub>3</sub> (162 mg, 0.459 mmol). The mixture was cooled to 0 °C before cyclopentylmagnesium bromide (9.2 mL of 2 M solution in diethyl ether) was added. The dark red to black reaction mixture was stirred at 0 °C for 1 h, then at room temperature for 18 h. The reaction was quenched carefully by adding water (30 mL), then extracted twice with EA (2 × 60 mL). The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by CC on silica gel, eluting with heptane/EA 9:1 to give isopropyl 5-chloro-6-cyclopentylnicotinate <b>93</b> (1.93 g, 78%) which was still contaminated with 5,6-dichloronicotinic acid isopropyl ester as a pale yellow oil. LC–MS: <i>t</i><sub>R</sub> = 0.87 min, [M + 1]<sup>+</sup> = 268.2. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.95 (d, <i>J</i> = 1.8 Hz, 1 H), 8.21 (d, <i>J</i> = 1.9 Hz, 1 H), 5.16 (hept, <i>J</i> = 6.3 Hz, 1 H), 3.66 (quint, <i>J</i> = 7.8 Hz, 1 H), 1.95–2.05 (m, 2 H), 1.74–1.88 (m, 4 H), 1.59–1.73 (m, 2 H), 1.34 (d, <i>J</i> = 6.2 Hz, 6 H).</div><div class="NLM_p">(c) To a solution of the above <b>93</b> (1.93 g, 7.21 mmol) and Pd(dppf)Cl<sub>2</sub> (60 mg, 74 μmol) in dioxane (30 mL) was added dimethylzinc (13.3 mL of a 1.2 M solution in toluene). The mixture was stirred at 75 °C for 18 h before the reaction was quenched at room temperature by carefully adding water (50 mL). The mixture was extracted twice with EA (2 × 100 mL). The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by CC on silica gel, eluting with heptane/EA 9:1 to give isopropyl 6-cyclopentyl-5-methylnicotinate <b>94</b> (600 mg, 36%, containing the corresponding methyl ester as impurity) as a pale yellow oil. LC–MS: <i>t</i><sub>R</sub> = 0.61 min, [M + 1]<sup>+</sup> = 248.31. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.01 (s, 1 H), 7.99 (s, 1 H), 5.27 (hept, <i>J</i> = 6.5 Hz, 1 H), 3.40 (quint, <i>J</i> = 7.5 Hz, 1 H), 2.41 (s, 3 H), 1.95–2.07 (m, 2 H), 1.83–1.95 (m, 4 H), 1.65–1.78 (m, 2 H), 1.38 (d, <i>J</i> = 6.2 Hz, 6 H).</div><div class="NLM_p last">(d) A solution of the above <b>94</b> (600 mg, 2.43 mmol) in MeOH (8 mL) and 2 M aqueous LiOH (2 mL) was stirred at room temperature for 2 h. The mixture was concentrated, diluted with water (15 mL) and EA (40 mL), and then neutralized by adding 2 N aqueous HCl (approximately 2 mL). The organic phase was separated, and the aqueous phase was extracted three more times with EA (3 × 40 mL). The organic extracts were combined, dried over MgSO<sub>4</sub>, filtered, concentrated, and dried to give the title compound (412 mg, 83%) as a pale yellow oil. LC–MS: <i>t</i><sub>R</sub> = 0.35 min, [M + 1]<sup>+</sup> = 206.39. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.14 (s, 1 H), 8.13 (s, 1 H), 3.45 (quint, <i>J</i> = 7.3 Hz, 1 H), 2.46 (s, 3 H), 2.01–2.11 (m, 2 H), 1.87–2.01 (m, 4 H), 1.64–1.84 (m, 2 H).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 5-Cyclopentyl-4-methylpicolinic Acid (<b>68</b>)</h3><div class="NLM_p">(a) Under argon, Pd(dppf)Cl<sub>2</sub> (161 mg, 0.198 mmol) and cyclopentylzinc bromide (39 mL of a 0.5 M solution in THF) were added to a solution of ethyl 5-bromo-4-methylpicolinate <b>107</b> (4.73 g, 19.4 mmol) in dioxane (250 mL). The mixture was stirred at 65 °C for 2 h before another portion of Pd(dppf)Cl<sub>2</sub> (161 mg, 0.198 mmol) and cyclopentylzinc bromide (19.5 mL) was added. Stirring was continued at 65 °C for 18 h. The mixture was cooled to room temperature before the reaction was quenched by carefully adding water (200 mL) and saturated aqueous NaHCO<sub>3</sub> solution (150 mL). The mixture was extracted six times with EA (6 × 100 mL) and DCM (100 mL). The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated to give crude ethyl 5-cyclopentyl-4-methylpicolinate <b>113</b> (3.96 g) as an orange oil containing about 10% of the corresponding cyclopentyl ester. LC–MS: <i>t</i><sub>R</sub> = 0.85 min, [M + 1]<sup>+</sup> = 234.05. Cyclopentyl ester, LC–MS: <i>t</i><sub>R</sub> = 0.95 min, [M + 1]<sup>+</sup> = 274.06.</div><div class="NLM_p last">(b) A solution of <b>113</b> (3.96 g, 17.0 mmol) in dioxane (2 mL) and 2 M aqueous LiOH (50 mL) was stirred at 75 °C for 5 h. The mixture was cooled to room temperature before it was extracted with EA. The aqueous phase was acidified by adding 1 N HCl and then extracted with EA. The second organic extract was dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by MPLC (ODS-AQ), eluting with a gradient of methanol in water to give <b>68</b> (532 mg, 15%) as a beige solid. LC–MS: <i>t</i><sub>R</sub> = 0.37 min, [M + 1]<sup>+</sup> = 206.31. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.52 (s, 1 H), 7.92 (s, 1 H), 3.21–3.31 (m, 1 H), 2.44 (s, 3 H), 1.99–2.11 (m, 2 H), 1.75–1.88 (m, 2 H), 1.56–1.75 (m, 4 H).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-Methyl-6-(pentan-3-yl)isonicotinic Acid (<b>76d</b>)</h3><div class="NLM_p">(a) To a suspension of 2-chloro-6-methylisonicotinic acid (20.0 g, 117 mmol) in isopropanol (80 mL) was added H<sub>2</sub>SO<sub>4</sub> (5 mL) dropwise. The mixture became warm (40 °C). The mixture was stirred for 24 h at room temperature, then at 90 °C for 28 h before the solvent was removed in vacuo. The residue was dissolved in diethyl ether (200 mL), washed with saturated aqueous NaHCO<sub>3</sub> solution (3 × 50 mL) followed by brine (3 × 50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give 2-chloro-6-methylisonicotinic acid isopropyl ester (21.0 g) as a colorless oil which slowly crystallizes. LC–MS: <i>t</i><sub>R</sub> = 0.97 min, [M + 1]<sup>+</sup> = 214.05. <sup>1</sup>H NMR (CD<sub>3</sub>OD). δ 7.64 (s, 1 H), 7.61 (s, 1 H), 5.21 (hept, <i>J</i> = 6.2 Hz, 1 H), 2.54 (s, 3 H), 1.37 (d, <i>J</i> = 6.3 Hz, 6 H).</div><div class="NLM_p">(b) A solution of 2-chloro-6-methylisonicotinic acid isopropyl ester (2.0 g, 9.36 mmol) in dioxane (75 mL) was degassed and put under argon before Pd(dppf)Cl<sub>2</sub> (229 mg, 0.281 mmol) was added. At room temperature, a 0.5 M solution of 1-ethylpropylzinc bromide in THF (46.8 mL, 23.4 mmol) was added dropwise to the mixture. The mixture was stirred at 80 °C for 16 h before the reaction was quenched by adding ice-cold water (200 mL). A precipitate forms, and the mixture was diluted with EA (200 mL) and filtered through Celite. The filtrate was transferred into a separatory funnel. The organic phase was collected, and the aqueous phase was extracted with EA (120 mL). The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by CC on silica gel, eluting with heptane/EA 9:1 to 4:1 to give isopropyl 2-(1-ethylpropyl)-6-methylisonicotinate <b>130d</b> (1.6 g, 69%) as a yellow oil containing a few percent of isopropyl 2-methyl-6-(pentan-2-yl)isonicotinate. LC–MS: <i>t</i><sub>R</sub> = 0.79 min, [M + 1]<sup>+</sup> = 250.14. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 0.70 (t, <i>J</i> = 7.3 Hz, 6 H), 1.33 (d, <i>J</i> = 6.3 Hz, 6 H), 1.58–1.70 (m, 4 H), 2.51 (s, 3 H), 2.55–2.63 (m, 1 H), 5.15 (hept, <i>J</i> = 5.8 Hz), 7.39 (s, 1 H), 7.49 (s, 1 H).</div><div class="NLM_p last">(c) A solution of <b>130d</b> (1.54 g, 6.18 mmol) in 25% aqueous HCl (60 mL) was stirred at 65 °C for 16 h. The solvent was removed in vacuo and the residue was dissolved in dioxane and concentrated again to give 2-(1-ethyl-propyl)-6-methylisonicotinic acid <b>76d</b> as hydrochloride salt (1.70 g) in the form of a brownish solid. LC–MS: <i>t</i><sub>R</sub> = 0.62 min, [M + 1]<sup>+</sup> = 208.52. <sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 8.23 (s, 1 H), 8.19 (s, 1 H), 3.00 (d, <i>J</i> = 7.4 Hz, 2 H), 2.88 (s, 3 H), 2.10–2.25 (m, 1 H), 1.05 (d, <i>J</i> = 6.6 Hz, 6 H).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-Cyclopentyl-6-methylisonicotinic Acid (<b>76f</b>)</h3><div class="NLM_p">(a) Under argon, Pd(dppf)Cl<sub>2</sub> (200 mg, 0.245 mmol) was added to a solution of 2-chloro-6-methylisonicotinic acid ethyl ester <b>129</b> (4.80 g, 24.0 mmol) in dioxane (60 mL). A solution of cyclopentylzinc chloride (50 mL, 24.0 mmol, ∼2 M solution in THF) was added dropwise. The mixture was stirred at 75 °C for 2 h before it was cooled to room temperature, carefully diluted with water, and extracted twice with EA. The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by CC on silica gel, eluting with heptane/EA 9:1 to give 2-cyclopentyl-6-methylisonicotinic acid ethyl ester <b>130f</b> (3.96 g, 71%) as an oil. LC–MS: <i>t</i><sub>R</sub> = 0.72 min, [M + 1]<sup>+</sup> = 234.11. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.56 (s, 1 H), 7.52 (s, 1 H), 4.42 (q, <i>J</i> = 7.1 Hz, 2 H), 3.18–3.29 (m, 1 H), 2.61 (s, 3 H), 2.06–2.18 (m, 2 H), 1.66–1.93 (m, 6 H), 1.43 (t, <i>J</i> = 7.1 Hz, 3 H).</div><div class="NLM_p last">(b) A solution of <b>130f</b> (3.96 g, 17.0 mmol) in 25% aqueous HCl (50 mL) was stirred at 75 °C for 16 h. The solvent was removed in vacuo and the remaining residue was dried under high vacuum to give <b>76f</b> as a hydrochloride salt (4.12 g, quantitative) in the form of a white solid. LC–MS: <i>t</i><sub>R</sub> = 0.54 min, [M + 1]<sup>+</sup> = 206.08. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.90 (s, 1 H), 7.85 (s, 1 H), 3.79 (s br, 2 H), 3.41–3.53 (m, 1 H), 2.73 (s, 3 H), 2.07–2.17 (m, 2 H), 1.63–1.89 (m, 6 H).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2-Cyclopentyl-6-ethylisonicotinic Acid (<b>77c</b>)</h3><div class="NLM_p last">The title compound (7.19 g) was prepared in analogy to <b>77a</b> (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). LC–MS: <i>t</i><sub>R</sub> = 0.59 min, [M + 1]<sup>+</sup> = 220.00. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.85 (s, 1 H), 7.83 (s, 1 H), 3.47–3.57 (m, 1 H), 3.02 (q, <i>J</i> = 7.5 Hz, 2 H), 2.06–2.16 (m, 2 H), 1.71–1.88 (m, 4 H), 1.64–1.71 (m, 2 H), 1.29 (t, <i>J</i> = 7.5 Hz, 3 H).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2-(Diethylamino)-6-methylisonicotinic Acid (<b>79</b>)</h3><div class="NLM_p">(a) A mixture of <i>tert</i>-butyl 2,6-dichloroisonicotinate <b>136</b> (11.3 g, 45.4 mmol) and diethylamine (3.32 g, 45.4 mmol) was stirred at 100 °C for 72 h in a sealed vessel. The mixture was cooled to room temperature, diluted with water (50 mL), and extracted three times with EA (3 × 100 mL). The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by CC on silica gel, eluting with heptane/EA 9:1 to give <i>tert</i>-butyl 2-chloro-6-(diethylamino)isonicotinate <b>137</b> (13.3 g, quantitative) as a pale yellow oil. LC–MS: <i>t</i><sub>R</sub> = 1.15 min, [M + 1]<sup>+</sup> = 285.05. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 6.88 (d, <i>J</i> = 0.9 Hz, 1 H), 6.80 (d, <i>J</i> = 0.8 Hz, 1 H), 3.50 (q, <i>J</i> = 7.0 Hz, 4 H), 1.54 (s, 9 H), 1.11 (t, <i>J</i> = 7.0 Hz, 6 H).</div><div class="NLM_p">(b) To solution of <b>137</b> (6.70 g, 23.5 mmol) and Pd(dppf)Cl<sub>2</sub> (196 mg, 240 μmol) in dioxane (50 mL) under argon was added dimethylzinc (70.6 mL, 1 M solution in THF). The mixture was stirred at 75 °C for 16 h before it was cooled to room temperature. The reaction was quenched by carefully adding water. The mixture was extracted twice with EA. The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by CC on silica gel, eluting with heptane/EA to give <i>tert</i>-butyl 2-(diethylamino)-6-methylisonicotinate <b>138</b> (2.54 g, 41%) as a yellow oil. LC–MS: <i>t</i><sub>R</sub> = 0.81 min, [M + 1]<sup>+</sup> = 265.09.</div><div class="NLM_p last">(c) A solution of <b>138</b> (2.53 g, 9.57 mmol) in 25% aqueous HCl (50 mL) was stirred at 80 °C for 24 h. The mixture was concentrated and dried under high vacuum to give the hydrochloride salt of <b>79</b> (2.45 g, quantitative) as a yellow oil. LC–MS: <i>t</i><sub>R</sub> = 0.48 min, [M + 1]<sup>+</sup> = 209.42. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.17 (s, 1 H), 6.97 (s, 1 H), 3.70 (q br, <i>J</i> = 7.0 Hz, 2 H), 2.56 (s, 3 H), 1.17 (t, <i>J</i> = 6.8 Hz, 6 H).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-((<i>S</i>)-3-[2-Ethyl-4-(<i>N</i>-hydroxycarbamimidoyl)-6-methylphenoxy]-2-hydroxypropyl)-2-hydroxyacetamide (<b>80</b>)</h3><div class="NLM_p">(a) To an ice-cold solution of H<sub>2</sub>SO<sub>4</sub> (150 mL) in water (250 mL) was added 2-ethyl-6-methylaniline (15.0 g, 111 mmol). The solution was treated with ice (150 g) before a solution of NaNO<sub>2</sub> (10.7 g, 155 mmol) in water (150 mL) and ice (50 g) was added dropwise. The mixture was stirred at 0 °C for 1 h. Then 50% aqueous H<sub>2</sub>SO<sub>4</sub> (200 mL) was added and stirring was continued at room temperature for 18 h. The mixture was extracted with DCM. The organic extracts were dried over MgSO<sub>4</sub> and evaporated. The crude product was purified by CC on silica gel, eluting with heptane/EA 9:1 to give 2-ethyl-6-methylphenol <b>81</b> (8.6 g, 57%) as a crimson oil. LC–MS: <i>t</i><sub>R</sub> = 0.89 min. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.03–6.95 (m, 2 H), 6.80 (t, <i>J</i> = 7.6 Hz, 1 H), 4.60 (s, 1 H), 2.64 (q, <i>J</i> = 7.6 Hz, 2 H), 2.25 (s, 3 H), 1.24 (t, <i>J</i> = 7.6 Hz, 3 H).</div><div class="NLM_p">(b) A solution of 2-ethyl-6-methylphenol <b>81</b> (200 g, 1.47 mol) and hexamethylenetetraamine (206 g, 1.47 mol) in acetic acid (1600 mL) and water (264 mL) was heated to reflux. The condensate was removed using a Dean–Stark apparatus until about 1200 mL of condensate was collected. The reaction mixture was cooled to room temperature, and water (1000 mL) was added. The thick suspension was filtered and the collected solid was dried at 60 °C under vacuum (10 mbar) to give 3-ethyl-4-hydroxy-5-methylbenzaldehyde <b>82</b> (191 g, 79%) as an orange solid. LC–MS: <i>t</i><sub>R</sub> = 0.86 min, [M + 1 + CH<sub>3</sub>CN]<sup>+</sup> = 206.27. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.84 (s, 1 H), 7.59 (s, 1 H), 7.57 (s, 1 H), 4.64 (s br, 1 H), 2.71 (q, <i>J</i> = 7.5 Hz, 2 H), 2.34 (s, 3 H), 1.30 (t, <i>J</i> = 7.5 Hz, 3 H).</div><div class="NLM_p">(c) A solution of <b>82</b> (5.32 g, 32.4 mmol) and hydroxylamine hydrochloride (3.38 g, 48.6 mmol) in NMP (35 mL) was stirred for 3 h at 80 °C under microwave irradiation (300 W, continuous cooling).<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> The mixture was diluted with water and extracted twice with diethyl ether. The organic extracts were washed with 2 N aqueous HCl, saturated aqueous NaHCO<sub>3</sub> solution, and brine. The organic extracts were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was purified by CC on silica gel, eluting with heptane/EA 3:2 to give 3-ethyl-4-hydroxy-5-methylbenzonitrile <b>83</b> as a pale yellow solid (4.80 g, 92%). LC–MS: <i>t</i><sub>R</sub> = 0.90 min. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.24 (t, <i>J</i> = 7.6 Hz, 3 H), 2.26 (s, 3 H), 2.63 (q, <i>J</i> = 7.6 Hz, 2 H), 5.19 (s, 1 H), 7.30 (s, 2 H).</div><div class="NLM_p">(d) To a solution of <b>83</b> (5.06 g, 31.4 mmol) in THF (80 mL) were added PPh<sub>3</sub> (9.06 g, 34.5 mmol) and (<i>R</i>)-glycidol (2.29 mL, 34.5 mmol). The mixture was cooled to 0 °C before DEAD in toluene (15.8 mL, 34.5 mmol) was added. The mixture was stirred for 18 h while warming up to room temperature. The solvent was evaporated and the crude product was purified by CC on silica gel, eluting with heptane/EA 7:3 to give (<i>S</i>)-3-ethyl-5-methyl-4-(oxiran-2-ylmethoxy)benzonitrile <b>84</b> (5.85 g, 86%) as a yellow oil. LC–MS: <i>t</i><sub>R</sub> = 0.96 min, [M + 42]<sup>+</sup> = 259.08. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.38 (s, 1 H), 7.35 (s, 1 H), 4.12–4.19 (m, 1 H), 3.73–3.80 (m, 1 H), 3.36–3.42 (m, 1 H), 2.90–2.96 (m, 1 H), 2.68–2.77 (m, 3 H), 2.34 (s, 3 H), 1.26 (t, <i>J</i> = 7.6 Hz, 3 H).</div><div class="NLM_p">(e) The above epoxide <b>84</b> (5.85 g, 26.9 mmol) was dissolved in 7 N NH<sub>3</sub> in methanol (250 mL), and the solution was stirred at 65 °C for 18 h. The solvent was evaporated to give crude (<i>S</i>)-4-(3-amino-2-hydroxypropoxy)-3-ethyl-5-methylbenzonitrile <b>85</b> (6.23 g, quantitative) as a yellow oil. LC–MS: <i>t</i><sub>R</sub> = 0.66 min, [M + 1]<sup>+</sup> = 235.11. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.54 (s, 2 H), 4.96 (s br, 1 H), 3.77–3.83 (m, 1 H), 3.68–3.77 (m, 2 H), 2.59–2.75 (m, 4 H), 2.28 (s, 3 H), 1.58 (s br, 2 H), 1.17 (t, <i>J</i> = 7.5 Hz, 3 H).</div><div class="NLM_p">(f) To a solution <b>85</b> (6.23 g, 26.6 mmol) were added glycolic acid (2.43 g, 31.9 mmol), HOBt (4.31 g, 31.9 mmol), and EDC hydrochloride (6.12 g, 31.9 mmol). The mixture was stirred at room temperature for 18 h before it was diluted with saturated aqueous NaHCO<sub>3</sub> and extracted twice with EA. The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by CC with DCM containing 8% of methanol to give (<i>S</i>)-<i>N</i>-[3-(4-cyano-2-ethyl-6-methylphenoxy)-2-hydroxypropyl]-2-hydroxyacetamide <b>86</b> (7.03 g, 90%) as a yellow oil. LC–MS: <i>t</i><sub>R</sub> = 0.74 min, [M + 1]<sup>+</sup> = 293.10. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.25 (t, <i>J</i> = 7.5 Hz, 3 H), 2.32 (s, 3 H), 2.69 (q, <i>J</i> = 7.5 Hz, 2 H), 3.48–3.56 (m, 3 H), 3.70–3.90 (m, 3 H), 4.19 (s, br, 3 H), 7.06 (m, 1 H), 7.36 (s, 1 H), 7.38 (s, 1 H).</div><div class="NLM_p last">(g) To a solution of <b>86</b> (19.6 g, 67 mmol) in methanol (500 mL) were added hydroxylamine hydrochloride (9.32 g, 134 mmol) and NaHCO<sub>3</sub> (11.3 g, 134 mmol).<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> The resulting suspension was stirred at 65 °C for 18 h. The mixture was filtered, and the filtrate was concentrated. The residue was dissolved in water (20 mL) and EA (300 mL). The aqueous phase was separated and extracted three times with EA. The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, concentrated, and dried to give the title compound <b>80</b> as a white solid (18.9 g, 87%). LC–MS: <i>t</i><sub>R</sub> = 0.51 min, [M + 1]<sup>+</sup> = 326.13. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.17 (t, <i>J</i> = 7.4 Hz, 3 H), 2.24 (s, 3H), 2.62 (q, <i>J</i> = 7.4 Hz, 2 H), 3.23 (m, 1 H), 3.43 (m, 1 H), 3.67 (m, 2 H), 3.83 (s, 2 H), 3.93 (m, 1 H), 5.27 (s br, 1 H), 5.58 (s br, 1 H), 5.70 (s, 2 H), 7.34 (s, 1 H), 7.36 (s, 1 H), 7.67 (m, 1 H), 9.46 (s br, 1H).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Method A: (<i>S</i>)-<i>N</i>-(3-(4-(5-(2-Cyclopentyl-6-ethylpyridin-4-yl)-1,2,4-oxadiazol-3-yl)-2-ethyl-6-methylphenoxy)-2-hydroxypropyl)-2-hydroxyacetamide (<b>50</b>)</h3><div class="NLM_p last">To a solution of 2-cyclopentyl-6-ethylisonicotinic acid hydrochloride <b>77c</b> (187 mg, 0.73 mmol) in DMF (20 mL) was added Hünig’s base (284 mg, 2.19 mmol) followed by TBTU (210 mg, 0.65 mmol). The mixture was stirred at room temperature for 10 min before <i>N</i>-((<i>S</i>)-3-[2-ethyl-4-(<i>N</i>-hydroxycarbamimidoyl)-6-methylphenoxy]-2-hydroxypropyl)-2-hydroxyacetamide <b>80</b> (251 mg, 0.77 mmol) was added. Stirring was continued at room temperature for 2 h. The mixture was diluted with EA (100 mL) and washed three times with saturated NaHCO<sub>3</sub> solution (2 × 30 mL). The organic extract was concentrated, and the residue was dissolved in dioxane (20 mL). The mixture was stirred at 100 °C for 16 h before it was concentrated. The crude product was purified on preparative HPLC (Waters XBridge, gradient of MeCN in water containing 0.5% NH<sub>3</sub>) to give <b>53</b> (281 mg, 76%) as beige wax. LC–MS: <i>t</i><sub>R</sub> = 0.66 min, [M + 1]<sup>+</sup> = 509.28. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.87 (s, 1 H), 7.86 (s, 1 H), 7.76 (s, 1 H), 7.73 (s, 1 H), 7.21 (t, <i>J</i> = 5.9 Hz, 1 H), 4.18–4.25 (m, 3 H), 3.82–3.93 (m, 2 H), 3.74–3.82 (m, 2 H), 3.60 (s br, 1 H), 3.49–3.58 (m, 1 H), 3.27–3.39 (m, 1 H), 2.95 (q, <i>J</i> = 7.5 Hz, 2 H), 2.75 (q, <i>J</i> = 7.5 Hz, 2 H), 2.39 (s, 3 H), 2.13–2.21 (m, 2 H), 1.73–1.95 (m, 6 H), 1.39 (t, <i>J</i> = 7.6 Hz, 3 H), 1.32 (t, <i>J</i> = 7.5 Hz, 3 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 174.5, 174.0, 168.8, 166.9, 164.3, 157.3, 137.6, 131.60, 131.55, 128.3, 126.6, 122.5, 116.8, 116.2, 74.2, 69.9, 62.1, 48.1, 42.3, 33.6, 31.4, 25.8, 22.8, 16.4, 14.8, 13.8. LC–HRMS: <i>t</i><sub>R</sub> = 2.21 min, [M + H]/<i>z</i> = 509.2764, found = 509.2762.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Method B: <i>N</i>-((<i>S</i>)-3-{4-[5-(2-Diethylamino-6-methylpyridin-4-yl)[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methylphenoxy}-2-hydroxypropyl)-2-hydroxyacetamide (<b>53</b>)</h3><div class="NLM_p">For an alternative, large scale synthesis, see Schmidt et al.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> (a) A solution of 2-(diethylamino)-6-methylisonicotinic acid hydrochloride <b>79</b> (6.96 g, 28.4 mmol), Hünig’s base (11.0 g, 85.3 mmol), and TBTU (9.13 g, 28.4 mmol) in DCM (100 mL) was stirred at room temperature for 10 min before 3-ethyl-<i>N</i>,4-dihydroxy-5-methylbenzimidamide (5.52 g, 28.4 mmol) was added. Stirring was continued at room temperature for 1 h. The mixture was diluted with DCM, washed with saturated aqueous NaHCO<sub>3</sub> solution, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was dissolved in dioxane (100 mL), and the mixture was stirred at 100 °C for 18 h. The solvent was evaporated and the crude product was purified by CC on silica gel, eluting with heptane/EA 5:1 to give 4-(5-(2-(diethylamino)-6-methylpyridin-4-yl)-1,2,4-oxadiazol-3-yl)-2-ethyl-6-methylphenol (6.40 g, 61%) as a yellow solid. LC–MS: <i>t</i><sub>R</sub> = 0.90 min, [M + 1]<sup>+</sup> = 367.16. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ: 7.85 (s, 2 H), 7.10 (s, 1 H), 7.01 (s, 1 H), 4.98 (s, 1 H), 3.63 (q, <i>J</i> = 7.0 Hz, 4 H), 2.73 (q, <i>J</i> = 7.4 Hz, 2 H), 2.49 (s, 3 H), 2.36 (s, 3 H), 1.33 (t, <i>J</i> = 7.5 Hz, 3 H), 1.25 (t, <i>J</i> = 6.9 Hz, 6 H).</div><div class="NLM_p">(b) To a solution of 4-(5-(2-(diethylamino)-6-methylpyridin-4-yl)-1,2,4-oxadiazol-3-yl)-2-ethyl-6-methylphenol (580 mg, 1.58 mmol) in isopropanol (15 mL) and 3 M aqueous NaOH (3 mL) was added (<i>R</i>)-epichlorohydrine (439 mg, 4.75 mmol), and the mixture was stirred at room temperature for 24 h before another portion of (<i>R</i>)-epichlorohydrine (439 mg, 4.75 mmol) was added. Stirring was continued for 24 h. The mixture was diluted with EA (100 mL) and washed with saturated aqueous NaHCO<sub>3</sub> solution. The organic extract was dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by CC on silica gel using heptane/EA 4:1 to give (<i>S</i>)-<i>N</i>,<i>N</i>-diethyl-4-(3-(3-ethyl-5-methyl-4-(oxiran-2-ylmethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-6-methylpyridin-2-amine (450 mg, 67%) as a yellow oil. LC–MS: <i>t</i><sub>R</sub> = 0.94 min, [M + 1]<sup>+</sup> = 423.19. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.88 (s, 1 H), 7.87 (s, 1 H), 7.10 (s, 1 H), 7.01 (s, 1 H), 4.18–4.27 (m, 1 H), 3.92 (d, <i>J</i> = 5.2 Hz, 2 H), 3.58–3.70 (m, 6 H), 2.77 (q, <i>J</i> = 7.6 Hz, 2 H), 2.50 (s, 3 H), 2.41 (s, 3 H), 1.33 (t, <i>J</i> = 7.5 Hz, 3 H), 1.25 (t, <i>J</i> = 7.0 Hz, 6 H).</div><div class="NLM_p">(c) A solution of (<i>S</i>)-<i>N</i>,<i>N</i>-diethyl-4-(3-(3-ethyl-5-methyl-4-(oxiran-2-ylmethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-6-methylpyridin-2-amine (5.70 g, 13.5 mmol) in 7 M NH<sub>3</sub> in MeOH (100 mL) was stirred in a sealed vessel at 60 °C for 24 h. The mixture was concentrated and the crude product was purified by CC on silica gel, eluting with DCM/MeOH 10:1 containing a small amount of 7 M NH<sub>3</sub> in MeOH to give (<i>S</i>)-1-amino-3-(4-(5-(2-(diethylamino)-6-methylpyridin-4-yl)-1,2,4-oxadiazol-3-yl)-2-ethyl-6-methylphenoxy)propan-2-ol (2.33 g, 39%) as a yellow oil. LC–MS: <i>t</i><sub>R</sub> = 0.70 min, [M + 1]<sup>+</sup> = 440.25. <sup>1</sup>H NMR δ: 7.88 (s, 1 H), 7.87 (s, 1 H), 7.10 (s, 1 H), 7.00 (s, 1 H), 3.97–4.05 (m, 1 H), 3.85–3.93 (m, 2 H), 3.62 (q, <i>J</i> = 7.0 Hz, 4 H), 3.23 (s, 1 H), 3.03 (dd, <i>J</i><sub>1</sub> = 12.8 Hz, <i>J</i><sub>2</sub> = 3.8 Hz, 1 H), 2.93 (dd, <i>J</i><sub>1</sub> = 12.8 Hz, <i>J</i><sub>2</sub> = 7.0 Hz, 1 H), 2.77 (q, <i>J</i> = 7.5 Hz, 2 H), 2.49 (s, 3 H), 2.40 (s, 3 H), 1.32 (t, <i>J</i> = 7.5 Hz, 3 H), 1.24 (t, <i>J</i> = 7.0 Hz, 6 H).</div><div class="NLM_p last">(d) To a solution of (<i>S</i>)-1-amino-3-(4-(5-(2-(diethylamino)-6-methylpyridin-4-yl)-1,2,4-oxadiazol-3-yl)-2-ethyl-6-methylphenoxy)propan-2-ol (2.33 g, 5.30 mmol) in DCM (25 mL) were added glycolic acid (443 mg, 5.83 mmol) and HOBt (788 mg, 5.83 mmol). The mixture was stirred for 10 min before EDC·HCl (1.12 g, 5.83 mmol) was added. The mixture was stirred at room temperature for 1 h before it was diluted with water and brine. The mixture was extracted twice with EA. The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by CC on silica gel, eluting with DCM/MeOH 10:1 to give <b>56</b> (2.20 g, 83%) as a yellow foam. LC–MS: <i>t</i><sub>R</sub> = 0.78 min, [M + 1]<sup>+</sup> = 498.22. HPLC with chiral stationary phase (Chiralpak AD-H 250 mm × 4.6 mm i.d., 5 μm; 85% hexane, 15% ethanol containing 0.1% DEA): <i>t</i><sub>R</sub> = 12.3 min, 100% ((<i>R</i>)-enantiomer, <i>t</i><sub>R</sub> = 10.2 min). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 7.79 (s, 2 H), 7.70 (t, <i>J</i> = 5.5 Hz, 1 H), 7.07 (s, 1 H), 6.99 (s, 1 H), 5.56 (t, <i>J</i> = 5.5 Hz, 1 H), 5.31 (d, <i>J</i> = 5.1 Hz, 1 H), 3.93–4.00 (m, 1 H), 3.84 (d, <i>J</i> = 5.2 Hz, 2 H), 3.70–3.81 (m, 2 H), 3.58 (q, <i>J</i> = 6.5 Hz, 4 H), 3.39–3.48 (m, 1 H), 3.20–3.29 (m, 1 H), 2.73 (q, <i>J</i> = 7.3 Hz, 2 H), 2.43 (s, 3 H), 2.35 (s, 3 H), 1.22 (t, <i>J</i> = 7.5 Hz, 3 H), 1.16 (t, <i>J</i> = 6.9 Hz, 6 H). LC-HRMS: <i>t</i><sub>R</sub> = 1.86 min, [M + H]/<i>z</i> = 498.2716, found = 498.2717.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-((<i>S</i>)-3-{2-Ethyl-4-[5-(6-isobutyl-5-methylpyridin-3-yl)[1,2,4]oxadiazol-3-yl]-6-methylphenoxy}-2-hydroxypropyl)-2-hydroxyacetamide (<b>8</b>)</h3><div class="NLM_p last"><b>8</b> was obtained with method A, using nicotinic acid <b>60</b>. Colorless resin (17 mg, 20%). LC–MS: <i>t</i><sub>R</sub> = 0.83 min, [M + 1]<sup>+</sup> = 483.23. HPLC with chiral stationary phase (Chiralpak AD-H 250 × 4.6 mm i.d., 5 μm; 80% heptane containing 0.05% DEA, 20% ethanol containing 0.05% DEA): <i>t</i><sub>R</sub> = 12.9 min, 98% ((<i>R</i>)-enantiomer, <i>t</i><sub>R</sub> = 11.3 min, 2%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.08 (d, <i>J</i> = 2.0 Hz, 1 H), 8.30 (d, <i>J</i> = 1.7 Hz, 1 H), 7.79 (s, 2 H), 7.72 (t, <i>J</i> = 5.8 Hz, 1 H), 5.58 (t, <i>J</i> = 5.7 Hz, 1 H), 5.33 (d, <i>J</i> = 5.2 Hz, 1 H), 3.93–4.01 (m, 1 H), 3.84 (d, <i>J</i> = 5.7 Hz, 2 H), 3.70–3.79 (m, 2 H), 3.40–3.48 (m, 1 H), 3.20–3.29 (m, 1 H), 2.69–2.78 (m, 4 H), 2.42 (s, 3 H), 2.34 (s, 3 H), 2.19 (hept, <i>J</i> = 6.8 Hz, 1 H), 1.22 (t, <i>J</i> = 7.5 Hz, 3 H), 0.94 (d, <i>J</i> = 6.6 Hz, 6 H). LC–HRMS: <i>t</i><sub>R</sub> = 1.93 min, [M + H]/<i>z</i> = 483.2607, found = 483.2612.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-((<i>S</i>)-3-{4-[5-(6-Cyclopentyl-5-methylpyridin-3-yl)[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methylphenoxy}-2-hydroxypropyl)-2-hydroxyacetamide (<b>12</b>)</h3><div class="NLM_p last"><b>12</b> was obtained with method A, using nicotinic acid <b>61</b>. Pale yellow oil (105 mg, 73%). LC–MS: <i>t</i><sub>R</sub> = 0.75 min, [M + 1]<sup>+</sup> = 495.31. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.20 (d, <i>J</i> = 2.0 Hz, 1 H), 8.20 (d, <i>J</i> = 1.5 Hz, 1 H), 7.87 (s, 1 H), 7.85 (s, 1 H), 7.17 (t, <i>J</i> = 5.8 Hz, 1 H), 4.18–4.25 (m, 3 H), 3.76–3.93 (m, 3 H), 3.40–3.57 (m, 2 H), 2.74 (q, <i>J</i> = 7.5 Hz, 2 H), 2.49 (s, 3 H), 2.38 (s, 3 H), 2.00–2.11 (m, 2 H), 1.88–2.00 (m, 4 H), 1.70–1.81 (m, 2 H), 1.31 (t, <i>J</i> = 7.5 Hz, 3 H). LC–HRMS: <i>t</i><sub>R</sub> = 2.11 min, [M + H]/<i>z</i> = 495.2607, found = 495.2609.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-((<i>S</i>)-3-{4-[5-(5-Cyclopentyl-4-methylpyridin-2-yl)[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methylphenoxy}-2-hydroxypropyl)-2-hydroxyacetamide (<b>21</b>)</h3><div class="NLM_p last"><b>21</b> was obtained with method A, using picolinic acid <b>68</b>. Beige resin (79 mg, 22%). LC–MS: <i>t</i><sub>R</sub> = 0.75 min, [M + 1]<sup>+</sup> = 495.34. <sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 8.62 (s, 1 H), 8.18 (s, 1 H), 8.00 (t, <i>J</i> = 6.0 Hz, 1 H), 7.90 (s, 1 H), 7.87 (s, 1 H), 4.11–4.19 (m, 1 H), 4.04 (s, 2 H), 3.84–3.92 (m, 2 H), 3.63–3.71 (m, 1 H), 3.37–3.52 (m, 2 H), 2.81 (q, <i>J</i> = 7.5 Hz, 2 H), 2.55 (s, 3 H), 2.41 (s, 3 H), 2.13–2.24 (m, 2 H), 1.68–1.99 (m, 6 H), 1.32 (t, <i>J</i> = 7.5 Hz, 3 H). LC–HRMS: <i>t</i><sub>R</sub> = 1.95 min, [M + H]/<i>z</i> = 495.2607, found = 495.2609.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-[(<i>S</i>)-3-(2-Ethyl-4-{5-[2-(1-ethylpropyl)-6-methylpyridin-4-yl][1,2,4]oxadiazol-3-yl}-6-methylphenoxy)-2-hydroxypropyl]-2-hydroxyacetamide (<b>44</b>)</h3><div class="NLM_p last"><b>44</b> was obtained with method A, using isonicotinic acid <b>76d</b>. Pale yellow solid (836 mg, 34%). LC–MS: <i>t</i><sub>R</sub> = 0.94 min, [M + 1]<sup>+</sup> = 497.19. HPLC with chiral stationary phase (Chiralpak AD-H 250 mm × 4.6 mm i.d., 5 μm; 80% heptane containing 0.05% DEA, 20% ethanol containing 0.05% DEA): <i>t</i><sub>R</sub> = 9.5 min, 100% ((<i>R</i>)-enantiomer, <i>t</i><sub>R</sub> = 7.5 min). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.90 (s, 1 H), 7.89 (s, 1 H), 7.75 (s, 1 H), 7.67 (s, 1 H), 6.99 (t, <i>J</i> = 5.5 Hz, 1 H), 4.19–4.27 (m, 3 H), 3.92 (dd, <i>J</i><sub>1</sub> = 9.6 Hz, <i>J</i><sub>2</sub> = 4.7 Hz, 1 H), 3.85 (dd, <i>J</i><sub>1</sub> = 9.5 Hz, <i>J</i><sub>2</sub> = 6.3 Hz, 1 H), 3.80 (ddd, <i>J</i><sub>1</sub> = 13.8 Hz, <i>J</i><sub>2</sub> = 6.0 Hz, <i>J</i><sub>3</sub> = 2.5 Hz, 1 H), 3.54 (ddd, <i>J</i><sub>1</sub> = 14.1 Hz, <i>J</i><sub>2</sub> = 7.3 Hz, <i>J</i><sub>3</sub> = 5.5 Hz, 1 H), 3.32 (d, <i>J</i> = 4.5 Hz, 1 H), 2.76 (q, <i>J</i> = 7.5 Hz, 2 H), 2.70 (s, 3 H), 2.55 (s br, 1 H), 2.41 (s, 3 H), 1.80 (quint, <i>J</i> = 7.4 Hz, 4 H), 1.33 (t, <i>J</i> = 7.6 Hz, 3 H), 0.85 (t, <i>J</i> = 7.4 Hz, 6 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 174.4, 173.8, 168.9, 166.7, 159.3, 157.3, 137.7, 131.6, 131.5, 128.4, 126.6, 122.5, 118.3, 116.9, 74.2, 70.0, 62.1, 51.5, 42.3, 28.1, 24.6, 22.9, 16.5, 14.8, 12.1. LC–HRMS: <i>t</i><sub>R</sub> = 2.01 min, [M + H]/<i>z</i> = 497.2764, found = 497.2767.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-((<i>S</i>)-3-{4-[5-(2-Cyclopentyl-6-methylpyridin-4-yl)[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methylphenoxy}-2-hydroxypropyl)-2-hydroxyacetamide (<b>46</b>)</h3><div class="NLM_p last"><b>46</b> was obtained with method A, using isonicotinic acid <b>76f</b>. Colorless oil (40 mg, 47%). LC–MS: <i>t</i><sub>R</sub> = 0.83 min, [M + 1]<sup>+</sup> = 495.30. HPLC with chiral stationary phase (Chiralpak AD-H 250 mm × 4.6 mm i.d., 5 μm; 80% heptane containing 0.05% DEA, 20% ethanol containing 0.05% DEA): <i>t</i><sub>R</sub> = 13.6 min, 100% ((<i>R</i>)-enantiomer, <i>t</i><sub>R</sub> = 10.5 min). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ: 7.89 (s, 1 H), 7.88 (s, 1 H), 7.76 (s, 1 H), 7.73 (s, 1 H), 7.03 (t, <i>J</i> = 5.5 Hz, 1 H), 4.18–4.27 (m, 3 H), 3.91 (dd, <i>J</i><sub>1</sub> = 9.6 Hz, <i>J</i><sub>2</sub> = 4.7 Hz, 1 H), 3.85 (dd, <i>J</i><sub>1</sub> = 9.5 Hz, <i>J</i><sub>2</sub> = 6.3 Hz, 1 H), 3.80 (ddd, <i>J</i><sub>1</sub> = 14.2 Hz, <i>J</i><sub>2</sub> = 6.7 Hz, <i>J</i><sub>3</sub> = 3.3 Hz, 1 H), 3.49–3.58 (m, 1 H), 3.38 (s br, 1 H), 3.25–3.35 (m, 1 H), 2.76 (q, <i>J</i> = 7.6 Hz, 2 H), 2.68 (s, 3 H), 2.40 (s, 3 H), 2.12–2.22 (m, 2 H), 1.73–1.95 (m, 6 H), 1.33 (t, <i>J</i> = 7.5 Hz, 3 H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 174.4, 173.3, 168.9, 167.0, 159.2, 157.3, 137.7, 131.7, 131.6, 128.4, 126.7, 122.5, 118.2, 116.0, 74.1, 70.2, 62.2, 48.2, 42.3, 33.7, 25.8, 24.6, 22.9, 16.5, 14.8. LC–HRMS: <i>t</i><sub>R</sub> = 1.98 min, [M + H]/<i>z</i> = 495.2607, found = 495.2600.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40"><a href="/doi/suppl/10.1021/jm4014696">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65016" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65016" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Additional experimental details on the synthesis and characterization of all target compounds and all intermediates not given above as well as data and a brief comment on mean arterial blood pressure and heart rate effects of compound <b>53</b> in spontaneously hypertensive rats are given. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm4014696/suppl_file/jm4014696_si_001.pdf">jm4014696_si_001.pdf (687.27 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm4014696" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73102" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73102" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin H. Bolli</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e885899a9c8186c68a87848481a8898b9c8d84818786c68b8785"><span class="__cf_email__" data-cfemail="7c111d0e081512521e131010153c1d1f081910151312521f1311">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan Abele</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Magdalena Birker</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberto Bravo</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Bur</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruben de Kanter</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Kohl</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julien Grimont</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Hess</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cyrille Lescop</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Boris Mathys</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claus Müller</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oliver Nayler</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus Rey</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Scherz</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gunther Schmidt</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jürgen Seifert</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beat Steiner</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jörg Velker</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Weller</span> - <span class="hlFld-Affiliation affiliation">Drug Discovery Chemistry, Actelion
Pharmaceuticals Ltd., Gewerbestrasse 16, CH-4123 Allschwil, Switzerland</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d959e7310-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24634" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24634" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors gratefully acknowledge their co-workers Maxime Boucher, Céline Bortolamiol, Stéphane Delahaye, Patrick Dörrwächter, Alexandre Flock, Hakim Hadana, Julie Hoerner, Benedikt Hofstetter, François Le Goff, Daniel Leuenberger, Claire Maciejasz, Céline Mangold, Katalin Menyhart, Matthias Merrettig, Christine Metzger, Markus Rey, Virginie Sippel, Mireille Tena Stern, Marco Tschanz, Gaby von Aesch, Daniel Wanner, Aude Weigel, and Rolf Wuest for the excellent work done and Martine Clozel for support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i42" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i42"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i43" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i43"> Abbreviations Used</h2><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">BuLi</td><td class="NLM_def"><p class="first last">butyllithium</p></td></tr><tr><td class="NLM_term">CC</td><td class="NLM_def"><p class="first last">column chromatography</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DEAD</td><td class="NLM_def"><p class="first last">diethyl azodicarbocylate</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">EA</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethyllaminopropyl)carbodiimide</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last"><i>N</i>-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">LC</td><td class="NLM_def"><p class="first last">lymphocyte count</p></td></tr><tr><td class="NLM_term">LC–MS</td><td class="NLM_def"><p class="first last">(high pressure) liquid chromatography combined with mass spectrometry</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsome</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TBTU</td><td class="NLM_def"><p class="first last"><i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium tetrafluoroborate</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">S1P</td><td class="NLM_def"><p class="first last">sphingosine 1-phosphate</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40347" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40347" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 134 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Lysophospholipid receptor as potential drug targets in tissue transplantation and autoimmune diseases</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.2174%2F138161206775193109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=16454733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD28XitlGjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=161-171&author=J.+Chunauthor=H.+Rosen&title=Lysophospholipid+receptor+as+potential+drug+targets+in+tissue+transplantation+and+autoimmune+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases</span></div><div class="casAuthors">Chun, Jerold; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-171</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  New therapies directed at ameliorating or altering autoimmune diseases represent an area of significant medical need.  Included amongst autoimmune diseases are problems related to transplantation rejection, as well as a no. of neurol. diseases such as Multiple Sclerosis (MS).  A new group of mol. targets that may lead to novel therapies are lysophospholipid (LP) receptors.  A large range of biol. activities has been attributed to the actions of these simple phospholipids that include well-studied members lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P).  Documented cellular effects of these lipid mols. encompass growth-factor-like influences on cells, including but not limited to survival, migration, adhesion differentiation, as well as pathophysiol. actions assocd. with cancer.  In turn, these cellular effects have roles in developing and adult organ systems such as the nervous system, cardiovascular system, reproductive system and, of relevance here, the immune system.  The mechanisms for these actions can be attributed to a growing family of cognate, 7-transmembrane G protein-coupled receptors (GPCRs), with documented validation through studies utilizing pharmacol., mol. genetics and an enlarging repertoire of chem. tools having agonist or antagonist properties.  The growing literature on immunol. effects of LP receptors, particularly those mediating the effects of S1P, has suggested possible therapeutic roles for this class of receptors.  In particular, entry into humans of a non-selective S1P receptor agonist, FTY720, for kidney transplantation and possibly other indications (e.g., Multiple Sclerosis), has raised prospects for efficacious treatment of human diseases based on LP receptor targets.  Here we provide a brief introduction to receptor-mediated lysophospholipid signaling and discuss its basic and potential therapeutic roles in autoimmune-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBKYnL_kPl8bVg90H21EOLACvtfcHk0ljwwaxbuYiNBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitlGjsg%253D%253D&md5=24b93c41f0750883794dd2ca824d4d6d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F138161206775193109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206775193109%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DLysophospholipid%2520receptor%2520as%2520potential%2520drug%2520targets%2520in%2520tissue%2520transplantation%2520and%2520autoimmune%2520diseases%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D161%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Nixon, G. F.</span><span> </span><span class="NLM_article-title">Sphingolipids in inflammation: pathological implications and potential therapeutic targets</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">982</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1111%2Fj.1476-5381.2009.00281.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=19563535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSks7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=982-993&author=G.+F.+Nixon&title=Sphingolipids+in+inflammation%3A+pathological+implications+and+potential+therapeutic+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipids in inflammation: pathological implications and potential therapeutic targets</span></div><div class="casAuthors">Nixon, Graeme F.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">982-993</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Sphingolipids are formed via the metab. of sphingomyelin, a constituent of the plasma membrane, or by de novo synthesis.  Enzymic pathways result in the formation of several different lipid mediators, which are known to have important roles in many cellular processes, including proliferation, apoptosis and migration.  Several studies now suggest that these sphingolipid mediators, including ceramide, ceramide 1-phosphate and sphingosine 1-phosphate (S1P), are likely to have an integral role in inflammation.  This can involve, for example, activation of pro-inflammatory transcription factors in different cell types and induction of cyclooxygenase-2, leading to prodn. of pro-inflammatory prostaglandins.  The mode of action of each sphingolipid is different.  Increased ceramide prodn. leads to the formation of ceramide-rich areas of the membrane, which may assemble signalling complexes, whereas S1P acts via high-affinity G-protein-coupled S1P receptors on the plasma membrane.  Recent studies have demonstrated that in vitro effects of sphingolipids on inflammation can translate into in vivo models.  This review will highlight the areas of research where sphingolipids are involved in inflammation and the mechanisms of action of each mediator.  In addn., the therapeutic potential of drugs that alter sphingolipid actions will be examd. with ref. to disease states, such as asthma and inflammatory bowel disease, which involve important inflammatory components.  A significant body of research now indicates that sphingolipids are intimately involved in the inflammatory process and recent studies have demonstrated that these lipids, together with assocd. enzymes and receptors, can provide effective drug targets for the treatment of pathol. inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvPGahcOR7kbVg90H21EOLACvtfcHk0ljwwaxbuYiNBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSks7nJ&md5=801f3e23dc2de1cea11545acf54c7f05</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00281.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00281.x%26sid%3Dliteratum%253Aachs%26aulast%3DNixon%26aufirst%3DG.%2BF.%26atitle%3DSphingolipids%2520in%2520inflammation%253A%2520pathological%2520implications%2520and%2520potential%2520therapeutic%2520targets%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D158%26spage%3D982%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Obinata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate in coagulation and inflammation</span> <span class="citation_source-journal">Semin. Immunopathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">91</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1007%2Fs00281-011-0287-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=21805322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1SgtrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2012&pages=73-91&author=H.+Obinataauthor=T.+Hla&title=Sphingosine+1-phosphate+in+coagulation+and+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate in coagulation and inflammation</span></div><div class="casAuthors">Obinata, Hideru; Hla, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Immunopathology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-91</span>CODEN:
                <span class="NLM_cas:coden">SIEMB7</span>;
        ISSN:<span class="NLM_cas:issn">1863-2297</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P) is a lipid mediator produced from sphingomyelin by the sequential enzymic actions of sphingomyelinase, ceramidase, and sphingosine kinase.  Five subtypes of cell surface G-protein-coupled receptors, S1P1-5, mediate the actions of S1P in various organs systems, most notably cardiovascular, immune, and central nervous systems.  S1P is enriched in blood and lymph but is present at much lower concns. in interstitial fluids of tissues.  This vascular S1P gradient is important for the regulation of trafficking of various immune cells.  FTY720, which was recently approved for the treatment of relapsing-remitting multiple sclerosis, potently sequesters lymphocytes into lymph nodes by functionally antagonizing the activity of the S1P1 receptor.  S1P also plays crit. roles in the vascular barrier integrity, thereby regulating inflammation, tumor metastasis, angiogenesis, and atherosclerosis.  Recent studies have also revealed the involvement of S1P signaling in coagulation and in tumor necrosis factor α-mediated signaling.  This review highlights the importance of S1P signaling in these inflammatory processes as well as the contribution of each receptor subtype, which exhibits both cooperative and redundant functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroukMZahVX47Vg90H21EOLACvtfcHk0ljwwaxbuYiNBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1SgtrrI&md5=7490782a120b6400295862f4521e5c88</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs00281-011-0287-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00281-011-0287-3%26sid%3Dliteratum%253Aachs%26aulast%3DObinata%26aufirst%3DH.%26aulast%3DHla%26aufirst%3DT.%26atitle%3DSphingosine%25201-phosphate%2520in%2520coagulation%2520and%2520inflammation%26jtitle%3DSemin.%2520Immunopathol.%26date%3D2012%26volume%3D34%26spage%3D73%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heining, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmouder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aradhye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burtin, P.</span><span> </span><span class="NLM_article-title">Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1038%2Fnrd3248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=21031003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=883-897&author=V.+Brinkmannauthor=A.+Billichauthor=T.+Baumrukerauthor=P.+Heiningauthor=R.+Schmouderauthor=G.+Francisauthor=S.+Aradhyeauthor=P.+Burtin&title=Fingolimod+%28FTY720%29%3A+discovery+and+development+of+an+oral+drug+to+treat+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis</span></div><div class="casAuthors">Brinkmann, Volker; Billich, Andreas; Baumruker, Thomas; Heining, Peter; Schmouder, Robert; Francis, Gordon; Aradhye, Shreeram; Burtin, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">883-897</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery of fingolimod (FTY720/Gilenya; Novartis), an orally active immunomodulatory drug, has opened up new approaches to the treatment of multiple sclerosis, the most common inflammatory disorder of the central nervous system.  Elucidation of the effects of fingolimod - mediated by the modulation of sphingosine 1-phosphate (S1P) receptors - has indicated that its therapeutic activity could be due to regulation of the migration of selected lymphocyte subsets into the central nervous system and direct effects on neural cells, particularly astrocytes.  An improved understanding of the biol. of S1P receptors has also been gained.  This article describes the discovery and development of fingolimod, which was approved by the US Food and Drug Administration in Sept. 2010 as a first-line treatment for relapsing forms of multiple sclerosis, thereby becoming the first oral disease-modifying therapy to be approved for multiple sclerosis in the United States.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr80U6QfXSJMbVg90H21EOLACvtfcHk0lgPXQaGx_DO0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL&md5=0f6dd60ef115079f3652e9d12d82e215</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd3248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3248%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DSchmouder%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DG.%26aulast%3DAradhye%26aufirst%3DS.%26aulast%3DBurtin%26aufirst%3DP.%26atitle%3DFingolimod%2520%2528FTY720%2529%253A%2520discovery%2520and%2520development%2520of%2520an%2520oral%2520drug%2520to%2520treat%2520multiple%2520sclerosis%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D883%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Kappos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radue, E.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohlfeld, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabresi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selmaj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agoropoulou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leyk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang-Auberson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burtin, P.</span><span> </span><span class="NLM_article-title">A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1056%2FNEJMoa0909494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=20089952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvVWltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=387-401&author=L.+Kapposauthor=E.-W.+Radueauthor=P.+O%E2%80%99Connorauthor=C.+Polmanauthor=R.+Hohlfeldauthor=P.+Calabresiauthor=K.+Selmajauthor=C.+Agoropoulouauthor=M.+Leykauthor=L.+Zhang-Aubersonauthor=P.+Burtin&title=A+placebo-controlled+trial+of+oral+fingolimod+in+relapsing+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis</span></div><div class="casAuthors">Kappos, Ludwig; Radue, Ernst-Wilhelm; O'Connor, Paul; Polman, Chris; Hohlfeld, Reinhard; Calabresi, Peter; Selmaj, Krzysztof; Agoropoulou, Catherine; Leyk, Malgorzata; Zhang-Auberson, Lixin; Burtin, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">387-401</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Oral fingolimod, a sphingosine-1-phosphate-receptor modulator that prevents the egress of lymphocytes from lymph nodes, significantly improved relapse rates and end points measured on magnetic resonance imaging (MRI), as compared with either placebo or i.m. interferon beta-1a, in phase 2 and 3 studies of multiple sclerosis.  METHODS: In our 24-mo, double-blind, randomized study, we enrolled patients who had relapsing-remitting multiple sclerosis, were 18 to 55 years of age, had a score of 0 to 5.5 on the Expanded Disability Status Scale (which ranges from 0 to 10, with higher scores indicating greater disability), and had one or more relapses in the previous year or two or more in the previous 2 years.  Patients received oral fingolimod at a dose of 0.5 mg or 1.25 mg daily or placebo.  End points included the annualized relapse rate (the primary end point) and the time to disability progression (a secondary end point).  RESULTS: A total of 1033 of the 1272 patients (81.2%) completed the study.  The annualized relapse rate was 0.18 with 0.5 mg of fingolimod, 0.16 with 1.25 mg of fingolimod, and 0.40 with placebo (P < 0.001 for either dose vs. placebo).  Fingolimod at doses of 0.5 mg and 1.25 mg significantly reduced the risk of disability progression over the 24-mo period (hazard ratio, 0.70 and 0.68, resp.; P = 0.02 vs. placebo, for both comparisons).  The cumulative probability of disability progression (confirmed after 3 mo) was 17.7% with 0.5 mg of fingolimod, 16.6% with 1.25 mg of fingolimod, and 24.1% with placebo.  Both fingolimod doses were superior to placebo with regard to MRI-related measures (no. of new or enlarged lesions on T2 -weighted images, gadolinium-enhancing lesions, and brain-vol. loss; P < 0.001 for all comparisons at 24 mo).  Causes of study discontinuation and adverse events related to fingolimod included bradycardia and atrioventricular conduction block at the time of fingolimod initiation, macular edema, elevated liver-enzyme levels, and mild hypertension.  CONCLUSIONS: As compared with placebo, both doses of oral fingolimod improved the relapse rate, the risk of disability progression, and end points on MRI.  These benefits will need to be weighed against possible long-term risks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZV83ylA8IarVg90H21EOLACvtfcHk0lgPXQaGx_DO0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvVWltr4%253D&md5=0c1a63e4b8850f3579b2a8f6c7f28ac0</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0909494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0909494%26sid%3Dliteratum%253Aachs%26aulast%3DKappos%26aufirst%3DL.%26aulast%3DRadue%26aufirst%3DE.-W.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%26aulast%3DPolman%26aufirst%3DC.%26aulast%3DHohlfeld%26aufirst%3DR.%26aulast%3DCalabresi%26aufirst%3DP.%26aulast%3DSelmaj%26aufirst%3DK.%26aulast%3DAgoropoulou%26aufirst%3DC.%26aulast%3DLeyk%26aufirst%3DM.%26aulast%3DZhang-Auberson%26aufirst%3DL.%26aulast%3DBurtin%26aufirst%3DP.%26atitle%3DA%2520placebo-controlled%2520trial%2520of%2520oral%2520fingolimod%2520in%2520relapsing%2520multiple%2520sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D387%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Cohen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Mechanisms of fingolimod’s efficacy and adverse effects in multiple sclerosis</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1002%2Fana.22426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=21520239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltVyhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2011&pages=759-777&author=J.+A.+Cohenauthor=J.+Chun&title=Mechanisms+of+fingolimod%E2%80%99s+efficacy+and+adverse+effects+in+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis</span></div><div class="casAuthors">Cohen, Jeffrey A.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">759-777</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Until recently, all approved multiple sclerosis (MS) disease treatments were administered parenterally.  Oral fingolimod was approved in Sept. 2010 by the US Food and Drug Administration to reduce relapses and disability progression in relapsing forms of MS.  In the clin. trials that led to approval, fingolimod reduced not only acute relapses and magnetic resonance imaging lesion activity but also disability progression and brain vol. loss, suggesting preservation of tissue.  Fingolimod's mechanism of action in MS is not known with certainty.  Its active form, fingolimod-phosphate (fingolimod-P), is a sphingosine 1-phosphate receptor (S1PR) modulator that inhibits egress of lymphocytes from lymph nodes and their recirculation, potentially reducing trafficking of pathogenic cells into the central nervous system (CNS).  Fingolimod also readily penetrates the CNS, and fingolimod-P formed in situ may have direct effects on neural cells.  Fingolimod potently inhibits the MS animal model, exptl. autoimmune encephalomyelitis, but is ineffective in mice with selective deficiency of the S1P1 S1PR subtype on astrocytes despite normal expression in the immune compartment.  These findings suggest that S1PR modulation by fingolimod in both the immune system and CNS, producing a combination of beneficial anti-inflammatory and possibly neuroprotective/reparative effects, may contribute to its efficacy in MS.  In clin. trials, fingolimod was generally safe and well tolerated.  Its interaction with S1PRs in a variety of tissues largely accounts for the reported adverse effects, which were seen more frequently with doses 2.5 to 10× the approved 0.5mg dose.  Fingolimod's unique mechanism of action distinguishes it from all other currently approved MS therapies.  Ann Neurol 2011;69:759-777.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaQ9gv8GATt7Vg90H21EOLACvtfcHk0lh3pKANCCoEHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltVyhtLo%253D&md5=8444099f3b8b40bf8fd529e374eaf294</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fana.22426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.22426%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DJ.%2BA.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DMechanisms%2520of%2520fingolimod%25E2%2580%2599s%2520efficacy%2520and%2520adverse%2520effects%2520in%2520multiple%2520sclerosis%26jtitle%3DAnn.%2520Neurol.%26date%3D2011%26volume%3D69%26spage%3D759%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Gasperini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggieri, S.</span><span> </span><span class="NLM_article-title">Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change theratpeutic paradigm approach</span> <span class="citation_source-journal">Drug Des., Dev. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.2147%2FDDDT.S8927" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A280%3ADC%252BC38fnsFOisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2012&pages=175-186&author=C.+Gasperiniauthor=S.+Ruggieri&title=Development+of+oral+agent+in+the+treatment+of+multiple+sclerosis%3A+how+the+first+available+oral+therapy%2C+fingolimod+will+change+theratpeutic+paradigm+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach</span></div><div class="casAuthors">Gasperini Claudio; Ruggieri Serena</div><div class="citationInfo"><span class="NLM_cas:title">Drug design, development and therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">175-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Multiple sclerosis (MS) is a chronic inflammatory disorder of the central nervous system, traditionally considered to be an autoimmune, demyelinating disease.  Based on this understanding, the initial therapeutic strategies were directed at immune modulation and inflammation control.  At present, there are five licensed first-line disease-modifying drugs and two second-line treatments in MS.  Currently available MS therapies have shown significant efficacy throughout many trials, but they produce different side-effect profiles in patients.  Since they are well known and safe, they require regular and frequent parenteral administration and are associated with limited long-term treatment adherence.  Thus, there is an important need for the development of new therapeutic strategies.  Several oral compounds are in late-stage development for treating MS.  Fingolimod (FTY720; Novartis, Basel, Switzerland) is an oral sphingosine-1-phosphase receptor modulator which has demonstrated superior efficacy compared with placebo and interferon β-1a in Phase III studies and has been approved in the treatment of MS.  We summarily review the oral compounds in study, focusing on the recent development, approval and the clinical experience with FTY720.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTB3MvBbEZueUloaUqgkFHkfW6udTcc2eaNKyqmBIZszrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38fnsFOisw%253D%253D&md5=4a0293c0c756a1df06649250cf8390d4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S8927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S8927%26sid%3Dliteratum%253Aachs%26aulast%3DGasperini%26aufirst%3DC.%26aulast%3DRuggieri%26aufirst%3DS.%26atitle%3DDevelopment%2520of%2520oral%2520agent%2520in%2520the%2520treatment%2520of%2520multiple%2520sclerosis%253A%2520how%2520the%2520first%2520available%2520oral%2520therapy%252C%2520fingolimod%2520will%2520change%2520theratpeutic%2520paradigm%2520approach%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2012%26volume%3D6%26spage%3D175%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Gergely, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traebert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groenewegen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitaliti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sing, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttringer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crumb, W. J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltzmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallström, E.</span><span> </span><span class="NLM_article-title">The selective S1P receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate: translation from preclinical to clinical studies</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1047</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1111%2Fj.1476-5381.2012.02061.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=22646698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A280%3ADC%252BC38nnsVShuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2012&pages=1035-1047&author=P.+Gergelyauthor=B.+Nuesslein-Hildesheimauthor=D.+Gueriniauthor=V.+Brinkmannauthor=M.+Traebertauthor=C.+Brunsauthor=S.+Panauthor=N.+S.+Grayauthor=K.+Hinterdingauthor=N.+G.+Cookeauthor=A.+Groenewegenauthor=A.+Vitalitiauthor=T.+Singauthor=O.+Luttringerauthor=J.+Yangauthor=A.+Gardinauthor=N.+Wangauthor=W.+J.+J.+Crumbauthor=M.+Saltzmannauthor=M.+Rosenbergauthor=E.+Wallstr%C3%B6m&title=The+selective+S1P+receptor+modulator+BAF312+redirects+lymphocyte+distribution+and+has+species-specific+effects+on+heart+rate%3A+translation+from+preclinical+to+clinical+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate</span></div><div class="casAuthors">Gergely P; Nuesslein-Hildesheim B; Guerini D; Brinkmann V; Traebert M; Bruns C; Pan S; Gray N S; Hinterding K; Cooke N G; Groenewegen A; Vitaliti A; Sing T; Luttringer O; Yang J; Gardin A; Wang N; Crumb W J Jr; Saltzman M; Rosenberg M; Wallstrom E</div><div class="citationInfo"><span class="NLM_cas:title">British journal of pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1035-47</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  BAF312 is a next-generation sphingosine 1-phosphate (S1P) receptor modulator, selective for S1P(1) and S1P(5 ) receptors.  S1P(1) receptors are essential for lymphocyte egress from lymph nodes and a drug target in immune-mediated diseases.  Here, we have characterized the immunomodulatory potential of BAF312 and the S1P receptor-mediated effects on heart rate using preclinical and human data.  EXPERIMENTAL APPROACH:  BAF312 was tested in a rat experimental autoimmune encephalomyelitis (EAE) model.  Electrophysiological recordings of G-protein-coupled inwardly rectifying potassium (GIRK) channels were carried out in human atrial myocytes.  A Phase I multiple-dose trial studied the pharmacokinetics, pharmacodynamics and safety of BAF312 in 48 healthy subjects.  KEY RESULTS:  BAF312 effectively suppressed EAE in rats by internalizing S1P(1) receptors, rendering them insensitive to the egress signal from lymph nodes.  In healthy volunteers, BAF312 caused preferential decreases in CD4(+) T cells, T(naive) , T(central memory) and B cells within 4-6 h.  Cell counts returned to normal ranges within a week after stopping treatment, in line with the elimination half-life of BAF312.  Despite sparing S1P(3) receptors (associated with bradycardia in mice), BAF312 induced rapid, transient (day 1 only) bradycardia in humans.  BAF312-mediated activation of GIRK channels in human atrial myocytes can fully explain the bradycardia.  CONCLUSION AND IMPLICATIONS:  This study illustrates species-specific differences in S1P receptor specificity for first-dose cardiac effects.  Based on its profound but rapidly reversible inhibition of lymphocyte trafficking, BAF312 may have potential as a treatment for immune-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRE_xcO_ghmTOLt9HypzAgQfW6udTcc2eaNKyqmBIZszrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nnsVShuw%253D%253D&md5=82575d2c2d2eeba851919e468e407c48</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02061.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02061.x%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DP.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DTraebert%26aufirst%3DM.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DGroenewegen%26aufirst%3DA.%26aulast%3DVitaliti%26aufirst%3DA.%26aulast%3DSing%26aufirst%3DT.%26aulast%3DLuttringer%26aufirst%3DO.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DCrumb%26aufirst%3DW.%2BJ.%2BJ.%26aulast%3DSaltzmann%26aufirst%3DM.%26aulast%3DRosenberg%26aufirst%3DM.%26aulast%3DWallstr%25C3%25B6m%26aufirst%3DE.%26atitle%3DThe%2520selective%2520S1P%2520receptor%2520modulator%2520BAF312%2520redirects%2520lymphocyte%2520distribution%2520and%2520has%2520species-specific%2520effects%2520on%2520heart%2520rate%253A%2520translation%2520from%2520preclinical%2520to%2520clinical%2520studies%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D167%26spage%3D1035%26epage%3D1047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">End, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heining, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span> </span><span class="NLM_article-title">Discovery of BAF312 (siponimod), a potent and selective S1P receptor modulator</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300396r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=333-337&author=S.+Panauthor=N.+Grayauthor=W.+Gaoauthor=Y.+Miauthor=Y.+Fanauthor=X.+Wangauthor=T.+Tuntlandauthor=J.+Cheauthor=S.+Lefebvreauthor=Y.+Chenauthor=A.+Chuauthor=K.+Hinterdingauthor=A.+Gardinauthor=P.+Endauthor=P.+Heiningauthor=C.+Brunsauthor=N.+G.+Cookeauthor=B.+Nuesslein-Hildesheim&title=Discovery+of+BAF312+%28siponimod%29%2C+a+potent+and+selective+S1P+receptor+modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fml300396r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300396r%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChu%26aufirst%3DA.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DEnd%26aufirst%3DP.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520BAF312%2520%2528siponimod%2529%252C%2520a%2520potent%2520and%2520selective%2520S1P%2520receptor%2520modulator%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D333%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Selmaj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kappos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuve, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieckmann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalban, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziemssen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auberson, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pohlmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlke, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallstrom, E.</span><span> </span><span class="NLM_article-title">Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">756</span><span class="NLM_x">–</span> <span class="NLM_lpage">767</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2FS1474-4422%2813%2970102-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=23764350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpt12huro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=756-767&author=K.+Selmajauthor=D.+K.+Liauthor=H.+P.+Hartungauthor=B.+Hemmerauthor=L.+Kapposauthor=M.+S.+Freedmanauthor=O.+Stuveauthor=P.+Rieckmannauthor=X.+Montalbanauthor=T.+Ziemssenauthor=L.+Z.+Aubersonauthor=H.+Pohlmannauthor=F.+Mercierauthor=F.+Dahlkeauthor=E.+Wallstrom&title=Siponimod+for+patients+with+relapsing-remitting+multiple+sclerosis+%28BOLD%29%3A+an+adaptive%2C+dose-ranging%2C+randomised%2C+phase+2+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study</span></div><div class="casAuthors">Selmaj, Krzysztof; Li, David KB; Hartung, Hans-Peter; Hemmer, Bernhard; Kappos, Ludwig; Freedman, Mark S.; Stuve, Olaf; Rieckmann, Peter; Montalban, Xavier; Ziemssen, Tjalf; Auberson, Lixin Zhang; Pohlmann, Harald; Mercier, Francois; Dahlke, Frank; Wallstrom, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">756-767</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Siponimod is an oral selective modulator of sphingosine 1-phosphate receptor types 1 and type 5, with an elimination half-life leading to washout in 7 days.  We aimed to det. the dose-response relation of siponimod in terms of its effects on brain MRI lesion activity and characterize safety and tolerability in patients with relapsing-remitting multiple sclerosis.In this double-blind, adaptive dose-ranging phase 2 study, we enrolled adults (aged 18-55 years) with relapsing-remitting multiple sclerosis at 73 medical centers in Europe and North America.  We tested two patient cohorts sequentially, sepd. by an interim anal. at 3 mo.  We randomly allocated patients in cohort 1 (1:1:1:1) to receive once-daily siponimod 10 mg, 2 mg, or 0·5 mg, or placebo for 6 mo.  We randomly allocated patients in cohort 2 (4:4:1) to siponimod 1·25 mg, siponimod 0·25 mg, or placebo once-daily for 3 mo.  Randomisation was done with a central, automated system and patients and investigators were masked to treatment assignment.  The primary endpoint was dose-response, assessed by percentage redn. in monthly no. of combined unique active lesions at 3 mo for siponimod vs. placebo; this endpoint was analyzed by a multiple comparison procedure with modeling techniques in all patients with at least one MRI scan up to 3 mo.  We assessed safety in all patients who received at least one dose of study drug.  This study is registered with ClinicalTrials.gov, no. NCT00879658.Between March 30, 2009, and Oct 22, 2010, we recruited 188 patients into cohort 1 and 109 patients into cohort 2.  We showed a dose-response relation (p=0·0001) across the five doses of siponimod, with redns. in combined unique active lesions at 3 mo compared with placebo of 35% (95% CI 17-57) for siponimod 0·25 mg (51 patients included in the primary endpoint anal.), 50% (29-69) for siponimod 0·5 mg (43 patients), 66% (48-80) for siponimod 1·25 mg (42 patients), 72% (57-84) for siponimod 2 mg (45 patients), and 82% (70-90) for siponimod 10 mg (44 patients).  In patients treated for 6 mo, 37 (86%) of 43 patients who received siponimod 0·5 mg had adverse events (eight serious), as did 48 (98%) of 49 patients who received siponimod 2 mg (four serious), 48 (96%) of 50 patients who received siponimod 10 mg (three serious), and 36 (80%) of 45 controls (none serious).  For individuals treated to 3 mo, 38 (74%) of 51 patients who received siponimod 0·25 mg had adverse events (none serious), as did 29 (69%) of 42 patients who received siponimod 1·25 mg (two serious) and 13 (81%) of 16 controls (none serious).Therapeutic effects of siponimod on MRI lesion activity in model-based analyses and its tolerability in relapsing-remitting multiple sclerosis warrant investigation in a phase 3 trial.Novartis Pharma AG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpdAutlVr0kLVg90H21EOLACvtfcHk0lgCF26X8eXzKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpt12huro%253D&md5=28e8ce2bc3e97f33c685d0ded9985b31</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2813%2970102-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252813%252970102-9%26sid%3Dliteratum%253Aachs%26aulast%3DSelmaj%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DD.%2BK.%26aulast%3DHartung%26aufirst%3DH.%2BP.%26aulast%3DHemmer%26aufirst%3DB.%26aulast%3DKappos%26aufirst%3DL.%26aulast%3DFreedman%26aufirst%3DM.%2BS.%26aulast%3DStuve%26aufirst%3DO.%26aulast%3DRieckmann%26aufirst%3DP.%26aulast%3DMontalban%26aufirst%3DX.%26aulast%3DZiemssen%26aufirst%3DT.%26aulast%3DAuberson%26aufirst%3DL.%2BZ.%26aulast%3DPohlmann%26aufirst%3DH.%26aulast%3DMercier%26aufirst%3DF.%26aulast%3DDahlke%26aufirst%3DF.%26aulast%3DWallstrom%26aufirst%3DE.%26atitle%3DSiponimod%2520for%2520patients%2520with%2520relapsing-remitting%2520multiple%2520sclerosis%2520%2528BOLD%2529%253A%2520an%2520adaptive%252C%2520dose-ranging%252C%2520randomised%252C%2520phase%25202%2520study%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D756%26epage%3D767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menyhart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4198</span><span class="NLM_x">–</span> <span class="NLM_lpage">4211</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100181s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4198-4211&author=M.+H.+Bolliauthor=S.+Abeleauthor=C.+Binkertauthor=R.+Bravoauthor=S.+Buchmannauthor=D.+Burauthor=J.+Gatfieldauthor=P.+Hessauthor=C.+Kohlauthor=C.+Mangoldauthor=B.+Mathysauthor=K.+Menyhartauthor=C.+M%C3%BCllerauthor=O.+Naylerauthor=M.+Scherzauthor=G.+Schmidtauthor=V.+Sippelauthor=B.+Steinerauthor=D.+Strasserauthor=A.+Treiberauthor=T.+Weller&title=2-imino-thiazolidin-4-one+derivatives+as+potent%2C+orally+active+S1P1+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm100181s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100181s%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DBinkert%26aufirst%3DC.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBuchmann%26aufirst%3DS.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DMangold%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DMenyhart%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DSippel%26aufirst%3DV.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DStrasser%26aufirst%3DD.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3D2-imino-thiazolidin-4-one%2520derivatives%2520as%2520potent%252C%2520orally%2520active%2520S1P1%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4198%26epage%3D4211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Freedman, M. S.; Olsson, T.; Melanson, M.; Fernández, O.; Boster, A.; Bach, D.; Berkani, O.; Mueller, M.; Sidorenko, T.; Pozzilli, C.</span><span> </span><span class="NLM_article-title">Dose-Dependent Effect of Ponesimod, an Oral, Selective Sphingosine 1-Phosphate Receptor-1 Modulator, on Magnetic Resonance Imaging Outcomes in Patients with Relapsing–Remitting Multiple Sclerosis</span>. Presented at the 28th Congress of the European Commitee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2012), Lyon, France, Oct 10–13,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>P923.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+S.+Freedman&author=T.+Olsson&author=M.+Melanson&author=O.+Fern%C3%A1ndez&author=A.+Boster&author=D.+Bach&author=O.+Berkani&author=M.+Mueller&author=T.+Sidorenko&author=C.+Pozzilli&title=Dose-Dependent+Effect+of+Ponesimod%2C+an+Oral%2C+Selective+Sphingosine+1-Phosphate+Receptor-1+Modulator%2C+on+Magnetic+Resonance+Imaging+Outcomes+in+Patients+with+Relapsing%E2%80%93Remitting+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DFreedman%26aufirst%3DM.%2BS.%26atitle%3DDose-Dependent%2520Effect%2520of%2520Ponesimod%252C%2520an%2520Oral%252C%2520Selective%2520Sphingosine%25201-Phosphate%2520Receptor-1%2520Modulator%252C%2520on%2520Magnetic%2520Resonance%2520Imaging%2520Outcomes%2520in%2520Patients%2520with%2520Relapsing%25E2%2580%2593Remitting%2520Multiple%2520Sclerosis%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kurata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shioya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habashita, H.</span><span> </span><span class="NLM_article-title">Structure–activity relationsphip studies of S1P agonists with a dihydronaphthalene scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=144-148&author=H.+Kurataauthor=K.+Kusumiauthor=K.+Otsukiauthor=R.+Suzukiauthor=M.+Kuronoauthor=N.+Tokudaauthor=Y.+Takadaauthor=H.+Shioyaauthor=H.+Mizunoauthor=T.+Komiyaauthor=T.+Onoauthor=H.+Hagiyaauthor=M.+Minamiauthor=S.+Nakadeauthor=H.+Habashita&title=Structure%E2%80%93activity+relationsphip+studies+of+S1P+agonists+with+a+dihydronaphthalene+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DKusumi%26aufirst%3DK.%26aulast%3DOtsuki%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DKurono%26aufirst%3DM.%26aulast%3DTokuda%26aufirst%3DN.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DShioya%26aufirst%3DH.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DKomiya%26aufirst%3DT.%26aulast%3DOno%26aufirst%3DT.%26aulast%3DHagiya%26aufirst%3DH.%26aulast%3DMinami%26aufirst%3DM.%26aulast%3DNakade%26aufirst%3DS.%26aulast%3DHabashita%26aufirst%3DH.%26atitle%3DStructure%25E2%2580%2593activity%2520relationsphip%2520studies%2520of%2520S1P%2520agonists%2520with%2520a%2520dihydronaphthalene%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D144%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Komiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shioya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakade, S.</span><span> </span><span class="NLM_article-title">Efficacy and immunomodulatory actions of ONO-4641, a novel selective agonist for sphingosine 1-phosphate receptors 1 and 5, in preclinical models of multiple sclerosis</span> <span class="citation_source-journal">Clin. Exp. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1111%2Fj.1365-2249.2012.04669.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=23199323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslKrtL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2013&pages=54-62&author=T.+Komiyaauthor=K.+Satoauthor=H.+Shioyaauthor=Y.+Inagakiauthor=H.+Hagiyaauthor=R.+Kozakiauthor=M.+Imaiauthor=Y.+Takadaauthor=T.+Maedaauthor=H.+Kurataauthor=M.+Kuronoauthor=R.+Suzukiauthor=K.+Otsukiauthor=H.+Habashitaauthor=S.+Nakade&title=Efficacy+and+immunomodulatory+actions+of+ONO-4641%2C+a+novel+selective+agonist+for+sphingosine+1-phosphate+receptors+1+and+5%2C+in+preclinical+models+of+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and immunomodulatory actions of ONO-4641, a novel selective agonist for sphingosine 1-phosphate receptors 1 and 5, in preclinical models of multiple sclerosis</span></div><div class="casAuthors">Komiya, T.; Sato, K.; Shioya, H.; Inagaki, Y.; Hagiya, H.; Kozaki, R.; Imai, M.; Takada, Y.; Maeda, T.; Kurata, H.; Kurono, M.; Suzuki, R.; Otsuki, K.; Habashita, H.; Nakade, S.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-62</span>CODEN:
                <span class="NLM_cas:coden">CEXIAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary: ONO-4641 is a next-generation sphingosine 1-phosphate (S1P) receptor agonist selective for S1P receptors 1 and 5.  The objective of the study was to characterize the immunomodulatory effects of ONO-4641 using preclin. data.  ONO-4641 was tested in both in-vitro pharmacol. studies as well as in-vivo models of transient or relapsing-remitting exptl. autoimmune encephalomyelitis (EAE).  In vitro, ONO-4641 showed highly potent agonistic activities vs. S1P receptors 1 and 5 [half maximal effective concn. (EC50) values of 0·0273 and 0·334 nM, resp.], and had profound S1P receptor 1 down-regulating effects on the cell membrane.  ONO-4641 decreased peripheral blood lymphocyte counts in rats by inhibiting lymphocyte egress from secondary lymphoid tissues.  In a rat exptl. autoimmune encephalomyelitis(EAE) model, ONO-4641 suppressed the onset of disease and inhibited lymphocyte infiltration into the spinal cord in a dose-dependent manner at doses of 0·03 and 0·1 mg/kg.  Furthermore, ONO-4641 prevented relapse of disease in a non-obese diabetic mouse model of relapsing-remitting EAE.  These observations suggest that ONO-4641 may provide therapeutic benefits in the treatment of multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFV76b9p5RfbVg90H21EOLACvtfcHk0lhmPsEGWJ1_kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslKrtL3E&md5=d4cd1078e245580132c50e1bb43aa039</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2249.2012.04669.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2249.2012.04669.x%26sid%3Dliteratum%253Aachs%26aulast%3DKomiya%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DShioya%26aufirst%3DH.%26aulast%3DInagaki%26aufirst%3DY.%26aulast%3DHagiya%26aufirst%3DH.%26aulast%3DKozaki%26aufirst%3DR.%26aulast%3DImai%26aufirst%3DM.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DMaeda%26aufirst%3DT.%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DKurono%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DOtsuki%26aufirst%3DK.%26aulast%3DHabashita%26aufirst%3DH.%26aulast%3DNakade%26aufirst%3DS.%26atitle%3DEfficacy%2520and%2520immunomodulatory%2520actions%2520of%2520ONO-4641%252C%2520a%2520novel%2520selective%2520agonist%2520for%2520sphingosine%25201-phosphate%2520receptors%25201%2520and%25205%252C%2520in%2520preclinical%2520models%2520of%2520multiple%2520sclerosis%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D2013%26volume%3D171%26spage%3D54%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span>ClinicalTrials.gov. Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis Patients. <a href="http://clinicaltrials.gov/show/NCT01628393" class="extLink">http://clinicaltrials.gov/show/NCT01628393</a> (accessed July<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Efficacy+and+Safety+Study+of+RPC1063+in+Relapsing+Multiple+Sclerosis+Patients.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01628393+%28accessed+July+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span>ClinicalTrials.gov. Dose Finding Study of MT-1303. <a href="http://clinicaltrials.gov/show/NCT01742052" class="extLink">http://clinicaltrials.gov/show/NCT01742052</a> (accessed Jan<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Dose+Finding+Study+of+MT-1303.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01742052+%28accessed+Jan+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span>ClinicalTrials.gov. Efficacy and Safety Study of RPC1063 in Ulcerative Colitis. <a href="http://clinicaltrials.gov/show/NCT01647516" class="extLink">http://clinicaltrials.gov/show/NCT01647516</a> (accessed July<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Efficacy+and+Safety+Study+of+RPC1063+in+Ulcerative+Colitis.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01647516+%28accessed+July+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span>ClinicalTrials.gov. Efficacy, Tolerability, Pharmacokinetcs and Pharmacodynamics Study of MT-1303 in Subjects with Inflammatory Bowel Disease. <a href="http://clinicaltrials.gov/show/NCT01666327" class="extLink">http://clinicaltrials.gov/show/NCT01666327</a> (accessed Jan<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Efficacy%2C+Tolerability%2C+Pharmacokinetcs+and+Pharmacodynamics+Study+of+MT-1303+in+Subjects+with+Inflammatory+Bowel+Disease.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01666327+%28accessed+Jan+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Nishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iio, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawase, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nara, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inaba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomisato, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimozato, T.</span><span> </span><span class="NLM_article-title">Discovery of CS-0777: a potent, selective, and orally active S1P<sub>1</sub> agonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">368</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100301k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=368-372&author=T.+Nishiauthor=S.+Miyazakiauthor=T.+Takemotoauthor=K.+Suzukiauthor=Y.+Iioauthor=K.+Nakajimaauthor=T.+Ohnukiauthor=Y.+Kawaseauthor=F.+Naraauthor=S.+Inabaauthor=T.+Izumiauthor=H.+Yuitaauthor=K.+Oshimaauthor=H.+Doiauthor=R.+Inoueauthor=W.+Tomisatoauthor=T.+Kagariauthor=T.+Shimozato&title=Discovery+of+CS-0777%3A+a+potent%2C+selective%2C+and+orally+active+S1P1+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fml100301k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100301k%26sid%3Dliteratum%253Aachs%26aulast%3DNishi%26aufirst%3DT.%26aulast%3DMiyazaki%26aufirst%3DS.%26aulast%3DTakemoto%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DIio%26aufirst%3DY.%26aulast%3DNakajima%26aufirst%3DK.%26aulast%3DOhnuki%26aufirst%3DT.%26aulast%3DKawase%26aufirst%3DY.%26aulast%3DNara%26aufirst%3DF.%26aulast%3DInaba%26aufirst%3DS.%26aulast%3DIzumi%26aufirst%3DT.%26aulast%3DYuita%26aufirst%3DH.%26aulast%3DOshima%26aufirst%3DK.%26aulast%3DDoi%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DR.%26aulast%3DTomisato%26aufirst%3DW.%26aulast%3DKagari%26aufirst%3DT.%26aulast%3DShimozato%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520CS-0777%253A%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520S1P1%2520agonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D368%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Moberly, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truitt, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollmer, T. L.</span><span> </span><span class="NLM_article-title">Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: results from a 12-week, open-label pilot study in multiple sclerosis patients</span> <span class="citation_source-journal">J. Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">246</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.jneuroim.2012.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=22465063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvF2jtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=2012&pages=100-107&author=J.+B.+Moberlyauthor=D.+M.+Fordauthor=H.+Zahirauthor=S.+Chenauthor=T.+Mochizukiauthor=K.+E.+Truittauthor=T.+L.+Vollmer&title=Pharmacological+effects+of+CS-0777%2C+a+selective+sphingosine+1-phosphate+receptor-1+modulator%3A+results+from+a+12-week%2C+open-label+pilot+study+in+multiple+sclerosis+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: Results from a 12-week, open-label pilot study in multiple sclerosis patients</span></div><div class="casAuthors">Moberly, James B.; Ford, Daniel M.; Zahir, Hamim; Chen, Shuquan; Mochizuki, Takashi; Truitt, Kenneth E.; Vollmer, Timothy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">100-107</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">CS-0777 is a selective sphingosine 1-phosphate receptor-1 modulator under investigation for treatment of multiple sclerosis (MS).  We conducted an open-label, pilot study in 25 MS patients to assess the safety, pharmacokinetics, pharmacodynamics and exploratory efficacy of oral CS-0777 (0.1, 0.3 and 0.6 mg), administered once weekly or every other week for 12 wk.  CS-0777 resulted in a pronounced, dose-dependent decrease in lymphocytes and CD4 T cell subsets, which returned to baseline within 4 wk after the last dose.  Overall, CS-0777 was safe and well-tolerated.  These results require confirmation in a double-blind, placebo-controlled and adequately powered phase 2 study in MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnUDMmZ5gpHLVg90H21EOLACvtfcHk0ljIW3kFDmhvKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvF2jtbY%253D&md5=ce750c33bbfd69ba65304cb02f7c22f9</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2012.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2012.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DMoberly%26aufirst%3DJ.%2BB.%26aulast%3DFord%26aufirst%3DD.%2BM.%26aulast%3DZahir%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DMochizuki%26aufirst%3DT.%26aulast%3DTruitt%26aufirst%3DK.%2BE.%26aulast%3DVollmer%26aufirst%3DT.%2BL.%26atitle%3DPharmacological%2520effects%2520of%2520CS-0777%252C%2520a%2520selective%2520sphingosine%25201-phosphate%2520receptor-1%2520modulator%253A%2520results%2520from%2520a%252012-week%252C%2520open-label%2520pilot%2520study%2520in%2520multiple%2520sclerosis%2520patients%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2012%26volume%3D246%26spage%3D100%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span>ClinicalTrials.gov. Exploring the Efficacy and Safety of Siponimod in Patients with Secondary Progressive Multiple Sclerosis (EXPAND). <a href="http://clinicaltrials.gov/show/NCT01665144" class="extLink">http://clinicaltrials.gov/show/NCT01665144</a> (accessed Dec<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Exploring+the+Efficacy+and+Safety+of+Siponimod+in+Patients+with+Secondary+Progressive+Multiple+Sclerosis+%28EXPAND%29.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01665144+%28accessed+Dec+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span>ClinicalTrials.gov. Efficacy and Tolerability of BAF312 in Patients with Polymyositis and Dermatomyositis. <a href="http://clinicaltrials.gov/show/NCT01148810" class="extLink">http://clinicaltrials.gov/show/NCT01148810</a> (accessed Dec<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Efficacy+and+Tolerability+of+BAF312+in+Patients+with+Polymyositis+and+Dermatomyositis.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01148810+%28accessed+Dec+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span>ClinicalTrials.gov. ACT-128800 in Patients with Moderate to Severe Chronic Plaque Psoriasis. <a href="http://clinicaltrials.gov/show/NCT01208090" class="extLink">http://clinicaltrials.gov/show/NCT01208090</a> accessed Aug<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+ACT-128800+in+Patients+with+Moderate+to+Severe+Chronic+Plaque+Psoriasis.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01208090+accessed+Aug+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span>Media Releases. Actelion’s Ponesimod Successful in Mid-Stage Trial in Patients with Moderate to Severe Chronic Plaque Psoriasis. <a href="http://www.actelion.com/en/investors/media-releases/index.page?pageId=2&amp;language=en" class="extLink">http://www.actelion.com/en/investors/media-releases/index.page?pageId=2&language=en</a> (accessed December 18<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Media+Releases.+Actelion%E2%80%99s+Ponesimod+Successful+in+Mid-Stage+Trial+in+Patients+with+Moderate+to+Severe+Chronic+Plaque+Psoriasis.+http%3A%2F%2Fwww.actelion.com%2Fen%2Finvestors%2Fmedia-releases%2Findex.page%3FpageId%3D2%26language%3Den+%28accessed+December+18+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Budde, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schütz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glander, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waiser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liefeldt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumayer, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böhler, T.</span><span> </span><span class="NLM_article-title">FTY720 (fingolimod) in renal transplantation</span> <span class="citation_source-journal">Clin. Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 17</span><span class="NLM_x">) </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1111%2Fj.1399-0012.2006.00596.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=17100697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A280%3ADC%252BD28nms1WltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=17-24&issue=Suppl.+17&author=K.+Buddeauthor=M.+Sch%C3%BCtzauthor=P.+Glanderauthor=H.+Petersauthor=J.+Waiserauthor=L.+Liefeldtauthor=H.+H.+Neumayerauthor=T.+B%C3%B6hler&title=FTY720+%28fingolimod%29+in+renal+transplantation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720 (fingolimod) in renal transplantation</span></div><div class="casAuthors">Budde Klemens; Schutz Manuela; Glander Petra; Peters Harm; Waiser Johannes; Liefeldt Lutz; Neumayer Hans-H; Bohler Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Clinical transplantation</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20 Suppl 17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17-24</span>
        ISSN:<span class="NLM_cas:issn">0902-0063</span>.
    </div><div class="casAbstract">FTY720 (Fingolimod) is a novel immunomodulator with a mode of action that is completely different from classical immunosuppressants.  FTY is a structural and functional analogue of the natural serum lipid, sphingosine, and is the first in a new class of drugs called sphingosine 1-phosphate receptor (S1P-R) modulators.  This review discusses the recent findings on the mechanism of action, preclinical models and outlines the results of the ongoing clinical development program.  FTY is highly effective in prolonging allograft survival in preclinical models of transplantation and in experimental models of autoimmune diseases.  In clinical trials, this novel compound was investigated in de novo renal transplantation and in multiple sclerosis.  Pharmacokinetics are characterized by a prolonged absorption phase, a large volume of distribution, and a long elimination half-life.  FTY induces a rapid and transient decrease in lymphocyte counts, which supports the modulatory effects of the drug on lymphocyte sequestration.  The most common adverse event was asymptomatic transient bradycardia, a pharmacodynamic effect modulated by atrial S1 P-R.  FTY failed to show an improvement in efficacy for the prevention of renal allograft rejection in two large phase III studies.  FTY treatment regimens were associated with impaired renal function and the development of macula edema.  Consequently, the further development in renal transplantation was stopped.  Because initial clinical studies strongly suggest that FTY is highly effective in multiple sclerosis FTY is now being explored in phase III studies for the treatment of demyelinating diseases, Ongoing studies in multiple sclerosis are eagerly awaited because they may provide novel therapeutic options for patients with autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRP88lC8yE9O9y3lHz94U-GfW6udTcc2eY9xtmvRusIvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28nms1WltQ%253D%253D&md5=3799360786675c4e7074e5c4d4b452ed</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-0012.2006.00596.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-0012.2006.00596.x%26sid%3Dliteratum%253Aachs%26aulast%3DBudde%26aufirst%3DK.%26aulast%3DSch%25C3%25BCtz%26aufirst%3DM.%26aulast%3DGlander%26aufirst%3DP.%26aulast%3DPeters%26aufirst%3DH.%26aulast%3DWaiser%26aufirst%3DJ.%26aulast%3DLiefeldt%26aufirst%3DL.%26aulast%3DNeumayer%26aufirst%3DH.%2BH.%26aulast%3DB%25C3%25B6hler%26aufirst%3DT.%26atitle%3DFTY720%2520%2528fingolimod%2529%2520in%2520renal%2520transplantation%26jtitle%3DClin.%2520Transplant.%26date%3D2006%26volume%3D20%26issue%3DSuppl.%252017%26spage%3D17%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Shimizu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakamata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enosawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeyoshi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, E.</span><span> </span><span class="NLM_article-title">KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and hear allografts</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2005&pages=222-229&author=H.+Shimizuauthor=M.+Takahashiauthor=T.+Kanekoauthor=T.+Murakamiauthor=Y.+Hakamataauthor=S.+Kudouauthor=T.+Kishiauthor=K.+Fukuchiauthor=S.+Iwanamiauthor=K.+Kuriyamaauthor=T.+Yasueauthor=S.+Enosawaauthor=K.+Matsumotoauthor=I.+Takeyoshiauthor=Y.+Morishitaauthor=E.+Kobayashi&title=KRP-203%2C+a+novel+synthetic+immunosuppressant%2C+prolongs+graft+survival+and+attenuates+chronic+rejection+in+rat+skin+and+hear+allografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DHakamata%26aufirst%3DY.%26aulast%3DKudou%26aufirst%3DS.%26aulast%3DKishi%26aufirst%3DT.%26aulast%3DFukuchi%26aufirst%3DK.%26aulast%3DIwanami%26aufirst%3DS.%26aulast%3DKuriyama%26aufirst%3DK.%26aulast%3DYasue%26aufirst%3DT.%26aulast%3DEnosawa%26aufirst%3DS.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DTakeyoshi%26aufirst%3DI.%26aulast%3DMorishita%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DE.%26atitle%3DKRP-203%252C%2520a%2520novel%2520synthetic%2520immunosuppressant%252C%2520prolongs%2520graft%2520survival%2520and%2520attenuates%2520chronic%2520rejection%2520in%2520rat%2520skin%2520and%2520hear%2520allografts%26jtitle%3DCirculation%26date%3D2005%26volume%3D111%26spage%3D222%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span>ClinicalTrials.gov. Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus. <a href="http://clinicaltrials.gov/show/NCT01294774" class="extLink">http://clinicaltrials.gov/show/NCT01294774</a> (accessed July<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Safety+and+Efficacy+of+KRP203+in+Subacute+Cutaneous+Lupus+Erythematosus.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01294774+%28accessed+July+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span>ClinicalTrials.gov. Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis Patients. <a href="http://clinicaltrials.gov/show/NCT01375179" class="extLink">http://clinicaltrials.gov/show/NCT01375179</a> (accessed July<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Efficacy+%26+Safety+in+Moderately+Active+Refractory+Ulcerative+Colitis+Patients.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01375179+%28accessed+July+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Buzard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoresen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrader, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sage, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Shamma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P<sub>1</sub> agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6013</span><span class="NLM_x">–</span> <span class="NLM_lpage">6018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6013-6018&author=D.+Buzardauthor=S.+Hanauthor=L.+Thoresenauthor=J.+Moodyauthor=L.+Lopezauthor=A.+Kawasakiauthor=T.+Schraderauthor=C.+Sageauthor=Y.+Gaoauthor=J.+Edwardsauthor=J.+Bardenauthor=J.+Thatteauthor=L.+Fuauthor=M.+Solomonauthor=L.+Liuauthor=H.+Al-Shammaauthor=J.+Gatlinauthor=M.+Leauthor=C.+Xingauthor=S.+Espinolaauthor=R.+M.+Jones&title=Discovery+and+characterization+of+potent+and+selective+4-oxo-4-%285-%285-phenyl-1%2C2%2C4-oxadiazol-3-yl%29indolin-1-yl%29butanoic+acids+as+S1P1+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DThoresen%26aufirst%3DL.%26aulast%3DMoody%26aufirst%3DJ.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DKawasaki%26aufirst%3DA.%26aulast%3DSchrader%26aufirst%3DT.%26aulast%3DSage%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DBarden%26aufirst%3DJ.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DSolomon%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DAl-Shamma%26aufirst%3DH.%26aulast%3DGatlin%26aufirst%3DJ.%26aulast%3DLe%26aufirst%3DM.%26aulast%3DXing%26aufirst%3DC.%26aulast%3DEspinola%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520potent%2520and%2520selective%25204-oxo-4-%25285-%25285-phenyl-1%252C2%252C4-oxadiazol-3-yl%2529indolin-1-yl%2529butanoic%2520acids%2520as%2520S1P1%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6013%26epage%3D6018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoresen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gharbaoui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usmani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadeque, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Shamma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Fused tricyclic indoles as S1P(1) agonists with robust efficacy in animal models of autoimmune disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4404</span><span class="NLM_x">–</span> <span class="NLM_lpage">4409</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4404-4409&author=D.+J.+Buzardauthor=S.+Hanauthor=L.+Lopezauthor=A.+Kawasakiauthor=J.+Moodyauthor=L.+Thoresenauthor=B.+Ullmanauthor=J.+Lehmannauthor=I.+Calderonauthor=X.+Zhuauthor=T.+Gharbaouiauthor=D.+Senguptaauthor=A.+Krishnanauthor=Y.+Gaoauthor=J.+Edwardsauthor=J.+Bardenauthor=M.+Morganauthor=K.+Usmaniauthor=C.+Chenauthor=A.+Sadequeauthor=J.+Thatteauthor=M.+Solomonauthor=L.+Fuauthor=K.+Whelanauthor=L.+Liuauthor=H.+Al-Shammaauthor=J.+Gatlinauthor=M.+Leauthor=C.+Xingauthor=S.+Espinolaauthor=R.+M.+Jones&title=Fused+tricyclic+indoles+as+S1P%281%29+agonists+with+robust+efficacy+in+animal+models+of+autoimmune+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DKawasaki%26aufirst%3DA.%26aulast%3DMoody%26aufirst%3DJ.%26aulast%3DThoresen%26aufirst%3DL.%26aulast%3DUllman%26aufirst%3DB.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DCalderon%26aufirst%3DI.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DGharbaoui%26aufirst%3DT.%26aulast%3DSengupta%26aufirst%3DD.%26aulast%3DKrishnan%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DBarden%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DUsmani%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DSadeque%26aufirst%3DA.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DSolomon%26aufirst%3DM.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DWhelan%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DAl-Shamma%26aufirst%3DH.%26aulast%3DGatlin%26aufirst%3DJ.%26aulast%3DLe%26aufirst%3DM.%26aulast%3DXing%26aufirst%3DC.%26aulast%3DEspinola%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DFused%2520tricyclic%2520indoles%2520as%2520S1P%25281%2529%2520agonists%2520with%2520robust%2520efficacy%2520in%2520animal%2520models%2520of%2520autoimmune%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4404%26epage%3D4409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Aguilar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grima, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segarra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godessart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarrason, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domenech, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armengol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordoba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabate, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casals, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, M.</span><span> </span><span class="NLM_article-title">Discovery of a novel class of zwitterionic, potent, selective and orally active S1P(1) direct agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7672</span><span class="NLM_x">–</span> <span class="NLM_lpage">7676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7672-7676&author=N.+Aguilarauthor=M.+Mirauthor=P.+M.+Grimaauthor=M.+Lopezauthor=V.+Segarraauthor=L.+Estebanauthor=I.+Morenoauthor=N.+Godessartauthor=G.+Tarrasonauthor=T.+Domenechauthor=D.+Vilellaauthor=C.+Armengolauthor=M.+Cordobaauthor=M.+Sabateauthor=D.+Casalsauthor=M.+Dominguez&title=Discovery+of+a+novel+class+of+zwitterionic%2C+potent%2C+selective+and+orally+active+S1P%281%29+direct+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAguilar%26aufirst%3DN.%26aulast%3DMir%26aufirst%3DM.%26aulast%3DGrima%26aufirst%3DP.%2BM.%26aulast%3DLopez%26aufirst%3DM.%26aulast%3DSegarra%26aufirst%3DV.%26aulast%3DEsteban%26aufirst%3DL.%26aulast%3DMoreno%26aufirst%3DI.%26aulast%3DGodessart%26aufirst%3DN.%26aulast%3DTarrason%26aufirst%3DG.%26aulast%3DDomenech%26aufirst%3DT.%26aulast%3DVilella%26aufirst%3DD.%26aulast%3DArmengol%26aufirst%3DC.%26aulast%3DCordoba%26aufirst%3DM.%26aulast%3DSabate%26aufirst%3DM.%26aulast%3DCasals%26aufirst%3DD.%26aulast%3DDominguez%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%2520zwitterionic%252C%2520potent%252C%2520selective%2520and%2520orally%2520active%2520S1P%25281%2529%2520direct%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7672%26epage%3D7676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span>Almirall. Product Development Pipeline. <a href="http://www.almirall.com/webcorp2/cda/ImD_03_02.jsp" class="extLink">http://www.almirall.com/webcorp2/cda/ImD_03_02.jsp</a> (accessed Jan<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Almirall.+Product+Development+Pipeline.+http%3A%2F%2Fwww.almirall.com%2Fwebcorp2%2Fcda%2FImD_03_02.jsp+%28accessed+Jan+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Demont, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arpino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeks, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaskin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orborne, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panchal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span> </span><span class="NLM_article-title">Discovery of a brain-penetrant S1P<sub>3</sub>-sparing direct agonist of the S1P<sub>1</sub> and S1P<sub>5</sub> receptors efficacious at low oral dose</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6724</span><span class="NLM_x">–</span> <span class="NLM_lpage">6733</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200609t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6724-6733&author=E.+H.+Demontauthor=S.+Arpinoauthor=R.+A.+Bitauthor=C.+A.+Campbellauthor=N.+Deeksauthor=S.+Desaiauthor=S.+J.+Dowellauthor=P.+Gaskinauthor=J.+R.+J.+Grayauthor=L.+A.+Harrisonauthor=A.+Haynesauthor=T.+D.+Heightmanauthor=D.+S.+Holmesauthor=P.+G.+Humphreysauthor=U.+Kumarauthor=M.+A.+Morseauthor=G.+J.+Orborneauthor=T.+Panchalauthor=K.+L.+Philpottauthor=S.+Taylorauthor=R.+Watsonauthor=R.+Willisauthor=J.+Witherington&title=Discovery+of+a+brain-penetrant+S1P3-sparing+direct+agonist+of+the+S1P1+and+S1P5+receptors+efficacious+at+low+oral+dose"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm200609t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200609t%26sid%3Dliteratum%253Aachs%26aulast%3DDemont%26aufirst%3DE.%2BH.%26aulast%3DArpino%26aufirst%3DS.%26aulast%3DBit%26aufirst%3DR.%2BA.%26aulast%3DCampbell%26aufirst%3DC.%2BA.%26aulast%3DDeeks%26aufirst%3DN.%26aulast%3DDesai%26aufirst%3DS.%26aulast%3DDowell%26aufirst%3DS.%2BJ.%26aulast%3DGaskin%26aufirst%3DP.%26aulast%3DGray%26aufirst%3DJ.%2BR.%2BJ.%26aulast%3DHarrison%26aufirst%3DL.%2BA.%26aulast%3DHaynes%26aufirst%3DA.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DHolmes%26aufirst%3DD.%2BS.%26aulast%3DHumphreys%26aufirst%3DP.%2BG.%26aulast%3DKumar%26aufirst%3DU.%26aulast%3DMorse%26aufirst%3DM.%2BA.%26aulast%3DOrborne%26aufirst%3DG.%2BJ.%26aulast%3DPanchal%26aufirst%3DT.%26aulast%3DPhilpott%26aufirst%3DK.%2BL.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DWatson%26aufirst%3DR.%26aulast%3DWillis%26aufirst%3DR.%26aulast%3DWitherington%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520brain-penetrant%2520S1P3-sparing%2520direct%2520agonist%2520of%2520the%2520S1P1%2520and%2520S1P5%2520receptors%2520efficacious%2520at%2520low%2520oral%2520dose%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6724%26epage%3D6733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Ren, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, J.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span> </span><span class="NLM_article-title">Discovery of novel 1,2,4-thiadiazole derivatives as potent, orally active agonists of sphingosine 1-phosphate subtype 1 (S1P<sub>1</sub>)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4286</span><span class="NLM_x">–</span> <span class="NLM_lpage">4295</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2016107" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4286-4295&author=F.+Renauthor=G.+Dengauthor=H.+Wangauthor=L.+Luanauthor=Q.+Mengauthor=Q.+Xuauthor=H.+Xuauthor=X.+Xuauthor=H.+Zhangauthor=B.+Zhaoauthor=C.+Liauthor=T.+B.+Guoauthor=J.+Yangauthor=W.+Zhangauthor=Y.+Zhaoauthor=Q.+Jiaauthor=H.+Luauthor=J.-N.+Xiangauthor=J.+D.+Elliottauthor=X.+Lin&title=Discovery+of+novel+1%2C2%2C4-thiadiazole+derivatives+as+potent%2C+orally+active+agonists+of+sphingosine+1-phosphate+subtype+1+%28S1P1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm2016107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2016107%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DF.%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLuan%26aufirst%3DL.%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DT.%2BB.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DJia%26aufirst%3DQ.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DXiang%26aufirst%3DJ.-N.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520novel%25201%252C2%252C4-thiadiazole%2520derivatives%2520as%2520potent%252C%2520orally%2520active%2520agonists%2520of%2520sphingosine%25201-phosphate%2520subtype%25201%2520%2528S1P1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4286%26epage%3D4295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeks, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaskin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavens, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cryan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garden, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span> </span><span class="NLM_article-title">The utility of pharmacokinetic-pharmacodynamic modeling in the discovery and optimization of selective S1P<sub>1</sub> agonists</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">686</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=671-686&author=S.+Taylorauthor=J.+R.+J.+Grayauthor=R.+Willisauthor=N.+Deeksauthor=A.+Haynesauthor=C.+Campbellauthor=P.+Gaskinauthor=K.+Leavensauthor=E.+Demontauthor=S.+Dowellauthor=J.+Cryanauthor=M.+Morseauthor=A.+Patelauthor=H.+Gardenauthor=J.+Witherington&title=The+utility+of+pharmacokinetic-pharmacodynamic+modeling+in+the+discovery+and+optimization+of+selective+S1P1+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DJ.%2BR.%2BJ.%26aulast%3DWillis%26aufirst%3DR.%26aulast%3DDeeks%26aufirst%3DN.%26aulast%3DHaynes%26aufirst%3DA.%26aulast%3DCampbell%26aufirst%3DC.%26aulast%3DGaskin%26aufirst%3DP.%26aulast%3DLeavens%26aufirst%3DK.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DDowell%26aufirst%3DS.%26aulast%3DCryan%26aufirst%3DJ.%26aulast%3DMorse%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DGarden%26aufirst%3DH.%26aulast%3DWitherington%26aufirst%3DJ.%26atitle%3DThe%2520utility%2520of%2520pharmacokinetic-pharmacodynamic%2520modeling%2520in%2520the%2520discovery%2520and%2520optimization%2520of%2520selective%2520S1P1%2520agonists%26jtitle%3DXenobiotica%26date%3D2012%26volume%3D42%26spage%3D671%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span>Bristol-Myers Squibb. In the Pipeline. <a href="http://www.bms.com/research/pipeline/Pages/default.aspx" class="extLink">http://www.bms.com/research/pipeline/Pages/default.aspx</a> (accessed Jan<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bristol-Myers+Squibb.+In+the+Pipeline.+http%3A%2F%2Fwww.bms.com%2Fresearch%2Fpipeline%2FPages%2Fdefault.aspx+%28accessed+Jan+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Cherney, R. J.; Wang, Z.</span><span> </span><span class="NLM_article-title">Heterocyclic Compounds as S1P1 Agonists for the Treatment of Autoimmune and Vascular Diseases</span>. WO2012061459, May 10,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=R.+J.+Cherney&author=Z.+Wang&title=Heterocyclic+Compounds+as+S1P1+Agonists+for+the+Treatment+of+Autoimmune+and+Vascular+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCherney%26aufirst%3DR.%2BJ.%26atitle%3DHeterocyclic%2520Compounds%2520as%2520S1P1%2520Agonists%2520for%2520the%2520Treatment%2520of%2520Autoimmune%2520and%2520Vascular%2520Diseases%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Recent progress in the development of selective S1P<sub>1</sub> receptor agonists for the treatment of inflammatory and autoimmune disorders</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1141</span><span class="NLM_x">–</span> <span class="NLM_lpage">1159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1517%2F13543776.18.10.1141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ais7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1141-1159&author=D.+J.+Buzardauthor=J.+Thatteauthor=M.+Lernerauthor=J.+Edwardsauthor=R.+M.+Jones&title=Recent+progress+in+the+development+of+selective+S1P1+receptor+agonists+for+the+treatment+of+inflammatory+and+autoimmune+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of selective S1P1 receptor agonists for the treatment of inflammatory and autoimmune disorders</span></div><div class="casAuthors">Buzard, Daniel J.; Thatte, Jayant; Lerner, Michael; Edwards, Jeffrey; Jones, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1141-1159</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The sphingosine-1-phosphate receptor 1 (S1P1) belongs to the endothelial differentiation gene family of G-protein-coupled receptors involved in embryonic development, cellular differentiation and survival, adherence and tight junction assembly, and leukocyte trafficking.  In vivo S1P1 is required for egress of thymocytes into the blood and of naive lymphocytes from secondary lymphoid organs back into the lymph.  Downregulation of S1P1 disrupts lymphocyte migration, tissue homing and recirculation.  To explore the immunomodulatory potential of S1P1, pharma is developing S1P1-selective agonists for treating autoimmune and inflammatory disorders.  FTY720 (fingolimod, Novartis AG), a nonselective S1P1 agonist that induces sustained lymphopenia, is a promising pseudo-lipid aminodiol prodrug that has been shown in preclin. and early clin. trials to be effective in suppressing various autoimmune conditions and to aid in acute organ transplant, and is currently in pivotal Phase III clin. trials for relapsing-remitting multiple sclerosis.  In this review article, we outline recent advances made in the discovery and patenting of new small-mol. S1P1 selective agonists and summarize a rapidly growing body of intellectual property.  Fingolimod-like S1P1 agonists with a novel mechanism of action have emerged as promising immunosuppressants.  S1P1 agonists induce T-cell sequestration in lymph nodes and Peyer's patches, diminishing their ability to reach distant sites and cause pathol.  Preclin. studies have already provided preliminary evidence that low-dose treatment with fingolimod in conjunction with subtherapeutic doses of cyclosporin A and tacrolimus enable potent immunosuppression in the absence of immediately serious side effects.  Future efforts will det. whether S1P1 agonists do indeed synergize with existing DMAs to create new mutidrug paradigms with superior efficacy and safety for the treatment of autoimmune diseases and the prevention of organ transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoio59l2iXb2rVg90H21EOLACvtfcHk0lgNW-7_uOnrSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ais7nK&md5=fe911f7d9d3fb961c7df50663bffc245</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.10.1141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.10.1141%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DLerner%26aufirst%3DM.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DRecent%2520progress%2520in%2520the%2520development%2520of%2520selective%2520S1P1%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520inflammatory%2520and%2520autoimmune%2520disorders%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2008%26volume%3D18%26spage%3D1141%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lescop, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span> </span><span class="NLM_article-title">Synthetic sphingosine 1-phosphate receptor modulators: opportunities and potential pitfalls</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">726</span><span class="NLM_x">–</span> <span class="NLM_lpage">757</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.2174%2F1568026611109060726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=21261590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=726-757&author=M.+H.+Bolliauthor=C.+Lescopauthor=O.+Nayler&title=Synthetic+sphingosine+1-phosphate+receptor+modulators%3A+opportunities+and+potential+pitfalls"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic sphingosine 1-phosphate receptor modulators - opportunities and potential pitfalls</span></div><div class="casAuthors">Bolli, Martin H.; Lescop, Cyrille; Nayler, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">726-757</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P) evokes a plethora of physiol. responses by stimulating members of a G protein-coupled receptor family, known as S1P receptors.  Currently five different mammalian S1P receptor subtypes, S1P1-5, each with a different cellular expression pattern, were identified.  The S1P1 receptor in particular has attracted major interest throughout the pharmaceutical industry following the breakthrough discovery that this S1P receptor subtype is critically involved in the regulation of lymphocyte trafficking through secondary lymphoid organs.  Since then, examples of synthetic S1P1 agonists with lymphocyte reducing and immunomodulating activity demonstrated efficacy in numerous preclin. models of autoimmune disease and transplantation.  Notably FTY720 (fingolimod), a pro-drug that is phosphorylated in vivo and converted into a non-selective S1P1,3,4,5 receptor agonist, has been widely used to increase the understanding of S1P1 receptor biol.  Results from recently completed phase III clin. trials using FTY720 paved the way for this non-selective S1P1 receptor agonist to become the first oral therapy in multiple sclerosis, with potential expansion into many other autoimmune diseases.  This review briefly outlines the field of S1P1 receptor biol. and summarizes recent approaches in medicinal chem. to discover potent and selective S1P1 receptor agonists.  In particular, the complexity of discovering a mol. akin to FTY720 but with an improved side-effect profile will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTTZ2jfUXEtrVg90H21EOLACvtfcHk0lgNW-7_uOnrSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSmsro%253D&md5=9f6d05909fb5615126ea642f4cc19271</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.2174%2F1568026611109060726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026611109060726%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DLescop%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26atitle%3DSynthetic%2520sphingosine%25201-phosphate%2520receptor%2520modulators%253A%2520opportunities%2520and%2520potential%2520pitfalls%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D726%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Dyckman, A. J.</span><span> </span><span class="NLM_article-title">Recent advances in the discovery and development of sphingosine-1-phosphate-1 receptor agonists</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=195-207&author=A.+J.+Dyckman&title=Recent+advances+in+the+discovery+and+development+of+sphingosine-1-phosphate-1+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520and%2520development%2520of%2520sphingosine-1-phosphate-1%2520receptor%2520agonists%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2012%26volume%3D47%26spage%3D195%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Roberts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate receptor agonists: a patent review (2010–2012)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">841</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1517%2F13543776.2013.783022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslCks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=817-841&author=E.+Robertsauthor=M.+Guerreroauthor=M.+Urbanoauthor=H.+Rosen&title=Sphingosine+1-phosphate+receptor+agonists%3A+a+patent+review+%282010%E2%80%932012%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate receptor agonists: a patent review (2010 - 2012)</span></div><div class="casAuthors">Roberts, Edward; Guerrero, Miguel; Urbano, Mariangela; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">817-841</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The sphingosine-1-phosphate (S1P)-driven signaling regulates fundamental biol. functions, including cell proliferation, angiogenesis, endothelial cell chemotaxis, immune cell trafficking and mitogenesis.  A large body of research has been focusing on the development of immunosuppressive S1P1 receptor (S1P1-R) agonist mols.  The S1P1,3 - 5-R pan-agonist fingolimod (FTY720) has been approved by the FDA for the treatment of relapsing-remitting multiple sclerosis.  However, FTY720 is now contraindicated in patients with compromised cardiac function.  Although the main adverse effect bradycardia has been linked to the S1P3-R activation, cardiovascular liabilities persist with more selective S1P1-R agonists that have entered clin. trials.  In contrast to the S1P1-R, the therapeutic application of the S1P2 - 5-Rs remains poorly explored.  Areas covered: This review provides the patent literature from 2010 to date on S1P-R agonist mols. and their relevant biol. properties.  Expert opinion: Limited progress has been made on agonists at S1P4,5-R subtypes, with some families of S1P5-R agonists showing promising results in animal models of age-related cognitive disorders.  A discrete no. of reviewed mols. are S1P1-R agonists with a promising clin. outlook in transplantation, inflammation, cancer and autoimmune settings.  Further preclin. and clin. studies will det. whether the new developed S1P1-R agonists do indeed improve the safety profile of FTY720.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIrASpSMDS37Vg90H21EOLACvtfcHk0lgNW-7_uOnrSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslCks7o%253D&md5=405b6350b777d3040e2be21adf85d440</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.783022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.783022%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DGuerrero%26aufirst%3DM.%26aulast%3DUrbano%26aufirst%3DM.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DSphingosine%25201-phosphate%2520receptor%2520agonists%253A%2520a%2520patent%2520review%2520%25282010%25E2%2580%25932012%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D817%26epage%3D841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetzl, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=265-269&author=J.+Chunauthor=E.+J.+Goetzlauthor=T.+Hlaauthor=Y.+Igarashiauthor=K.+R.+Lynchauthor=W.+Moolenaarauthor=S.+Pyneauthor=G.+Tigyi&title=International+Union+of+Pharmacology.+XXXIV.+Lysophospholipid+receptor+nomenclature"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DGoetzl%26aufirst%3DE.%2BJ.%26aulast%3DHla%26aufirst%3DT.%26aulast%3DIgarashi%26aufirst%3DY.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMoolenaar%26aufirst%3DW.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DTigyi%26aufirst%3DG.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology.%2520XXXIV.%2520Lysophospholipid%2520receptor%2520nomenclature%26jtitle%3DPharmacol.%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D265%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Meyer-zu-Heringdorf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakobs, K. H.</span><span> </span><span class="NLM_article-title">Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1768</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">940</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1768&publication_year=2006&pages=923-940&author=D.+Meyer-zu-Heringdorfauthor=K.+H.+Jakobs&title=Lysophospholipid+receptors%3A+signalling%2C+pharmacology+and+regulation+by+lysophospholipid+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer-zu-Heringdorf%26aufirst%3DD.%26aulast%3DJakobs%26aufirst%3DK.%2BH.%26atitle%3DLysophospholipid%2520receptors%253A%2520signalling%252C%2520pharmacology%2520and%2520regulation%2520by%2520lysophospholipid%2520metabolism%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2006%26volume%3D1768%26spage%3D923%26epage%3D940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.pharmthera.2007.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=17561264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntFyiur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2007&pages=84-105&author=V.+Brinkmann&title=Sphingosine+1-phosphate+receptors+in+health+and+disease%3A+mechanistic+insights+from+gene+deletion+studies+and+reverse+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology</span></div><div class="casAuthors">Brinkmann, Volker</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-105</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P) is a bioactive sphingolipid that is critically involved in the embryonic development of the cardiovascular and central nervous systems.  In the adult, S1P can produce cytoskeletal re-arrangements in many cell types to regulate immune cell trafficking, vascular homeostasis and cell communication in the central nervous system.  S1P is contained in body fluids and tissues at different concns., and excessive prodn. of the pleiotropic mediator at inflammatory sites may participate in various pathol. conditions.  Gene deletion studies and reverse pharmacol. (techniques aiming to identify both ligands and function of receptors) provided evidence that many effects of S1P are mediated via five G-protein-coupled S1P receptor subtypes, and novel therapeutic strategies based on interaction with these receptors are being initiated.  The prototype S1P receptor modulator, FTY720 (fingolimod), targets four of the five S1P receptor subtypes and may act at several levels to modulate lymphocyte trafficking via lymphocytic and endothelial S1P1 and, perhaps, other inflammatory processes through addnl. S1P receptor subtypes.  A recently completed Phase II clin. trial suggested that the drug may provide an effective treatment of relapsing-remitting multiple sclerosis.  FTY720 is currently being evaluated in larger-scale, longer-term, Phase III studies.  This review provides an overview on S1P activities and S1P receptor function in health and disease, and summarizes the clin. experience with FTY720 in transplantation and multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGbwKhZo2vLrVg90H21EOLACvtfcHk0lgPXH9_tGzxHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntFyiur0%253D&md5=cacdb374439270734f34a0ca4771ca3d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26atitle%3DSphingosine%25201-phosphate%2520receptors%2520in%2520health%2520and%2520disease%253A%2520mechanistic%2520insights%2520from%2520gene%2520deletion%2520studies%2520and%2520reverse%2520pharmacology%26jtitle%3DPharmacol.%2520Ther.%26date%3D2007%26volume%3D115%26spage%3D84%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Takabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paugh, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">“Inside-out” signaling of sphingosine-1-phosphate: therapeutic targets</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=181-195&author=K.+Takabeauthor=S.+W.+Paughauthor=S.+Milstienauthor=S.+Spiegel&title=%E2%80%9CInside-out%E2%80%9D+signaling+of+sphingosine-1-phosphate%3A+therapeutic+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakabe%26aufirst%3DK.%26aulast%3DPaugh%26aufirst%3DS.%2BW.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3D%25E2%2580%259CInside-out%25E2%2580%259D%2520signaling%2520of%2520sphingosine-1-phosphate%253A%2520therapeutic%2520targets%26jtitle%3DPharmacol.%2520Rev.%26date%3D2008%26volume%3D60%26spage%3D181%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span> </span><span class="NLM_article-title">Pulmonary and vascular pharmacology of sphingosine 1-phosphate</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.coph.2005.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=16563863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFynu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=244-250&author=V.+Brinkmannauthor=T.+Baumruker&title=Pulmonary+and+vascular+pharmacology+of+sphingosine+1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Pulmonary and vascular pharmacology of sphingosine 1-phosphate</span></div><div class="casAuthors">Brinkmann, Volker; Baumruker, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">244-250</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Dysregulation of vasomotor tone, endothelial barrier function and immune cell trafficking are central to the pathol. of many lung diseases, including acute lung injury, adult respiratory distress syndrome, chronic obstructive pulmonary disease and asthma.  There is increasing evidence that the serum sphingolipid sphingosine 1-phosphate and its G-protein-coupled receptors are pivotal not only in the regulation of lymphocyte migration, but also in the maintenance of vascular homeostasis and the preservation of permeability barriers that sep. discrete compartments in the lung.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogmZxjsblpVLVg90H21EOLACvtfcHk0liPzpIS9IKP9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFynu78%253D&md5=6e55263d754e331bcfa5d82ddc3eed7a</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2005.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2005.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBaumruker%26aufirst%3DT.%26atitle%3DPulmonary%2520and%2520vascular%2520pharmacology%2520of%2520sphingosine%25201-phosphate%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2006%26volume%3D6%26spage%3D244%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Hait, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oskeritzian, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paugh, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1758</span><span class="NLM_x">, </span> <span class="NLM_fpage">2016</span><span class="NLM_x">–</span> <span class="NLM_lpage">2026</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1758&publication_year=2006&pages=2016-2026&author=N.+C.+Haitauthor=C.+A.+Oskeritzianauthor=S.+W.+Paughauthor=S.+Milstienauthor=S.+Spiegel&title=Sphingosine+kinases%2C+sphingosine+1-phosphate%2C+apoptosis+and+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHait%26aufirst%3DN.%2BC.%26aulast%3DOskeritzian%26aufirst%3DC.%2BA.%26aulast%3DPaugh%26aufirst%3DS.%2BW.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine%2520kinases%252C%2520sphingosine%25201-phosphate%252C%2520apoptosis%2520and%2520diseases%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2006%26volume%3D1758%26spage%3D2016%26epage%3D2026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Alvarez, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Autocrine and paracrine roles of sphingosine-1-phosphate</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">300</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.tem.2007.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=17904858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGrsbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=300-307&author=S.+E.+Alvarezauthor=S.+Milstienauthor=S.+Spiegel&title=Autocrine+and+paracrine+roles+of+sphingosine-1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Autocrine and paracrine roles of sphingosine-1-phosphate</span></div><div class="casAuthors">Alvarez, Sergio E.; Milstien, Sheldon; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">300-307</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid metabolite that has been implicated in many biol. processes, including cell migration, survival, proliferation, angiogenesis and immune and allergic responses.  S1P levels inside cells are regulated tightly by the balance between its synthesis by sphingosine kinases and degrdn. by S1P lyases and S1P phosphatases.  Activation of sphingosine kinase by any of a variety of agonists increases S1P levels, which in turn can function intracellularly as a second messenger or in an autocrine and/or paracrine fashion to activate and signal through S1P receptors present on the surface of the cell.  This review summarizes recent findings on the roles of S1P as a mediator of the actions of cytokines, growth factors and hormones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnhbcsK8o6BbVg90H21EOLACvtfcHk0liPzpIS9IKP9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGrsbfN&md5=45c8596fc7ade7db8ad6e85bccb13bc6</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2007.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2007.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez%26aufirst%3DS.%2BE.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DAutocrine%2520and%2520paracrine%2520roles%2520of%2520sphingosine-1-phosphate%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2007%26volume%3D18%26spage%3D300%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Marsolais, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=297-307&author=D.+Marsolaisauthor=H.+Rosen&title=Chemical+modulators+of+sphingosine-1-phosphate+receptors+as+barrier-oriented+therapeutic+molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarsolais%26aufirst%3DD.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DChemical%2520modulators%2520of%2520sphingosine-1-phosphate%2520receptors%2520as%2520barrier-oriented%2520therapeutic%2520molecules%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D297%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Okada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahangeer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span> </span><span class="NLM_article-title">Sphingosine kinase/sphingosine 1-phosphate signalling in central nervous system</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.cellsig.2008.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=18694820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVeks7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=7-13&author=T.+Okadaauthor=T.+Kajimotoauthor=S.+Jahangeerauthor=S.+Nakamura&title=Sphingosine+kinase%2Fsphingosine+1-phosphate+signalling+in+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine kinase/sphingosine 1-phosphate signalling in central nervous system</span></div><div class="casAuthors">Okada, Taro; Kajimoto, Taketoshi; Jahangeer, Saleem; Nakamura, Shun-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-13</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids were once regarded as inert structural components of cell membranes.  Now these metabolites are generally believed to be important bioactive mols. that control a wide repertoire of cellular processes such as proliferation and survival of cells.  Along with these ubiquitous cell functions obsd. in many peripheral tissues sphingolipid metabolites, esp. sphingosine 1-phosphate, exert important neuron-specific functions such as regulation of neurotransmitter release.  This review summarizes physiol. and pathol. roles of sphingolipid metabolites emphasizing the role of sphingosine 1-phosphate in the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvd7-soq4atbVg90H21EOLACvtfcHk0lgrqHKZ7UwxEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVeks7%252FI&md5=99538d7efb7f9866723a691e4d05f877</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2008.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2008.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DKajimoto%26aufirst%3DT.%26aulast%3DJahangeer%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DS.%26atitle%3DSphingosine%2520kinase%252Fsphingosine%25201-phosphate%2520signalling%2520in%2520central%2520nervous%2520system%26jtitle%3DCell.%2520Signalling%26date%3D2009%26volume%3D21%26spage%3D7%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gude, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate in neural signalling and function</span> <span class="citation_source-journal">Acta Paediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1111%2Fj.1651-2227.2007.00206.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A280%3ADC%252BD2s7ptVCqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=40-43&author=S.+Milstienauthor=D.+Gudeauthor=S.+Spiegel&title=Sphingosine+1-phosphate+in+neural+signalling+and+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate in neural signalling and function</span></div><div class="casAuthors">Milstien Sheldon; Gude David; Spiegel Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Acta paediatrica (Oslo, Norway : 1992). Supplement</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">455</span>),
    <span class="NLM_cas:pages">40-3</span>
        ISSN:<span class="NLM_cas:issn">0803-5326</span>.
    </div><div class="casAbstract">UNLABELLED:  Complex sphingolipids are particularly enriched in the central nervous system.  Although they were long considered to be structural components of membranes, in the last decades it has become apparent that they have other important functions.  More recently, attention has been given to the sphingolipid metabolites ceramide, sphingosine and sphingosine 1-phosphate (S1P), which have been implicated in the regulation of many aspects of neuronal proliferation, differentiation, survival and apoptosis.  Dysregulation of the relative levels of these bioactive sphingolipid metabolites may have implications for a wide array of neurodegenerative disorders and neural malformations.  In this paper, we will focus on studies from our laboratory over the past few years using cultured neurons to examine the roles of the sphingolipid metabolite S1P in neuronal survival and differentiation.  CONCLUSION:  Identification of potential intracellular targets of S1P remains a crucial objective for attaining a better understanding of the potent role this molecule plays in regulating cell fate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRizPA9-bzd8dyzdcP07UmufW6udTcc2eaMoJQhTcTEvLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s7ptVCqtg%253D%253D&md5=f85adf9a8590bc956cd2e2e6de2c427a</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1111%2Fj.1651-2227.2007.00206.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1651-2227.2007.00206.x%26sid%3Dliteratum%253Aachs%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DGude%26aufirst%3DD.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine%25201-phosphate%2520in%2520neural%2520signalling%2520and%2520function%26jtitle%3DActa%2520Paediatr.%26date%3D2007%26volume%3D96%26spage%3D40%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Dev, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullershausen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilbe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mir, A.</span><span> </span><span class="NLM_article-title">Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.pharmthera.2007.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=17961662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2008&pages=77-93&author=K.+K.+Devauthor=F.+Mullershausenauthor=H.+Mattesauthor=R.+R.+Kuhnauthor=G.+Bilbeauthor=D.+Hoyerauthor=A.+Mir&title=Brain+sphingosine-1-phosphate+receptors%3A+implication+for+FTY720+in+the+treatment+of+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis</span></div><div class="casAuthors">Dev, Kumlesh K.; Mullershausen, Florian; Mattes, Henri; Kuhn, Rainer R.; Bilbe, Graeme; Hoyer, Daniel; Mir, Anis</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-93</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Multiple sclerosis (MS) is an autoimmune, neurol. disability with unknown etiol.  The current therapies available for MS work by an immunomodulatory action, preventing T-cell- and macrophage-mediated destruction of brain-resident oligodendrocytes and axonal loss.  Recently, FTY720 (fingolimod) was shown to significantly reduce relapse rates in MS patients and is currently in Phase III clin. trials.  This drug attenuates trafficking of harmful T cells entering the brain by regulating sphingosine-1-phosphate (S1P) receptors.  Here, we outline the direct roles that S1P receptors play in the central nervous system (CNS) and discuss addnl. modalities by which FTY720 may provide direct neuroprotection in MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYlyd4S2EeELVg90H21EOLACvtfcHk0lgrqHKZ7UwxEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtL3J&md5=d5cf04a35f8bb06f3e094d2e75c698c0</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DDev%26aufirst%3DK.%2BK.%26aulast%3DMullershausen%26aufirst%3DF.%26aulast%3DMattes%26aufirst%3DH.%26aulast%3DKuhn%26aufirst%3DR.%2BR.%26aulast%3DBilbe%26aufirst%3DG.%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DMir%26aufirst%3DA.%26atitle%3DBrain%2520sphingosine-1-phosphate%2520receptors%253A%2520implication%2520for%2520FTY720%2520in%2520the%2520treatment%2520of%2520multiple%2520sclerosis%26jtitle%3DPharmacol.%2520Ther.%26date%3D2008%26volume%3D117%26spage%3D77%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Uhlig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulbins, E.</span><span> </span><span class="NLM_article-title">Sphingolipids in the lungs</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">1100</span><span class="NLM_x">–</span> <span class="NLM_lpage">1114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1164%2Frccm.200804-595SO" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=18755926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvVentA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2008&pages=1100-1114&author=S.+Uhligauthor=E.+Gulbins&title=Sphingolipids+in+the+lungs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipids in the lungs</span></div><div class="casAuthors">Uhlig, Stefan; Gulbins, Erich</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1100-1114</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">A review.  Sphingolipids such as sphingosine-1-phosphate (S1P), ceramide, or sphingomyelin are essential constituents of plasma membranes and regulate many (patho)physiol. cellular responses inducing apoptosis and cell survival, vascular permeability, mast cell activation, and airway smooth muscle functions.  The complexity of sphingolipid biol. is generated by a great variety of compds., diverse receptors, and often antagonistic functions of different sphingolipids.  For instance, apoptosis is promoted by ceramide and prevented by S1P, and pulmonary vascular permeability is increased by S1P2/3 receptors and by ceramide, whereas S1P1 receptors stabilize barrier integrity.  Several enzymes of the sphingolipid metab. respond to external stimuli such as sphingomyelinase isoenzymes that are activated by many stress stimuli and the sphingosine kinase isoenzymes that are activated by allergens.  The past years have provided increasing evidence that these processes contribute to pulmonary disorders including asthma, chronic obstructive pulmonary disease, acute lung injury, and cystic fibrosis.  Sphingolipid metab. offers several novel therapeutic targets for the treatment of lung diseases such as emphysema, asthma, cystic fibrosis, respiratory tract infection, sepsis, and acute lung injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1c1qpC7wtVLVg90H21EOLACvtfcHk0lhLGMkZtYEzQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvVentA%253D%253D&md5=b10c3ec2970d660c9f4acd57657ae380</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1164%2Frccm.200804-595SO&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200804-595SO%26sid%3Dliteratum%253Aachs%26aulast%3DUhlig%26aufirst%3DS.%26aulast%3DGulbins%26aufirst%3DE.%26atitle%3DSphingolipids%2520in%2520the%2520lungs%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2008%26volume%3D178%26spage%3D1100%26epage%3D1114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Augé, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nègre-Salvayre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvayre, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levade, T.</span><span> </span><span class="NLM_article-title">Sphingomyelin metabolites in vascular cell signaling and atherogenesis</span> <span class="citation_source-journal">Prog. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2FS0163-7827%2800%2900007-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=10799716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktlSqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=207-229&author=N.+Aug%C3%A9author=A.+N%C3%A8gre-Salvayreauthor=R.+Salvayreauthor=T.+Levade&title=Sphingomyelin+metabolites+in+vascular+cell+signaling+and+atherogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingomyelin metabolites in vascular cell signaling and atherogenesis</span></div><div class="casAuthors">Auge, Nathalie; Negre-Salvayre, Anne; Salvayre, Robert; Levade, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-229</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 186 refs.  The atherosclerotic lesion most probably develops through a no. of cellular events which implicate all vascular cell types and include synthesis of extracellular proteins, cell proliferation, differentiation and death.  Sphingolipids and sphingolipid metabolizing enzymes may play important roles in atherogenesis, not only because of lipoprotein alterations but also by mediating a no. of cellular events which are believed to be crucial in the development of the vascular lesions such as proliferation or cell death.  Exogenous sphingolipids may mediate various biol. effects such as apoptosis, mitogenesis or differentiation depending on the cell type.  Moreover, several mols. present in the atherogenic lesion, such as oxidized LDL, growth factors or cytokines, which activate intracellular signaling pathways leading to vascular cell modifications, can stimulate sphingomyelin hydrolysis and generation of ceramide (and other metabolites as sphingosine-1-phosphate).  Here we review the potential implication of the sphingomyelin/ceramide cycle in vascular cell signaling related to atherosclerosis, and more generally the role of sphingolipids in the events obsd. during the atherosclerotic process as cell differentiation, migration, adhesion, retraction, proliferation and death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR0eHtIWIEnrVg90H21EOLACvtfcHk0lhLGMkZtYEzQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktlSqsbs%253D&md5=bc3809c124061cac95443445af340377</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS0163-7827%2800%2900007-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7827%252800%252900007-2%26sid%3Dliteratum%253Aachs%26aulast%3DAug%25C3%25A9%26aufirst%3DN.%26aulast%3DN%25C3%25A8gre-Salvayre%26aufirst%3DA.%26aulast%3DSalvayre%26aufirst%3DR.%26aulast%3DLevade%26aufirst%3DT.%26atitle%3DSphingomyelin%2520metabolites%2520in%2520vascular%2520cell%2520signaling%2520and%2520atherogenesis%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2000%26volume%3D39%26spage%3D207%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Alewijnse, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, S. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, M. C.</span><span> </span><span class="NLM_article-title">Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1038%2Fsj.bjp.0705934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=15504747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOitrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2004&pages=666-684&author=A.+E.+Alewijnseauthor=S.+L.+M.+Petersauthor=M.+C.+Michel&title=Cardiovascular+effects+of+sphingosine-1-phosphate+and+other+sphingomyelin+metabolites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites</span></div><div class="casAuthors">Alewijnse, Astrid E.; Peters, Stephan L. M.; Michel, Martin C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">666-684</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Upon various stimuli, cells metabolize sphingomyelin from the cellular plasma membrane to form sphingosylphosphorylcholine (SPC) or ceramide.  The latter can be further metabolized to sphingosine and then sphingosine-1-phosphate (S1P).  Apart from local formation, S1P and SPC are major constituents of blood plasma.  All four sphingomyelin metabolites (SMM) can act upon intracellular targets, and at least S1P and probably also SPC can addnl. act upon G-protein-coupled receptors.  While the mol. identity of the SPC receptors remains unclear, several subtypes of S1P receptors have been cloned and their distribution in cardiovascular tissues is described.  In the heart SMM can alter intracellular Ca2+ release, particularly via the ryanodine receptor, and conductance of various ion channels in the plasma membrane, particularly IK(Ach).  While the various SMM differ somewhat in their effects, the above alterations of ion homeostasis result in reduced cardiac function in most cases, and ceramide and/or sphingosine may be the mediators of the neg. inotropic effects of tumor necrosis factor.  In the vasculature, SMM mainly act as acute vasoconstrictors in most vessels, but ceramide can be a vasodilator.  SMM-induced vasoconstriction involves mobilization of Ca2+ from intracellular stores, influx of extracellular Ca2+ via L-type channels and activation of a rho-kinase.  Extended exposure to SMM, particularly S1P, promotes several stages of the angiogenic process like endothelial cell activation, migration, proliferation, tube formation and vascular maturation.  The authors propose that SMM are an important class of endogenous modulators of cardiovascular function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm47o1k_ITeLVg90H21EOLACvtfcHk0lhLGMkZtYEzQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOitrrN&md5=b1f804471e653a56ad6794fd5092803f</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705934%26sid%3Dliteratum%253Aachs%26aulast%3DAlewijnse%26aufirst%3DA.%2BE.%26aulast%3DPeters%26aufirst%3DS.%2BL.%2BM.%26aulast%3DMichel%26aufirst%3DM.%2BC.%26atitle%3DCardiovascular%2520effects%2520of%2520sphingosine-1-phosphate%2520and%2520other%2520sphingomyelin%2520metabolites%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D143%26spage%3D666%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Yatomi, Y.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular disease</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">575</span><span class="NLM_x">–</span> <span class="NLM_lpage">587</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.2174%2F138161206775474404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=16472149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVGqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=575-587&author=Y.+Yatomi&title=Sphingosine+1-phosphate+in+vascular+biology%3A+possible+therapeutic+strategies+to+control+vascular+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases</span></div><div class="casAuthors">Yatomi, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">575-587</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Blood platelets are very unique in that they store sphingosine 1-phosphate (Sph-1-P) abundantly (possibly due to the existence of highly active sphingosine kinase and a lack of Sph-1-P lyase) and release this bioactive lipid extracellularly upon stimulation.  Vascular endothelial cells (ECs) and smooth muscle cells (SMCs) respond dramatically to this platelet-derived bioactive lipid mainly through a family of G protein-coupled Sph-1-P receptors named S1P1, 2, 3, 4, and 5, originally referred to as EDG-1, 5, 3, 6, and 8, resp.  In fact, the importance of Sph-1-P in platelet-vascular cell interactions has been revealed in a no. of recent reports.  Through interaction with ECs, Sph-1-P can mediate physiol. wound healing processes such as vascular repair, although this important bioactive lipid can become atherogenic and thrombogenic, and cause or aggravate cardiovascular diseases esp. under certain pathol. conditions.  Sph-1-P induces vasoconstriction through interaction with SMCs.  It is likely that regulation of Sph-1-P biol. activities is important for the therapeutical purpose to control vascular disorders.  Particularly, the development of specific S1P receptor agonists or antagonists seems a reasonable strategy to selectively regulate the bioactivity of Sph-1-P, considering that a great diversity of Sph-1-P actions has been reported and that this diversity depends mainly on the S1P receptor subtype involved.  In this review, I will summarize recent findings on possible roles of Sph-1-P in vascular biol. and its therapeutical implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTzHZO1dz1pLVg90H21EOLACvtfcHk0lhqWfQgqyzbnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVGqsrc%253D&md5=8aaf620c15964f6b5a4db05df0f9c042</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.2174%2F138161206775474404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206775474404%26sid%3Dliteratum%253Aachs%26aulast%3DYatomi%26aufirst%3DY.%26atitle%3DSphingosine%25201-phosphate%2520in%2520vascular%2520biology%253A%2520possible%2520therapeutic%2520strategies%2520to%2520control%2520vascular%2520disease%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D575%26epage%3D587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahalan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.</span><span> </span><span class="NLM_article-title">Tipping the gatekeeper: S1P regulation of endothelial barrier function</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.it.2007.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=17276731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1GrtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=102-107&author=H.+Rosenauthor=M.+G.+Sannaauthor=S.+M.+Cahalanauthor=P.+J.+Gonzalez-Cabrera&title=Tipping+the+gatekeeper%3A+S1P+regulation+of+endothelial+barrier+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Tipping the gatekeeper: S1P regulation of endothelial barrier function</span></div><div class="casAuthors">Rosen, Hugh; Sanna, M. Germana; Cahalan, Stuart M.; Gonzalez-Cabrera, Pedro J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">102-107</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The lysophospholipid sphingosine 1-phosphate (S1P) is a pleiotropic signaling lipid present constitutively in plasma, and secreted locally at elevated concns. at sites of inflammation.  S1P maintains essential variable homeostatic functions in addn. to inducing pathophysiol. through the activation of five specific high-affinity G-protein-coupled receptors.  Therefore, S1P can function as an extracellular rheostat regulating tonic and acutely evoked functions.  Although S1P receptors can regulate lymphoid development and lymphocyte trafficking, and different opinions exist on the roles of receptor agonism and functional antagonism in regulating lymphocyte recirculation, this personal perspective highlights the pivotal control points regulated by constitutive and induced S1P receptor tone at vascular endothelial and lymphatic endothelial barriers, through which S1P agonism impacts on both innate and adaptive immunity.  The authors also emphasize how specific, proof-of-concept chem. tools complement genetic approaches by enabling reversible perturbation of the S1P-S1P1 receptor axis and, thus, clarifying in vivo mechanisms in the absence of developmental compensations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR5AFhhSUSlLVg90H21EOLACvtfcHk0lhqWfQgqyzbnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1GrtL4%253D&md5=2ccb920fd60591f904189b7e69597a99</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2007.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2007.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DCahalan%26aufirst%3DS.%2BM.%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26atitle%3DTipping%2520the%2520gatekeeper%253A%2520S1P%2520regulation%2520of%2520endothelial%2520barrier%2520function%26jtitle%3DTrends%2520Immunol.%26date%3D2007%26volume%3D28%26spage%3D102%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Michel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulders, A. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jongsma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alewijnse, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, S. L. M.</span><span> </span><span class="NLM_article-title">Vascular effects of sphingolipids</span> <span class="citation_source-journal">Acta Paediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1111%2Fj.1651-2227.2007.00036.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=17187602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A280%3ADC%252BD2s7ptVCqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=44-48&author=M.+C.+Michelauthor=A.+C.+M.+Muldersauthor=M.+Jongsmaauthor=A.+E.+Alewijnseauthor=S.+L.+M.+Peters&title=Vascular+effects+of+sphingolipids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular effects of sphingolipids</span></div><div class="casAuthors">Michel Martin C; Mulders Arthur C M; Jongsma Maikel; Alewijnse Astrid E; Peters Stephan L M</div><div class="citationInfo"><span class="NLM_cas:title">Acta paediatrica (Oslo, Norway : 1992). Supplement</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">455</span>),
    <span class="NLM_cas:pages">44-8</span>
        ISSN:<span class="NLM_cas:issn">0803-5326</span>.
    </div><div class="casAbstract">UNLABELLED:  The sphingomyelin metabolites ceramide, sphingosine 1-phosphate (S1P) and sphingosylphosphorylcholine (SPC) are emerging modulators of vascular tone.  While ceramide appears to act primarily intracellularly, S1P and SPC appear to mainly work via specific receptors, although those for SPC have not yet been defined unequivocally.  Each of the sphingomyelin metabolites can induce both vasoconstriction and vasodilatation and, in some cases--ceramide on the one hand, and S1P and SPC on the other hand--have opposite effects on vascular tone.  The differences in effects between vessels may relate to the relative roles of endothelial and smooth muscle cells in mediating them, as well as to the distinct expression patterns of S1P receptors among vascular beds and among endothelial and smooth muscle cells.  Recent evidence suggests that vascular tone is not only modulated by sphingomyelin metabolites which are exogenously added or reach the vessel wall via the bloodstream but also by those formed locally by cells in the vessel wall.  Such local formation can be induced by known vasoactive agents such as angiotensin II and may serve a signalling function.  CONCLUSION:  We conclude that sphingomyelin metabolites are important endogenous modulators of vascular function, which may contribute to the pathophysiology of some diseases and be targets for therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRizPA9-bzd8XthwrmtH4OBfW6udTcc2eZAcxwq6OCkPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s7ptVCqtw%253D%253D&md5=a17c857de85079a74c4413b418953097</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1111%2Fj.1651-2227.2007.00036.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1651-2227.2007.00036.x%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DM.%2BC.%26aulast%3DMulders%26aufirst%3DA.%2BC.%2BM.%26aulast%3DJongsma%26aufirst%3DM.%26aulast%3DAlewijnse%26aufirst%3DA.%2BE.%26aulast%3DPeters%26aufirst%3DS.%2BL.%2BM.%26atitle%3DVascular%2520effects%2520of%2520sphingolipids%26jtitle%3DActa%2520Paediatr.%26date%3D2007%26volume%3D96%26spage%3D44%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetzl, E. J.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1038%2Fnri1650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=15999095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsl2itr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=560-570&author=H.+Rosenauthor=E.+J.+Goetzl&title=Sphingosine+1-phosphate+and+its+receptors%3A+an+autocrine+and+paracrine+network"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network</span></div><div class="casAuthors">Rosen, Hugh; Goetzl, Edward J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">560-570</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P) is a biol. active lysophospholipid that transmits signals through a family of G-protein-coupled receptors to control cellular differentiation and survival, as well as the vital functions of several types of immune cell.  In this Review article, the authors discuss recent results that indicate that S1P and its receptors are required for the emigration of thymocytes from the thymus, the trafficking of lymphocytes in secondary lymphoid organs and the migration of B cells into splenic follicles.  In an autocrine manner, through interactions with different G-protein-coupled receptors, S1P also enhances optimal mast-cell migration and release of pro-inflammatory mediators in allergic reactions.  S1P-S1P-receptor regulatory systems might therefore be novel targets for the therapy of diverse immunol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6-Zo0R14YILVg90H21EOLACvtfcHk0lifwoXg2V_Jcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsl2itr4%253D&md5=b680f6c9e29d407579ab7f056209d853</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fnri1650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1650%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DGoetzl%26aufirst%3DE.%2BJ.%26atitle%3DSphingosine%25201-phosphate%2520and%2520its%2520receptors%253A%2520an%2520autocrine%2520and%2520paracrine%2520network%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2005%26volume%3D5%26spage%3D560%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Oskeritzian, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate in allergic responses, asthma and anaphylaxis</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.pharmthera.2007.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=17669501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWhsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2007&pages=390-399&author=C.+A.+Oskeritzianauthor=S.+Milstienauthor=S.+Spiegel&title=Sphingosine-1-phosphate+in+allergic+responses%2C+asthma+and+anaphylaxis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate in allergic responses, asthma and anaphylaxis</span></div><div class="casAuthors">Oskeritzian, Carole A.; Milstien, Sheldon; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">390-399</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid metabolite involved in many cellular processes, acting not only as an extracellular ligand to its specific G protein-coupled receptors, but also as a putative intracellular messenger with yet unidentified targets.  Mast cells are tissue-dwelling pivotal early effectors of allergic responses, which produce and secrete S1P that can bind to its receptors present on mast cells to influence their activation and functions.  In this review, we will first discuss the current knowledge of S1P prodn. by two isoenzymes of sphingosine kinase (SphK).  Mechanisms of SphK activation will be discussed, with an emphasis on exptl. approaches developed to study their differential activation and biol. roles in the context of mast cells.  The relevance of mast cells in the etiol. of allergic disorders, asthma and anaphylaxis is well established.  In this review, this concept will be revisited, focusing on the contribution of S1P prodn. and secretion to the symptoms assocd. with dysregulated inflammatory responses.  To conclude, counteracting the proinflammatory effects of S1P could be envisioned as a therapeutic strategy to treat allergic disorders, exacerbated airway inflammation, and anaphylactic reactions, and various options will be discussed, such as the development of pharmacol. tools to inhibit SphKs, S1P neutralizing monoclonal antibody, and S1P receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU658KZB9wzbVg90H21EOLACvtfcHk0lifwoXg2V_Jcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWhsLfL&md5=6ca77f4bc8322527e1d6ad3db24b6244</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DOskeritzian%26aufirst%3DC.%2BA.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine-1-phosphate%2520in%2520allergic%2520responses%252C%2520asthma%2520and%2520anaphylaxis%26jtitle%3DPharmacol.%2520Ther.%26date%3D2007%26volume%3D115%26spage%3D390%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Rivera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivera, A.</span><span> </span><span class="NLM_article-title">The alliance of sphingosine-1-phosphate and its receptors in immunity</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1038%2Fnri2400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=18787560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFKkur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=753-763&author=J.+Riveraauthor=R.+L.+Proiaauthor=A.+Olivera&title=The+alliance+of+sphingosine-1-phosphate+and+its+receptors+in+immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The alliance of sphingosine-1-phosphate and its receptors in immunity</span></div><div class="casAuthors">Rivera, Juan; Proia, Richard L.; Olivera, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">753-763</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Sphingosine-1-phosphate (S1P) is a biol. active metabolite of plasma membrane sphingolipids that is essential for immune cell trafficking.  Its concn. is increased in many inflammatory conditions, such as asthma and autoimmunity.  Much of the immune function of S1P results from the engagement of a family of G-protein-coupled receptors (S1PR1-S1PR5).  Recent findings on the role of S1P in immunosurveillance, the discovery of regulatory mechanisms in S1P-mediated immune-cell trafficking and new advances in understanding the mechanism by which S1P affects immune-cell function indicate that the alliance between S1P and its receptors has a fundamental role in immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogShP9St3JD7Vg90H21EOLACvtfcHk0ljiUB1RlZR_5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFKkur%252FI&md5=27e4cbfcd2f91fb1ff9cab462f0e44b7</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fnri2400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2400%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DOlivera%26aufirst%3DA.%26atitle%3DThe%2520alliance%2520of%2520sphingosine-1-phosphate%2520and%2520its%2520receptors%2520in%2520immunity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2008%26volume%3D8%26spage%3D753%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Ishii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klauschen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier-Schellersheim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, R. N.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">458</span><span class="NLM_x">, </span> <span class="NLM_fpage">524</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=524-528&author=M.+Ishiiauthor=J.+G.+Egenauthor=F.+Klauschenauthor=M.+Meier-Schellersheimauthor=Y.+Saekiauthor=J.+Vacherauthor=R.+L.+Proiaauthor=R.+N.+Germain&title=Sphingosine-1-phosphate+mobilizes+osteoclast+precursors+and+regulates+bone+homeostasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshii%26aufirst%3DM.%26aulast%3DEgen%26aufirst%3DJ.%2BG.%26aulast%3DKlauschen%26aufirst%3DF.%26aulast%3DMeier-Schellersheim%26aufirst%3DM.%26aulast%3DSaeki%26aufirst%3DY.%26aulast%3DVacher%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DGermain%26aufirst%3DR.%2BN.%26atitle%3DSphingosine-1-phosphate%2520mobilizes%2520osteoclast%2520precursors%2520and%2520regulates%2520bone%2520homeostasis%26jtitle%3DNature%26date%3D2009%26volume%3D458%26spage%3D524%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Alewijnse, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, S. L. M.</span><span> </span><span class="NLM_article-title">Sphingolipid signalling in the cardiovascular system: good, bad or both?</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">585</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.ejphar.2008.02.089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=18420192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD1cXls1Snt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=585&publication_year=2008&pages=292-302&author=A.+E.+Alewijnseauthor=S.+L.+M.+Peters&title=Sphingolipid+signalling+in+the+cardiovascular+system%3A+good%2C+bad+or+both%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipid signalling in the cardiovascular system: Good, bad or both?</span></div><div class="casAuthors">Alewijnse, Astrid E.; Peters, Stephan L. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">585</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">292-302</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids are biol. active lipids that play important roles in various cellular processes and the sphingomyelin metabolites ceramide, sphingosine and sphingosine-1-phosphate can act as signaling mols. in most cell types.  With the recent development of the immunosuppressant drug FTY720 (Fingolimod) which after phosphorylation in vivo acts as a sphingosine-1-phosphate receptor agonist, research on the role of sphingolipids in the immune and other organ systems was triggered enormously.  Since it was reported that FTY720 induced a modest, but significant transient decrease in heart rate in animals and humans, the question was raised which pharmacol. properties of drugs targeting sphingolipid signaling will affect cardiovascular function in vivo.  The answer to this question will most likely also indicate what type of drug could be used to treat cardiovascular disease.  The latter is becoming increasingly important because of the increasing population carrying characteristics of the metabolic syndrome.  This syndrome is, amongst others, characterized by obesity, hypertension, atherosclerosis and diabetes.  As such, individuals with this syndrome are at increased risk of heart disease.  Now numerous studies have investigated sphingolipid effects in the cardiovascular system, can we speculate whether certain sphingolipids under specific conditions are good, bad or maybe both.  In this review we will give a brief overview of the pathophysiol. role of sphingolipids in cardiovascular disease.  In addn., we will try to answer how drugs that target sphingolipid signaling will potentially influence cardiovascular function and whether these drugs would be useful to treat cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCrn1VPopZK7Vg90H21EOLACvtfcHk0ljiUB1RlZR_5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXls1Snt74%253D&md5=259b21af9aa684253974c6772861c859</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.02.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.02.089%26sid%3Dliteratum%253Aachs%26aulast%3DAlewijnse%26aufirst%3DA.%2BE.%26aulast%3DPeters%26aufirst%3DS.%2BL.%2BM.%26atitle%3DSphingolipid%2520signalling%2520in%2520the%2520cardiovascular%2520system%253A%2520good%252C%2520bad%2520or%2520both%253F%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D585%26spage%3D292%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Chi, H.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate and immune regulation: trafficking and beyond</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2010&pages=16-24&author=H.+Chi&title=Sphingosine-1-phosphate+and+immune+regulation%3A+trafficking+and+beyond"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChi%26aufirst%3DH.%26atitle%3DSphingosine-1-phosphate%2520and%2520immune%2520regulation%253A%2520trafficking%2520and%2520beyond%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2010%26volume%3D32%26spage%3D16%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Pyne, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate and cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">503</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1038%2Fnrc2875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=20555359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsFKis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=489-503&author=N.+J.+Pyneauthor=S.+Pyne&title=Sphingosine+1-phosphate+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate and cancer</span></div><div class="casAuthors">Pyne, Nigel J.; Pyne, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">489-503</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is substantial evidence that sphingosine 1-phosphate (S1P) is involved in cancer.  S1P regulates processes such as inflammation, which can drive tumorigenesis; neovascularization, which provides cancer cells with nutrients and oxygen; and cell growth and survival.  This occurs at multiple levels and involves S1P receptors, sphingosine kinases, S1P phosphatases and S1P lyase.  This Review summarizes current research findings and examines the potential for new therapeutics designed to alter S1P signalling and function in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopcjXMo4lyC7Vg90H21EOLACvtfcHk0li9fDWA1FVhRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsFKis7s%253D&md5=b6963178dfee638d875f652546d009bc</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fnrc2875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2875%26sid%3Dliteratum%253Aachs%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DPyne%26aufirst%3DS.%26atitle%3DSphingosine%25201-phosphate%2520and%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D489%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Maceyka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harikumar, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate signaling and its role in disease</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.tcb.2011.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=22001186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Wguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=50-60&author=M.+Maceykaauthor=K.+B.+Harikumarauthor=S.+Milstienauthor=S.+Spiegel&title=Sphingosine-1-phosphate+signaling+and+its+role+in+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate signaling and its role in disease</span></div><div class="casAuthors">Maceyka, Michael; Harikumar, Kuzhuvelil B.; Milstien, Sheldon; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-60</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The bioactive sphingolipid metabolite sphingosine-1-phosphate (S1P) is now recognized as a crit. regulator of many physiol. and pathophysiol. processes, including cancer, atherosclerosis, diabetes and osteoporosis.  S1P is produced in cells by two sphingosine kinase isoenzymes, SphK1 and SphK2.  Many cells secrete S1P, which can then act in an autocrine or paracrine manner.  Most of the known actions of S1P are mediated by a family of five specific G protein-coupled receptors.  More recently, it was shown that S1P also has important intracellular targets involved in inflammation, cancer and Alzheimer's disease.  This suggests that S1P actions are much more complex than previously thought, with important ramifications for development of therapeutics.  This review highlights recent advances in our understanding of the mechanisms of action of S1P and its roles in disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0UHcgnAzcArVg90H21EOLACvtfcHk0li9fDWA1FVhRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Wguw%253D%253D&md5=93baaa54059ffec593c9e0092716f02e</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2011.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2011.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DMaceyka%26aufirst%3DM.%26aulast%3DHarikumar%26aufirst%3DK.%2BB.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine-1-phosphate%2520signaling%2520and%2520its%2520role%2520in%2520disease%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2012%26volume%3D22%26spage%3D50%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abo-Elmatty, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahangeer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.-i.</span><span> </span><span class="NLM_article-title">Roles of extracellular and intracellular sphingosine 1-phosphate in cell migration</span> <span class="citation_source-journal">Genes Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">605</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1111%2Fj.1365-2443.2009.01295.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=19371379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvVCmu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=597-605&author=H.+Yuauthor=T.+Okadaauthor=M.+Kobayashiauthor=D.+M.+Abo-Elmattyauthor=S.+Jahangeerauthor=S.-i.+Nakamura&title=Roles+of+extracellular+and+intracellular+sphingosine+1-phosphate+in+cell+migration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of extracellular and intracellular sphingosine 1-phosphate in cell migration</span></div><div class="casAuthors">Yu, Huan; Okada, Taro; Kobayashi, Masako; Abo-Elmatty, Dina M.; Jahangeer, Saleem; Nakamura, Shun-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">597-605</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1356-9597</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is an important factor for the regulation of cell motility acting both inside and outside the cells.  The precise role of S1P in the control of cell motility, however, remains unclear.  Here, the authors describe the roles of S1P in the regulation of cell motility by dissecting them into intracellular and extracellular actions using a liposomal S1P transfer technique.  In a Boyden chamber assay, free S1P enhanced directional cell movement, whereas liposomal S1P induced nondirectional cell movement.  Furthermore, inhibition of sphingosine kinase (SphK) 1 by several inhibitors or knockdown of enzyme expression by siRNA caused reduced wound-faced cell polarity formation as assessed by wound-healing assay.  Moreover, S1P-induced cell migration was strongly inhibited by SphK inhibitors.  These results indicate that extracellular S1P acting through S1P receptors facilitates the formation of cell polarity, whereas S1P generated inside the cells functions as an intracellular mediator per se to enhance nondirectional cell movement; thus, S1P enhances directional cell movement in a coordinated fashion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCREjEQK0WA7Vg90H21EOLACvtfcHk0li9fDWA1FVhRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvVCmu74%253D&md5=dbc65bd3f677f7a8aaee4906a7dd41af</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2443.2009.01295.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2443.2009.01295.x%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DAbo-Elmatty%26aufirst%3DD.%2BM.%26aulast%3DJahangeer%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DS.-i.%26atitle%3DRoles%2520of%2520extracellular%2520and%2520intracellular%2520sphingosine%25201-phosphate%2520in%2520cell%2520migration%26jtitle%3DGenes%2520Cells%26date%3D2009%26volume%3D14%26spage%3D597%26epage%3D605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1205</span><span class="NLM_x">–</span> <span class="NLM_lpage">1213</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.jhep.2010.08.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=21145832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVygsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1205-1213&author=C.+Liauthor=S.+Zhengauthor=H.+Youauthor=X.+Liuauthor=M.+Linauthor=L.+Yangauthor=L.+Li&title=Sphingosine+1-phosphate+%28S1P%29%2FS1P+receptors+are+involved+in+human+liver+fibrosis+by+action+on+hepatic+myofibroblasts+motility"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility</span></div><div class="casAuthors">Li, Changyong; Zheng, Sujun; You, Hong; Liu, Xihong; Lin, Minghua; Yang, Lin; Li, Liying</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1205-1213</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Directed migration of hepatic myofibroblasts (hMFs) contributes to the development of liver fibrosis.  However, the signals regulating the motility of these cells are incompletely understood.  We have recently shown that sphingosine 1-phosphate (S1P) and S1P receptors (S1PRs) are involved in mouse liver fibrogenesis.  Here, we investigated the role of S1P/S1PRs signals in human liver fibrosis involving motility of human hMFs.  S1P level in the liver was examd. by high-performance liq. chromatog.  Expression of S1PRs was characterized, in biopsy specimens of human liver and cultured hMFs, by immunofluorescence and real-time RT-PCR or Western blot anal.  Cell migration was detd. in Boyden chambers, by using the selective S1P receptor agonist or antagonist and silencing of S1PRs expression with small interfering RNA.  S1P level in the human fibrotic liver was increased through up-regulation of sphingosine kinase (SphK), irresp. of the etiol. of fibrosis.  S1P receptors type 1, 2, and 3 (S1P1,2,3) were expressed in human hMFs in vivo and in vitro.  Interestingly, S1P1,3 were strongly induced in human fibrotic samples, whereas expression of S1P2 was massively decreased.  S1P exerted a powerful migratory action on human hMFs.  Furthermore, the effect of S1P was mimicked by SEW2871 (an S1P1 agonist), and blocked by suramin (an S1P3 antagonist) and by silencing S1P1,3 expression.  In contrast, JTE-013 (an S1P2 antagonist) and silencing of S1P2 expression enhanced S1P-induced migration.  SphK/S1P/S1PRs signaling axis plays an important role in human liver fibrosis and is involved in the directed migration of human hMFs into the damaged areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5zOBiC9Y4Q7Vg90H21EOLACvtfcHk0lgLI8smoz-2Qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVygsbw%253D&md5=83e7b15dda5c6a643fa234882cfa060b</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2010.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2010.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DYou%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DSphingosine%25201-phosphate%2520%2528S1P%2529%252FS1P%2520receptors%2520are%2520involved%2520in%2520human%2520liver%2520fibrosis%2520by%2520action%2520on%2520hepatic%2520myofibroblasts%2520motility%26jtitle%3DJ.%2520Hepatol.%26date%3D2011%26volume%3D54%26spage%3D1205%26epage%3D1213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreier, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">Expression of the sphingosine 1-phosphate receptor, S1P<sub>1</sub>, on T-cells controls thymic emigration</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">15396</span><span class="NLM_x">–</span> <span class="NLM_lpage">15401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=15396-15401&author=M.+L.+Allendeauthor=J.+L.+Dreierauthor=S.+Mandalaauthor=R.+L.+Proia&title=Expression+of+the+sphingosine+1-phosphate+receptor%2C+S1P1%2C+on+T-cells+controls+thymic+emigration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DDreier%26aufirst%3DJ.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DExpression%2520of%2520the%2520sphingosine%25201-phosphate%2520receptor%252C%2520S1P1%252C%2520on%2520T-cells%2520controls%2520thymic%2520emigration%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D15396%26epage%3D15401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Weigert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruene, B.</span><span> </span><span class="NLM_article-title">Regulation of macrophage function by sphinosine-1-phosphate</span> <span class="citation_source-journal">Immunobiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">214</span><span class="NLM_x">, </span> <span class="NLM_fpage">748</span><span class="NLM_x">–</span> <span class="NLM_lpage">760</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=2009&pages=748-760&author=A.+Weigertauthor=N.+Weisauthor=B.+Bruene&title=Regulation+of+macrophage+function+by+sphinosine-1-phosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeigert%26aufirst%3DA.%26aulast%3DWeis%26aufirst%3DN.%26aulast%3DBruene%26aufirst%3DB.%26atitle%3DRegulation%2520of%2520macrophage%2520function%2520by%2520sphinosine-1-phosphate%26jtitle%3DImmunobiology%26date%3D2009%26volume%3D214%26spage%3D748%26epage%3D760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuymetova, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifacino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">S1P1 receptor directs the release of immature B cells from bone marrow into blood</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">207</span><span class="NLM_x">, </span> <span class="NLM_fpage">1113</span><span class="NLM_x">–</span> <span class="NLM_lpage">1124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2010&pages=1113-1124&author=M.+L.+Allendeauthor=G.+Tuymetovaauthor=B.+G.+Leeauthor=E.+Bonifacinoauthor=Y.-P.+Wuauthor=R.+L.+Proia&title=S1P1+receptor+directs+the+release+of+immature+B+cells+from+bone+marrow+into+blood"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DTuymetova%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DB.%2BG.%26aulast%3DBonifacino%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DY.-P.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DS1P1%2520receptor%2520directs%2520the%2520release%2520of%2520immature%2520B%2520cells%2520from%2520bone%2520marrow%2520into%2520blood%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2010%26volume%3D207%26spage%3D1113%26epage%3D1124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Rathinasamy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czeloth, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pabst, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Förster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernhardt, G.</span><span> </span><span class="NLM_article-title">The origin and maturity of dendritic cells determine the pattern of sphingosine 1-phosphate receptors expressed and required for efficient migration</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">4072</span><span class="NLM_x">–</span> <span class="NLM_lpage">4081</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2010&pages=4072-4081&author=A.+Rathinasamyauthor=N.+Czelothauthor=O.+Pabstauthor=R.+F%C3%B6rsterauthor=G.+Bernhardt&title=The+origin+and+maturity+of+dendritic+cells+determine+the+pattern+of+sphingosine+1-phosphate+receptors+expressed+and+required+for+efficient+migration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRathinasamy%26aufirst%3DA.%26aulast%3DCzeloth%26aufirst%3DN.%26aulast%3DPabst%26aufirst%3DO.%26aulast%3DF%25C3%25B6rster%26aufirst%3DR.%26aulast%3DBernhardt%26aufirst%3DG.%26atitle%3DThe%2520origin%2520and%2520maturity%2520of%2520dendritic%2520cells%2520determine%2520the%2520pattern%2520of%2520sphingosine%25201-phosphate%2520receptors%2520expressed%2520and%2520required%2520for%2520efficient%2520migration%26jtitle%3DJ.%2520Immunol.%26date%3D2010%26volume%3D185%26spage%3D4072%26epage%3D4081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Cyster, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, S. R.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1146%2Fannurev-immunol-020711-075011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=22149932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVKmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=69-94&author=J.+G.+Cysterauthor=S.+R.+Schwab&title=Sphingosine-1-phosphate+and+lymphocyte+egress+from+lymphoid+organs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs</span></div><div class="casAuthors">Cyster, Jason G.; Schwab, Susan R.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">69-94</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Much has been learned about how cells enter lymphoid tissues.  But how do they leave.  Sphingosine-1-phosphate (S1P) has emerged over the past decade as a central mediator of lymphocyte egress.  In this review, we summarize the current understanding of how S1P promotes exit from the secondary lymphoid organs and thymus.  We review what is known about addnl. requirements for emigration and summarize the mostly distinct requirements for exit from the bone marrow.  Egress from lymphoid organs is limited during immune responses, and we examine how this regulation works.  There is accumulating evidence for roles of S1P in directing immune cell behavior within lymphoid tissues.  How such actions can fit together with the egress-promoting role of S1P is discussed.  Finally, we examine current understanding of how FTY720, a drug that targets S1P receptors and is approved for the treatment of multiple sclerosis, causes immune suppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhvMroRvgkZrVg90H21EOLACvtfcHk0ljivoZnDnYYYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVKmtLY%253D&md5=c9f9ef63f2248594b0f9ce4d06024bba</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1146%2Fannurev-immunol-020711-075011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-immunol-020711-075011%26sid%3Dliteratum%253Aachs%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26aulast%3DSchwab%26aufirst%3DS.%2BR.%26atitle%3DSphingosine-1-phosphate%2520and%2520lymphocyte%2520egress%2520from%2520lymphoid%2520organs%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2012%26volume%3D30%26spage%3D69%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=346-349&author=S.+Mandalaauthor=R.+Hajduauthor=J.+Bergstromauthor=E.+Quackenbushauthor=J.+Xieauthor=J.+Milliganauthor=R.+Thorntonauthor=G.-J.+Sheiauthor=D.+Cardauthor=C.+A.+Keohaneauthor=M.+Rosenbachauthor=J.+Haleauthor=C.+L.+Lynchauthor=K.+Rupprechtauthor=W.+Parsonsauthor=H.+Rosen&title=Alteration+of+lymphocyte+trafficking+by+sphingosine-1-phosphate+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DRupprecht%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520lymphocyte%2520trafficking%2520by%2520sphingosine-1-phosphate%2520receptor%2520agonists%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D346%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieschl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zollinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">21453</span><span class="NLM_x">–</span> <span class="NLM_lpage">21457</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1074%2Fjbc.C200176200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=11967257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=21453-21457&author=V.+Brinkmannauthor=M.+D.+Davisauthor=C.+E.+Heiseauthor=R.+Albertauthor=S.+Cottensauthor=R.+Hofauthor=C.+Brunsauthor=E.+Prieschlauthor=T.+Baumrukerauthor=P.+Hiestandauthor=C.+A.+Fosterauthor=M.+Zollingerauthor=K.+R.+Lynch&title=The+immune+modulator+FTY720+targets+sphingosine+1-phosphate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span></div><div class="casAuthors">Brinkmann, Volker; Davis, Michael D.; Heise, Christopher E.; Albert, Rainer; Cottens, Sylvain; Hof, Robert; Bruns, Christian; Prieschl, Eva; Baumruker, Thomas; Hiestand, Peter; Foster, Carolyn A.; Zollinger, Markus; Lynch, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21453-21457</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Immunosuppressant drugs such as cyclosporin have allowed widespread organ transplantation, but their utility remains limited by toxicities, and they are ineffective in chronic management of autoimmune diseases such as multiple sclerosis.  In contrast, the immune modulating drug FTY720 is efficacious in a variety of transplant and autoimmune models without inducing a generalized immunosuppressed state and is effective in human kidney transplantation.  FTY720 elicits a lymphopenia resulting from a reversible redistribution of lymphocytes from circulation to secondary lymphoid tissues by unknown mechanisms.  Using FTY720 and several analogs, we show now that FTY720 is phosphorylated by sphingosine kinase; the phosphorylated compd. is a potent agonist at four sphingosine 1-phosphate receptors and represents the therapeutic principle in a rodent model of multiple sclerosis.  Our results suggest that FTY720, after phosphorylation, acts through sphingosine 1-phosphate signaling pathways to modulate chemotactic responses and lymphocyte trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6zyZnHOYNbVg90H21EOLACvtfcHk0ljivoZnDnYYYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D&md5=b59856fffa9ebae7fb8182d18daa025f</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200176200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200176200%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DHof%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPrieschl%26aufirst%3DE.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DThe%2520immune%2520modulator%2520FTY720%2520targets%2520sphingosine%25201-phosphate%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D21453%26epage%3D21457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Matloubian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinamon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesneski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">427</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2004&pages=355-360&author=M.+Matloubianauthor=C.+G.+Loauthor=G.+Cinamonauthor=M.+J.+Lesneskiauthor=Y.+Xuauthor=V.+Brinkmannauthor=M.+L.+Allendeauthor=R.+L.+Proiaauthor=J.+G.+Cyster&title=Lymphocyte+egress+from+thymus+and+peripheral+lymphoid+organs+is+dependent+on+S1P+receptor+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatloubian%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DC.%2BG.%26aulast%3DCinamon%26aufirst%3DG.%26aulast%3DLesneski%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DLymphocyte%2520egress%2520from%2520thymus%2520and%2520peripheral%2520lymphoid%2520organs%2520is%2520dependent%2520on%2520S1P%2520receptor%25201%26jtitle%3DNature%26date%3D2004%26volume%3D427%26spage%3D355%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1146%2Fannurev.immunol.23.021704.115628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=15771568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFOjtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=127-159&author=J.+G.+Cyster&title=Chemokines%2C+sphingosine-1-phosphate%2C+and+cell+migration+in+secondary+lymphoid+organs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs</span></div><div class="casAuthors">Cyster, Jason G.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-159</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Secondary lymphoid organs serve as hubs for the adaptive immune system, bringing together antigen, antigen-presenting cells, and lymphocytes.  Two families of G protein-coupled receptors play essential roles in lymphocyte migration through these organs: chemokine receptors and sphingosine-1-phosphate (S1P) receptors.  Chemokines expressed by lymphoid stromal cells guide lymphocyte and dendritic cell movements during antigen surveillance and the initiation of adaptive immune responses.  S1P receptor-1 is required for lymphocyte egress from thymus and secondary lymphoid organs and is downregulated by the immunosuppressive drug FTY720.  Here, the authors review the steps assocd. with the initiation of adaptive immune responses in secondary lymphoid organs, highlighting the roles of chemokines and S1P.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp45ipo25abUbVg90H21EOLACvtfcHk0lhf6-RbvysiOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFOjtbg%253D&md5=3263792a06b255396daed4eec96e1599</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.23.021704.115628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.23.021704.115628%26sid%3Dliteratum%253Aachs%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DChemokines%252C%2520sphingosine-1-phosphate%252C%2520and%2520cell%2520migration%2520in%2520secondary%2520lymphoid%2520organs%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2005%26volume%3D23%26spage%3D127%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Selecting against S1P<sub>3</sub> enhances the acute cardiovascular tolerability of 3-(<i>N</i>-benzyl)aminopropylphosphonic acid S1P receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3501</span><span class="NLM_x">–</span> <span class="NLM_lpage">3505</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3501-3505&author=J.+J.+Haleauthor=G.+Dohertyauthor=L.+Tothauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+Rosenbachauthor=J.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=M.+Forrestauthor=S.-Y.+Sunauthor=S.+Westauthor=H.+Xieauthor=N.+Nomuraauthor=H.+Rosenauthor=S.+Mandala&title=Selecting+against+S1P3+enhances+the+acute+cardiovascular+tolerability+of+3-%28N-benzyl%29aminopropylphosphonic+acid+S1P+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DToth%26aufirst%3DL.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-Y.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DSelecting%2520against%2520S1P3%2520enhances%2520the%2520acute%2520cardiovascular%2520tolerability%2520of%25203-%2528N-benzyl%2529aminopropylphosphonic%2520acid%2520S1P%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3501%26epage%3D3505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1124%2Fjpet.103.062828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=14747617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=758-768&author=M.+Forrestauthor=S.-Y.+Sunauthor=R.+Hajduauthor=J.+Bergstromauthor=D.+Cardauthor=G.+Dohertyauthor=J.+Haleauthor=C.+Keohaneauthor=C.+Meyersauthor=J.+Milliganauthor=S.+Millsauthor=N.+Nomuraauthor=H.+Rosenauthor=M.+Rosenbachauthor=G.-J.+Sheiauthor=I.+I.+Singerauthor=M.+Tianauthor=S.+Westauthor=V.+Whiteauthor=J.+Xieauthor=R.+L.+Proiaauthor=S.+Mandala&title=Immune+cell+regulation+and+cardiovascular+effects+of+sphingosine+1-phosphate+receptor+agonists+in+rodents+are+mediated+via+distinct+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span></div><div class="casAuthors">Forrest, M.; Sun, S.-Y.; Hajdu, R.; Bergstrom, J.; Card, D.; Doherty, G.; Hale, J.; Keohane, C.; Meyers, C.; Milligan, J.; Mills, S.; Nomura, N.; Rosen, H.; Rosenbach, M.; Shei, G.-J.; Singer, I. I.; Tian, M.; West, S.; White, V.; Xie, J.; Proia, R. L.; Mandala, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">758-768</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a bioactive lysolipid with pleiotropic functions mediated through a family of G protein-coupled receptors, S1P1,2,3,4,5.  Physiol. effects of S1P receptor agonists include regulation of cardiovascular function and immunosuppression via redistribution of lymphocytes from blood to secondary lymphoid organs.  The phosphorylated metabolite of the immunosuppressant agent FTY720 (2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol) and other phosphonate analogs with differential receptor selectivity were investigated.  No significant species differences in compd. potency or rank order of activity on receptors cloned from human, murine, and rat sources were obsd.  All synthetic analogs were high-affinity agonists on S1P1, with IC50 values for ligand binding between 0.3 and 14 nM.  The correlation between S1P1 receptor activation and the ED50 for lymphocyte redn. was highly significant (p < 0.001) and lower for the other receptors.  In contrast to S1P1-mediated effects on lymphocyte recirculation, three lines of evidence link S1P3 receptor activity with acute toxicity and cardiovascular regulation: compd. potency on S1P3 correlated with toxicity and bradycardia; the shift in potency of phosphorylated-FTY720 for inducing lymphopenia vs. bradycardia and hypertension was consistent with affinity for S1P1 relative to S1P3; and toxicity, bradycardia, and hypertension were absent in S1P3-/- mice.  Blood pressure effects of agonists in anesthetized rats were complex, whereas hypertension was the predominant effect in conscious rats and mice.  Immunolocalization of S1P3 in rodent heart revealed abundant expression on myocytes and perivascular smooth muscle cells consistent with regulation of bradycardia and hypertension, whereas S1P1 expression was restricted to the vascular endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKo2vpih4eoLVg90H21EOLACvtfcHk0lh1TsVdV_Ufmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D&md5=27183d4991bffbc5d2b88174b1386d5a</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.062828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.062828%26sid%3Dliteratum%253Aachs%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-Y.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DMeyers%26aufirst%3DC.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DMills%26aufirst%3DS.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DSinger%26aufirst%3DI.%2BI.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DImmune%2520cell%2520regulation%2520and%2520cardiovascular%2520effects%2520of%2520sphingosine%25201-phosphate%2520receptor%2520agonists%2520in%2520rodents%2520are%2520mediated%2520via%2520distinct%2520receptor%2520subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D758%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate (S1P) receptor subtypes S1P<sub>1</sub> and S1P<sub>3</sub>, respectively, regulate lymphocyte recirculation and heart rate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">13839</span><span class="NLM_x">–</span> <span class="NLM_lpage">13848</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=13839-13848&author=M.+G.+Sannaauthor=J.+Liaoauthor=E.+Joauthor=C.+Alfonsoauthor=M.-Y.+Ahnauthor=M.+S.+Petersonauthor=B.+Webbauthor=S.+Lefebvreauthor=J.+Chunauthor=N.+Grayauthor=H.+Rosen&title=Sphingosine+1-phosphate+%28S1P%29+receptor+subtypes+S1P1+and+S1P3%2C+respectively%2C+regulate+lymphocyte+recirculation+and+heart+rate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DAlfonso%26aufirst%3DC.%26aulast%3DAhn%26aufirst%3DM.-Y.%26aulast%3DPeterson%26aufirst%3DM.%2BS.%26aulast%3DWebb%26aufirst%3DB.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DSphingosine%25201-phosphate%2520%2528S1P%2529%2520receptor%2520subtypes%2520S1P1%2520and%2520S1P3%252C%2520respectively%252C%2520regulate%2520lymphocyte%2520recirculation%2520and%2520heart%2520rate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D13839%26epage%3D13848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Salomone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyndall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ip, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waeber, C.</span><span> </span><span class="NLM_article-title">Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1038%2Fsj.bjp.0707581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=18026125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlyntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=140-147&author=S.+Salomoneauthor=E.+M.+Pottsauthor=S.+Tyndallauthor=P.+C.+Ipauthor=J.+Chunauthor=V.+Brinkmannauthor=C.+Waeber&title=Analysis+of+sphingosine+1-phosphate+receptors+involved+in+constriction+of+isolated+cerebral+arteries+with+receptor+null+mice+and+pharmacological+tools"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools</span></div><div class="casAuthors">Salomone, S.; Potts, E. M.; Tyndall, S.; Ip, P. C.; Chun, J.; Brinkmann, V.; Waeber, C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-147</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: Sphingosine 1-phosphate (S1P) selectively and potently constricts isolated cerebral arteries, but this response has not been pharmacol. characterized.  Exptl. approach: The receptor subtype(s) involved in S1P-induced cerebrovascular constriction were characterized using genetic (S1P2 and S1P3 receptor null mice) and pharmacol. tools (phospho-FTY720, a S1P1/3/4/5 receptor agonist; SEW2871, a S1P1 receptor agonist, JTE-013, a S1P2 receptor antagonist, VPC23019, a S1P1/3 receptor antagonist).  Isolated basilar or peripheral (femoral, mesenteric resistance) arteries, from either rat or mouse, were studied in a wire myograph.  Key results: S1P concn.-dependently constricted basilar artery in rat, wild-type (WT) and S1P2 null mice, but barely affected vascular tone in S1P3 null mice.  Vasoconstriction to U46619 (a thromboxane analog) or to endothelin-1 did not differ between WT, S1P2 and S1P3 null mice.  JTE-013 inhibited not only S1P-induced vasoconstriction, but also KCl-, U46619- and endothelin-1-induced constriction.  This effect was obsd. in WT as well as in S1P2 null mice.  VPC23019 increased the concn.-dependent vasoconstriction to S1P in both rat and mouse basilar arteries with intact endothelium, but not in rat basilar artery without endothelium.  Phospho-FTY720 concn.-dependently constricted rat basilar arteries, but not femoral or mesenteric resistance arteries, while SEW2871 did not induce any response in the same arteries.  Conclusions and implications: S1P constricts cerebral arteries through S1P3 receptors.  The purported S1P2 receptor antagonist JTE-013 does not appear to be selective, at least in rodents.  Enhancement of S1P-induced contraction by VPC23019 might be related to blockade of S1P1 receptors and NO generation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkx6pcvW_Q37Vg90H21EOLACvtfcHk0lh1TsVdV_Ufmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlyntg%253D%253D&md5=1e8bef7d6f2df66b4436300fab09df06</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707581%26sid%3Dliteratum%253Aachs%26aulast%3DSalomone%26aufirst%3DS.%26aulast%3DPotts%26aufirst%3DE.%2BM.%26aulast%3DTyndall%26aufirst%3DS.%26aulast%3DIp%26aufirst%3DP.%2BC.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DWaeber%26aufirst%3DC.%26atitle%3DAnalysis%2520of%2520sphingosine%25201-phosphate%2520receptors%2520involved%2520in%2520constriction%2520of%2520isolated%2520cerebral%2520arteries%2520with%2520receptor%2520null%2520mice%2520and%2520pharmacological%2520tools%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D140%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Murakami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taksugi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnuma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koide, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasamori, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakura, N.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P<sub>3</sub> receptor: investigation based on a new S1P<sub>3</sub> receptor antagonist</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=704-713&author=A.+Murakamiauthor=H.+Taksugiauthor=S.+Ohnumaauthor=Y.+Koideauthor=A.+Sakuraiauthor=S.+Takedaauthor=T.+Hasegawaauthor=J.+Sasamoriauthor=T.+Konnoauthor=K.+Hayashiauthor=Y.+Watanabeauthor=K.+Moriauthor=Y.+Satoauthor=A.+Takahashiauthor=N.+Mochizukiauthor=N.+Takakura&title=Sphingosine+1-phosphate+%28S1P%29+regulates+vascular+contraction+via+S1P3+receptor%3A+investigation+based+on+a+new+S1P3+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DA.%26aulast%3DTaksugi%26aufirst%3DH.%26aulast%3DOhnuma%26aufirst%3DS.%26aulast%3DKoide%26aufirst%3DY.%26aulast%3DSakurai%26aufirst%3DA.%26aulast%3DTakeda%26aufirst%3DS.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DSasamori%26aufirst%3DJ.%26aulast%3DKonno%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DMochizuki%26aufirst%3DN.%26aulast%3DTakakura%26aufirst%3DN.%26atitle%3DSphingosine%25201-phosphate%2520%2528S1P%2529%2520regulates%2520vascular%2520contraction%2520via%2520S1P3%2520receptor%253A%2520investigation%2520based%2520on%2520a%2520new%2520S1P3%2520receptor%2520antagonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D77%26spage%3D704%26epage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Hamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomatsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asayama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, K.</span><span> </span><span class="NLM_article-title">Removal of sphingosine 1-phosphate receptor-3 (S1P<sub>3</sub>) agonism is essential, but inadequate to obtain immunomodulating 2-aminopropane-1,3-diol S1P<sub>1</sub> agonists with reduced effect on heart rate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3154</span><span class="NLM_x">–</span> <span class="NLM_lpage">3168</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901776q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3154-3168&author=M.+Hamadaauthor=M.+Nakamuraauthor=M.+Kiuchiauthor=K.+Marukawaauthor=A.+Tomatsuauthor=K.+Shimanoauthor=N.+Satoauthor=K.+Sugaharaauthor=M.+Asayamaauthor=K.+Takagiauthor=K.+Adachi&title=Removal+of+sphingosine+1-phosphate+receptor-3+%28S1P3%29+agonism+is+essential%2C+but+inadequate+to+obtain+immunomodulating+2-aminopropane-1%2C3-diol+S1P1+agonists+with+reduced+effect+on+heart+rate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm901776q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901776q%26sid%3Dliteratum%253Aachs%26aulast%3DHamada%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DKiuchi%26aufirst%3DM.%26aulast%3DMarukawa%26aufirst%3DK.%26aulast%3DTomatsu%26aufirst%3DA.%26aulast%3DShimano%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DSugahara%26aufirst%3DK.%26aulast%3DAsayama%26aufirst%3DM.%26aulast%3DTakagi%26aufirst%3DK.%26aulast%3DAdachi%26aufirst%3DK.%26atitle%3DRemoval%2520of%2520sphingosine%25201-phosphate%2520receptor-3%2520%2528S1P3%2529%2520agonism%2520is%2520essential%252C%2520but%2520inadequate%2520to%2520obtain%2520immunomodulating%25202-aminopropane-1%252C3-diol%2520S1P1%2520agonists%2520with%2520reduced%2520effect%2520on%2520heart%2520rate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3154%26epage%3D3168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Fryer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muthukumarana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nodop Mazurek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinallo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaude, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modis, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, G. A.</span><span> </span><span class="NLM_article-title">The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P(1)) and hypertension (S1P(3)) in rat</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e52985</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e52985&author=R.+M.+Fryerauthor=A.+Muthukumaranaauthor=P.+C.+Harrisonauthor=S.+Nodop+Mazurekauthor=R.+R.+Chenauthor=K.+E.+Harringtonauthor=R.+M.+Dinalloauthor=J.+C.+Horanauthor=L.+Patnaudeauthor=L.+K.+Modisauthor=G.+A.+Reinhart&title=The+clinically-tested+S1P+receptor+agonists%2C+FTY720+and+BAF312%2C+demonstrate+subtype-specific+bradycardia+%28S1P%281%29%29+and+hypertension+%28S1P%283%29%29+in+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFryer%26aufirst%3DR.%2BM.%26aulast%3DMuthukumarana%26aufirst%3DA.%26aulast%3DHarrison%26aufirst%3DP.%2BC.%26aulast%3DNodop%2BMazurek%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DR.%2BR.%26aulast%3DHarrington%26aufirst%3DK.%2BE.%26aulast%3DDinallo%26aufirst%3DR.%2BM.%26aulast%3DHoran%26aufirst%3DJ.%2BC.%26aulast%3DPatnaude%26aufirst%3DL.%26aulast%3DModis%26aufirst%3DL.%2BK.%26aulast%3DReinhart%26aufirst%3DG.%2BA.%26atitle%3DThe%2520clinically-tested%2520S1P%2520receptor%2520agonists%252C%2520FTY720%2520and%2520BAF312%252C%2520demonstrate%2520subtype-specific%2520bradycardia%2520%2528S1P%25281%2529%2529%2520and%2520hypertension%2520%2528S1P%25283%2529%2529%2520in%2520rat%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De52985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Lucke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levkau, B.</span><span> </span><span class="NLM_article-title">Endothelial functions of sphingosine-1-phosphate</span> <span class="citation_source-journal">Cell. Physiol. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1159%2F000315109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=20502008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVOms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=87-96&author=S.+Luckeauthor=B.+Levkau&title=Endothelial+functions+of+sphingosine-1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelial Functions of Sphingosine-1-phosphate</span></div><div class="casAuthors">Lucke, Susann; Levkau, Bodo</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-96</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  The biol. active sphingolipid sphingosine-1-phosphate (S1P) plays key functions in the immune, inflammatory, and cardiovascular systems.  In the vasculature, S1P and its receptors are involved in vessel morphogenesis and angiogenesis during embryonic development and in the adult organism both under normal and pathol. conditions.  Via its actions on endothelial and smooth muscle cells, S1P regulates arterial tone, vascular permeability, and tissue perfusion.  Elevated local S1P levels during inflammation induce endothelial adhesion mols., recruit inflammatory cells, and activate dendritic cells.  At the same time, S1P activates a neg. feedback loop that consecutively seals endothelial cell-cell contacts, decreases vascular leakage, and inhibits cytokine-induced leukocyte adhesion.  Thus S1P dets. not only the build-up, magnitude, and duration of an inflammatory reaction but also the pace of its resoln.  This review focuses on the role S1P plays in endothelial function, its receptors and signalling pathways, and the role its major carrier high-d. lipoproteins (HDL) play in its bioavailability and transport.  We will also discuss the potential of interfering with S1P-S1P receptor interactions for the treatment of endothelial disorders and vascular pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgsnbdFMWkH7Vg90H21EOLACvtfcHk0lgYf42NoGrALw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVOms74%253D&md5=7cb409784dfea08b42abaa924e5b3bff</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1159%2F000315109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000315109%26sid%3Dliteratum%253Aachs%26aulast%3DLucke%26aufirst%3DS.%26aulast%3DLevkau%26aufirst%3DB.%26atitle%3DEndothelial%2520functions%2520of%2520sphingosine-1-phosphate%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2010%26volume%3D26%26spage%3D87%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Takuwa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizugishi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanuma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satouchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitumori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takuwa, Y.</span><span> </span><span class="NLM_article-title">S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">484</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2009&pages=484-493&author=N.+Takuwaauthor=S.+Ohkuraauthor=S.+Takashimaauthor=K.+Ohtaniauthor=Y.+Okamotoauthor=T.+Tanakaauthor=K.+Hiranoauthor=S.+Usuiauthor=F.+Wangauthor=W.+Duauthor=K.+Yoshiokaauthor=Y.+Bannoauthor=M.+Sasakiauthor=I.+Ichiauthor=M.+Okamuraauthor=N.+Sugimotoauthor=K.+Mizugishiauthor=Y.+Nakanumaauthor=I.+Ishiiauthor=M.+Takamuraauthor=S.+Kanekoauthor=S.+Kojoauthor=K.+Satouchiauthor=K.+Mitumoriauthor=J.+Chunauthor=Y.+Takuwa&title=S1P3-mediated+cardiac+fibrosis+in+sphingosine+kinase+1+transgenic+mice+involves+reactive+oxygen+species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakuwa%26aufirst%3DN.%26aulast%3DOhkura%26aufirst%3DS.%26aulast%3DTakashima%26aufirst%3DS.%26aulast%3DOhtani%26aufirst%3DK.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DHirano%26aufirst%3DK.%26aulast%3DUsui%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DDu%26aufirst%3DW.%26aulast%3DYoshioka%26aufirst%3DK.%26aulast%3DBanno%26aufirst%3DY.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DIchi%26aufirst%3DI.%26aulast%3DOkamura%26aufirst%3DM.%26aulast%3DSugimoto%26aufirst%3DN.%26aulast%3DMizugishi%26aufirst%3DK.%26aulast%3DNakanuma%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DI.%26aulast%3DTakamura%26aufirst%3DM.%26aulast%3DKaneko%26aufirst%3DS.%26aulast%3DKojo%26aufirst%3DS.%26aulast%3DSatouchi%26aufirst%3DK.%26aulast%3DMitumori%26aufirst%3DK.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DTakuwa%26aufirst%3DY.%26atitle%3DS1P3-mediated%2520cardiac%2520fibrosis%2520in%2520sphingosine%2520kinase%25201%2520transgenic%2520mice%2520involves%2520reactive%2520oxygen%2520species%26jtitle%3DCardiovasc.%2520Res.%26date%3D2009%26volume%3D85%26spage%3D484%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Sobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menyhart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Killer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P<sub>2</sub> and S1P<sub>3</sub> receptors and Smad-independent signaling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">14839</span><span class="NLM_x">–</span> <span class="NLM_lpage">14851</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=14839-14851&author=K.+Sobelauthor=K.+Menyhartauthor=N.+Killerauthor=B.+Renaultauthor=Y.+Bauerauthor=R.+Studerauthor=B.+Steinerauthor=M.+H.+Bolliauthor=O.+Naylerauthor=J.+Gatfield&title=Sphingosine-1-phosphate+%28S1P%29+receptor+agonists+mediate+pro-fibrotic+responses+in+normal+human+lung+fibroblasts+via+S1P2+and+S1P3+receptors+and+Smad-independent+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSobel%26aufirst%3DK.%26aulast%3DMenyhart%26aufirst%3DK.%26aulast%3DKiller%26aufirst%3DN.%26aulast%3DRenault%26aufirst%3DB.%26aulast%3DBauer%26aufirst%3DY.%26aulast%3DStuder%26aufirst%3DR.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DGatfield%26aufirst%3DJ.%26atitle%3DSphingosine-1-phosphate%2520%2528S1P%2529%2520receptor%2520agonists%2520mediate%2520pro-fibrotic%2520responses%2520in%2520normal%2520human%2520lung%2520fibroblasts%2520via%2520S1P2%2520and%2520S1P3%2520receptors%2520and%2520Smad-independent%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D14839%26epage%3D14851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Pyne, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span> </span><span class="NLM_article-title">Role of sphingosine 1-phosphate and lysophosphatidic acid in fibrosis</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1831</span><span class="NLM_x">, </span> <span class="NLM_fpage">228</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1831&publication_year=2013&pages=228-38&author=N.+J.+Pyneauthor=G.+Duboisauthor=S.+Pyne&title=Role+of+sphingosine+1-phosphate+and+lysophosphatidic+acid+in+fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DDubois%26aufirst%3DG.%26aulast%3DPyne%26aufirst%3DS.%26atitle%3DRole%2520of%2520sphingosine%25201-phosphate%2520and%2520lysophosphatidic%2520acid%2520in%2520fibrosis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2013%26volume%3D1831%26spage%3D228%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Foster, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweitzer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persohn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balatoni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuschel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span> </span><span class="NLM_article-title">Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1124%2Fjpet.107.127183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=17682127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ynsLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2007&pages=469-476&author=C.+A.+Fosterauthor=L.+M.+Howardauthor=A.+Schweitzerauthor=E.+Persohnauthor=P.+C.+Hiestandauthor=B.+Balatoniauthor=R.+Reuschelauthor=C.+Beerliauthor=M.+Schwartzauthor=A.+Billich&title=Brain+penetration+of+the+oral+immunomodulatory+drug+FTY720+and+its+phosphorylation+in+the+central+nervous+system+during+experimental+autoimmune+encephalomyelitis%3A+consequences+for+mode+of+action+in+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis</span></div><div class="casAuthors">Foster, Carolyn A.; Howard, Laurence M.; Schweitzer, Alain; Persohn, Elke; Hiestand, Peter C.; Balatoni, Balazs; Reuschel, Roland; Beerli, Christian; Schwartz, Manuela; Billich, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">469-476</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">FTY720 [2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride] is an oral sphingosine-1-phosphate receptor modulator under development for the treatment of multiple sclerosis (MS).  The drug is phosphorylated in vivo by sphingosine kinase 2 to its bioactive form, FTY720-P.  Although treatment with FTY720 is accompanied by a redn. of the peripheral lymphocyte count, its efficacy in MS and exptl. autoimmune encephalomyelitis (EAE) may be due to addnl., direct effects in the central nervous system (CNS).  We now show that FTY720 localizes to the CNS white matter, preferentially along myelin sheaths.  Brain trough levels of FTY720 and FTY720-P in rat EAE are of the same magnitude and dose dependently increase; they are in the range of 40 to 540 ng/g in the brain tissue at efficacious doses and exceed blood concns. severalfold.  In a rat model of chronic EAE, prolonged treatment with 0.03 mg/kg was efficacious, but limiting the dosing period failed to prevent EAE despite a significant decrease in blood lymphocytes.  FTY720 effectiveness is likely due to a culmination of mechanisms involving redn. of autoreactive T cells, neuroprotective influence of FTY720-P in the CNS, and inhibition of inflammatory mediators in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq37e2tpDlreLVg90H21EOLACvtfcHk0lhqodosUyc97A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ynsLfP&md5=a4f414517a4b567e8d8905f0da2b4706</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.127183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.127183%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DHoward%26aufirst%3DL.%2BM.%26aulast%3DSchweitzer%26aufirst%3DA.%26aulast%3DPersohn%26aufirst%3DE.%26aulast%3DHiestand%26aufirst%3DP.%2BC.%26aulast%3DBalatoni%26aufirst%3DB.%26aulast%3DReuschel%26aufirst%3DR.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DSchwartz%26aufirst%3DM.%26aulast%3DBillich%26aufirst%3DA.%26atitle%3DBrain%2520penetration%2520of%2520the%2520oral%2520immunomodulatory%2520drug%2520FTY720%2520and%2520its%2520phosphorylation%2520in%2520the%2520central%2520nervous%2520system%2520during%2520experimental%2520autoimmune%2520encephalomyelitis%253A%2520consequences%2520for%2520mode%2520of%2520action%2520in%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D323%26spage%3D469%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Balatoni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storch, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swoboda, E.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schönborn, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koziel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambrou, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C. A.</span><span> </span><span class="NLM_article-title">FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis</span> <span class="citation_source-journal">Brain Res. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">316</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.brainresbull.2007.06.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=17845905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWhs7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=307-316&author=B.+Balatoniauthor=M.+K.+Storchauthor=E.-M.+Swobodaauthor=V.+Sch%C3%B6nbornauthor=A.+Kozielauthor=G.+N.+Lambrouauthor=P.+C.+Hiestandauthor=R.+Weissertauthor=C.+A.+Foster&title=FTY720+sustains+and+restores+neuronal+function+in+the+DA+rat+model+of+MOG-induced+experimental+autoimmune+encephalomyelitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis</span></div><div class="casAuthors">Balatoni, Balazs; Storch, Maria K.; Swoboda, Eva-M.; Schoenborn, Vinzenz; Koziel, Agnieszka; Lambrou, George N.; Hiestand, Peter C.; Weissert, Robert; Foster, Carolyn A.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">307-316</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">FTY720 (fingolimod) is an oral sphingosine 1-phosphate (S1P) receptor modulator under development for the treatment of multiple sclerosis (MS).  To elucidate its effects in the central nervous system (CNS), we compared functional parameters of nerve conductance in the DA rat model of myelin oligodendrocyte glycoprotein (MOG)-induced exptl. autoimmune encephalomyelitis (EAE) after preventive and therapeutic treatment.  We demonstrate that prophylactic therapy protected against the emergence of EAE symptoms, neuropathol., and disturbances to visual and somatosensory evoked potentials (VEP, SEP).  Moreover, therapeutic treatment from day 25 to 45 markedly reversed paralysis in established EAE and normalized the electrophysiol. responses, correlating with decreased demyelination in the brain and spinal cord.  The effectiveness of FTY720 in this model is likely due to several contributing factors.  Evidence thus far supports its role in the redn. of inflammation and preservation of blood-brain-barrier integrity.  FTY720 may also act via S1P receptors in glial cells to promote endogenous repair mechanisms that complement its immunomodulatory action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFwogDXcfLFrVg90H21EOLACvtfcHk0ljCe9IaGk-Gwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWhs7jL&md5=5fb8cec643e3ca6d7b35eaf3b020b873</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresbull.2007.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresbull.2007.06.023%26sid%3Dliteratum%253Aachs%26aulast%3DBalatoni%26aufirst%3DB.%26aulast%3DStorch%26aufirst%3DM.%2BK.%26aulast%3DSwoboda%26aufirst%3DE.-M.%26aulast%3DSch%25C3%25B6nborn%26aufirst%3DV.%26aulast%3DKoziel%26aufirst%3DA.%26aulast%3DLambrou%26aufirst%3DG.%2BN.%26aulast%3DHiestand%26aufirst%3DP.%2BC.%26aulast%3DWeissert%26aufirst%3DR.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26atitle%3DFTY720%2520sustains%2520and%2520restores%2520neuronal%2520function%2520in%2520the%2520DA%2520rat%2520model%2520of%2520MOG-induced%2520experimental%2520autoimmune%2520encephalomyelitis%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2007%26volume%3D74%26spage%3D307%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span> </span><span class="NLM_article-title">FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and central nervous system</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">1173</span><span class="NLM_x">–</span> <span class="NLM_lpage">1182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1111%2Fj.1476-5381.2009.00451.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=19814729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSks7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=1173-1182&author=V.+Brinkmann&title=FTY720+%28fingolimod%29+in+multiple+sclerosis%3A+therapeutic+effects+in+the+immune+and+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system</span></div><div class="casAuthors">Brinkmann, Volker</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1173-1182</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  FTY720 (fingolimod) is a first-in-class sphingosine 1-phosphate (S1P) receptor modulator that was highly effective in Phase II clin. trials for Multiple Sclerosis (MS).  FTY720 is phosphorylated in vivo by sphingosine kinase-2 to form the active moiety FTY720-phosphate that binds to four of the five G protein-coupled S1P receptor subtypes.  Studies using conditional S1P1 receptor-deficient and sphingosine kinase-deficient mice showed that the egress of lymphocytes from lymph nodes requires signaling of lymphocytic S1P1 receptors by the endogenous ligand S1P.  The S1P mimetic FTY720-phosphate causes internalization and degrdn. of cell membrane-expressed S1P1, thereby antagonizing S1P action at the receptor.  In models of human MS and demyelinating polyneuropathies, functional antagonism of lymphocytic S1P1 slows S1P-driven egress of lymphocytes from lymph nodes, thereby reducing the nos. of autoaggressive TH17 cells that recirculate via lymph and blood to the central nervous system and the sciatic/ischiatic nerves.  Based on its lipophilic nature, FTY720 crosses the blood-brain barrier, and ongoing expts. suggest that the drug also down-modulates S1P1 in neural cells/astrocytes to reduce astrogliosis, a phenomenon assocd. with neurodegeneration in MS.  This may help restore gap-junctional communication of astrocytes with neurons and cells of the blood-brain barrier.  Addnl. effects may result from (down-) modulation of S1P3 in astrocytes and of S1P1 and S1P5 in oligodendrocytes.  In conclusion, FTY720 may act through immune-based and central mechanisms to reduce inflammation and support structural restoration of the central nervous system parenchyma.  Beyond the autoimmune indications, very recent studies suggest that short-term, low-dose administration of FTY720 could help treat chronic (viral) infections.  Differential effects of the drug on the trafficking of naive, central memory and effector memory T cell subsets are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOQw7bGw9977Vg90H21EOLACvtfcHk0ljCe9IaGk-Gwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSks7fO&md5=33c85af3e092990c4c43fbeae5512de4</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00451.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00451.x%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26atitle%3DFTY720%2520%2528fingolimod%2529%2520in%2520multiple%2520sclerosis%253A%2520therapeutic%2520effects%2520in%2520the%2520immune%2520and%2520central%2520nervous%2520system%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D158%26spage%3D1173%26epage%3D1182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Coelho, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saini, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato-Bigbee, C.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate and oligodendrocytes: from cell development to the treatment of multiple sclerosis</span> <span class="citation_source-journal">Prostaglandins Other Lipid Mediators</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.prostaglandins.2009.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=19808013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslSiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2010&pages=139-144&author=R.+P.+Coelhoauthor=H.+S.+Sainiauthor=C.+Sato-Bigbee&title=Sphingosine-1-phosphate+and+oligodendrocytes%3A+from+cell+development+to+the+treatment+of+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate and oligodendrocytes: From cell development to the treatment of multiple sclerosis</span></div><div class="casAuthors">Coelho, Rochelle P.; Saini, Harsimran S.; Sato-Bigbee, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">139-144</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid that mediates a wide variety of biol. effects in different cells and tissues.  This review discusses the effects of S1P signaling in oligodendrocytes, the myelin making cells of the central nervous system (CNS).  Results from different labs. have uncovered direct actions of S1P at different maturational stages along the oligodendroglial lineage.  There is also evidence for the existence in oligodendrocytes of interactions between S1P and signaling by factors which, like neurotrophin-3 (NT-3) and platelet-derived growth factor (PDGF), have profound effects on oligodendrocyte development and myelination.  Moreover, S1P signaling in oligodendrocytes may not only play an important role during normal CNS development but also offer new therapeutic avenues to stimulate remyelination in demyelinating diseases like multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXpUozYYh8nbVg90H21EOLACvtfcHk0ljCe9IaGk-Gwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslSiu7c%253D&md5=2eebef84125efc6e433a29f47adc1d5c</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2009.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2009.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DCoelho%26aufirst%3DR.%2BP.%26aulast%3DSaini%26aufirst%3DH.%2BS.%26aulast%3DSato-Bigbee%26aufirst%3DC.%26atitle%3DSphingosine-1-phosphate%2520and%2520oligodendrocytes%253A%2520from%2520cell%2520development%2520to%2520the%2520treatment%2520of%2520multiple%2520sclerosis%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2010%26volume%3D91%26spage%3D139%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Miron, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwin, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarjour, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soliven, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antel, J. P.</span><span> </span><span class="NLM_article-title">Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">2682</span><span class="NLM_x">–</span> <span class="NLM_lpage">2694</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.2353%2Fajpath.2010.091234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=20413685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptFKrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2010&pages=2682-2694&author=V.+E.+Mironauthor=S.+K.+Ludwinauthor=P.+J.+Darlingtonauthor=A.+A.+Jarjourauthor=B.+Solivenauthor=T.+E.+Kennedyauthor=J.+P.+Antel&title=Fingolimod+%28FTY720%29+enhances+remyelination+following+demyelination+of+organotypic+cerebellar+slices"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices</span></div><div class="casAuthors">Miron, Veronique E.; Ludwin, Samuel K.; Darlington, Peter J.; Jarjour, Andrew A.; Soliven, Betty; Kennedy, Timothy E.; Antel, Jack P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2682-2694</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Remyelination, which occurs subsequent to demyelination, contributes to functional recovery and is mediated by oligodendrocyte progenitor cells (OPCs) that have differentiated into myelinating cells.  Therapeutics that impact remyelination in the CNS could be crit. determinants of long-term functional outcome in multiple sclerosis (MS).  Fingolimod is a S1P receptor modulator in MS clin. trials due to systemic anti-inflammatory properties, yet may impact cells within the CNS by crossing the blood-brain barrier.  Previous studies using isolated dissocd. cultures indicate that neural cells express S1P receptors and respond to receptor engagement.  Our objective was to assess the effects of fingolimod on myelinrelated processes within a multicellular environment that maintains physiol. cell-cell interactions, using organotypic cerebellar slice cultures.  Fingolimod treatment had no impact on myelin under basal conditions.  Fingolimod treatment subsequent to lysolecithin-induced demyelination enhanced remyelination and process extension by OPCs and mature oligodendrocytes, while increasing microglia nos. and immunoreactivity for the astrocytic marker glial fibrillary acidic protein.  The no. of phagocytosing microglia was not increased by fingolimod.  Using S1P receptor specific agonists and antagonists, we detd. that fingolimod-induced effects on remyelination and astrogliosis were mediated primarily through S1P3 and S1P5, whereas enhanced microgliosis was mediated through S1P1 and S1P5.  Taken together, these data demonstrate that fingolimod modulates multiple neuroglial cell responses, resulting in enhanced remyelination in organotypic slice cultures that maintain the complex cellular interactions of the mammalian brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGradvge9335h7Vg90H21EOLACvtfcHk0lj098ay2MM1XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptFKrs7c%253D&md5=6e7efa55ed7482a64dad66c6ec384de8</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2010.091234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2010.091234%26sid%3Dliteratum%253Aachs%26aulast%3DMiron%26aufirst%3DV.%2BE.%26aulast%3DLudwin%26aufirst%3DS.%2BK.%26aulast%3DDarlington%26aufirst%3DP.%2BJ.%26aulast%3DJarjour%26aufirst%3DA.%2BA.%26aulast%3DSoliven%26aufirst%3DB.%26aulast%3DKennedy%26aufirst%3DT.%2BE.%26aulast%3DAntel%26aufirst%3DJ.%2BP.%26atitle%3DFingolimod%2520%2528FTY720%2529%2520enhances%2520remyelination%2520following%2520demyelination%2520of%2520organotypic%2520cerebellar%2520slices%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2010%26volume%3D176%26spage%3D2682%26epage%3D2694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Choi, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardell, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teo, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yung, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P<sub>1</sub>) modulation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">751</span><span class="NLM_x">–</span> <span class="NLM_lpage">756</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=751-756&author=J.+W.+Choiauthor=S.+E.+Gardellauthor=D.+R.+Herrauthor=R.+Riveraauthor=C.-W.+Leeauthor=K.+Noguchiauthor=S.+T.+Teoauthor=Y.+C.+Yungauthor=M.+Luauthor=G.+Kennedyauthor=J.+Chun&title=FTY720+%28fingolimod%29+efficacy+in+an+animal+model+of+multiple+sclerosis+requires+astrocyte+sphingosine+1-phosphate+receptor+1+%28S1P1%29+modulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DGardell%26aufirst%3DS.%2BE.%26aulast%3DHerr%26aufirst%3DD.%2BR.%26aulast%3DRivera%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.-W.%26aulast%3DNoguchi%26aufirst%3DK.%26aulast%3DTeo%26aufirst%3DS.%2BT.%26aulast%3DYung%26aufirst%3DY.%2BC.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DKennedy%26aufirst%3DG.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DFTY720%2520%2528fingolimod%2529%2520efficacy%2520in%2520an%2520animal%2520model%2520of%2520multiple%2520sclerosis%2520requires%2520astrocyte%2520sphingosine%25201-phosphate%2520receptor%25201%2520%2528S1P1%2529%2520modulation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D751%26epage%3D756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Groves, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy</span> <span class="citation_source-journal">J Neurol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.jns.2013.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=23518370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlGit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2013&pages=9-18&author=A.+Grovesauthor=Y.+Kiharaauthor=J.+Chun&title=Fingolimod%3A+direct+CNS+effects+of+sphingosine+1-phosphate+%28S1P%29+receptor+modulation+and+implications+in+multiple+sclerosis+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy</span></div><div class="casAuthors">Groves, Aran; Kihara, Yasuyuki; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Neurological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">328</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">9-18</span>CODEN:
                <span class="NLM_cas:coden">JNSCAG</span>;
        ISSN:<span class="NLM_cas:issn">0022-510X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Fingolimod is the first oral disease-modifying therapy approved for relapsing forms of multiple sclerosis (MS).  Following phosphorylation in vivo, the active agent, fingolimod phosphate (fingolimod-P), acts as a sphingosine 1-phosphate (S1P) receptor modulator, binding with high affinity to four of the five known S1P receptors (S1P1, S1P3, S1P4 and S1P5).  The mechanism of action of fingolimod in MS has primarily been considered as immunomodulatory, whereby fingolimod-P modulates S1P1 on lymphocytes, selectively retaining autoreactive lymphocytes in lymph nodes to reduce damaging infiltration into the central nervous system (CNS).  However, emerging evidence indicates that fingolimod has direct effects in the CNS in MS.  For example, in the MS animal model of exptl. autoimmune encephalomyelitis (EAE), fingolimod is highly efficacious in both a prophylactic and therapeutic setting, yet becomes ineffective in animals selectively deficient for S1P1 on astrocytes, despite maintained normal immunol. receptor expression and functions, and S1P-mediated immune activities.  Here we review S1P signaling effects relevant to MS in neural cell types expressing S1P receptors, including astrocytes, oligodendrocytes, neurons, microglia and dendritic cells.  The direct effects of fingolimod on these CNS cells obsd. in preclin. studies are discussed in view of the functional consequences of reducing neurodegenerative processes and promoting myelin preservation and repair.  The therapeutic implications of S1P modulation in the CNS are considered in terms of the clin. outcomes of MS, such as reducing MS-related brain atrophy, and other CNS disorders.  Addnl., we briefly outline other existing and investigational MS therapies that may also have effects in the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru2tvngjfbNrVg90H21EOLACvtfcHk0lj098ay2MM1XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlGit78%253D&md5=22b2eb7c069d299a36b9dbbb1a40208c</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.jns.2013.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jns.2013.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DGroves%26aufirst%3DA.%26aulast%3DKihara%26aufirst%3DY.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DFingolimod%253A%2520direct%2520CNS%2520effects%2520of%2520sphingosine%25201-phosphate%2520%2528S1P%2529%2520receptor%2520modulation%2520and%2520implications%2520in%2520multiple%2520sclerosis%2520therapy%26jtitle%3DJ%2520Neurol.%2520Sci.%26date%3D2013%26volume%3D328%26spage%3D9%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kanter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span> </span><span class="NLM_article-title">Novel S1P<sub>1</sub> receptor agonists - Part 2: From bicyclo[3.1.0]hexane fused thiophenes to isobutyl substituted thiophenes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1021/jm401456d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401456d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=M.+H.+Bolliauthor=J.+Velkerauthor=C.+M%C3%BCllerauthor=B.+Mathysauthor=M.+Birkerauthor=R.+Bravoauthor=D.+Burauthor=R.+de+Kanterauthor=P.+Hessauthor=C.+Kohlauthor=D.+Lehmannauthor=S.+Meyerauthor=O.+Naylerauthor=M.+Reyauthor=M.+Scherzauthor=B.+Steiner&title=Novel+S1P1+receptor+agonists+-+Part+2%3A+From+bicyclo%5B3.1.0%5Dhexane+fused+thiophenes+to+isobutyl+substituted+thiophenes&doi=10.1021%2Fjm401456d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fjm401456d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401456d%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DVelker%26aufirst%3DJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DBirker%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBur%26aufirst%3DD.%26aulast%3Dde%2BKanter%26aufirst%3DR.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DLehmann%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DRey%26aufirst%3DM.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSteiner%26aufirst%3DB.%26atitle%3DNovel%2520S1P1%2520receptor%2520agonists%2520-%2520Part%25202%253A%2520From%2520bicyclo%255B3.1.0%255Dhexane%2520fused%2520thiophenes%2520to%2520isobutyl%2520substituted%2520thiophenes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26doi%3D10.1021%2Fjm401456d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and developement settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+developement+settings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520developement%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Hann, M. M.</span><span> </span><span class="NLM_article-title">Molecular obesity, potency and other addictions in drug discovery</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1039%2FC1MD00017A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1Kht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=349-355&author=M.+M.+Hann&title=Molecular+obesity%2C+potency+and+other+addictions+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular obesity, potency and other addictions in drug discovery</span></div><div class="casAuthors">Hann, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">349-355</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Despite the increase in global biol. and chem. knowledge the discovery of effective and safe new drugs seems to become harder rather than easier.  Some of this challenge is due to increasing demands for safety and novelty, but some of the risk involved in this should be controllable if we had more effectively learned from our failures.  This perspective reflects on some of the learnings of recent years in relation to the causes of attrition.  The term Mol. Obesity is introduced to describe our tendency to build potency into mols. by the inappropriate use of lipophilicity which leads to the premature demise of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSlF7TPy6fHLVg90H21EOLACvtfcHk0li89I4NG-4Efw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1Kht7g%253D&md5=954870db4b1d9e846612c3bb256582f7</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1039%2FC1MD00017A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC1MD00017A%26sid%3Dliteratum%253Aachs%26aulast%3DHann%26aufirst%3DM.%2BM.%26atitle%3DMolecular%2520obesity%252C%2520potency%2520and%2520other%2520addictions%2520in%2520drug%2520discovery%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D349%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Waring, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, C.</span><span> </span><span class="NLM_article-title">A quantitative assessment of hERG liability as a function of lipophilicity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1759</span><span class="NLM_x">–</span> <span class="NLM_lpage">1764</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.bmcl.2006.12.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=17239590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1yrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1759-1764&author=M.+J.+Waringauthor=C.+Johnstone&title=A+quantitative+assessment+of+hERG+liability+as+a+function+of+lipophilicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative assessment of hERG liability as a function of lipophilicity</span></div><div class="casAuthors">Waring, Michael J.; Johnstone, Craig</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1759-1764</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The impact of lipophilicity as a factor contributing to hERG potency is assessed for a large dataset of compds. of differing ionization type.  This dataset is derived from compds. tested in the Ionworks-based in vitro electrophysiol. hERG assay at AstraZeneca.  Using logistic regression, a quantification of the risk assocd. with increasing lipophilicity is presented.  The anticipated differences between acidic, basic and neutral compds. are apparent in the data but lipophilicity is shown to be a stronger driver for hERG potency than might have been expected.  Simple rules defining target lipophilicity values for minimizing hERG liability are derived.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlCr9mVGL2-LVg90H21EOLACvtfcHk0lh37ylOHiTeLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1yrtb8%253D&md5=3819e045d7b773f129773f1ff567b980</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.061%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DC.%26atitle%3DA%2520quantitative%2520assessment%2520of%2520hERG%2520liability%2520as%2520a%2520function%2520of%2520lipophilicity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1759%26epage%3D1764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span> </span><span class="NLM_article-title">Role of physicochemical properties and ligand lipophilicity efficiency in addressing drug safety risks</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2FS0065-7743%2810%2945023-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=380-391&author=M.+P.+Edwardsauthor=D.+A.+Price&title=Role+of+physicochemical+properties+and+ligand+lipophilicity+efficiency+in+addressing+drug+safety+risks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2FS0065-7743%2810%2945023-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-7743%252810%252945023-X%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26atitle%3DRole%2520of%2520physicochemical%2520properties%2520and%2520ligand%2520lipophilicity%2520efficiency%2520in%2520addressing%2520drug%2520safety%2520risks%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D380%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Walters, W. P.</span><span> </span><span class="NLM_article-title">Going further than Lipinski’s rule in drug design</span> <span class="citation_source-journal">Expert Opin. Drug. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=99-107&author=W.+P.+Walters&title=Going+further+than+Lipinski%E2%80%99s+rule+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalters%26aufirst%3DW.%2BP.%26atitle%3DGoing%2520further%2520than%2520Lipinski%25E2%2580%2599s%2520rule%2520in%2520drug%2520design%26jtitle%3DExpert%2520Opin.%2520Drug.%2520Discovery%26date%3D2012%26volume%3D7%26spage%3D99%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Miyaura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, A.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed cross-coupling reactions of organoboron compounds</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2457</span><span class="NLM_x">–</span> <span class="NLM_lpage">2483</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00039a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=2457-2483&author=N.+Miyauraauthor=A.+Suzuki&title=Palladium-catalyzed+cross-coupling+reactions+of+organoboron+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span></div><div class="casAuthors">Miyaura, Norio; Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2457-83</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with >250 refs. including title reactions and their mechanisms, prepn. of organoboron reagents, alkoxycarbonylation and dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHwupBJT1UCbVg90H21EOLACvtfcHk0lh37ylOHiTeLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D&md5=d127b414a75161652876eebc3ed0c486</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1021%2Fcr00039a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00039a007%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DPalladium-catalyzed%2520cross-coupling%2520reactions%2520of%2520organoboron%2520compounds%26jtitle%3DChem.%2520Rev.%26date%3D1995%26volume%3D95%26spage%3D2457%26epage%3D2483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Doucet, H.</span><span> </span><span class="NLM_article-title">Suzuki–Miyaura cross-coupling reactions of alkylboronic acid derivatives or alkyltrifluoroborates with aryl, alkenyl or alkyl halides and triflates</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">2013</span><span class="NLM_x">–</span> <span class="NLM_lpage">2030</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2008&publication_year=2008&pages=2013-2030&author=H.+Doucet&title=Suzuki%E2%80%93Miyaura+cross-coupling+reactions+of+alkylboronic+acid+derivatives+or+alkyltrifluoroborates+with+aryl%2C+alkenyl+or+alkyl+halides+and+triflates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoucet%26aufirst%3DH.%26atitle%3DSuzuki%25E2%2580%2593Miyaura%2520cross-coupling%2520reactions%2520of%2520alkylboronic%2520acid%2520derivatives%2520or%2520alkyltrifluoroborates%2520with%2520aryl%252C%2520alkenyl%2520or%2520alkyl%2520halides%2520and%2520triflates%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2008%26volume%3D2008%26spage%3D2013%26epage%3D2030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Jana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathak, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigman, M. S.</span><span> </span><span class="NLM_article-title">Advances in transition metal (Pd,Ni,Fe)-catalyzed cross-coupling reactions using alkyl-organometallics as reaction partners</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1492</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr100327p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFeisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=1417-1492&author=R.+Janaauthor=T.+P.+Pathakauthor=M.+S.+Sigman&title=Advances+in+transition+metal+%28Pd%2CNi%2CFe%29-catalyzed+cross-coupling+reactions+using+alkyl-organometallics+as+reaction+partners"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in Transition Metal (Pd, Ni, Fe)-Catalyzed Cross-Coupling Reactions Using Alkyl-organometallics as Reaction Partners</span></div><div class="casAuthors">Jana, Ranjan; Pathak, Tejas P.; Sigman, Matthew S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1417-1492</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review was given discussing the synthesis, stability, and transition metal-catalyzed(Pd, Ni, Fe) cross-coupling of sp3-organonetallics possessing β-H(s) using alkylzinc (Negishi), allylboron (Suzuki-Miyaura), alkylmagnesium (Kumada), alkyltin (Stille), alkylsilicon (Hiyama), and alkylindium.  Besides their detailed development and mechanistic investigations, extension to asym. catalysis and applications in total synthesis were described.  Organometallic reagents that cannot undergo β-H- elimination were not reviewed comprehensively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz1NzFql_8krVg90H21EOLACvtfcHk0lhV2-8wu1EGzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFeisbk%253D&md5=30863f277ba20b5aec43f14125260cd4</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1021%2Fcr100327p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr100327p%26sid%3Dliteratum%253Aachs%26aulast%3DJana%26aufirst%3DR.%26aulast%3DPathak%26aufirst%3DT.%2BP.%26aulast%3DSigman%26aufirst%3DM.%2BS.%26atitle%3DAdvances%2520in%2520transition%2520metal%2520%2528Pd%252CNi%252CFe%2529-catalyzed%2520cross-coupling%2520reactions%2520using%2520alkyl-organometallics%2520as%2520reaction%2520partners%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D1417%26epage%3D1492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Fürstner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitner, A.</span><span> </span><span class="NLM_article-title">Iron-catalyzed cross-coupling reactions of alkyl-Grignard reagents with aryl chloride, tosylates and triflates</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=609-612&author=A.+F%C3%BCrstnerauthor=A.+Leitner&title=Iron-catalyzed+cross-coupling+reactions+of+alkyl-Grignard+reagents+with+aryl+chloride%2C+tosylates+and+triflates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25BCrstner%26aufirst%3DA.%26aulast%3DLeitner%26aufirst%3DA.%26atitle%3DIron-catalyzed%2520cross-coupling%2520reactions%2520of%2520alkyl-Grignard%2520reagents%2520with%2520aryl%2520chloride%252C%2520tosylates%2520and%2520triflates%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2002%26volume%3D41%26spage%3D609%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Fürstner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, H.</span><span> </span><span class="NLM_article-title">Iron-catalyzed cross coupling reactions</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">13856</span><span class="NLM_x">–</span> <span class="NLM_lpage">13863</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja027190t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=13856-13863&author=A.+F%C3%BCrstnerauthor=A.+Leitnerauthor=M.+M%C3%A9ndezauthor=H.+Krause&title=Iron-catalyzed+cross+coupling+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Fja027190t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja027190t%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25BCrstner%26aufirst%3DA.%26aulast%3DLeitner%26aufirst%3DA.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DM.%26aulast%3DKrause%26aufirst%3DH.%26atitle%3DIron-catalyzed%2520cross%2520coupling%2520reactions%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26spage%3D13856%26epage%3D13863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Hartwig, J. F.</span><span> </span><span class="NLM_article-title">Transition metal catalyzed synthesis of arylamines and aryl ethers from aryl halides and triflates: scope and mechanism</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2046</span><span class="NLM_x">–</span> <span class="NLM_lpage">2067</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1002%2F%28SICI%291521-3773%2819980817%2937%3A15%3C2046%3A%3AAID-ANIE2046%3E3.0.CO%3B2-L" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADyaK1cXls12lsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=2046-2067&author=J.+F.+Hartwig&title=Transition+metal+catalyzed+synthesis+of+arylamines+and+aryl+ethers+from+aryl+halides+and+triflates%3A+scope+and+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Transition metal catalyzed synthesis of arylamines and aryl ethers from aryl halides and triflates: scope and mechanism</span></div><div class="casAuthors">Hartwig, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2046-2067</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">The transition metal catalyzed synthesis of arylamines by the reaction of aryl halides or triflates (triflate = trifluoromethanesulfonyl) with primary or secondary amines has rapidly become a valuable synthetic tool for a variety of applications.  This process can form monoalkyl- or dialkylanilines as well as mixed diaryl- or triarylamines.  The chem. can be extended to the formation of aryl ethers from aryl halides, although this process is currently less general than the synthesis of arylamines.  The mechanism of this reaction involves several novel organometallic reactions.  For example, the C-N or C-O bond is formed by reductive elimination of amines or ethers, and the metal-amido complexes that undergo reductive elimination can be formed in the catalytic cycle by N-H activation.  Side products are formed by β-H elimination from amides, examples of which have recently been obsd. directly.  This synthetic methods to form arylamines by this Pd-catalyzed chem.  In addn. to information on syntheses, a description of the pertinent mechanistic data on the overall catalytic cycle, on each elementary reaction in the catalytic cycle, and on competing side reactions is presented.  This review, with 185 refs., covers manuscripts that appeared in press before July 1, 1997 as well as those submitted by the author and co-workers before this date.  A brief discussion of papers that appeared between July 1, 1997 and Mar. 1, 1998 is included as an appendix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN62JEgQmn5rVg90H21EOLACvtfcHk0lhV2-8wu1EGzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXls12lsbY%253D&md5=8e5c153e91706b01c8fc99f622a484a9</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819980817%2937%3A15%3C2046%3A%3AAID-ANIE2046%3E3.0.CO%3B2-L&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819980817%252937%253A15%253C2046%253A%253AAID-ANIE2046%253E3.0.CO%253B2-L%26sid%3Dliteratum%253Aachs%26aulast%3DHartwig%26aufirst%3DJ.%2BF.%26atitle%3DTransition%2520metal%2520catalyzed%2520synthesis%2520of%2520arylamines%2520and%2520aryl%2520ethers%2520from%2520aryl%2520halides%2520and%2520triflates%253A%2520scope%2520and%2520mechanism%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1998%26volume%3D37%26spage%3D2046%26epage%3D2067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Kerins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, D. F.</span><span> </span><span class="NLM_article-title">Generation of substituted styrenes via Suzuki cross-coupling of aryl halides with 2,4,6-trivinylcyclotriboroxane</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">4968</span><span class="NLM_x">–</span> <span class="NLM_lpage">4971</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo020074o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvVaisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=4968-4971&author=F.+Kerinsauthor=D.+F.+O%E2%80%99Shea&title=Generation+of+substituted+styrenes+via+Suzuki+cross-coupling+of+aryl+halides+with+2%2C4%2C6-trivinylcyclotriboroxane"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of Substituted Styrenes via Suzuki Cross-Coupling of Aryl Halides with 2,4,6-Trivinylcyclotriboroxane</span></div><div class="casAuthors">Kerins, Fergal; O'Shea, Donal F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4968-4971</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of functionalized styrene derivs. can be readily achieved utilizing a Suzuki cross-coupling protocol between aryl halides and 2,4,6-trivinylcyclotriboroxane-pyridine complex.  The scope and limitations of the procedure were demonstrated by investigation of an array of ortho-substituted aryl halides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphXIT69_FaBLVg90H21EOLACvtfcHk0lghto6Oqt5QFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvVaisbY%253D&md5=00265b1ba9a6f0dc782c062ed3e85827</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Fjo020074o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo020074o%26sid%3Dliteratum%253Aachs%26aulast%3DKerins%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DD.%2BF.%26atitle%3DGeneration%2520of%2520substituted%2520styrenes%2520via%2520Suzuki%2520cross-coupling%2520of%2520aryl%2520halides%2520with%25202%252C4%252C6-trivinylcyclotriboroxane%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D4968%26epage%3D4971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Beck, G.; Heitzer, H.</span><span> </span><span class="NLM_article-title">Verfahren zur Herstellung von 2-Halogenpyridinaldehyden und Neue 2-Halogenpyridinaldehyde</span>. EP0702003, Mar 20,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=G.+Beck&author=H.+Heitzer&title=Verfahren+zur+Herstellung+von+2-Halogenpyridinaldehyden+und+Neue+2-Halogenpyridinaldehyde"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DG.%26atitle%3DVerfahren%2520zur%2520Herstellung%2520von%25202-Halogenpyridinaldehyden%2520und%2520Neue%25202-Halogenpyridinaldehyde%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Buratti, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardini, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minisci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perchinunno, M.</span><span> </span><span class="NLM_article-title">Nucleophilic character of alkyl radicals. V: Selective homolytic α-oxyalkylation of heteroaromatic bases</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3655</span><span class="NLM_x">–</span> <span class="NLM_lpage">3668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1971&pages=3655-3668&author=W.+Burattiauthor=G.+P.+Gardiniauthor=F.+Minisciauthor=F.+Bertiniauthor=R.+Galliauthor=M.+Perchinunno&title=Nucleophilic+character+of+alkyl+radicals.+V%3A+Selective+homolytic+%CE%B1-oxyalkylation+of+heteroaromatic+bases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuratti%26aufirst%3DW.%26aulast%3DGardini%26aufirst%3DG.%2BP.%26aulast%3DMinisci%26aufirst%3DF.%26aulast%3DBertini%26aufirst%3DF.%26aulast%3DGalli%26aufirst%3DR.%26aulast%3DPerchinunno%26aufirst%3DM.%26atitle%3DNucleophilic%2520character%2520of%2520alkyl%2520radicals.%2520V%253A%2520Selective%2520homolytic%2520%25CE%25B1-oxyalkylation%2520of%2520heteroaromatic%2520bases%26jtitle%3DTetrahedron%26date%3D1971%26volume%3D27%26spage%3D3655%26epage%3D3668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Minisci, F.</span><span> </span><span class="NLM_article-title">Novel applications of free-radical reactions in preparative organic chemistry</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">1973</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1055%2Fs-1973-22123" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1973&publication_year=1973&pages=1-24&author=F.+Minisci&title=Novel+applications+of+free-radical+reactions+in+preparative+organic+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1055%2Fs-1973-22123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1973-22123%26sid%3Dliteratum%253Aachs%26aulast%3DMinisci%26aufirst%3DF.%26atitle%3DNovel%2520applications%2520of%2520free-radical%2520reactions%2520in%2520preparative%2520organic%2520chemistry%26jtitle%3DSynthesis%26date%3D1973%26volume%3D1973%26spage%3D1%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Duncton, M. A. J.</span><span> </span><span class="NLM_article-title">Minisci reactions: versatile CH-functionalizations for medicinal chemists</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1135</span><span class="NLM_x">–</span> <span class="NLM_lpage">1161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1039%2Fc1md00134e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFeju77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=1135-1161&author=M.+A.+J.+Duncton&title=Minisci+reactions%3A+versatile+CH-functionalizations+for+medicinal+chemists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Minisci reactions. Versatile CH-functionalizations for medicinal chemists</span></div><div class="casAuthors">Duncton, Matthew A. J.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1135-1161</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The addn. of a radical to a heteroarom. base is commonly referred to as a Minsici reaction.  Such reactions constitute a broad-set of selective CH-functionalization processes.  This review described some of the major applications of Minisci reactions and related processes to medicinal or biol. chem., and highlights some potential developments within this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4rms5MglIuLVg90H21EOLACvtfcHk0lghto6Oqt5QFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFeju77E&md5=49d9076c79e5caf19d21b8fbd74ff0c2</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1039%2Fc1md00134e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00134e%26sid%3Dliteratum%253Aachs%26aulast%3DDuncton%26aufirst%3DM.%2BA.%2BJ.%26atitle%3DMinisci%2520reactions%253A%2520versatile%2520CH-functionalizations%2520for%2520medicinal%2520chemists%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D1135%26epage%3D1161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">Novel S1P<sub>1</sub> receptor agonists—Part 1: From pyrazoles to thiophenes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9737</span><span class="NLM_x">–</span> <span class="NLM_lpage">9755</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4014373" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9737-9755&author=M.+H.+Bolliauthor=C.+M%C3%BCllerauthor=B.+Mathysauthor=S.+Abeleauthor=M.+Birkerauthor=R.+Bravoauthor=D.+Burauthor=P.+Hessauthor=C.+Kohlauthor=D.+Lehmannauthor=O.+Naylerauthor=M.+Reyauthor=S.+Meyerauthor=M.+Scherzauthor=G.+Schmidtauthor=B.+Steinerauthor=A.+Treiberauthor=J.+Velkerauthor=T.+Weller&title=Novel+S1P1+receptor+agonists%E2%80%94Part+1%3A+From+pyrazoles+to+thiophenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fjm4014373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4014373%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DBirker%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DLehmann%26aufirst%3DD.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DRey%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DVelker%26aufirst%3DJ.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3DNovel%2520S1P1%2520receptor%2520agonists%25E2%2580%2594Part%25201%253A%2520From%2520pyrazoles%2520to%2520thiophenes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9737%26epage%3D9755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Brossard, P.; D’Ambrosio, D.; Ipek, M.; Dingemanse, J.</span><span> </span><span class="NLM_article-title">Effects on Heart Rate of Three Different Up-Titration Regimens of Ponesimod, a Selective S1P<sub>1</sub> Receptor Modulator, and of Re-Initiation of Treatment in Healthy Male and Female Subjects</span>. Presented at the 28th Congress of the European Commitee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2012), Lyon, France, Oct 10–13,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>P468.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=P.+Brossard&author=D.+D%E2%80%99Ambrosio&author=M.+Ipek&author=J.+Dingemanse&title=Effects+on+Heart+Rate+of+Three+Different+Up-Titration+Regimens+of+Ponesimod%2C+a+Selective+S1P1+Receptor+Modulator%2C+and+of+Re-Initiation+of+Treatment+in+Healthy+Male+and+Female+Subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBrossard%26aufirst%3DP.%26atitle%3DEffects%2520on%2520Heart%2520Rate%2520of%2520Three%2520Different%2520Up-Titration%2520Regimens%2520of%2520Ponesimod%252C%2520a%2520Selective%2520S1P1%2520Receptor%2520Modulator%252C%2520and%2520of%2520Re-Initiation%2520of%2520Treatment%2520in%2520Healthy%2520Male%2520and%2520Female%2520Subjects%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Gergely, P.; Wallström, E.; Nuesslein-Hildesheim, B.; Bruns, C.; Zécri, F. J.; Cooke, N. G.; Traebert, M.; Tuntland, T.; Rosenberg, M.; Saltzman, M.</span><span> </span><span class="NLM_article-title">Phase I Study with the Selective S1P1/S1P5 Receptor Modulator BAF312 Indicates That S1P1 Rather Than S1P3 Mediates Transient Heart Rate Reduction in Humans</span>. Presented at the 25th Congress of the European Committe for Treatment and Research in Multiple Sclerosis (ECTRIMS), Düsseldorf, Germany, Sep 9–12,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>P437.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=P.+Gergely&author=E.+Wallstr%C3%B6m&author=B.+Nuesslein-Hildesheim&author=C.+Bruns&author=F.+J.+Z%C3%A9cri&author=N.+G.+Cooke&author=M.+Traebert&author=T.+Tuntland&author=M.+Rosenberg&author=M.+Saltzman&title=Phase+I+Study+with+the+Selective+S1P1%2FS1P5+Receptor+Modulator+BAF312+Indicates+That+S1P1+Rather+Than+S1P3+Mediates+Transient+Heart+Rate+Reduction+in+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DP.%26atitle%3DPhase%2520I%2520Study%2520with%2520the%2520Selective%2520S1P1%252FS1P5%2520Receptor%2520Modulator%2520BAF312%2520Indicates%2520That%2520S1P1%2520Rather%2520Than%2520S1P3%2520Mediates%2520Transient%2520Heart%2520Rate%2520Reduction%2520in%2520Humans%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Wallström, E.; Gergely, P.; Nuesslein-Hildesheim, B.; Zécri, F. J.; Cooke, N. G.; Bruns, C.; Luttringer, O.; Sing, T.; Groenewegen, A.; Rosenberg, M.; Saltzman, M.</span><span> </span><span class="NLM_article-title">BAF312, a Selective S1P1/S1P5 Receptor Modulator, Effectively Reduces Absolute Lymphocyte Counts in Human Volunteers and Demonstrates the Relevance of S1P1 in Mediating a Transient Heart Rate Reduction</span>. Presented at the 62nd Annual Meeting of the American Academy of Neurology, Toronto, Ontario, Canada, Apr 10–17,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>PO5.052.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=E.+Wallstr%C3%B6m&author=P.+Gergely&author=B.+Nuesslein-Hildesheim&author=F.+J.+Z%C3%A9cri&author=N.+G.+Cooke&author=C.+Bruns&author=O.+Luttringer&author=T.+Sing&author=A.+Groenewegen&author=M.+Rosenberg&author=M.+Saltzman&title=BAF312%2C+a+Selective+S1P1%2FS1P5+Receptor+Modulator%2C+Effectively+Reduces+Absolute+Lymphocyte+Counts+in+Human+Volunteers+and+Demonstrates+the+Relevance+of+S1P1+in+Mediating+a+Transient+Heart+Rate+Reduction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DWallstr%25C3%25B6m%26aufirst%3DE.%26atitle%3DBAF312%252C%2520a%2520Selective%2520S1P1%252FS1P5%2520Receptor%2520Modulator%252C%2520Effectively%2520Reduces%2520Absolute%2520Lymphocyte%2520Counts%2520in%2520Human%2520Volunteers%2520and%2520Demonstrates%2520the%2520Relevance%2520of%2520S1P1%2520in%2520Mediating%2520a%2520Transient%2520Heart%2520Rate%2520Reduction%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Rey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delahaye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span> </span><span class="NLM_article-title">Desensitization by progressive up-titration prevents first-dose effects on the heart: guinea pig study with ponesimod, a selective S1P1 receptor modulator</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e74285</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e74285&author=M.+Reyauthor=P.+Hessauthor=M.+Clozelauthor=S.+Delahayeauthor=J.+Gatfieldauthor=O.+Naylerauthor=B.+Steiner&title=Desensitization+by+progressive+up-titration+prevents+first-dose+effects+on+the+heart%3A+guinea+pig+study+with+ponesimod%2C+a+selective+S1P1+receptor+modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRey%26aufirst%3DM.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DDelahaye%26aufirst%3DS.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DSteiner%26aufirst%3DB.%26atitle%3DDesensitization%2520by%2520progressive%2520up-titration%2520prevents%2520first-dose%2520effects%2520on%2520the%2520heart%253A%2520guinea%2520pig%2520study%2520with%2520ponesimod%252C%2520a%2520selective%2520S1P1%2520receptor%2520modulator%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De74285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottschlich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seelig, A.</span><span> </span><span class="NLM_article-title">Blood–brain barrier permeation: molecular parameters governing passive diffusion</span> <span class="citation_source-journal">J. Membr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1007%2Fs002329900434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=9767674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADyaK1cXmsFOlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=1998&pages=201-211&author=H.+Fischerauthor=R.+Gottschlichauthor=A.+Seelig&title=Blood%E2%80%93brain+barrier+permeation%3A+molecular+parameters+governing+passive+diffusion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier permeation: molecular parameters governing passive diffusion</span></div><div class="casAuthors">Fischer, H.; Gottschlich, R.; Seelig, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Membrane Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">201-211</span>CODEN:
                <span class="NLM_cas:coden">JMBBBO</span>;
        ISSN:<span class="NLM_cas:issn">0022-2631</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag New York Inc.</span>)
        </div><div class="casAbstract">Fifty-three compds. with clin. established ability to cross or not to cross the blood-brain barrier by passive diffusion were characterized by means of surface activity measurements in terms of three parameters, i.e., the air-water partition coeff., Kaw, the crit. micelle concn., CMCD, and the cross-sectional area, AD.  A three-dimensional plot in which the surface area, AD, is plotted as a function of Kaw-1 and CMCD shows essentially three groups of compds.: (i) very hydrophobic compds. with large air-water partition coeffs. and large cross-sectional areas, AD > 80 Å2, which do not cross the blood-brain barrier, (ii) compds. with lower air-water partition coeffs. and an av. cross-sectional area, AD ≃ 50 Å2, which easily cross the blood-brain barrier, and (iii) hydrophilic compds. with low air-water partition coeffs. (AD < 50 Å2) which cross the blood-brain barrier only if applied at high concns.  It was shown that the lipid membrane-water partition coeff., Klw, measured previously, can be correlated with the air-water partition coeff. if the addnl. work against the internal lateral bilayer pressure, πbi = 34 ± 4 mN/m, is taken into account.  The partitioning into anisotropic lipid membranes decreases exponentially with increasing cross-sectional areas, AD, according to Klw = const. Kaw exp(-ADπbi/kT), where kT is the thermal energy.  The cross-sectional area of the mol. oriented at a hydrophilic-hydrophobic interface is thus the main determinant for membrane permeation provided the mol. is surface active and has a pKa > 4 for acids and a pKa < 10 for bases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvYrDWv9GpI7Vg90H21EOLACvtfcHk0lgfWb5FpT66tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsFOlsL4%253D&md5=a549eaf6f7ce81af291868899e3d0ab0</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1007%2Fs002329900434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002329900434%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DGottschlich%26aufirst%3DR.%26aulast%3DSeelig%26aufirst%3DA.%26atitle%3DBlood%25E2%2580%2593brain%2520barrier%2520permeation%253A%2520molecular%2520parameters%2520governing%2520passive%2520diffusion%26jtitle%3DJ.%2520Membr.%2520Biol.%26date%3D1998%26volume%3D165%26spage%3D201%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Van De Waterbeemd, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camenisch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chretien, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raevsky, O. A.</span><span> </span><span class="NLM_article-title">Estimation of blood–brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors</span> <span class="citation_source-journal">J. Drug Targeting</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.3109%2F10611869808997889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=9886238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADyaK1MXkvFKmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=151-165&author=H.+Van+De+Waterbeemdauthor=G.+Camenischauthor=G.+Folkersauthor=J.+R.+Chretienauthor=O.+A.+Raevsky&title=Estimation+of+blood%E2%80%93brain+barrier+crossing+of+drugs+using+molecular+size+and+shape%2C+and+H-bonding+descriptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors</span></div><div class="casAuthors">Van de Waterbeemd, Han; Camenisch, Gian; Folkers, Gerd; Chretien, Jacques R.; Raevsky, Oleg A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-165</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">The influence of physicochem. properties, including lipophilicity, H-bonding capacity and mol. size and shape descriptors on brain uptake has been investigated using a selection of marketed CNS and CNS-inactive drugs.  It is demonstrated that the polar surface area of a drug can be used as a suitable descriptor for the drugs' H-bonding potential.  A combination of a H-bonding and a mol. size descriptor, i.e., the major components of lipophilicity and permeability, avoiding knowledge of distribution coeffs., is proposed to est. brain penetration potential of new drug candidates.  Previously reported exptl. surface activity data appear to be strongly correlated to mol. size of the drug compds.  Present anal. offers a modern basis for property-based design and targeting of CNS drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0yCKmlzsa37Vg90H21EOLACvtfcHk0lgfWb5FpT66tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvFKmtg%253D%253D&md5=9106ff6aa0755ff76fd0634822857d4a</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.3109%2F10611869808997889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10611869808997889%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDe%2BWaterbeemd%26aufirst%3DH.%26aulast%3DCamenisch%26aufirst%3DG.%26aulast%3DFolkers%26aufirst%3DG.%26aulast%3DChretien%26aufirst%3DJ.%2BR.%26aulast%3DRaevsky%26aufirst%3DO.%2BA.%26atitle%3DEstimation%2520of%2520blood%25E2%2580%2593brain%2520barrier%2520crossing%2520of%2520drugs%2520using%2520molecular%2520size%2520and%2520shape%252C%2520and%2520H-bonding%2520descriptors%26jtitle%3DJ.%2520Drug%2520Targeting%26date%3D1998%26volume%3D6%26spage%3D151%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Clark, D. E.</span><span> </span><span class="NLM_article-title">Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood–brain barrier penetration</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=815-821&author=D.+E.+Clark&title=Rapid+calculation+of+polar+molecular+surface+area+and+its+application+to+the+prediction+of+transport+phenomena.+2.+Prediction+of+blood%E2%80%93brain+barrier+penetration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DRapid%2520calculation%2520of%2520polar%2520molecular%2520surface%2520area%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520transport%2520phenomena.%25202.%2520Prediction%2520of%2520blood%25E2%2580%2593brain%2520barrier%2520penetration%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D815%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Norinder, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haeberlein, M.</span><span> </span><span class="NLM_article-title">Computational approaches to the prediction of the blood–brain distribution</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=291-313&author=U.+Norinderauthor=M.+Haeberlein&title=Computational+approaches+to+the+prediction+of+the+blood%E2%80%93brain+distribution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNorinder%26aufirst%3DU.%26aulast%3DHaeberlein%26aufirst%3DM.%26atitle%3DComputational%2520approaches%2520to%2520the%2520prediction%2520of%2520the%2520blood%25E2%2580%2593brain%2520distribution%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D291%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Abbott, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolman, D. E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patabendige, A. K.</span><span> </span><span class="NLM_article-title">Assays to predict drug permeation across the blood–brain barrier, and distribution to brain</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">901</span><span class="NLM_x">–</span> <span class="NLM_lpage">910</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.2174%2F138920008786485182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=18991587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivF2nsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=901-910&author=N.+J.+Abbottauthor=D.+E.+M.+Dolmanauthor=A.+K.+Patabendige&title=Assays+to+predict+drug+permeation+across+the+blood%E2%80%93brain+barrier%2C+and+distribution+to+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Assays to predict drug permeation across the blood-brain barrier, and distribution to brain</span></div><div class="casAuthors">Abbott, N. J.; Dolman, D. E. M.; Patabendige, A. K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">901-910</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug discovery programs to target or avoid the brain need to take into account the properties of the blood-brain barrier (BBB).  The importance to CNS PK of the free drug concn. in brain is increasingly recognized, and assays for drug discovery programs are being adjusted accordingly.  In vitro models of the BBB continue to play an important role in this process.  Good cell-based models using brain endothelium have been developed and validated for mechanistic studies, and some are suitable for medium to high throughput permeability screening and toxicol.  Brain homogenate and brain slice methods allow estn. of drug partition into brain.  In combination with in silico and in vivo models, the portfolio of methods establishing and predicting CNS drug PK is now very powerful, allowing much more accurate iterative feedback to chemists to optimize compd. profiles through the drug discovery and development program.  The advantage of using models based on real BBB cellular anatomy and physiol. is that they have the power to reveal and incorporate previously undiscovered properties, such as new transporters, metabolic enzymes and modulation, to form the basis for models mimicking neurol. disorders as well as normal function, and to allow physiol.-based pharmacokinetic (PBPK) extrapolation from animal models to humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvzxDfnsvLpLVg90H21EOLACvtfcHk0liHoOpsUQi4lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivF2nsbo%253D&md5=8b5559e705ceb125855d64bceccea68d</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.2174%2F138920008786485182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008786485182%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DN.%2BJ.%26aulast%3DDolman%26aufirst%3DD.%2BE.%2BM.%26aulast%3DPatabendige%26aufirst%3DA.%2BK.%26atitle%3DAssays%2520to%2520predict%2520drug%2520permeation%2520across%2520the%2520blood%25E2%2580%2593brain%2520barrier%252C%2520and%2520distribution%2520to%2520brain%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D901%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span> </span><span class="NLM_article-title">Strategies to optimize the brain availability of central nervous system drug candidates</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=371-381&author=T.+T.+Wagerauthor=A.+Villalobosauthor=P.+R.+Verhoestauthor=X.+Houauthor=C.+L.+Shaffer&title=Strategies+to+optimize+the+brain+availability+of+central+nervous+system+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26atitle%3DStrategies%2520to%2520optimize%2520the%2520brain%2520availability%2520of%2520central%2520nervous%2520system%2520drug%2520candidates%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D371%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lguZmWBUQddAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+desirable+central+nervous+system+drug+space+through+the+alignment+of+molecular+properties%2C+in+vitro+ADME%2C+and+safety+attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0lguZmWBUQddAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520desirable%2520central%2520nervous%2520system%2520drug%2520space%2520through%2520the%2520alignment%2520of%2520molecular%2520properties%252C%2520in%2520vitro%2520ADME%252C%2520and%2520safety%2520attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Gerebtzoff, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seelig, A.</span><span> </span><span class="NLM_article-title">In silico prediction of blood–brain barrier permeation using the calculated molecular cross-sectional area as main parameter</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2638</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci0600814" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVakurbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=2638-50&author=G.+Gerebtzoffauthor=A.+Seelig&title=In+silico+prediction+of+blood%E2%80%93brain+barrier+permeation+using+the+calculated+molecular+cross-sectional+area+as+main+parameter"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">In silico prediction of blood-brain barrier permeation using the calculated molecular cross-sectional area as main parameter</span></div><div class="casAuthors">Gerebtzoff, Gregori; Seelig, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2638-2650</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cross-sectional area, AD, of a compd. oriented in an amphiphilic gradient such as the air-water or lipid-water interface has previously been shown to be crucial for membrane partitioning and permeation, resp.  Here, the authors developed an algorithm that dets. the mol. axis of amphiphilicity and the cross-sectional area, ADcalc, perpendicular to this axis.  Starting from the conformational ensemble of each mol., the three-dimensional conformation selected as the membrane-binding conformation was the one with the smallest cross-sectional area, ADcalcM, and the strongest amphiphilicity.  The calcd., ADcalcM, and the measured, AD, cross-sectional areas correlated linearly (n = 55, slope, m = 1.04, detn. coeff., r2 = 0.95).  The calcd. cross-sectional areas, ADcalcM, were then used together with the calcd. octanol-water distribution coeffs., log D7.4, of the 55 compds. (with a known ability to permeate the blood-brain barrier) to establish a calibration diagram for the prediction of blood-brain barrier permeation.  It yielded a limiting cross-sectional area (ADcalcM = 70 Å2) and an optimal range of octanol-water distribution coeffs. (-1.4 ≤ log D7.4 < 7.0).  The calibration diagram was validated with an independent set of 43 compds. with the known ability to permeate the blood-brain barrier, yielding a prediction accuracy of 86%.  The incorrectly predicted compds. exhibited log D7.4 values comprised between -0.6 and -1.4, suggesting that the limitation for log D7.4 is less rigorous than the limitation for AD.  An accuracy of 83% has been obtained for a second validation set of 42 compds. which were previously shown to be difficult to predict.  The calcd. parameters, ADcalcM and log D7.4, thus allow for a fast and accurate prediction of blood-brain barrier permeation.  Analogous calibration diagrams can be established for other membrane barriers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozSE1BCDh_XbVg90H21EOLACvtfcHk0lguZmWBUQddAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVakurbL&md5=f27ce493f0560331674f9a7e9b11cb30</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fci0600814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci0600814%26sid%3Dliteratum%253Aachs%26aulast%3DGerebtzoff%26aufirst%3DG.%26aulast%3DSeelig%26aufirst%3DA.%26atitle%3DIn%2520silico%2520prediction%2520of%2520blood%25E2%2580%2593brain%2520barrier%2520permeation%2520using%2520the%2520calculated%2520molecular%2520cross-sectional%2520area%2520as%2520main%2520parameter%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2006%26volume%3D46%26spage%3D2638%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Boström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plowright, A. T.</span><span> </span><span class="NLM_article-title">Oxadiazoles in medicinal chemsitry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1817</span><span class="NLM_x">–</span> <span class="NLM_lpage">1830</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2013248" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1817-1830&author=J.+Bostr%C3%B6mauthor=A.+Hognerauthor=A.+Llin%C3%A0sauthor=E.+Wellnerauthor=A.+T.+Plowright&title=Oxadiazoles+in+medicinal+chemsitry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fjm2013248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2013248%26sid%3Dliteratum%253Aachs%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DHogner%26aufirst%3DA.%26aulast%3DLlin%25C3%25A0s%26aufirst%3DA.%26aulast%3DWellner%26aufirst%3DE.%26aulast%3DPlowright%26aufirst%3DA.%2BT.%26atitle%3DOxadiazoles%2520in%2520medicinal%2520chemsitry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1817%26epage%3D1830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Grimont, J.; Le Goff, F.; Bourquin, G.; Silva, J.</span><span> </span><span class="NLM_article-title">Quality Assessment and Concentration Determination of Actelion’s Compound Solutions by Automated LCMS and Quantitative NMR</span>. Presented at MipTec 2010—The Leading European Event for Drug Discovery, Basel, Switzerland, Sep 20–24,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+Grimont&author=F.+Le+Goff&author=G.+Bourquin&author=J.+Silva&title=Quality+Assessment+and+Concentration+Determination+of+Actelion%E2%80%99s+Compound+Solutions+by+Automated+LCMS+and+Quantitative+NMR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGrimont%26aufirst%3DJ.%26atitle%3DQuality%2520Assessment%2520and%2520Concentration%2520Determination%2520of%2520Actelion%25E2%2580%2599s%2520Compound%2520Solutions%2520by%2520Automated%2520LCMS%2520and%2520Quantitative%2520NMR%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span>openmolecules.org. Property Explorer Applet. <a href="http://www.openmolecules.org/propertyexplorer/applet" class="extLink">http://www.openmolecules.org/propertyexplorer/applet</a> (accessed October<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=openmolecules.org.+Property+Explorer+Applet.+http%3A%2F%2Fwww.openmolecules.org%2Fpropertyexplorer%2Fapplet+%28accessed+October+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed-Hagen, A. E.</span><span> </span><span class="NLM_article-title">Measurement of Michaelis constants for cytochrome P450-mediated biotransformation reactions using a substrate depletion approach</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=831-837&author=R.+S.+Obachauthor=A.+E.+Reed-Hagen&title=Measurement+of+Michaelis+constants+for+cytochrome+P450-mediated+biotransformation+reactions+using+a+substrate+depletion+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DReed-Hagen%26aufirst%3DA.%2BE.%26atitle%3DMeasurement%2520of%2520Michaelis%2520constants%2520for%2520cytochrome%2520P450-mediated%2520biotransformation%2520reactions%2520using%2520a%2520substrate%2520depletion%2520approach%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2002%26volume%3D30%26spage%3D831%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Chakraborti, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, G.</span><span> </span><span class="NLM_article-title">One-pot synthesis of nitriles from aldehydes under microwave irradiation: influence of the medium and mode of microwave irradiation on product formation</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">13265</span><span class="NLM_x">–</span> <span class="NLM_lpage">13268</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=13265-13268&author=A.+K.+Chakrabortiauthor=G.+Kaur&title=One-pot+synthesis+of+nitriles+from+aldehydes+under+microwave+irradiation%3A+influence+of+the+medium+and+mode+of+microwave+irradiation+on+product+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChakraborti%26aufirst%3DA.%2BK.%26aulast%3DKaur%26aufirst%3DG.%26atitle%3DOne-pot%2520synthesis%2520of%2520nitriles%2520from%2520aldehydes%2520under%2520microwave%2520irradiation%253A%2520influence%2520of%2520the%2520medium%2520and%2520mode%2520of%2520microwave%2520irradiation%2520on%2520product%2520formation%26jtitle%3DTetrahedron%26date%3D1999%26volume%3D55%26spage%3D13265%26epage%3D13268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Meyer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joussef, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallardo, H.</span><span> </span><span class="NLM_article-title">Synthesis of new 1,2,4- and 1,3,4-oxadiazole derivatives</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2003</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">905</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1055%2Fs-2003-38681" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2003&publication_year=2003&pages=899-905&author=E.+Meyerauthor=A.+C.+Joussefauthor=H.+Gallardo&title=Synthesis+of+new+1%2C2%2C4-+and+1%2C3%2C4-oxadiazole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1055%2Fs-2003-38681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2003-38681%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DE.%26aulast%3DJoussef%26aufirst%3DA.%2BC.%26aulast%3DGallardo%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520new%25201%252C2%252C4-%2520and%25201%252C3%252C4-oxadiazole%2520derivatives%26jtitle%3DSynthesis%26date%3D2003%26volume%3D2003%26spage%3D899%26epage%3D905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span> </span><span class="NLM_article-title">Practical and scalable synthesis of S1P<sub>1</sub> receptor agonist ACT-209905</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">604</span></span><div class="citationLinks">[<a href="/doi/10.1021/op200326s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Oisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=595-604&author=G.+Schmidtauthor=S.+Reberauthor=M.+H.+Bolliauthor=S.+Abele&title=Practical+and+scalable+synthesis+of+S1P1+receptor+agonist+ACT-209905"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Practical and scalable synthesis of S1P1 receptor agonist ACT-209905</span></div><div class="casAuthors">Schmidt, Gunther; Reber, Stefan; Bolli, Martin H.; Abele, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">595-604</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A practical and scalable route for the fast delivery of 12 kg of S1P1 agonist (ACT-209905) has been developed.  ACT-209905 is composed of an amino pyridine group, an oxadiazole spacer, a 2-ethyl-5-methylphenol moiety and a chiral 1-amino-2-propanol side chain.  The convergent synthesis consists of 16 steps with 9 isolated intermediates and is chromatog.-free.  Key building blocks are accessed from low-cost starting materials, such as acetone, di-Et oxalate, cyanoacetamide, and 2-ethyl-5-Me aniline.  A Negishi coupling that was troubled by the use of metal reagents and concomitant metal waste streams has been replaced by a less expensive Guareschi-Thorpe reaction to build up an amino isonicotinic acid.  The chiral 1-amino-2-propanol moiety was secured by selective ring-opening of an epoxide with lithium hexamethyldisilazide as an ammonia surrogate, thus omitting the notorious double alkylated byproduct.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqRMtjnTWGN7Vg90H21EOLACvtfcHk0liRJHSZ-yjQqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Oisrc%253D&md5=455e2fb1f56ce5cd9601d141392877c6</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Fop200326s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop200326s%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DReber%26aufirst%3DS.%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DAbele%26aufirst%3DS.%26atitle%3DPractical%2520and%2520scalable%2520synthesis%2520of%2520S1P1%2520receptor%2520agonist%2520ACT-209905%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2012%26volume%3D16%26spage%3D595%26epage%3D604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 14 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>  . </span><span class="cited-content_cbyCitation_article-title">Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P1) Agonists and Future Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5267-5289. <a href="https://doi.org/10.1021/acs.jmedchem.6b01575" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01575%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DModulators%252Bof%252BSphingosine-1-phosphate%252BPathway%252BBiology%25253A%252BRecent%252BAdvances%252Bof%252BSphingosine-1-phosphate%252BReceptor%252B1%252B%252528S1P1%252529%252BAgonists%252Band%252BFuture%252BPerspectives%26aulast%3DDyckman%26aufirst%3DAlaric%2BJ.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D24102016%26date%3D30032017%26date%3D13072017%26date%3D14032017%26volume%3D60%26issue%3D13%26spage%3D5267%26epage%3D5289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hai-Yun  Xiao</span>, <span class="hlFld-ContribAuthor ">Scott H.  Watterson</span>, <span class="hlFld-ContribAuthor ">Charles M.  Langevine</span>, <span class="hlFld-ContribAuthor ">Anurag S.  Srivastava</span>, <span class="hlFld-ContribAuthor ">Soo S.  Ko</span>, <span class="hlFld-ContribAuthor ">Yanlei  Zhang</span>, <span class="hlFld-ContribAuthor ">Robert J.  Cherney</span>, <span class="hlFld-ContribAuthor ">Wei-Wei  Guo</span>, <span class="hlFld-ContribAuthor ">John L.  Gilmore</span>, <span class="hlFld-ContribAuthor ">James E.  Sheppeck, II</span>, <span class="hlFld-ContribAuthor ">Dauh-Rurng  Wu</span>, <span class="hlFld-ContribAuthor ">Peng  Li</span>, <span class="hlFld-ContribAuthor ">Duraisamy  Ramasamy</span>, <span class="hlFld-ContribAuthor ">Piramanayagam  Arunachalam</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>, <span class="hlFld-ContribAuthor ">Tracy L.  Taylor</span>, <span class="hlFld-ContribAuthor ">David J.  Shuster</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Ding-Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Melissa  Yarde</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Cvijic</span>, <span class="hlFld-ContribAuthor ">Anthony M.  Marino</span>, <span class="hlFld-ContribAuthor ">Praveen V.  Balimane</span>, <span class="hlFld-ContribAuthor ">Zheng  Yang</span>, <span class="hlFld-ContribAuthor ">Dana M.  Banas</span>, <span class="hlFld-ContribAuthor ">Georgia  Cornelius</span>, <span class="hlFld-ContribAuthor ">Celia J.  D’Arienzo</span>, <span class="hlFld-ContribAuthor ">Bethanne M.  Warrack</span>, <span class="hlFld-ContribAuthor ">Lois  Lehman-McKeeman</span>, <span class="hlFld-ContribAuthor ">Luisa M.  Salter-Cid</span>, <span class="hlFld-ContribAuthor ">Jenny  Xie</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Percy H.  Carter</span>, <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>, and <span class="hlFld-ContribAuthor ">T. G. Murali  Dhar</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P1) Employing Ligand-Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (21)
                                     , 9837-9854. <a href="https://doi.org/10.1021/acs.jmedchem.6b01099" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01099%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BTricyclic%252BAgonists%252Bof%252BSphingosine-1-phosphate%252BReceptor%252B1%252B%252528S1P1%252529%252BEmploying%252BLigand-Based%252BDrug%252BDesign%26aulast%3DXiao%26aufirst%3DHai-Yun%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D25072016%26date%3D20102016%26date%3D10112016%26date%3D11102016%26volume%3D59%26issue%3D21%26spage%3D9837%26epage%3D9854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John L.  Gilmore</span>, <span class="hlFld-ContribAuthor ">James E.  Sheppeck, II</span>, <span class="hlFld-ContribAuthor ">Scott H.  Watterson</span>, <span class="hlFld-ContribAuthor ">Lauren  Haque</span>, <span class="hlFld-ContribAuthor ">Parag  Mukhopadhyay</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Tebben</span>, <span class="hlFld-ContribAuthor ">Michael A.  Galella</span>, <span class="hlFld-ContribAuthor ">Ding Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Melissa  Yarde</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Cvijic</span>, <span class="hlFld-ContribAuthor ">Virna  Borowski</span>, <span class="hlFld-ContribAuthor ">Kathleen  Gillooly</span>, <span class="hlFld-ContribAuthor ">Tracy  Taylor</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Bethanne  Warrack</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Julia P.  Li</span>, <span class="hlFld-ContribAuthor ">Georgia  Cornelius</span>, <span class="hlFld-ContribAuthor ">Celia  D’Arienzo</span>, <span class="hlFld-ContribAuthor ">Anthony  Marino</span>, <span class="hlFld-ContribAuthor ">Praveen  Balimane</span>, <span class="hlFld-ContribAuthor ">Luisa  Salter-Cid</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">William J.  Pitts</span>, <span class="hlFld-ContribAuthor ">Percy H.  Carter</span>, <span class="hlFld-ContribAuthor ">Jenny  Xie</span>, and <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Structure–Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (13)
                                     , 6248-6264. <a href="https://doi.org/10.1021/acs.jmedchem.6b00373" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00373</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00373%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252B%252528SAR%252529%252Bof%252Ba%252BSeries%252Bof%252BEthanolamine-Based%252BDirect-Acting%252BAgonists%252Bof%252BSphingosine-1-phosphate%252B%252528S1P1%252529%26aulast%3DGilmore%26aufirst%3DJohn%2BL.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29032016%26date%3D01072016%26date%3D14072016%26date%3D16062016%26volume%3D59%26issue%3D13%26spage%3D6248%26epage%3D6264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott H.  Watterson</span>, <span class="hlFld-ContribAuthor ">Junqing  Guo</span>, <span class="hlFld-ContribAuthor ">Steve H.  Spergel</span>, <span class="hlFld-ContribAuthor ">Charles M.  Langevine</span>, <span class="hlFld-ContribAuthor ">Robert V.  Moquin</span>, <span class="hlFld-ContribAuthor ">Ding Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Melissa  Yarde</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Cvijic</span>, <span class="hlFld-ContribAuthor ">Dana  Banas</span>, <span class="hlFld-ContribAuthor ">Richard  Liu</span>, <span class="hlFld-ContribAuthor ">Suzanne J.  Suchard</span>, <span class="hlFld-ContribAuthor ">Kathleen  Gillooly</span>, <span class="hlFld-ContribAuthor ">Tracy  Taylor</span>, <span class="hlFld-ContribAuthor ">Sandra  Rex-Rabe</span>, <span class="hlFld-ContribAuthor ">David J.  Shuster</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Georgia  Cornelius</span>, <span class="hlFld-ContribAuthor ">Celia  D’Arienzo</span>, <span class="hlFld-ContribAuthor ">Anthony  Marino</span>, <span class="hlFld-ContribAuthor ">Praveen  Balimane</span>, <span class="hlFld-ContribAuthor ">Bethanne  Warrack</span>, <span class="hlFld-ContribAuthor ">Luisa  Salter-Cid</span>, <span class="hlFld-ContribAuthor ">Murray  McKinnon</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Percy H.  Carter</span>, <span class="hlFld-ContribAuthor ">William J.  Pitts</span>, <span class="hlFld-ContribAuthor ">Jenny  Xie</span>, and <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>  . </span><span class="cited-content_cbyCitation_article-title">Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (6)
                                     , 2820-2840. <a href="https://doi.org/10.1021/acs.jmedchem.6b00089" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00089%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%252Band%252BSelective%252BAgonists%252Bof%252BSphingosine%252B1-Phosphate%252B1%252B%252528S1P1%252529%25253A%252BDiscovery%252Band%252BSAR%252Bof%252Ba%252BNovel%252BIsoxazole%252BBased%252BSeries%26aulast%3DWatterson%26aufirst%3DScott%2BH.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D19012016%26date%3D10032016%26date%3D24032016%26date%3D28022016%26volume%3D59%26issue%3D6%26spage%3D2820%26epage%3D2840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emmanuel H.  Demont</span>, <span class="hlFld-ContribAuthor ">James M.  Bailey</span>, <span class="hlFld-ContribAuthor ">Rino A.  Bit</span>, <span class="hlFld-ContribAuthor ">Jack A.  Brown</span>, <span class="hlFld-ContribAuthor ">Colin A.  Campbell</span>, <span class="hlFld-ContribAuthor ">Nigel  Deeks</span>, <span class="hlFld-ContribAuthor ">Simon J.  Dowell</span>, <span class="hlFld-ContribAuthor ">Colin  Eldred</span>, <span class="hlFld-ContribAuthor ">Pam  Gaskin</span>, <span class="hlFld-ContribAuthor ">James R. J.  Gray</span>, <span class="hlFld-ContribAuthor ">Andrea  Haynes</span>, <span class="hlFld-ContribAuthor ">David J.  Hirst</span>, <span class="hlFld-ContribAuthor ">Duncan S.  Holmes</span>, <span class="hlFld-ContribAuthor ">Umesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Mary A.  Morse</span>, <span class="hlFld-ContribAuthor ">Greg J.  Osborne</span>, <span class="hlFld-ContribAuthor ">Jessica F.  Renaux</span>, <span class="hlFld-ContribAuthor ">Gail A. L.  Seal</span>, <span class="hlFld-ContribAuthor ">Chris A.  Smethurst</span>, <span class="hlFld-ContribAuthor ">Simon  Taylor</span>, <span class="hlFld-ContribAuthor ">Robert  Watson</span>, <span class="hlFld-ContribAuthor ">Robert  Willis</span>, and <span class="hlFld-ContribAuthor ">Jason  Witherington</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (3)
                                     , 1003-1020. <a href="https://doi.org/10.1021/acs.jmedchem.5b01512" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01512</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01512%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BTetrahydropyrazolopyridine%252Bas%252BSphingosine%252B1-Phosphate%252BReceptor%252B3%252B%252528S1P3%252529-Sparing%252BS1P1%252BAgonists%252BActive%252Bat%252BLow%252BOral%252BDoses%26aulast%3DDemont%26aufirst%3DEmmanuel%2BH.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D29092015%26date%3D22012016%26date%3D11022016%26date%3D11012016%26volume%3D59%26issue%3D3%26spage%3D1003%26epage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robin B.  Bedford</span>, <span class="hlFld-ContribAuthor ">Peter B.  Brenner</span>, <span class="hlFld-ContribAuthor ">Emma  Carter</span>, <span class="hlFld-ContribAuthor ">Jamie  Clifton</span>, <span class="hlFld-ContribAuthor ">Paul M.  Cogswell</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Gower</span>, <span class="hlFld-ContribAuthor ">Mairi F.  Haddow</span>, <span class="hlFld-ContribAuthor ">Jeremy N.  Harvey</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Kehl</span>, <span class="hlFld-ContribAuthor ">Damien M.  Murphy</span>, <span class="hlFld-ContribAuthor ">Emily C.  Neeve</span>, <span class="hlFld-ContribAuthor ">Michael L.  Neidig</span>, <span class="hlFld-ContribAuthor ">Joshua  Nunn</span>, <span class="hlFld-ContribAuthor ">Benjamin E. R.  Snyder</span>, and <span class="hlFld-ContribAuthor ">Joseph  Taylor</span>  . </span><span class="cited-content_cbyCitation_article-title">Iron Phosphine Catalyzed Cross-Coupling of Tetraorganoborates and Related Group 13 Nucleophiles with Alkyl Halides. </span><span class="cited-content_cbyCitation_journal-name">Organometallics</span><span> <strong>2014,</strong> <em>33 </em>
                                    (20)
                                     , 5767-5780. <a href="https://doi.org/10.1021/om500518r" title="DOI URL">https://doi.org/10.1021/om500518r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/om500518r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fom500518r%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganometallics%26atitle%3DIron%252BPhosphine%252BCatalyzed%252BCross-Coupling%252Bof%252BTetraorganoborates%252Band%252BRelated%252BGroup%252B13%252BNucleophiles%252Bwith%252BAlkyl%252BHalides%26aulast%3DBedford%26aufirst%3DRobin%2BB.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D15052014%26date%3D05082014%26date%3D27102014%26volume%3D33%26issue%3D20%26spage%3D5767%26epage%3D5780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jérémy  Stemper</span>, <span class="hlFld-ContribAuthor ">Wei  Tuo</span>, <span class="hlFld-ContribAuthor ">Eva  Mazarío</span>, <span class="hlFld-ContribAuthor ">Ahmed S.  Helal</span>, <span class="hlFld-ContribAuthor ">Alexandre  Djurovic</span>, <span class="hlFld-ContribAuthor ">Claude  Lion</span>, <span class="hlFld-ContribAuthor ">Jean-Michel  El Hage Chahine</span>, <span class="hlFld-ContribAuthor ">François  Maurel</span>, <span class="hlFld-ContribAuthor ">Miryana  Hémadi</span>, <span class="hlFld-ContribAuthor ">Thierry  Le Gall</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of bis(amidoxime)s and evaluation of their properties as uranyl-complexing agents. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (21)
                                     , 2641-2649. <a href="https://doi.org/10.1016/j.tet.2018.04.016" title="DOI URL">https://doi.org/10.1016/j.tet.2018.04.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.04.016%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DSynthesis%252Bof%252Bbis%252528amidoxime%252529s%252Band%252Bevaluation%252Bof%252Btheir%252Bproperties%252Bas%252Buranyl-complexing%252Bagents%26aulast%3DStemper%26aufirst%3DJ%25C3%25A9r%25C3%25A9my%26date%3D2018%26volume%3D74%26issue%3D21%26spage%3D2641%26epage%3D2649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irina V.  Tiper</span>, <span class="hlFld-ContribAuthor ">James E.  East</span>, <span class="hlFld-ContribAuthor ">Priyanka B.  Subrahmanyam</span>, <span class="hlFld-ContribAuthor ">Tonya J.  Webb</span>, . </span><span class="cited-content_cbyCitation_article-title">Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection. </span><span class="cited-content_cbyCitation_journal-name">Pathogens and Disease</span><span> <strong>2016,</strong> <em>74 </em>
                                    (6)
                                     , ftw063. <a href="https://doi.org/10.1093/femspd/ftw063" title="DOI URL">https://doi.org/10.1093/femspd/ftw063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/femspd/ftw063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Ffemspd%2Fftw063%26sid%3Dliteratum%253Aachs%26jtitle%3DPathogens%2520and%2520Disease%26atitle%3DSphingosine%252B1-phosphate%252Bsignaling%252Bimpacts%252Blymphocyte%252Bmigration%25252C%252Binflammation%252Band%252Binfection%26aulast%3DTiper%26aufirst%3DIrina%2BV.%26date%3D2016%26date%3D2016%26volume%3D74%26issue%3D6%26spage%3Dftw063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin H.  Bolli</span>, <span class="hlFld-ContribAuthor ">Cyrille  Lescop</span>, <span class="hlFld-ContribAuthor ">Magdalena  Birker</span>, <span class="hlFld-ContribAuthor ">Ruben  de Kanter</span>, <span class="hlFld-ContribAuthor ">Patrick  Hess</span>, <span class="hlFld-ContribAuthor ">Christopher  Kohl</span>, <span class="hlFld-ContribAuthor ">Oliver  Nayler</span>, <span class="hlFld-ContribAuthor ">Markus  Rey</span>, <span class="hlFld-ContribAuthor ">Patrick  Sieber</span>, <span class="hlFld-ContribAuthor ">Jörg  Velker</span>, <span class="hlFld-ContribAuthor ">Thomas  Weller</span>, <span class="hlFld-ContribAuthor ">Beat  Steiner</span>. </span><span class="cited-content_cbyCitation_article-title">Novel S1P1 receptor agonists – Part 5: From amino-to alkoxy-pyridines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>115 </em>, 326-341. <a href="https://doi.org/10.1016/j.ejmech.2016.03.020" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.03.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.03.020%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BS1P1%252Breceptor%252Bagonists%252B%2525E2%252580%252593%252BPart%252B5%25253A%252BFrom%252Bamino-to%252Balkoxy-pyridines%26aulast%3DBolli%26aufirst%3DMartin%2BH.%26date%3D2016%26volume%3D115%26spage%3D326%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cyrille  Lescop</span>, <span class="hlFld-ContribAuthor ">Claus  Müller</span>, <span class="hlFld-ContribAuthor ">Boris  Mathys</span>, <span class="hlFld-ContribAuthor ">Magdalena  Birker</span>, <span class="hlFld-ContribAuthor ">Ruben  de Kanter</span>, <span class="hlFld-ContribAuthor ">Christopher  Kohl</span>, <span class="hlFld-ContribAuthor ">Patrick  Hess</span>, <span class="hlFld-ContribAuthor ">Oliver  Nayler</span>, <span class="hlFld-ContribAuthor ">Markus  Rey</span>, <span class="hlFld-ContribAuthor ">Patrick  Sieber</span>, <span class="hlFld-ContribAuthor ">Beat  Steiner</span>, <span class="hlFld-ContribAuthor ">Thomas  Weller</span>, <span class="hlFld-ContribAuthor ">Martin H.  Bolli</span>. </span><span class="cited-content_cbyCitation_article-title">Novel S1P 1 receptor agonists – Part 4: Alkylaminomethyl substituted aryl head groups. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>116 </em>, 222-238. <a href="https://doi.org/10.1016/j.ejmech.2016.03.048" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.03.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.03.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.03.048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BS1P%252B1%252Breceptor%252Bagonists%252B%2525E2%252580%252593%252BPart%252B4%25253A%252BAlkylaminomethyl%252Bsubstituted%252Baryl%252Bhead%252Bgroups%26aulast%3DLescop%26aufirst%3DCyrille%26date%3D2016%26volume%3D116%26spage%3D222%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sergey  Baykov</span>, <span class="hlFld-ContribAuthor ">Tatyana  Sharonova</span>, <span class="hlFld-ContribAuthor ">Angelina  Osipyan</span>, <span class="hlFld-ContribAuthor ">Sergey  Rozhkov</span>, <span class="hlFld-ContribAuthor ">Anton  Shetnev</span>, <span class="hlFld-ContribAuthor ">Alexey  Smirnov</span>. </span><span class="cited-content_cbyCitation_article-title">A convenient and mild method for 1,2,4-oxadiazole preparation: cyclodehydration of  O -acylamidoximes in the superbase system MOH/DMSO. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2016,</strong> <em>57 </em>
                                    (26)
                                     , 2898-2900. <a href="https://doi.org/10.1016/j.tetlet.2016.05.071" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.05.071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.05.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.05.071%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bconvenient%252Band%252Bmild%252Bmethod%252Bfor%252B1%25252C2%25252C4-oxadiazole%252Bpreparation%25253A%252Bcyclodehydration%252Bof%252BO%252B-acylamidoximes%252Bin%252Bthe%252Bsuperbase%252Bsystem%252BMOH%25252FDMSO%26aulast%3DBaykov%26aufirst%3DSergey%26date%3D2016%26volume%3D57%26issue%3D26%26spage%3D2898%26epage%3D2900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junqing  Guo</span>, <span class="hlFld-ContribAuthor ">Scott H.  Watterson</span>, <span class="hlFld-ContribAuthor ">Steven H.  Spergel</span>, <span class="hlFld-ContribAuthor ">James  Kempson</span>, <span class="hlFld-ContribAuthor ">Charles M.  Langevine</span>, <span class="hlFld-ContribAuthor ">Ding Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Melissa  Yarde</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Cvijic</span>, <span class="hlFld-ContribAuthor ">Dana  Banas</span>, <span class="hlFld-ContribAuthor ">Richard  Liu</span>, <span class="hlFld-ContribAuthor ">Suzanne J.  Suchard</span>, <span class="hlFld-ContribAuthor ">Kathleen  Gillooly</span>, <span class="hlFld-ContribAuthor ">Tracy  Taylor</span>, <span class="hlFld-ContribAuthor ">Sandra  Rex-Rabe</span>, <span class="hlFld-ContribAuthor ">David J.  Shuster</span>, <span class="hlFld-ContribAuthor ">Kim W.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Georgia  Cornelius</span>, <span class="hlFld-ContribAuthor ">Celia  D’Arienzo</span>, <span class="hlFld-ContribAuthor ">Anthony  Marino</span>, <span class="hlFld-ContribAuthor ">Praveen  Balimane</span>, <span class="hlFld-ContribAuthor ">Luisa  Salter-Cid</span>, <span class="hlFld-ContribAuthor ">Murray  McKinnon</span>, <span class="hlFld-ContribAuthor ">Joel C.  Barrish</span>, <span class="hlFld-ContribAuthor ">Percy H.  Carter</span>, <span class="hlFld-ContribAuthor ">William J.  Pitts</span>, <span class="hlFld-ContribAuthor ">Jenny  Xie</span>, <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and synthesis of potent and selective pyridyl-isoxazole based agonists of sphingosine-1-phosphate 1 (S1P1). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (10)
                                     , 2470-2474. <a href="https://doi.org/10.1016/j.bmcl.2016.03.105" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.03.105</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.03.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.03.105%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Band%252Bsynthesis%252Bof%252Bpotent%252Band%252Bselective%252Bpyridyl-isoxazole%252Bbased%252Bagonists%252Bof%252Bsphingosine-1-phosphate%252B1%252B%252528S1P1%252529%26aulast%3DGuo%26aufirst%3DJunqing%26date%3D2016%26volume%3D26%26issue%3D10%26spage%3D2470%26epage%3D2474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joshua C.  Horan</span>, <span class="hlFld-ContribAuthor ">Daniel  Kuzmich</span>, <span class="hlFld-ContribAuthor ">Pingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Darren  DiSalvo</span>, <span class="hlFld-ContribAuthor ">John  Lord</span>, <span class="hlFld-ContribAuthor ">Can  Mao</span>, <span class="hlFld-ContribAuthor ">Tamara D.  Hopkins</span>, <span class="hlFld-ContribAuthor ">Hui  Yu</span>, <span class="hlFld-ContribAuthor ">Christian  Harcken</span>, <span class="hlFld-ContribAuthor ">Raj  Betageri</span>, <span class="hlFld-ContribAuthor ">Melissa  Hill-Drzewi</span>, <span class="hlFld-ContribAuthor ">Lori  Patenaude</span>, <span class="hlFld-ContribAuthor ">Monica  Patel</span>, <span class="hlFld-ContribAuthor ">Kimberly  Fletcher</span>, <span class="hlFld-ContribAuthor ">Donna  Terenzzio</span>, <span class="hlFld-ContribAuthor ">Brian  Linehan</span>, <span class="hlFld-ContribAuthor ">Heather  Xia</span>, <span class="hlFld-ContribAuthor ">Mita  Patel</span>, <span class="hlFld-ContribAuthor ">Debbie  Studwell</span>, <span class="hlFld-ContribAuthor ">Craig  Miller</span>, <span class="hlFld-ContribAuthor ">Eugene  Hickey</span>, <span class="hlFld-ContribAuthor ">Jeremy I.  Levin</span>, <span class="hlFld-ContribAuthor ">Dustin  Smith</span>, <span class="hlFld-ContribAuthor ">Raymond A.  Kemper</span>, <span class="hlFld-ContribAuthor ">Louise K.  Modis</span>, <span class="hlFld-ContribAuthor ">Lynne C.  Bannen</span>, <span class="hlFld-ContribAuthor ">Diva S.  Chan</span>, <span class="hlFld-ContribAuthor ">Morrison B.  Mac</span>, <span class="hlFld-ContribAuthor ">Stephanie  Ng</span>, <span class="hlFld-ContribAuthor ">Yong  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Xu</span>, <span class="hlFld-ContribAuthor ">René M.  Lemieux</span>. </span><span class="cited-content_cbyCitation_article-title">Late-stage optimization of a tercyclic class of S1P 3 -sparing, S1P 1 receptor agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (2)
                                     , 466-471. <a href="https://doi.org/10.1016/j.bmcl.2015.11.090" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.11.090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.11.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.11.090%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DLate-stage%252Boptimization%252Bof%252Ba%252Btercyclic%252Bclass%252Bof%252BS1P%252B3%252B-sparing%25252C%252BS1P%252B1%252Breceptor%252Bagonists%26aulast%3DHoran%26aufirst%3DJoshua%2BC.%26date%3D2016%26volume%3D26%26issue%3D2%26spage%3D466%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Briana  Prager</span>, <span class="hlFld-ContribAuthor ">Simona F.  Spampinato</span>, <span class="hlFld-ContribAuthor ">Richard M.  Ransohoff</span>. </span><span class="cited-content_cbyCitation_article-title">Sphingosine 1-phosphate signaling at the blood–brain barrier. </span><span class="cited-content_cbyCitation_journal-name">Trends in Molecular Medicine</span><span> <strong>2015,</strong> <em>21 </em>
                                    (6)
                                     , 354-363. <a href="https://doi.org/10.1016/j.molmed.2015.03.006" title="DOI URL">https://doi.org/10.1016/j.molmed.2015.03.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molmed.2015.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molmed.2015.03.006%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Molecular%2520Medicine%26atitle%3DSphingosine%252B1-phosphate%252Bsignaling%252Bat%252Bthe%252Bblood%2525E2%252580%252593brain%252Bbarrier%26aulast%3DPrager%26aufirst%3DBriana%26date%3D2015%26volume%3D21%26issue%3D6%26spage%3D354%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014696&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of thiophene based S1P<sub>1</sub> receptor agonist <b>1</b> and a first 3-pyridine analogue <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014696&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Assembling the Central Oxadiazole Ring<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014696&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HOBt, EDC HCl, THF, rt, 18 h; or TBTU, Hünig’s base, DMF, rt, 1 h; (b) dioxane, 80 °C, 18 h, 6–76% (two steps).</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of the <i>N</i>-Hydroxybenzamidine Building Block <b>80</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014696&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) hexamethylenetetraamine, HOAc, H<sub>2</sub>O, 120 °C, Dean–Stark 2–3 h, 53–97%; (b) HONH<sub>2</sub> HCl, NMP, microwave 80–100 °C, 0.5–3 h; 86–95%; (c) (<i>R</i>)-glycidol, PPh<sub>3</sub>, DEAD, THF, 0–20 °C, 18 h, 72–86%; (d) 7 N NH<sub>3</sub> in MeOH, 65 °C, 18 h (sealed vessel), quantitative (crude); (e) glycolic acid, EDC HCl, HOBt, rt, 18 h, 51–90%; (f) HONH<sub>2</sub> HCl, NaHCO<sub>3</sub> or Et<sub>3</sub>N, MeOH or EtOH 60–80 °C, 18 h, 60–87%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of 6-Alkylnicotinic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014696&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-alkenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, Pd(PPh<sub>3</sub>)<sub>4</sub>, PPh<sub>3</sub>, 2 M aq K<sub>2</sub>CO<sub>3</sub>, 80 °C, 18 h, 66%, then 5 bar of H<sub>2</sub>, Pd/C, methanol, 18 h, 46%; (b) alkylmagnesium bromide, Fe(acac)<sub>3</sub>, THF, NMP, −75 °C, 1–4 h, 47–93% (c) 4–7 N aq HCl, 65–80 °C, 18–24 h, 91–97%; (d) 50% H<sub>2</sub>O<sub>2</sub>, HCOOH, 0 °C, 15 h, 47–87%; (e) EtOH, H<sub>2</sub>SO<sub>4</sub>, or TMSCl, reflux 18–42 h, 65–92%; (f) 2,4,6-tri(2-methylpropenyl)cyclotriboroxanepyridine complex or alkenylboronic acid pinacol ester, Ph<sub>3</sub>P, Pd(PPh<sub>3</sub>)<sub>4</sub>, DME or dioxane, 2 M aq K<sub>2</sub>CO<sub>3</sub>, 90 °C, 20 h, 71–73%; (g) Pd/C, H<sub>2</sub>, MeOH, THF, rt, 15 h, 61–99%; (h) cyclopentylmagnesium bromide, Fe(acac)<sub>3</sub>, THF, NMP, 0 °C, 1 h, rt, 18 h, 78%; (i) Me<sub>2</sub>Zn, Pd(dppf)Cl<sub>2</sub>, dioxane, 75–85 °C, 3–18 h, 36–58%; (j) 2 M aq LiOH, MeOH or EtOH, rt, 1–2 h, 83–88%; (k) 2,4,6-tri(2-methylpropenyl)cyclotriboroxanepyridine complex, Ph<sub>3</sub>P, Pd(PPh<sub>3</sub>)<sub>4</sub>, DME, 2 M aq K<sub>2</sub>CO<sub>3</sub>, 100 °C, 4.5 h, 92%; (l) 2,4,6-trivinylcyclotriboroxanepyridine complex, Cs<sub>2</sub>CO<sub>3</sub>, tri-<i>tert</i>-butylphosphine, Pd<sub>2</sub>(dba)<sub>3</sub>, or PPh<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, 100 °C, 16–40 h, 59–67%; (m) <i>n</i>-BuLi, 3-pentanone, THF, −70 °C, 2 h, 37%; (n) KMnO<sub>4</sub>, acetone, rt, 24 h, quantitative crude; (o) Burgess reagent, dioxane, 80 °C, 1 h microwave, 76%; (p) 1 bar of H<sub>2</sub>, Pd/C, THF/methanol 1:1, rt, 4 h, 80%.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of 6-Aminonicotinic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014696&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>1</sub>R<sub>2</sub>NH, 80–100 °C, 1 day to 3 weeks, 85–99%; (b) 4–7 N aq HCl, 65–80 °C, 18–24 h, quantitative; (c) Et<sub>2</sub>Zn, Pd(dppf)Cl<sub>2</sub>, dioxane, 75 °C, 18–24 h, 84% to quantitative; (d) 3 N aq NaOH, MeOH, 75 °C, 18 h, 79%.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Preparation of Picolinic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014696&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2,4,6-trivinylcyclotriboroxanepyridine complex, 2 M aq K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DME, 80 °C, 15 h, 49–99%; (b) KMnO<sub>4</sub>, acetone, water, rt, 3 days, quantitative crude; (c) EtOH, H<sub>2</sub>SO<sub>4</sub> or TMSCl, 70 °C, 18 h, 40–95%; (d) 2,4,6-tri(2-methylpropenyl)cycloboroxanepyridine complex, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M aq K<sub>2</sub>CO<sub>3</sub>, DME, 80 °C, 6 h, 37–68%; (e) H<sub>2</sub>, Pd/C, THF, EtOH, rt, 15 h, 95%; (f) 6–7 N aq HCl, 65 °C, 48 h, 64–94%; (g) cyclopentylzinc bromide, Pd(dppf)Cl<sub>2</sub>, dioxane, 65 °C, 18 h, 28–70% (h) 2 M aq LiOH, dioxane, 75 °C, 5 h, 15–88%; (i) Et<sub>2</sub>NH, Pd(OAc)<sub>2</sub>, xanthphos, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 90–110 °C, 18–24 h, 1–9%; (j) MeOH, H<sub>2</sub>SO<sub>4</sub>, ammonium peroxydisulfate, 75 °C, 2 h, 19–28%; (k) Et<sub>2</sub>NH, BuOH, reflux 16 h; EtOH, H<sub>2</sub>SO<sub>4</sub>, 70 °C, 18 h; 6 N aq HCl, 65 °C, 18 h, 40% (three steps).</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of Pyridine-4-carboxylic Acids<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014696&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) alkylzinc bromide or chloride, or dialkylzinc, Pd(dppf)Cl<sub>2</sub>, dioxane, 75–80 °C, 2–24 h, 21–84%; (b) alkylmagnesium bromide or chloride, Fe(acac)<sub>3</sub>, THF, NMP, −75 °C, 1 h, rt, 1 h, 26–40%; (c) 6–7 M aq HCl, 60–95 °C, 3–20 h, 37% to quantitative; (d) 2,4,6-trialkenylcycloboroxanepyridine complex, PPh<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, 2 M aq K<sub>2</sub>CO<sub>3</sub>, DME, 75–90 °C, 6–20 h, 50–95%; (e) H<sub>2</sub>, Pd/C, THF, MeOH, rt, 5–16 h, 98%; (f) Et<sub>2</sub>Zn, Pd(dppf)Cl<sub>2</sub>, dioxane, 75–80 °C, 1–2 h, 79–82%; (g) diethylamine, 70–100 °C, 2–72 h, 95% to quantitative; (h) ethylamine, Cs<sub>2</sub>CO<sub>3</sub>, Pd(OAc)<sub>2</sub>, Xanthphos, dioxane, 90 °C, 15 h, 44–47%; (i) 3 N aq NaOH, EtOH, 60 °C, 72 h; 87%.</p></p></figure><figure data-id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. LC (A) and plasma concentrations (B) of a dose response experiment with amino pyridine <b>53</b> in Wistar rats: □, vehicle (<i>n</i> = 5); ●, 0.1 mg/kg (<i>n</i> = 5); ▲, 0.3 mg/kg (<i>n</i> = 5); ▼, 1 mg/kg (<i>n</i> = 5); ◆, 3 mg/kg (<i>n</i> = 5); ■, 10 mg/kg (<i>n</i> = 5). (A) LC fully recovered 96 h after administration of all doses tested (data not shown). (B) 24 h after administration of 0.1 mg/kg and 96 h after administration of 0.3, 1, 3, and 10 mg/kg plasma concentrations were below the limit of quantification (BLQ) of 1.5 ng/mL.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014696&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/medium/jm-2013-014696_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Plasma concentrations (A) and blood LC (B) at days 1 and 7 after repeated daily dosing of 3 (mg/kg)/day compound <b>53</b> to Wistar rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-1/jm4014696/production/images/large/jm-2013-014696_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4014696&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20158" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20158" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 134 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Lysophospholipid receptor as potential drug targets in tissue transplantation and autoimmune diseases</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.2174%2F138161206775193109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=16454733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD28XitlGjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=161-171&author=J.+Chunauthor=H.+Rosen&title=Lysophospholipid+receptor+as+potential+drug+targets+in+tissue+transplantation+and+autoimmune+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases</span></div><div class="casAuthors">Chun, Jerold; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-171</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  New therapies directed at ameliorating or altering autoimmune diseases represent an area of significant medical need.  Included amongst autoimmune diseases are problems related to transplantation rejection, as well as a no. of neurol. diseases such as Multiple Sclerosis (MS).  A new group of mol. targets that may lead to novel therapies are lysophospholipid (LP) receptors.  A large range of biol. activities has been attributed to the actions of these simple phospholipids that include well-studied members lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P).  Documented cellular effects of these lipid mols. encompass growth-factor-like influences on cells, including but not limited to survival, migration, adhesion differentiation, as well as pathophysiol. actions assocd. with cancer.  In turn, these cellular effects have roles in developing and adult organ systems such as the nervous system, cardiovascular system, reproductive system and, of relevance here, the immune system.  The mechanisms for these actions can be attributed to a growing family of cognate, 7-transmembrane G protein-coupled receptors (GPCRs), with documented validation through studies utilizing pharmacol., mol. genetics and an enlarging repertoire of chem. tools having agonist or antagonist properties.  The growing literature on immunol. effects of LP receptors, particularly those mediating the effects of S1P, has suggested possible therapeutic roles for this class of receptors.  In particular, entry into humans of a non-selective S1P receptor agonist, FTY720, for kidney transplantation and possibly other indications (e.g., Multiple Sclerosis), has raised prospects for efficacious treatment of human diseases based on LP receptor targets.  Here we provide a brief introduction to receptor-mediated lysophospholipid signaling and discuss its basic and potential therapeutic roles in autoimmune-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBKYnL_kPl8bVg90H21EOLACvtfcHk0li-7Q55pBlIDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitlGjsg%253D%253D&md5=24b93c41f0750883794dd2ca824d4d6d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F138161206775193109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206775193109%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DLysophospholipid%2520receptor%2520as%2520potential%2520drug%2520targets%2520in%2520tissue%2520transplantation%2520and%2520autoimmune%2520diseases%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D161%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Nixon, G. F.</span><span> </span><span class="NLM_article-title">Sphingolipids in inflammation: pathological implications and potential therapeutic targets</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">982</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1111%2Fj.1476-5381.2009.00281.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=19563535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSks7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=982-993&author=G.+F.+Nixon&title=Sphingolipids+in+inflammation%3A+pathological+implications+and+potential+therapeutic+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipids in inflammation: pathological implications and potential therapeutic targets</span></div><div class="casAuthors">Nixon, Graeme F.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">982-993</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Sphingolipids are formed via the metab. of sphingomyelin, a constituent of the plasma membrane, or by de novo synthesis.  Enzymic pathways result in the formation of several different lipid mediators, which are known to have important roles in many cellular processes, including proliferation, apoptosis and migration.  Several studies now suggest that these sphingolipid mediators, including ceramide, ceramide 1-phosphate and sphingosine 1-phosphate (S1P), are likely to have an integral role in inflammation.  This can involve, for example, activation of pro-inflammatory transcription factors in different cell types and induction of cyclooxygenase-2, leading to prodn. of pro-inflammatory prostaglandins.  The mode of action of each sphingolipid is different.  Increased ceramide prodn. leads to the formation of ceramide-rich areas of the membrane, which may assemble signalling complexes, whereas S1P acts via high-affinity G-protein-coupled S1P receptors on the plasma membrane.  Recent studies have demonstrated that in vitro effects of sphingolipids on inflammation can translate into in vivo models.  This review will highlight the areas of research where sphingolipids are involved in inflammation and the mechanisms of action of each mediator.  In addn., the therapeutic potential of drugs that alter sphingolipid actions will be examd. with ref. to disease states, such as asthma and inflammatory bowel disease, which involve important inflammatory components.  A significant body of research now indicates that sphingolipids are intimately involved in the inflammatory process and recent studies have demonstrated that these lipids, together with assocd. enzymes and receptors, can provide effective drug targets for the treatment of pathol. inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvPGahcOR7kbVg90H21EOLACvtfcHk0li-7Q55pBlIDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSks7nJ&md5=801f3e23dc2de1cea11545acf54c7f05</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00281.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00281.x%26sid%3Dliteratum%253Aachs%26aulast%3DNixon%26aufirst%3DG.%2BF.%26atitle%3DSphingolipids%2520in%2520inflammation%253A%2520pathological%2520implications%2520and%2520potential%2520therapeutic%2520targets%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D158%26spage%3D982%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Obinata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate in coagulation and inflammation</span> <span class="citation_source-journal">Semin. Immunopathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">91</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1007%2Fs00281-011-0287-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=21805322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1SgtrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2012&pages=73-91&author=H.+Obinataauthor=T.+Hla&title=Sphingosine+1-phosphate+in+coagulation+and+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate in coagulation and inflammation</span></div><div class="casAuthors">Obinata, Hideru; Hla, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Immunopathology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-91</span>CODEN:
                <span class="NLM_cas:coden">SIEMB7</span>;
        ISSN:<span class="NLM_cas:issn">1863-2297</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P) is a lipid mediator produced from sphingomyelin by the sequential enzymic actions of sphingomyelinase, ceramidase, and sphingosine kinase.  Five subtypes of cell surface G-protein-coupled receptors, S1P1-5, mediate the actions of S1P in various organs systems, most notably cardiovascular, immune, and central nervous systems.  S1P is enriched in blood and lymph but is present at much lower concns. in interstitial fluids of tissues.  This vascular S1P gradient is important for the regulation of trafficking of various immune cells.  FTY720, which was recently approved for the treatment of relapsing-remitting multiple sclerosis, potently sequesters lymphocytes into lymph nodes by functionally antagonizing the activity of the S1P1 receptor.  S1P also plays crit. roles in the vascular barrier integrity, thereby regulating inflammation, tumor metastasis, angiogenesis, and atherosclerosis.  Recent studies have also revealed the involvement of S1P signaling in coagulation and in tumor necrosis factor α-mediated signaling.  This review highlights the importance of S1P signaling in these inflammatory processes as well as the contribution of each receptor subtype, which exhibits both cooperative and redundant functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroukMZahVX47Vg90H21EOLACvtfcHk0li84_yw4CZFMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1SgtrrI&md5=7490782a120b6400295862f4521e5c88</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs00281-011-0287-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00281-011-0287-3%26sid%3Dliteratum%253Aachs%26aulast%3DObinata%26aufirst%3DH.%26aulast%3DHla%26aufirst%3DT.%26atitle%3DSphingosine%25201-phosphate%2520in%2520coagulation%2520and%2520inflammation%26jtitle%3DSemin.%2520Immunopathol.%26date%3D2012%26volume%3D34%26spage%3D73%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heining, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmouder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aradhye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burtin, P.</span><span> </span><span class="NLM_article-title">Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1038%2Fnrd3248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=21031003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=883-897&author=V.+Brinkmannauthor=A.+Billichauthor=T.+Baumrukerauthor=P.+Heiningauthor=R.+Schmouderauthor=G.+Francisauthor=S.+Aradhyeauthor=P.+Burtin&title=Fingolimod+%28FTY720%29%3A+discovery+and+development+of+an+oral+drug+to+treat+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis</span></div><div class="casAuthors">Brinkmann, Volker; Billich, Andreas; Baumruker, Thomas; Heining, Peter; Schmouder, Robert; Francis, Gordon; Aradhye, Shreeram; Burtin, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">883-897</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The discovery of fingolimod (FTY720/Gilenya; Novartis), an orally active immunomodulatory drug, has opened up new approaches to the treatment of multiple sclerosis, the most common inflammatory disorder of the central nervous system.  Elucidation of the effects of fingolimod - mediated by the modulation of sphingosine 1-phosphate (S1P) receptors - has indicated that its therapeutic activity could be due to regulation of the migration of selected lymphocyte subsets into the central nervous system and direct effects on neural cells, particularly astrocytes.  An improved understanding of the biol. of S1P receptors has also been gained.  This article describes the discovery and development of fingolimod, which was approved by the US Food and Drug Administration in Sept. 2010 as a first-line treatment for relapsing forms of multiple sclerosis, thereby becoming the first oral disease-modifying therapy to be approved for multiple sclerosis in the United States.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr80U6QfXSJMbVg90H21EOLACvtfcHk0li84_yw4CZFMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCqsr%252FL&md5=0f6dd60ef115079f3652e9d12d82e215</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd3248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3248%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DSchmouder%26aufirst%3DR.%26aulast%3DFrancis%26aufirst%3DG.%26aulast%3DAradhye%26aufirst%3DS.%26aulast%3DBurtin%26aufirst%3DP.%26atitle%3DFingolimod%2520%2528FTY720%2529%253A%2520discovery%2520and%2520development%2520of%2520an%2520oral%2520drug%2520to%2520treat%2520multiple%2520sclerosis%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D883%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Kappos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radue, E.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohlfeld, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabresi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selmaj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agoropoulou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leyk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang-Auberson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burtin, P.</span><span> </span><span class="NLM_article-title">A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1056%2FNEJMoa0909494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=20089952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvVWltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=387-401&author=L.+Kapposauthor=E.-W.+Radueauthor=P.+O%E2%80%99Connorauthor=C.+Polmanauthor=R.+Hohlfeldauthor=P.+Calabresiauthor=K.+Selmajauthor=C.+Agoropoulouauthor=M.+Leykauthor=L.+Zhang-Aubersonauthor=P.+Burtin&title=A+placebo-controlled+trial+of+oral+fingolimod+in+relapsing+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis</span></div><div class="casAuthors">Kappos, Ludwig; Radue, Ernst-Wilhelm; O'Connor, Paul; Polman, Chris; Hohlfeld, Reinhard; Calabresi, Peter; Selmaj, Krzysztof; Agoropoulou, Catherine; Leyk, Malgorzata; Zhang-Auberson, Lixin; Burtin, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">387-401</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Oral fingolimod, a sphingosine-1-phosphate-receptor modulator that prevents the egress of lymphocytes from lymph nodes, significantly improved relapse rates and end points measured on magnetic resonance imaging (MRI), as compared with either placebo or i.m. interferon beta-1a, in phase 2 and 3 studies of multiple sclerosis.  METHODS: In our 24-mo, double-blind, randomized study, we enrolled patients who had relapsing-remitting multiple sclerosis, were 18 to 55 years of age, had a score of 0 to 5.5 on the Expanded Disability Status Scale (which ranges from 0 to 10, with higher scores indicating greater disability), and had one or more relapses in the previous year or two or more in the previous 2 years.  Patients received oral fingolimod at a dose of 0.5 mg or 1.25 mg daily or placebo.  End points included the annualized relapse rate (the primary end point) and the time to disability progression (a secondary end point).  RESULTS: A total of 1033 of the 1272 patients (81.2%) completed the study.  The annualized relapse rate was 0.18 with 0.5 mg of fingolimod, 0.16 with 1.25 mg of fingolimod, and 0.40 with placebo (P < 0.001 for either dose vs. placebo).  Fingolimod at doses of 0.5 mg and 1.25 mg significantly reduced the risk of disability progression over the 24-mo period (hazard ratio, 0.70 and 0.68, resp.; P = 0.02 vs. placebo, for both comparisons).  The cumulative probability of disability progression (confirmed after 3 mo) was 17.7% with 0.5 mg of fingolimod, 16.6% with 1.25 mg of fingolimod, and 24.1% with placebo.  Both fingolimod doses were superior to placebo with regard to MRI-related measures (no. of new or enlarged lesions on T2 -weighted images, gadolinium-enhancing lesions, and brain-vol. loss; P < 0.001 for all comparisons at 24 mo).  Causes of study discontinuation and adverse events related to fingolimod included bradycardia and atrioventricular conduction block at the time of fingolimod initiation, macular edema, elevated liver-enzyme levels, and mild hypertension.  CONCLUSIONS: As compared with placebo, both doses of oral fingolimod improved the relapse rate, the risk of disability progression, and end points on MRI.  These benefits will need to be weighed against possible long-term risks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZV83ylA8IarVg90H21EOLACvtfcHk0ljJcAWzCZapoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvVWltr4%253D&md5=0c1a63e4b8850f3579b2a8f6c7f28ac0</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0909494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0909494%26sid%3Dliteratum%253Aachs%26aulast%3DKappos%26aufirst%3DL.%26aulast%3DRadue%26aufirst%3DE.-W.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%26aulast%3DPolman%26aufirst%3DC.%26aulast%3DHohlfeld%26aufirst%3DR.%26aulast%3DCalabresi%26aufirst%3DP.%26aulast%3DSelmaj%26aufirst%3DK.%26aulast%3DAgoropoulou%26aufirst%3DC.%26aulast%3DLeyk%26aufirst%3DM.%26aulast%3DZhang-Auberson%26aufirst%3DL.%26aulast%3DBurtin%26aufirst%3DP.%26atitle%3DA%2520placebo-controlled%2520trial%2520of%2520oral%2520fingolimod%2520in%2520relapsing%2520multiple%2520sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D387%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Cohen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Mechanisms of fingolimod’s efficacy and adverse effects in multiple sclerosis</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1002%2Fana.22426" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=21520239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltVyhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2011&pages=759-777&author=J.+A.+Cohenauthor=J.+Chun&title=Mechanisms+of+fingolimod%E2%80%99s+efficacy+and+adverse+effects+in+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis</span></div><div class="casAuthors">Cohen, Jeffrey A.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">759-777</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Until recently, all approved multiple sclerosis (MS) disease treatments were administered parenterally.  Oral fingolimod was approved in Sept. 2010 by the US Food and Drug Administration to reduce relapses and disability progression in relapsing forms of MS.  In the clin. trials that led to approval, fingolimod reduced not only acute relapses and magnetic resonance imaging lesion activity but also disability progression and brain vol. loss, suggesting preservation of tissue.  Fingolimod's mechanism of action in MS is not known with certainty.  Its active form, fingolimod-phosphate (fingolimod-P), is a sphingosine 1-phosphate receptor (S1PR) modulator that inhibits egress of lymphocytes from lymph nodes and their recirculation, potentially reducing trafficking of pathogenic cells into the central nervous system (CNS).  Fingolimod also readily penetrates the CNS, and fingolimod-P formed in situ may have direct effects on neural cells.  Fingolimod potently inhibits the MS animal model, exptl. autoimmune encephalomyelitis, but is ineffective in mice with selective deficiency of the S1P1 S1PR subtype on astrocytes despite normal expression in the immune compartment.  These findings suggest that S1PR modulation by fingolimod in both the immune system and CNS, producing a combination of beneficial anti-inflammatory and possibly neuroprotective/reparative effects, may contribute to its efficacy in MS.  In clin. trials, fingolimod was generally safe and well tolerated.  Its interaction with S1PRs in a variety of tissues largely accounts for the reported adverse effects, which were seen more frequently with doses 2.5 to 10× the approved 0.5mg dose.  Fingolimod's unique mechanism of action distinguishes it from all other currently approved MS therapies.  Ann Neurol 2011;69:759-777.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaQ9gv8GATt7Vg90H21EOLACvtfcHk0ljJcAWzCZapoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltVyhtLo%253D&md5=8444099f3b8b40bf8fd529e374eaf294</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fana.22426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.22426%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DJ.%2BA.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DMechanisms%2520of%2520fingolimod%25E2%2580%2599s%2520efficacy%2520and%2520adverse%2520effects%2520in%2520multiple%2520sclerosis%26jtitle%3DAnn.%2520Neurol.%26date%3D2011%26volume%3D69%26spage%3D759%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Gasperini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggieri, S.</span><span> </span><span class="NLM_article-title">Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change theratpeutic paradigm approach</span> <span class="citation_source-journal">Drug Des., Dev. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.2147%2FDDDT.S8927" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A280%3ADC%252BC38fnsFOisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2012&pages=175-186&author=C.+Gasperiniauthor=S.+Ruggieri&title=Development+of+oral+agent+in+the+treatment+of+multiple+sclerosis%3A+how+the+first+available+oral+therapy%2C+fingolimod+will+change+theratpeutic+paradigm+approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach</span></div><div class="casAuthors">Gasperini Claudio; Ruggieri Serena</div><div class="citationInfo"><span class="NLM_cas:title">Drug design, development and therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">175-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Multiple sclerosis (MS) is a chronic inflammatory disorder of the central nervous system, traditionally considered to be an autoimmune, demyelinating disease.  Based on this understanding, the initial therapeutic strategies were directed at immune modulation and inflammation control.  At present, there are five licensed first-line disease-modifying drugs and two second-line treatments in MS.  Currently available MS therapies have shown significant efficacy throughout many trials, but they produce different side-effect profiles in patients.  Since they are well known and safe, they require regular and frequent parenteral administration and are associated with limited long-term treatment adherence.  Thus, there is an important need for the development of new therapeutic strategies.  Several oral compounds are in late-stage development for treating MS.  Fingolimod (FTY720; Novartis, Basel, Switzerland) is an oral sphingosine-1-phosphase receptor modulator which has demonstrated superior efficacy compared with placebo and interferon β-1a in Phase III studies and has been approved in the treatment of MS.  We summarily review the oral compounds in study, focusing on the recent development, approval and the clinical experience with FTY720.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTB3MvBbEZueUloaUqgkFHkfW6udTcc2ebIV8u8oNeT4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38fnsFOisw%253D%253D&md5=4a0293c0c756a1df06649250cf8390d4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S8927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S8927%26sid%3Dliteratum%253Aachs%26aulast%3DGasperini%26aufirst%3DC.%26aulast%3DRuggieri%26aufirst%3DS.%26atitle%3DDevelopment%2520of%2520oral%2520agent%2520in%2520the%2520treatment%2520of%2520multiple%2520sclerosis%253A%2520how%2520the%2520first%2520available%2520oral%2520therapy%252C%2520fingolimod%2520will%2520change%2520theratpeutic%2520paradigm%2520approach%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2012%26volume%3D6%26spage%3D175%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Gergely, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traebert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groenewegen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitaliti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sing, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luttringer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crumb, W. J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltzmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallström, E.</span><span> </span><span class="NLM_article-title">The selective S1P receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate: translation from preclinical to clinical studies</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1047</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1111%2Fj.1476-5381.2012.02061.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=22646698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A280%3ADC%252BC38nnsVShuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2012&pages=1035-1047&author=P.+Gergelyauthor=B.+Nuesslein-Hildesheimauthor=D.+Gueriniauthor=V.+Brinkmannauthor=M.+Traebertauthor=C.+Brunsauthor=S.+Panauthor=N.+S.+Grayauthor=K.+Hinterdingauthor=N.+G.+Cookeauthor=A.+Groenewegenauthor=A.+Vitalitiauthor=T.+Singauthor=O.+Luttringerauthor=J.+Yangauthor=A.+Gardinauthor=N.+Wangauthor=W.+J.+J.+Crumbauthor=M.+Saltzmannauthor=M.+Rosenbergauthor=E.+Wallstr%C3%B6m&title=The+selective+S1P+receptor+modulator+BAF312+redirects+lymphocyte+distribution+and+has+species-specific+effects+on+heart+rate%3A+translation+from+preclinical+to+clinical+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate</span></div><div class="casAuthors">Gergely P; Nuesslein-Hildesheim B; Guerini D; Brinkmann V; Traebert M; Bruns C; Pan S; Gray N S; Hinterding K; Cooke N G; Groenewegen A; Vitaliti A; Sing T; Luttringer O; Yang J; Gardin A; Wang N; Crumb W J Jr; Saltzman M; Rosenberg M; Wallstrom E</div><div class="citationInfo"><span class="NLM_cas:title">British journal of pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1035-47</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  BAF312 is a next-generation sphingosine 1-phosphate (S1P) receptor modulator, selective for S1P(1) and S1P(5 ) receptors.  S1P(1) receptors are essential for lymphocyte egress from lymph nodes and a drug target in immune-mediated diseases.  Here, we have characterized the immunomodulatory potential of BAF312 and the S1P receptor-mediated effects on heart rate using preclinical and human data.  EXPERIMENTAL APPROACH:  BAF312 was tested in a rat experimental autoimmune encephalomyelitis (EAE) model.  Electrophysiological recordings of G-protein-coupled inwardly rectifying potassium (GIRK) channels were carried out in human atrial myocytes.  A Phase I multiple-dose trial studied the pharmacokinetics, pharmacodynamics and safety of BAF312 in 48 healthy subjects.  KEY RESULTS:  BAF312 effectively suppressed EAE in rats by internalizing S1P(1) receptors, rendering them insensitive to the egress signal from lymph nodes.  In healthy volunteers, BAF312 caused preferential decreases in CD4(+) T cells, T(naive) , T(central memory) and B cells within 4-6 h.  Cell counts returned to normal ranges within a week after stopping treatment, in line with the elimination half-life of BAF312.  Despite sparing S1P(3) receptors (associated with bradycardia in mice), BAF312 induced rapid, transient (day 1 only) bradycardia in humans.  BAF312-mediated activation of GIRK channels in human atrial myocytes can fully explain the bradycardia.  CONCLUSION AND IMPLICATIONS:  This study illustrates species-specific differences in S1P receptor specificity for first-dose cardiac effects.  Based on its profound but rapidly reversible inhibition of lymphocyte trafficking, BAF312 may have potential as a treatment for immune-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRE_xcO_ghmTOLt9HypzAgQfW6udTcc2eZ38F5WDS0Lzrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nnsVShuw%253D%253D&md5=82575d2c2d2eeba851919e468e407c48</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02061.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02061.x%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DP.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DTraebert%26aufirst%3DM.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DGroenewegen%26aufirst%3DA.%26aulast%3DVitaliti%26aufirst%3DA.%26aulast%3DSing%26aufirst%3DT.%26aulast%3DLuttringer%26aufirst%3DO.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DCrumb%26aufirst%3DW.%2BJ.%2BJ.%26aulast%3DSaltzmann%26aufirst%3DM.%26aulast%3DRosenberg%26aufirst%3DM.%26aulast%3DWallstr%25C3%25B6m%26aufirst%3DE.%26atitle%3DThe%2520selective%2520S1P%2520receptor%2520modulator%2520BAF312%2520redirects%2520lymphocyte%2520distribution%2520and%2520has%2520species-specific%2520effects%2520on%2520heart%2520rate%253A%2520translation%2520from%2520preclinical%2520to%2520clinical%2520studies%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D167%26spage%3D1035%26epage%3D1047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">End, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heining, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-Hildesheim, B.</span><span> </span><span class="NLM_article-title">Discovery of BAF312 (siponimod), a potent and selective S1P receptor modulator</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">337</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300396r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=333-337&author=S.+Panauthor=N.+Grayauthor=W.+Gaoauthor=Y.+Miauthor=Y.+Fanauthor=X.+Wangauthor=T.+Tuntlandauthor=J.+Cheauthor=S.+Lefebvreauthor=Y.+Chenauthor=A.+Chuauthor=K.+Hinterdingauthor=A.+Gardinauthor=P.+Endauthor=P.+Heiningauthor=C.+Brunsauthor=N.+G.+Cookeauthor=B.+Nuesslein-Hildesheim&title=Discovery+of+BAF312+%28siponimod%29%2C+a+potent+and+selective+S1P+receptor+modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fml300396r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300396r%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChu%26aufirst%3DA.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DGardin%26aufirst%3DA.%26aulast%3DEnd%26aufirst%3DP.%26aulast%3DHeining%26aufirst%3DP.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DCooke%26aufirst%3DN.%2BG.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520BAF312%2520%2528siponimod%2529%252C%2520a%2520potent%2520and%2520selective%2520S1P%2520receptor%2520modulator%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D333%26epage%3D337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Selmaj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kappos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuve, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieckmann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalban, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziemssen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auberson, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pohlmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlke, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallstrom, E.</span><span> </span><span class="NLM_article-title">Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">756</span><span class="NLM_x">–</span> <span class="NLM_lpage">767</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2FS1474-4422%2813%2970102-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=23764350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpt12huro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=756-767&author=K.+Selmajauthor=D.+K.+Liauthor=H.+P.+Hartungauthor=B.+Hemmerauthor=L.+Kapposauthor=M.+S.+Freedmanauthor=O.+Stuveauthor=P.+Rieckmannauthor=X.+Montalbanauthor=T.+Ziemssenauthor=L.+Z.+Aubersonauthor=H.+Pohlmannauthor=F.+Mercierauthor=F.+Dahlkeauthor=E.+Wallstrom&title=Siponimod+for+patients+with+relapsing-remitting+multiple+sclerosis+%28BOLD%29%3A+an+adaptive%2C+dose-ranging%2C+randomised%2C+phase+2+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study</span></div><div class="casAuthors">Selmaj, Krzysztof; Li, David KB; Hartung, Hans-Peter; Hemmer, Bernhard; Kappos, Ludwig; Freedman, Mark S.; Stuve, Olaf; Rieckmann, Peter; Montalban, Xavier; Ziemssen, Tjalf; Auberson, Lixin Zhang; Pohlmann, Harald; Mercier, Francois; Dahlke, Frank; Wallstrom, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">756-767</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Siponimod is an oral selective modulator of sphingosine 1-phosphate receptor types 1 and type 5, with an elimination half-life leading to washout in 7 days.  We aimed to det. the dose-response relation of siponimod in terms of its effects on brain MRI lesion activity and characterize safety and tolerability in patients with relapsing-remitting multiple sclerosis.In this double-blind, adaptive dose-ranging phase 2 study, we enrolled adults (aged 18-55 years) with relapsing-remitting multiple sclerosis at 73 medical centers in Europe and North America.  We tested two patient cohorts sequentially, sepd. by an interim anal. at 3 mo.  We randomly allocated patients in cohort 1 (1:1:1:1) to receive once-daily siponimod 10 mg, 2 mg, or 0·5 mg, or placebo for 6 mo.  We randomly allocated patients in cohort 2 (4:4:1) to siponimod 1·25 mg, siponimod 0·25 mg, or placebo once-daily for 3 mo.  Randomisation was done with a central, automated system and patients and investigators were masked to treatment assignment.  The primary endpoint was dose-response, assessed by percentage redn. in monthly no. of combined unique active lesions at 3 mo for siponimod vs. placebo; this endpoint was analyzed by a multiple comparison procedure with modeling techniques in all patients with at least one MRI scan up to 3 mo.  We assessed safety in all patients who received at least one dose of study drug.  This study is registered with ClinicalTrials.gov, no. NCT00879658.Between March 30, 2009, and Oct 22, 2010, we recruited 188 patients into cohort 1 and 109 patients into cohort 2.  We showed a dose-response relation (p=0·0001) across the five doses of siponimod, with redns. in combined unique active lesions at 3 mo compared with placebo of 35% (95% CI 17-57) for siponimod 0·25 mg (51 patients included in the primary endpoint anal.), 50% (29-69) for siponimod 0·5 mg (43 patients), 66% (48-80) for siponimod 1·25 mg (42 patients), 72% (57-84) for siponimod 2 mg (45 patients), and 82% (70-90) for siponimod 10 mg (44 patients).  In patients treated for 6 mo, 37 (86%) of 43 patients who received siponimod 0·5 mg had adverse events (eight serious), as did 48 (98%) of 49 patients who received siponimod 2 mg (four serious), 48 (96%) of 50 patients who received siponimod 10 mg (three serious), and 36 (80%) of 45 controls (none serious).  For individuals treated to 3 mo, 38 (74%) of 51 patients who received siponimod 0·25 mg had adverse events (none serious), as did 29 (69%) of 42 patients who received siponimod 1·25 mg (two serious) and 13 (81%) of 16 controls (none serious).Therapeutic effects of siponimod on MRI lesion activity in model-based analyses and its tolerability in relapsing-remitting multiple sclerosis warrant investigation in a phase 3 trial.Novartis Pharma AG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpdAutlVr0kLVg90H21EOLACvtfcHk0lhhJ3D8xqMbEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpt12huro%253D&md5=28e8ce2bc3e97f33c685d0ded9985b31</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2813%2970102-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252813%252970102-9%26sid%3Dliteratum%253Aachs%26aulast%3DSelmaj%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DD.%2BK.%26aulast%3DHartung%26aufirst%3DH.%2BP.%26aulast%3DHemmer%26aufirst%3DB.%26aulast%3DKappos%26aufirst%3DL.%26aulast%3DFreedman%26aufirst%3DM.%2BS.%26aulast%3DStuve%26aufirst%3DO.%26aulast%3DRieckmann%26aufirst%3DP.%26aulast%3DMontalban%26aufirst%3DX.%26aulast%3DZiemssen%26aufirst%3DT.%26aulast%3DAuberson%26aufirst%3DL.%2BZ.%26aulast%3DPohlmann%26aufirst%3DH.%26aulast%3DMercier%26aufirst%3DF.%26aulast%3DDahlke%26aufirst%3DF.%26aulast%3DWallstrom%26aufirst%3DE.%26atitle%3DSiponimod%2520for%2520patients%2520with%2520relapsing-remitting%2520multiple%2520sclerosis%2520%2528BOLD%2529%253A%2520an%2520adaptive%252C%2520dose-ranging%252C%2520randomised%252C%2520phase%25202%2520study%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D756%26epage%3D767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menyhart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4198</span><span class="NLM_x">–</span> <span class="NLM_lpage">4211</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100181s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4198-4211&author=M.+H.+Bolliauthor=S.+Abeleauthor=C.+Binkertauthor=R.+Bravoauthor=S.+Buchmannauthor=D.+Burauthor=J.+Gatfieldauthor=P.+Hessauthor=C.+Kohlauthor=C.+Mangoldauthor=B.+Mathysauthor=K.+Menyhartauthor=C.+M%C3%BCllerauthor=O.+Naylerauthor=M.+Scherzauthor=G.+Schmidtauthor=V.+Sippelauthor=B.+Steinerauthor=D.+Strasserauthor=A.+Treiberauthor=T.+Weller&title=2-imino-thiazolidin-4-one+derivatives+as+potent%2C+orally+active+S1P1+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm100181s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100181s%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DBinkert%26aufirst%3DC.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBuchmann%26aufirst%3DS.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DMangold%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DMenyhart%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DSippel%26aufirst%3DV.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DStrasser%26aufirst%3DD.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3D2-imino-thiazolidin-4-one%2520derivatives%2520as%2520potent%252C%2520orally%2520active%2520S1P1%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4198%26epage%3D4211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Freedman, M. S.; Olsson, T.; Melanson, M.; Fernández, O.; Boster, A.; Bach, D.; Berkani, O.; Mueller, M.; Sidorenko, T.; Pozzilli, C.</span><span> </span><span class="NLM_article-title">Dose-Dependent Effect of Ponesimod, an Oral, Selective Sphingosine 1-Phosphate Receptor-1 Modulator, on Magnetic Resonance Imaging Outcomes in Patients with Relapsing–Remitting Multiple Sclerosis</span>. Presented at the 28th Congress of the European Commitee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2012), Lyon, France, Oct 10–13,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>P923.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+S.+Freedman&author=T.+Olsson&author=M.+Melanson&author=O.+Fern%C3%A1ndez&author=A.+Boster&author=D.+Bach&author=O.+Berkani&author=M.+Mueller&author=T.+Sidorenko&author=C.+Pozzilli&title=Dose-Dependent+Effect+of+Ponesimod%2C+an+Oral%2C+Selective+Sphingosine+1-Phosphate+Receptor-1+Modulator%2C+on+Magnetic+Resonance+Imaging+Outcomes+in+Patients+with+Relapsing%E2%80%93Remitting+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DFreedman%26aufirst%3DM.%2BS.%26atitle%3DDose-Dependent%2520Effect%2520of%2520Ponesimod%252C%2520an%2520Oral%252C%2520Selective%2520Sphingosine%25201-Phosphate%2520Receptor-1%2520Modulator%252C%2520on%2520Magnetic%2520Resonance%2520Imaging%2520Outcomes%2520in%2520Patients%2520with%2520Relapsing%25E2%2580%2593Remitting%2520Multiple%2520Sclerosis%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kurata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokuda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shioya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habashita, H.</span><span> </span><span class="NLM_article-title">Structure–activity relationsphip studies of S1P agonists with a dihydronaphthalene scaffold</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">144</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=144-148&author=H.+Kurataauthor=K.+Kusumiauthor=K.+Otsukiauthor=R.+Suzukiauthor=M.+Kuronoauthor=N.+Tokudaauthor=Y.+Takadaauthor=H.+Shioyaauthor=H.+Mizunoauthor=T.+Komiyaauthor=T.+Onoauthor=H.+Hagiyaauthor=M.+Minamiauthor=S.+Nakadeauthor=H.+Habashita&title=Structure%E2%80%93activity+relationsphip+studies+of+S1P+agonists+with+a+dihydronaphthalene+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DKusumi%26aufirst%3DK.%26aulast%3DOtsuki%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DKurono%26aufirst%3DM.%26aulast%3DTokuda%26aufirst%3DN.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DShioya%26aufirst%3DH.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DKomiya%26aufirst%3DT.%26aulast%3DOno%26aufirst%3DT.%26aulast%3DHagiya%26aufirst%3DH.%26aulast%3DMinami%26aufirst%3DM.%26aulast%3DNakade%26aufirst%3DS.%26aulast%3DHabashita%26aufirst%3DH.%26atitle%3DStructure%25E2%2580%2593activity%2520relationsphip%2520studies%2520of%2520S1P%2520agonists%2520with%2520a%2520dihydronaphthalene%2520scaffold%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D144%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Komiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shioya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakade, S.</span><span> </span><span class="NLM_article-title">Efficacy and immunomodulatory actions of ONO-4641, a novel selective agonist for sphingosine 1-phosphate receptors 1 and 5, in preclinical models of multiple sclerosis</span> <span class="citation_source-journal">Clin. Exp. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1111%2Fj.1365-2249.2012.04669.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=23199323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslKrtL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2013&pages=54-62&author=T.+Komiyaauthor=K.+Satoauthor=H.+Shioyaauthor=Y.+Inagakiauthor=H.+Hagiyaauthor=R.+Kozakiauthor=M.+Imaiauthor=Y.+Takadaauthor=T.+Maedaauthor=H.+Kurataauthor=M.+Kuronoauthor=R.+Suzukiauthor=K.+Otsukiauthor=H.+Habashitaauthor=S.+Nakade&title=Efficacy+and+immunomodulatory+actions+of+ONO-4641%2C+a+novel+selective+agonist+for+sphingosine+1-phosphate+receptors+1+and+5%2C+in+preclinical+models+of+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and immunomodulatory actions of ONO-4641, a novel selective agonist for sphingosine 1-phosphate receptors 1 and 5, in preclinical models of multiple sclerosis</span></div><div class="casAuthors">Komiya, T.; Sato, K.; Shioya, H.; Inagaki, Y.; Hagiya, H.; Kozaki, R.; Imai, M.; Takada, Y.; Maeda, T.; Kurata, H.; Kurono, M.; Suzuki, R.; Otsuki, K.; Habashita, H.; Nakade, S.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Immunology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-62</span>CODEN:
                <span class="NLM_cas:coden">CEXIAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary: ONO-4641 is a next-generation sphingosine 1-phosphate (S1P) receptor agonist selective for S1P receptors 1 and 5.  The objective of the study was to characterize the immunomodulatory effects of ONO-4641 using preclin. data.  ONO-4641 was tested in both in-vitro pharmacol. studies as well as in-vivo models of transient or relapsing-remitting exptl. autoimmune encephalomyelitis (EAE).  In vitro, ONO-4641 showed highly potent agonistic activities vs. S1P receptors 1 and 5 [half maximal effective concn. (EC50) values of 0·0273 and 0·334 nM, resp.], and had profound S1P receptor 1 down-regulating effects on the cell membrane.  ONO-4641 decreased peripheral blood lymphocyte counts in rats by inhibiting lymphocyte egress from secondary lymphoid tissues.  In a rat exptl. autoimmune encephalomyelitis(EAE) model, ONO-4641 suppressed the onset of disease and inhibited lymphocyte infiltration into the spinal cord in a dose-dependent manner at doses of 0·03 and 0·1 mg/kg.  Furthermore, ONO-4641 prevented relapse of disease in a non-obese diabetic mouse model of relapsing-remitting EAE.  These observations suggest that ONO-4641 may provide therapeutic benefits in the treatment of multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFV76b9p5RfbVg90H21EOLACvtfcHk0liN57iNSmuE5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslKrtL3E&md5=d4cd1078e245580132c50e1bb43aa039</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2249.2012.04669.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2249.2012.04669.x%26sid%3Dliteratum%253Aachs%26aulast%3DKomiya%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DShioya%26aufirst%3DH.%26aulast%3DInagaki%26aufirst%3DY.%26aulast%3DHagiya%26aufirst%3DH.%26aulast%3DKozaki%26aufirst%3DR.%26aulast%3DImai%26aufirst%3DM.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DMaeda%26aufirst%3DT.%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DKurono%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DOtsuki%26aufirst%3DK.%26aulast%3DHabashita%26aufirst%3DH.%26aulast%3DNakade%26aufirst%3DS.%26atitle%3DEfficacy%2520and%2520immunomodulatory%2520actions%2520of%2520ONO-4641%252C%2520a%2520novel%2520selective%2520agonist%2520for%2520sphingosine%25201-phosphate%2520receptors%25201%2520and%25205%252C%2520in%2520preclinical%2520models%2520of%2520multiple%2520sclerosis%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D2013%26volume%3D171%26spage%3D54%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span>ClinicalTrials.gov. Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis Patients. <a href="http://clinicaltrials.gov/show/NCT01628393" class="extLink">http://clinicaltrials.gov/show/NCT01628393</a> (accessed July<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Efficacy+and+Safety+Study+of+RPC1063+in+Relapsing+Multiple+Sclerosis+Patients.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01628393+%28accessed+July+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span>ClinicalTrials.gov. Dose Finding Study of MT-1303. <a href="http://clinicaltrials.gov/show/NCT01742052" class="extLink">http://clinicaltrials.gov/show/NCT01742052</a> (accessed Jan<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Dose+Finding+Study+of+MT-1303.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01742052+%28accessed+Jan+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span>ClinicalTrials.gov. Efficacy and Safety Study of RPC1063 in Ulcerative Colitis. <a href="http://clinicaltrials.gov/show/NCT01647516" class="extLink">http://clinicaltrials.gov/show/NCT01647516</a> (accessed July<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Efficacy+and+Safety+Study+of+RPC1063+in+Ulcerative+Colitis.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01647516+%28accessed+July+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span>ClinicalTrials.gov. Efficacy, Tolerability, Pharmacokinetcs and Pharmacodynamics Study of MT-1303 in Subjects with Inflammatory Bowel Disease. <a href="http://clinicaltrials.gov/show/NCT01666327" class="extLink">http://clinicaltrials.gov/show/NCT01666327</a> (accessed Jan<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Efficacy%2C+Tolerability%2C+Pharmacokinetcs+and+Pharmacodynamics+Study+of+MT-1303+in+Subjects+with+Inflammatory+Bowel+Disease.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01666327+%28accessed+Jan+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Nishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iio, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawase, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nara, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inaba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomisato, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimozato, T.</span><span> </span><span class="NLM_article-title">Discovery of CS-0777: a potent, selective, and orally active S1P<sub>1</sub> agonist</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">368</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100301k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=368-372&author=T.+Nishiauthor=S.+Miyazakiauthor=T.+Takemotoauthor=K.+Suzukiauthor=Y.+Iioauthor=K.+Nakajimaauthor=T.+Ohnukiauthor=Y.+Kawaseauthor=F.+Naraauthor=S.+Inabaauthor=T.+Izumiauthor=H.+Yuitaauthor=K.+Oshimaauthor=H.+Doiauthor=R.+Inoueauthor=W.+Tomisatoauthor=T.+Kagariauthor=T.+Shimozato&title=Discovery+of+CS-0777%3A+a+potent%2C+selective%2C+and+orally+active+S1P1+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fml100301k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100301k%26sid%3Dliteratum%253Aachs%26aulast%3DNishi%26aufirst%3DT.%26aulast%3DMiyazaki%26aufirst%3DS.%26aulast%3DTakemoto%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DIio%26aufirst%3DY.%26aulast%3DNakajima%26aufirst%3DK.%26aulast%3DOhnuki%26aufirst%3DT.%26aulast%3DKawase%26aufirst%3DY.%26aulast%3DNara%26aufirst%3DF.%26aulast%3DInaba%26aufirst%3DS.%26aulast%3DIzumi%26aufirst%3DT.%26aulast%3DYuita%26aufirst%3DH.%26aulast%3DOshima%26aufirst%3DK.%26aulast%3DDoi%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DR.%26aulast%3DTomisato%26aufirst%3DW.%26aulast%3DKagari%26aufirst%3DT.%26aulast%3DShimozato%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520CS-0777%253A%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520S1P1%2520agonist%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D368%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Moberly, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zahir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truitt, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollmer, T. L.</span><span> </span><span class="NLM_article-title">Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: results from a 12-week, open-label pilot study in multiple sclerosis patients</span> <span class="citation_source-journal">J. Neuroimmunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">246</span><span class="NLM_x">, </span> <span class="NLM_fpage">100</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.jneuroim.2012.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=22465063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvF2jtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=246&publication_year=2012&pages=100-107&author=J.+B.+Moberlyauthor=D.+M.+Fordauthor=H.+Zahirauthor=S.+Chenauthor=T.+Mochizukiauthor=K.+E.+Truittauthor=T.+L.+Vollmer&title=Pharmacological+effects+of+CS-0777%2C+a+selective+sphingosine+1-phosphate+receptor-1+modulator%3A+results+from+a+12-week%2C+open-label+pilot+study+in+multiple+sclerosis+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: Results from a 12-week, open-label pilot study in multiple sclerosis patients</span></div><div class="casAuthors">Moberly, James B.; Ford, Daniel M.; Zahir, Hamim; Chen, Shuquan; Mochizuki, Takashi; Truitt, Kenneth E.; Vollmer, Timothy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroimmunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">246</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">100-107</span>CODEN:
                <span class="NLM_cas:coden">JNRIDW</span>;
        ISSN:<span class="NLM_cas:issn">0165-5728</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">CS-0777 is a selective sphingosine 1-phosphate receptor-1 modulator under investigation for treatment of multiple sclerosis (MS).  We conducted an open-label, pilot study in 25 MS patients to assess the safety, pharmacokinetics, pharmacodynamics and exploratory efficacy of oral CS-0777 (0.1, 0.3 and 0.6 mg), administered once weekly or every other week for 12 wk.  CS-0777 resulted in a pronounced, dose-dependent decrease in lymphocytes and CD4 T cell subsets, which returned to baseline within 4 wk after the last dose.  Overall, CS-0777 was safe and well-tolerated.  These results require confirmation in a double-blind, placebo-controlled and adequately powered phase 2 study in MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnUDMmZ5gpHLVg90H21EOLACvtfcHk0lhcUlCKTf9KOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvF2jtbY%253D&md5=ce750c33bbfd69ba65304cb02f7c22f9</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.jneuroim.2012.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneuroim.2012.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DMoberly%26aufirst%3DJ.%2BB.%26aulast%3DFord%26aufirst%3DD.%2BM.%26aulast%3DZahir%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DMochizuki%26aufirst%3DT.%26aulast%3DTruitt%26aufirst%3DK.%2BE.%26aulast%3DVollmer%26aufirst%3DT.%2BL.%26atitle%3DPharmacological%2520effects%2520of%2520CS-0777%252C%2520a%2520selective%2520sphingosine%25201-phosphate%2520receptor-1%2520modulator%253A%2520results%2520from%2520a%252012-week%252C%2520open-label%2520pilot%2520study%2520in%2520multiple%2520sclerosis%2520patients%26jtitle%3DJ.%2520Neuroimmunol.%26date%3D2012%26volume%3D246%26spage%3D100%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span>ClinicalTrials.gov. Exploring the Efficacy and Safety of Siponimod in Patients with Secondary Progressive Multiple Sclerosis (EXPAND). <a href="http://clinicaltrials.gov/show/NCT01665144" class="extLink">http://clinicaltrials.gov/show/NCT01665144</a> (accessed Dec<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Exploring+the+Efficacy+and+Safety+of+Siponimod+in+Patients+with+Secondary+Progressive+Multiple+Sclerosis+%28EXPAND%29.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01665144+%28accessed+Dec+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span>ClinicalTrials.gov. Efficacy and Tolerability of BAF312 in Patients with Polymyositis and Dermatomyositis. <a href="http://clinicaltrials.gov/show/NCT01148810" class="extLink">http://clinicaltrials.gov/show/NCT01148810</a> (accessed Dec<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Efficacy+and+Tolerability+of+BAF312+in+Patients+with+Polymyositis+and+Dermatomyositis.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01148810+%28accessed+Dec+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span>ClinicalTrials.gov. ACT-128800 in Patients with Moderate to Severe Chronic Plaque Psoriasis. <a href="http://clinicaltrials.gov/show/NCT01208090" class="extLink">http://clinicaltrials.gov/show/NCT01208090</a> accessed Aug<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+ACT-128800+in+Patients+with+Moderate+to+Severe+Chronic+Plaque+Psoriasis.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01208090+accessed+Aug+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span>Media Releases. Actelion’s Ponesimod Successful in Mid-Stage Trial in Patients with Moderate to Severe Chronic Plaque Psoriasis. <a href="http://www.actelion.com/en/investors/media-releases/index.page?pageId=2&amp;language=en" class="extLink">http://www.actelion.com/en/investors/media-releases/index.page?pageId=2&language=en</a> (accessed December 18<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Media+Releases.+Actelion%E2%80%99s+Ponesimod+Successful+in+Mid-Stage+Trial+in+Patients+with+Moderate+to+Severe+Chronic+Plaque+Psoriasis.+http%3A%2F%2Fwww.actelion.com%2Fen%2Finvestors%2Fmedia-releases%2Findex.page%3FpageId%3D2%26language%3Den+%28accessed+December+18+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Budde, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schütz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glander, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waiser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liefeldt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumayer, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böhler, T.</span><span> </span><span class="NLM_article-title">FTY720 (fingolimod) in renal transplantation</span> <span class="citation_source-journal">Clin. Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 17</span><span class="NLM_x">) </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1111%2Fj.1399-0012.2006.00596.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=17100697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A280%3ADC%252BD28nms1WltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=17-24&issue=Suppl.+17&author=K.+Buddeauthor=M.+Sch%C3%BCtzauthor=P.+Glanderauthor=H.+Petersauthor=J.+Waiserauthor=L.+Liefeldtauthor=H.+H.+Neumayerauthor=T.+B%C3%B6hler&title=FTY720+%28fingolimod%29+in+renal+transplantation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720 (fingolimod) in renal transplantation</span></div><div class="casAuthors">Budde Klemens; Schutz Manuela; Glander Petra; Peters Harm; Waiser Johannes; Liefeldt Lutz; Neumayer Hans-H; Bohler Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Clinical transplantation</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20 Suppl 17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17-24</span>
        ISSN:<span class="NLM_cas:issn">0902-0063</span>.
    </div><div class="casAbstract">FTY720 (Fingolimod) is a novel immunomodulator with a mode of action that is completely different from classical immunosuppressants.  FTY is a structural and functional analogue of the natural serum lipid, sphingosine, and is the first in a new class of drugs called sphingosine 1-phosphate receptor (S1P-R) modulators.  This review discusses the recent findings on the mechanism of action, preclinical models and outlines the results of the ongoing clinical development program.  FTY is highly effective in prolonging allograft survival in preclinical models of transplantation and in experimental models of autoimmune diseases.  In clinical trials, this novel compound was investigated in de novo renal transplantation and in multiple sclerosis.  Pharmacokinetics are characterized by a prolonged absorption phase, a large volume of distribution, and a long elimination half-life.  FTY induces a rapid and transient decrease in lymphocyte counts, which supports the modulatory effects of the drug on lymphocyte sequestration.  The most common adverse event was asymptomatic transient bradycardia, a pharmacodynamic effect modulated by atrial S1 P-R.  FTY failed to show an improvement in efficacy for the prevention of renal allograft rejection in two large phase III studies.  FTY treatment regimens were associated with impaired renal function and the development of macula edema.  Consequently, the further development in renal transplantation was stopped.  Because initial clinical studies strongly suggest that FTY is highly effective in multiple sclerosis FTY is now being explored in phase III studies for the treatment of demyelinating diseases, Ongoing studies in multiple sclerosis are eagerly awaited because they may provide novel therapeutic options for patients with autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRP88lC8yE9O9y3lHz94U-GfW6udTcc2eY9TLycQtSr2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28nms1WltQ%253D%253D&md5=3799360786675c4e7074e5c4d4b452ed</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-0012.2006.00596.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-0012.2006.00596.x%26sid%3Dliteratum%253Aachs%26aulast%3DBudde%26aufirst%3DK.%26aulast%3DSch%25C3%25BCtz%26aufirst%3DM.%26aulast%3DGlander%26aufirst%3DP.%26aulast%3DPeters%26aufirst%3DH.%26aulast%3DWaiser%26aufirst%3DJ.%26aulast%3DLiefeldt%26aufirst%3DL.%26aulast%3DNeumayer%26aufirst%3DH.%2BH.%26aulast%3DB%25C3%25B6hler%26aufirst%3DT.%26atitle%3DFTY720%2520%2528fingolimod%2529%2520in%2520renal%2520transplantation%26jtitle%3DClin.%2520Transplant.%26date%3D2006%26volume%3D20%26issue%3DSuppl.%252017%26spage%3D17%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Shimizu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakamata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enosawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeyoshi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, E.</span><span> </span><span class="NLM_article-title">KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and hear allografts</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2005&pages=222-229&author=H.+Shimizuauthor=M.+Takahashiauthor=T.+Kanekoauthor=T.+Murakamiauthor=Y.+Hakamataauthor=S.+Kudouauthor=T.+Kishiauthor=K.+Fukuchiauthor=S.+Iwanamiauthor=K.+Kuriyamaauthor=T.+Yasueauthor=S.+Enosawaauthor=K.+Matsumotoauthor=I.+Takeyoshiauthor=Y.+Morishitaauthor=E.+Kobayashi&title=KRP-203%2C+a+novel+synthetic+immunosuppressant%2C+prolongs+graft+survival+and+attenuates+chronic+rejection+in+rat+skin+and+hear+allografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DHakamata%26aufirst%3DY.%26aulast%3DKudou%26aufirst%3DS.%26aulast%3DKishi%26aufirst%3DT.%26aulast%3DFukuchi%26aufirst%3DK.%26aulast%3DIwanami%26aufirst%3DS.%26aulast%3DKuriyama%26aufirst%3DK.%26aulast%3DYasue%26aufirst%3DT.%26aulast%3DEnosawa%26aufirst%3DS.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DTakeyoshi%26aufirst%3DI.%26aulast%3DMorishita%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DE.%26atitle%3DKRP-203%252C%2520a%2520novel%2520synthetic%2520immunosuppressant%252C%2520prolongs%2520graft%2520survival%2520and%2520attenuates%2520chronic%2520rejection%2520in%2520rat%2520skin%2520and%2520hear%2520allografts%26jtitle%3DCirculation%26date%3D2005%26volume%3D111%26spage%3D222%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span>ClinicalTrials.gov. Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus. <a href="http://clinicaltrials.gov/show/NCT01294774" class="extLink">http://clinicaltrials.gov/show/NCT01294774</a> (accessed July<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Safety+and+Efficacy+of+KRP203+in+Subacute+Cutaneous+Lupus+Erythematosus.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01294774+%28accessed+July+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span>ClinicalTrials.gov. Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis Patients. <a href="http://clinicaltrials.gov/show/NCT01375179" class="extLink">http://clinicaltrials.gov/show/NCT01375179</a> (accessed July<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Efficacy+%26+Safety+in+Moderately+Active+Refractory+Ulcerative+Colitis+Patients.+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01375179+%28accessed+July+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Buzard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoresen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrader, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sage, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Shamma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P<sub>1</sub> agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6013</span><span class="NLM_x">–</span> <span class="NLM_lpage">6018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6013-6018&author=D.+Buzardauthor=S.+Hanauthor=L.+Thoresenauthor=J.+Moodyauthor=L.+Lopezauthor=A.+Kawasakiauthor=T.+Schraderauthor=C.+Sageauthor=Y.+Gaoauthor=J.+Edwardsauthor=J.+Bardenauthor=J.+Thatteauthor=L.+Fuauthor=M.+Solomonauthor=L.+Liuauthor=H.+Al-Shammaauthor=J.+Gatlinauthor=M.+Leauthor=C.+Xingauthor=S.+Espinolaauthor=R.+M.+Jones&title=Discovery+and+characterization+of+potent+and+selective+4-oxo-4-%285-%285-phenyl-1%2C2%2C4-oxadiazol-3-yl%29indolin-1-yl%29butanoic+acids+as+S1P1+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DThoresen%26aufirst%3DL.%26aulast%3DMoody%26aufirst%3DJ.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DKawasaki%26aufirst%3DA.%26aulast%3DSchrader%26aufirst%3DT.%26aulast%3DSage%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DBarden%26aufirst%3DJ.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DSolomon%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DAl-Shamma%26aufirst%3DH.%26aulast%3DGatlin%26aufirst%3DJ.%26aulast%3DLe%26aufirst%3DM.%26aulast%3DXing%26aufirst%3DC.%26aulast%3DEspinola%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520potent%2520and%2520selective%25204-oxo-4-%25285-%25285-phenyl-1%252C2%252C4-oxadiazol-3-yl%2529indolin-1-yl%2529butanoic%2520acids%2520as%2520S1P1%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6013%26epage%3D6018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moody, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoresen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gharbaoui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sengupta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usmani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadeque, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Shamma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatlin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Fused tricyclic indoles as S1P(1) agonists with robust efficacy in animal models of autoimmune disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4404</span><span class="NLM_x">–</span> <span class="NLM_lpage">4409</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4404-4409&author=D.+J.+Buzardauthor=S.+Hanauthor=L.+Lopezauthor=A.+Kawasakiauthor=J.+Moodyauthor=L.+Thoresenauthor=B.+Ullmanauthor=J.+Lehmannauthor=I.+Calderonauthor=X.+Zhuauthor=T.+Gharbaouiauthor=D.+Senguptaauthor=A.+Krishnanauthor=Y.+Gaoauthor=J.+Edwardsauthor=J.+Bardenauthor=M.+Morganauthor=K.+Usmaniauthor=C.+Chenauthor=A.+Sadequeauthor=J.+Thatteauthor=M.+Solomonauthor=L.+Fuauthor=K.+Whelanauthor=L.+Liuauthor=H.+Al-Shammaauthor=J.+Gatlinauthor=M.+Leauthor=C.+Xingauthor=S.+Espinolaauthor=R.+M.+Jones&title=Fused+tricyclic+indoles+as+S1P%281%29+agonists+with+robust+efficacy+in+animal+models+of+autoimmune+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DKawasaki%26aufirst%3DA.%26aulast%3DMoody%26aufirst%3DJ.%26aulast%3DThoresen%26aufirst%3DL.%26aulast%3DUllman%26aufirst%3DB.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DCalderon%26aufirst%3DI.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DGharbaoui%26aufirst%3DT.%26aulast%3DSengupta%26aufirst%3DD.%26aulast%3DKrishnan%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DBarden%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DUsmani%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DSadeque%26aufirst%3DA.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DSolomon%26aufirst%3DM.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DWhelan%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DAl-Shamma%26aufirst%3DH.%26aulast%3DGatlin%26aufirst%3DJ.%26aulast%3DLe%26aufirst%3DM.%26aulast%3DXing%26aufirst%3DC.%26aulast%3DEspinola%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DFused%2520tricyclic%2520indoles%2520as%2520S1P%25281%2529%2520agonists%2520with%2520robust%2520efficacy%2520in%2520animal%2520models%2520of%2520autoimmune%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4404%26epage%3D4409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Aguilar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grima, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segarra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godessart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarrason, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domenech, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armengol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordoba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabate, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casals, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, M.</span><span> </span><span class="NLM_article-title">Discovery of a novel class of zwitterionic, potent, selective and orally active S1P(1) direct agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7672</span><span class="NLM_x">–</span> <span class="NLM_lpage">7676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7672-7676&author=N.+Aguilarauthor=M.+Mirauthor=P.+M.+Grimaauthor=M.+Lopezauthor=V.+Segarraauthor=L.+Estebanauthor=I.+Morenoauthor=N.+Godessartauthor=G.+Tarrasonauthor=T.+Domenechauthor=D.+Vilellaauthor=C.+Armengolauthor=M.+Cordobaauthor=M.+Sabateauthor=D.+Casalsauthor=M.+Dominguez&title=Discovery+of+a+novel+class+of+zwitterionic%2C+potent%2C+selective+and+orally+active+S1P%281%29+direct+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAguilar%26aufirst%3DN.%26aulast%3DMir%26aufirst%3DM.%26aulast%3DGrima%26aufirst%3DP.%2BM.%26aulast%3DLopez%26aufirst%3DM.%26aulast%3DSegarra%26aufirst%3DV.%26aulast%3DEsteban%26aufirst%3DL.%26aulast%3DMoreno%26aufirst%3DI.%26aulast%3DGodessart%26aufirst%3DN.%26aulast%3DTarrason%26aufirst%3DG.%26aulast%3DDomenech%26aufirst%3DT.%26aulast%3DVilella%26aufirst%3DD.%26aulast%3DArmengol%26aufirst%3DC.%26aulast%3DCordoba%26aufirst%3DM.%26aulast%3DSabate%26aufirst%3DM.%26aulast%3DCasals%26aufirst%3DD.%26aulast%3DDominguez%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%2520zwitterionic%252C%2520potent%252C%2520selective%2520and%2520orally%2520active%2520S1P%25281%2529%2520direct%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7672%26epage%3D7676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span>Almirall. Product Development Pipeline. <a href="http://www.almirall.com/webcorp2/cda/ImD_03_02.jsp" class="extLink">http://www.almirall.com/webcorp2/cda/ImD_03_02.jsp</a> (accessed Jan<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Almirall.+Product+Development+Pipeline.+http%3A%2F%2Fwww.almirall.com%2Fwebcorp2%2Fcda%2FImD_03_02.jsp+%28accessed+Jan+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Demont, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arpino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeks, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaskin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orborne, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panchal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span> </span><span class="NLM_article-title">Discovery of a brain-penetrant S1P<sub>3</sub>-sparing direct agonist of the S1P<sub>1</sub> and S1P<sub>5</sub> receptors efficacious at low oral dose</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6724</span><span class="NLM_x">–</span> <span class="NLM_lpage">6733</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200609t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6724-6733&author=E.+H.+Demontauthor=S.+Arpinoauthor=R.+A.+Bitauthor=C.+A.+Campbellauthor=N.+Deeksauthor=S.+Desaiauthor=S.+J.+Dowellauthor=P.+Gaskinauthor=J.+R.+J.+Grayauthor=L.+A.+Harrisonauthor=A.+Haynesauthor=T.+D.+Heightmanauthor=D.+S.+Holmesauthor=P.+G.+Humphreysauthor=U.+Kumarauthor=M.+A.+Morseauthor=G.+J.+Orborneauthor=T.+Panchalauthor=K.+L.+Philpottauthor=S.+Taylorauthor=R.+Watsonauthor=R.+Willisauthor=J.+Witherington&title=Discovery+of+a+brain-penetrant+S1P3-sparing+direct+agonist+of+the+S1P1+and+S1P5+receptors+efficacious+at+low+oral+dose"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm200609t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200609t%26sid%3Dliteratum%253Aachs%26aulast%3DDemont%26aufirst%3DE.%2BH.%26aulast%3DArpino%26aufirst%3DS.%26aulast%3DBit%26aufirst%3DR.%2BA.%26aulast%3DCampbell%26aufirst%3DC.%2BA.%26aulast%3DDeeks%26aufirst%3DN.%26aulast%3DDesai%26aufirst%3DS.%26aulast%3DDowell%26aufirst%3DS.%2BJ.%26aulast%3DGaskin%26aufirst%3DP.%26aulast%3DGray%26aufirst%3DJ.%2BR.%2BJ.%26aulast%3DHarrison%26aufirst%3DL.%2BA.%26aulast%3DHaynes%26aufirst%3DA.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DHolmes%26aufirst%3DD.%2BS.%26aulast%3DHumphreys%26aufirst%3DP.%2BG.%26aulast%3DKumar%26aufirst%3DU.%26aulast%3DMorse%26aufirst%3DM.%2BA.%26aulast%3DOrborne%26aufirst%3DG.%2BJ.%26aulast%3DPanchal%26aufirst%3DT.%26aulast%3DPhilpott%26aufirst%3DK.%2BL.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DWatson%26aufirst%3DR.%26aulast%3DWillis%26aufirst%3DR.%26aulast%3DWitherington%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520brain-penetrant%2520S1P3-sparing%2520direct%2520agonist%2520of%2520the%2520S1P1%2520and%2520S1P5%2520receptors%2520efficacious%2520at%2520low%2520oral%2520dose%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6724%26epage%3D6733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Ren, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, J.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span> </span><span class="NLM_article-title">Discovery of novel 1,2,4-thiadiazole derivatives as potent, orally active agonists of sphingosine 1-phosphate subtype 1 (S1P<sub>1</sub>)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4286</span><span class="NLM_x">–</span> <span class="NLM_lpage">4295</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2016107" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4286-4295&author=F.+Renauthor=G.+Dengauthor=H.+Wangauthor=L.+Luanauthor=Q.+Mengauthor=Q.+Xuauthor=H.+Xuauthor=X.+Xuauthor=H.+Zhangauthor=B.+Zhaoauthor=C.+Liauthor=T.+B.+Guoauthor=J.+Yangauthor=W.+Zhangauthor=Y.+Zhaoauthor=Q.+Jiaauthor=H.+Luauthor=J.-N.+Xiangauthor=J.+D.+Elliottauthor=X.+Lin&title=Discovery+of+novel+1%2C2%2C4-thiadiazole+derivatives+as+potent%2C+orally+active+agonists+of+sphingosine+1-phosphate+subtype+1+%28S1P1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm2016107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2016107%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DF.%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLuan%26aufirst%3DL.%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DT.%2BB.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DJia%26aufirst%3DQ.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DXiang%26aufirst%3DJ.-N.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520novel%25201%252C2%252C4-thiadiazole%2520derivatives%2520as%2520potent%252C%2520orally%2520active%2520agonists%2520of%2520sphingosine%25201-phosphate%2520subtype%25201%2520%2528S1P1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4286%26epage%3D4295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeks, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaskin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavens, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cryan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garden, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span> </span><span class="NLM_article-title">The utility of pharmacokinetic-pharmacodynamic modeling in the discovery and optimization of selective S1P<sub>1</sub> agonists</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">686</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=671-686&author=S.+Taylorauthor=J.+R.+J.+Grayauthor=R.+Willisauthor=N.+Deeksauthor=A.+Haynesauthor=C.+Campbellauthor=P.+Gaskinauthor=K.+Leavensauthor=E.+Demontauthor=S.+Dowellauthor=J.+Cryanauthor=M.+Morseauthor=A.+Patelauthor=H.+Gardenauthor=J.+Witherington&title=The+utility+of+pharmacokinetic-pharmacodynamic+modeling+in+the+discovery+and+optimization+of+selective+S1P1+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DJ.%2BR.%2BJ.%26aulast%3DWillis%26aufirst%3DR.%26aulast%3DDeeks%26aufirst%3DN.%26aulast%3DHaynes%26aufirst%3DA.%26aulast%3DCampbell%26aufirst%3DC.%26aulast%3DGaskin%26aufirst%3DP.%26aulast%3DLeavens%26aufirst%3DK.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DDowell%26aufirst%3DS.%26aulast%3DCryan%26aufirst%3DJ.%26aulast%3DMorse%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DGarden%26aufirst%3DH.%26aulast%3DWitherington%26aufirst%3DJ.%26atitle%3DThe%2520utility%2520of%2520pharmacokinetic-pharmacodynamic%2520modeling%2520in%2520the%2520discovery%2520and%2520optimization%2520of%2520selective%2520S1P1%2520agonists%26jtitle%3DXenobiotica%26date%3D2012%26volume%3D42%26spage%3D671%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span>Bristol-Myers Squibb. In the Pipeline. <a href="http://www.bms.com/research/pipeline/Pages/default.aspx" class="extLink">http://www.bms.com/research/pipeline/Pages/default.aspx</a> (accessed Jan<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bristol-Myers+Squibb.+In+the+Pipeline.+http%3A%2F%2Fwww.bms.com%2Fresearch%2Fpipeline%2FPages%2Fdefault.aspx+%28accessed+Jan+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Cherney, R. J.; Wang, Z.</span><span> </span><span class="NLM_article-title">Heterocyclic Compounds as S1P1 Agonists for the Treatment of Autoimmune and Vascular Diseases</span>. WO2012061459, May 10,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=R.+J.+Cherney&author=Z.+Wang&title=Heterocyclic+Compounds+as+S1P1+Agonists+for+the+Treatment+of+Autoimmune+and+Vascular+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCherney%26aufirst%3DR.%2BJ.%26atitle%3DHeterocyclic%2520Compounds%2520as%2520S1P1%2520Agonists%2520for%2520the%2520Treatment%2520of%2520Autoimmune%2520and%2520Vascular%2520Diseases%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thatte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Recent progress in the development of selective S1P<sub>1</sub> receptor agonists for the treatment of inflammatory and autoimmune disorders</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1141</span><span class="NLM_x">–</span> <span class="NLM_lpage">1159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1517%2F13543776.18.10.1141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ais7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1141-1159&author=D.+J.+Buzardauthor=J.+Thatteauthor=M.+Lernerauthor=J.+Edwardsauthor=R.+M.+Jones&title=Recent+progress+in+the+development+of+selective+S1P1+receptor+agonists+for+the+treatment+of+inflammatory+and+autoimmune+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of selective S1P1 receptor agonists for the treatment of inflammatory and autoimmune disorders</span></div><div class="casAuthors">Buzard, Daniel J.; Thatte, Jayant; Lerner, Michael; Edwards, Jeffrey; Jones, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1141-1159</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The sphingosine-1-phosphate receptor 1 (S1P1) belongs to the endothelial differentiation gene family of G-protein-coupled receptors involved in embryonic development, cellular differentiation and survival, adherence and tight junction assembly, and leukocyte trafficking.  In vivo S1P1 is required for egress of thymocytes into the blood and of naive lymphocytes from secondary lymphoid organs back into the lymph.  Downregulation of S1P1 disrupts lymphocyte migration, tissue homing and recirculation.  To explore the immunomodulatory potential of S1P1, pharma is developing S1P1-selective agonists for treating autoimmune and inflammatory disorders.  FTY720 (fingolimod, Novartis AG), a nonselective S1P1 agonist that induces sustained lymphopenia, is a promising pseudo-lipid aminodiol prodrug that has been shown in preclin. and early clin. trials to be effective in suppressing various autoimmune conditions and to aid in acute organ transplant, and is currently in pivotal Phase III clin. trials for relapsing-remitting multiple sclerosis.  In this review article, we outline recent advances made in the discovery and patenting of new small-mol. S1P1 selective agonists and summarize a rapidly growing body of intellectual property.  Fingolimod-like S1P1 agonists with a novel mechanism of action have emerged as promising immunosuppressants.  S1P1 agonists induce T-cell sequestration in lymph nodes and Peyer's patches, diminishing their ability to reach distant sites and cause pathol.  Preclin. studies have already provided preliminary evidence that low-dose treatment with fingolimod in conjunction with subtherapeutic doses of cyclosporin A and tacrolimus enable potent immunosuppression in the absence of immediately serious side effects.  Future efforts will det. whether S1P1 agonists do indeed synergize with existing DMAs to create new mutidrug paradigms with superior efficacy and safety for the treatment of autoimmune diseases and the prevention of organ transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoio59l2iXb2rVg90H21EOLACvtfcHk0lg4ZVquqYaF9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ais7nK&md5=fe911f7d9d3fb961c7df50663bffc245</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.10.1141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.10.1141%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DLerner%26aufirst%3DM.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DRecent%2520progress%2520in%2520the%2520development%2520of%2520selective%2520S1P1%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520inflammatory%2520and%2520autoimmune%2520disorders%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2008%26volume%3D18%26spage%3D1141%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lescop, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span> </span><span class="NLM_article-title">Synthetic sphingosine 1-phosphate receptor modulators: opportunities and potential pitfalls</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">726</span><span class="NLM_x">–</span> <span class="NLM_lpage">757</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.2174%2F1568026611109060726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=21261590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=726-757&author=M.+H.+Bolliauthor=C.+Lescopauthor=O.+Nayler&title=Synthetic+sphingosine+1-phosphate+receptor+modulators%3A+opportunities+and+potential+pitfalls"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic sphingosine 1-phosphate receptor modulators - opportunities and potential pitfalls</span></div><div class="casAuthors">Bolli, Martin H.; Lescop, Cyrille; Nayler, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">726-757</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P) evokes a plethora of physiol. responses by stimulating members of a G protein-coupled receptor family, known as S1P receptors.  Currently five different mammalian S1P receptor subtypes, S1P1-5, each with a different cellular expression pattern, were identified.  The S1P1 receptor in particular has attracted major interest throughout the pharmaceutical industry following the breakthrough discovery that this S1P receptor subtype is critically involved in the regulation of lymphocyte trafficking through secondary lymphoid organs.  Since then, examples of synthetic S1P1 agonists with lymphocyte reducing and immunomodulating activity demonstrated efficacy in numerous preclin. models of autoimmune disease and transplantation.  Notably FTY720 (fingolimod), a pro-drug that is phosphorylated in vivo and converted into a non-selective S1P1,3,4,5 receptor agonist, has been widely used to increase the understanding of S1P1 receptor biol.  Results from recently completed phase III clin. trials using FTY720 paved the way for this non-selective S1P1 receptor agonist to become the first oral therapy in multiple sclerosis, with potential expansion into many other autoimmune diseases.  This review briefly outlines the field of S1P1 receptor biol. and summarizes recent approaches in medicinal chem. to discover potent and selective S1P1 receptor agonists.  In particular, the complexity of discovering a mol. akin to FTY720 but with an improved side-effect profile will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTTZ2jfUXEtrVg90H21EOLACvtfcHk0lg4ZVquqYaF9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSmsro%253D&md5=9f6d05909fb5615126ea642f4cc19271</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.2174%2F1568026611109060726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026611109060726%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DLescop%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26atitle%3DSynthetic%2520sphingosine%25201-phosphate%2520receptor%2520modulators%253A%2520opportunities%2520and%2520potential%2520pitfalls%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D726%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Dyckman, A. J.</span><span> </span><span class="NLM_article-title">Recent advances in the discovery and development of sphingosine-1-phosphate-1 receptor agonists</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2012&pages=195-207&author=A.+J.+Dyckman&title=Recent+advances+in+the+discovery+and+development+of+sphingosine-1-phosphate-1+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520and%2520development%2520of%2520sphingosine-1-phosphate-1%2520receptor%2520agonists%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2012%26volume%3D47%26spage%3D195%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Roberts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate receptor agonists: a patent review (2010–2012)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">841</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1517%2F13543776.2013.783022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslCks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=817-841&author=E.+Robertsauthor=M.+Guerreroauthor=M.+Urbanoauthor=H.+Rosen&title=Sphingosine+1-phosphate+receptor+agonists%3A+a+patent+review+%282010%E2%80%932012%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate receptor agonists: a patent review (2010 - 2012)</span></div><div class="casAuthors">Roberts, Edward; Guerrero, Miguel; Urbano, Mariangela; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">817-841</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The sphingosine-1-phosphate (S1P)-driven signaling regulates fundamental biol. functions, including cell proliferation, angiogenesis, endothelial cell chemotaxis, immune cell trafficking and mitogenesis.  A large body of research has been focusing on the development of immunosuppressive S1P1 receptor (S1P1-R) agonist mols.  The S1P1,3 - 5-R pan-agonist fingolimod (FTY720) has been approved by the FDA for the treatment of relapsing-remitting multiple sclerosis.  However, FTY720 is now contraindicated in patients with compromised cardiac function.  Although the main adverse effect bradycardia has been linked to the S1P3-R activation, cardiovascular liabilities persist with more selective S1P1-R agonists that have entered clin. trials.  In contrast to the S1P1-R, the therapeutic application of the S1P2 - 5-Rs remains poorly explored.  Areas covered: This review provides the patent literature from 2010 to date on S1P-R agonist mols. and their relevant biol. properties.  Expert opinion: Limited progress has been made on agonists at S1P4,5-R subtypes, with some families of S1P5-R agonists showing promising results in animal models of age-related cognitive disorders.  A discrete no. of reviewed mols. are S1P1-R agonists with a promising clin. outlook in transplantation, inflammation, cancer and autoimmune settings.  Further preclin. and clin. studies will det. whether the new developed S1P1-R agonists do indeed improve the safety profile of FTY720.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIrASpSMDS37Vg90H21EOLACvtfcHk0lg4ZVquqYaF9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslCks7o%253D&md5=405b6350b777d3040e2be21adf85d440</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.783022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.783022%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DGuerrero%26aufirst%3DM.%26aulast%3DUrbano%26aufirst%3DM.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DSphingosine%25201-phosphate%2520receptor%2520agonists%253A%2520a%2520patent%2520review%2520%25282010%25E2%2580%25932012%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D817%26epage%3D841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetzl, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moolenaar, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=265-269&author=J.+Chunauthor=E.+J.+Goetzlauthor=T.+Hlaauthor=Y.+Igarashiauthor=K.+R.+Lynchauthor=W.+Moolenaarauthor=S.+Pyneauthor=G.+Tigyi&title=International+Union+of+Pharmacology.+XXXIV.+Lysophospholipid+receptor+nomenclature"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DGoetzl%26aufirst%3DE.%2BJ.%26aulast%3DHla%26aufirst%3DT.%26aulast%3DIgarashi%26aufirst%3DY.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMoolenaar%26aufirst%3DW.%26aulast%3DPyne%26aufirst%3DS.%26aulast%3DTigyi%26aufirst%3DG.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology.%2520XXXIV.%2520Lysophospholipid%2520receptor%2520nomenclature%26jtitle%3DPharmacol.%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D265%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Meyer-zu-Heringdorf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakobs, K. H.</span><span> </span><span class="NLM_article-title">Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1768</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">940</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1768&publication_year=2006&pages=923-940&author=D.+Meyer-zu-Heringdorfauthor=K.+H.+Jakobs&title=Lysophospholipid+receptors%3A+signalling%2C+pharmacology+and+regulation+by+lysophospholipid+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer-zu-Heringdorf%26aufirst%3DD.%26aulast%3DJakobs%26aufirst%3DK.%2BH.%26atitle%3DLysophospholipid%2520receptors%253A%2520signalling%252C%2520pharmacology%2520and%2520regulation%2520by%2520lysophospholipid%2520metabolism%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2006%26volume%3D1768%26spage%3D923%26epage%3D940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.pharmthera.2007.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=17561264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntFyiur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2007&pages=84-105&author=V.+Brinkmann&title=Sphingosine+1-phosphate+receptors+in+health+and+disease%3A+mechanistic+insights+from+gene+deletion+studies+and+reverse+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology</span></div><div class="casAuthors">Brinkmann, Volker</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-105</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P) is a bioactive sphingolipid that is critically involved in the embryonic development of the cardiovascular and central nervous systems.  In the adult, S1P can produce cytoskeletal re-arrangements in many cell types to regulate immune cell trafficking, vascular homeostasis and cell communication in the central nervous system.  S1P is contained in body fluids and tissues at different concns., and excessive prodn. of the pleiotropic mediator at inflammatory sites may participate in various pathol. conditions.  Gene deletion studies and reverse pharmacol. (techniques aiming to identify both ligands and function of receptors) provided evidence that many effects of S1P are mediated via five G-protein-coupled S1P receptor subtypes, and novel therapeutic strategies based on interaction with these receptors are being initiated.  The prototype S1P receptor modulator, FTY720 (fingolimod), targets four of the five S1P receptor subtypes and may act at several levels to modulate lymphocyte trafficking via lymphocytic and endothelial S1P1 and, perhaps, other inflammatory processes through addnl. S1P receptor subtypes.  A recently completed Phase II clin. trial suggested that the drug may provide an effective treatment of relapsing-remitting multiple sclerosis.  FTY720 is currently being evaluated in larger-scale, longer-term, Phase III studies.  This review provides an overview on S1P activities and S1P receptor function in health and disease, and summarizes the clin. experience with FTY720 in transplantation and multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGbwKhZo2vLrVg90H21EOLACvtfcHk0lhrdnMl202FgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntFyiur0%253D&md5=cacdb374439270734f34a0ca4771ca3d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26atitle%3DSphingosine%25201-phosphate%2520receptors%2520in%2520health%2520and%2520disease%253A%2520mechanistic%2520insights%2520from%2520gene%2520deletion%2520studies%2520and%2520reverse%2520pharmacology%26jtitle%3DPharmacol.%2520Ther.%26date%3D2007%26volume%3D115%26spage%3D84%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Takabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paugh, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">“Inside-out” signaling of sphingosine-1-phosphate: therapeutic targets</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=181-195&author=K.+Takabeauthor=S.+W.+Paughauthor=S.+Milstienauthor=S.+Spiegel&title=%E2%80%9CInside-out%E2%80%9D+signaling+of+sphingosine-1-phosphate%3A+therapeutic+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakabe%26aufirst%3DK.%26aulast%3DPaugh%26aufirst%3DS.%2BW.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3D%25E2%2580%259CInside-out%25E2%2580%259D%2520signaling%2520of%2520sphingosine-1-phosphate%253A%2520therapeutic%2520targets%26jtitle%3DPharmacol.%2520Rev.%26date%3D2008%26volume%3D60%26spage%3D181%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span> </span><span class="NLM_article-title">Pulmonary and vascular pharmacology of sphingosine 1-phosphate</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.coph.2005.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=16563863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFynu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=244-250&author=V.+Brinkmannauthor=T.+Baumruker&title=Pulmonary+and+vascular+pharmacology+of+sphingosine+1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Pulmonary and vascular pharmacology of sphingosine 1-phosphate</span></div><div class="casAuthors">Brinkmann, Volker; Baumruker, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">244-250</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Dysregulation of vasomotor tone, endothelial barrier function and immune cell trafficking are central to the pathol. of many lung diseases, including acute lung injury, adult respiratory distress syndrome, chronic obstructive pulmonary disease and asthma.  There is increasing evidence that the serum sphingolipid sphingosine 1-phosphate and its G-protein-coupled receptors are pivotal not only in the regulation of lymphocyte migration, but also in the maintenance of vascular homeostasis and the preservation of permeability barriers that sep. discrete compartments in the lung.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogmZxjsblpVLVg90H21EOLACvtfcHk0limODqNLIsFcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFynu78%253D&md5=6e55263d754e331bcfa5d82ddc3eed7a</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2005.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2005.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBaumruker%26aufirst%3DT.%26atitle%3DPulmonary%2520and%2520vascular%2520pharmacology%2520of%2520sphingosine%25201-phosphate%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2006%26volume%3D6%26spage%3D244%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Hait, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oskeritzian, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paugh, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1758</span><span class="NLM_x">, </span> <span class="NLM_fpage">2016</span><span class="NLM_x">–</span> <span class="NLM_lpage">2026</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1758&publication_year=2006&pages=2016-2026&author=N.+C.+Haitauthor=C.+A.+Oskeritzianauthor=S.+W.+Paughauthor=S.+Milstienauthor=S.+Spiegel&title=Sphingosine+kinases%2C+sphingosine+1-phosphate%2C+apoptosis+and+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHait%26aufirst%3DN.%2BC.%26aulast%3DOskeritzian%26aufirst%3DC.%2BA.%26aulast%3DPaugh%26aufirst%3DS.%2BW.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine%2520kinases%252C%2520sphingosine%25201-phosphate%252C%2520apoptosis%2520and%2520diseases%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2006%26volume%3D1758%26spage%3D2016%26epage%3D2026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Alvarez, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Autocrine and paracrine roles of sphingosine-1-phosphate</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">300</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.tem.2007.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=17904858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGrsbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=300-307&author=S.+E.+Alvarezauthor=S.+Milstienauthor=S.+Spiegel&title=Autocrine+and+paracrine+roles+of+sphingosine-1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Autocrine and paracrine roles of sphingosine-1-phosphate</span></div><div class="casAuthors">Alvarez, Sergio E.; Milstien, Sheldon; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">300-307</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid metabolite that has been implicated in many biol. processes, including cell migration, survival, proliferation, angiogenesis and immune and allergic responses.  S1P levels inside cells are regulated tightly by the balance between its synthesis by sphingosine kinases and degrdn. by S1P lyases and S1P phosphatases.  Activation of sphingosine kinase by any of a variety of agonists increases S1P levels, which in turn can function intracellularly as a second messenger or in an autocrine and/or paracrine fashion to activate and signal through S1P receptors present on the surface of the cell.  This review summarizes recent findings on the roles of S1P as a mediator of the actions of cytokines, growth factors and hormones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnhbcsK8o6BbVg90H21EOLACvtfcHk0limODqNLIsFcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGrsbfN&md5=45c8596fc7ade7db8ad6e85bccb13bc6</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2007.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2007.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez%26aufirst%3DS.%2BE.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DAutocrine%2520and%2520paracrine%2520roles%2520of%2520sphingosine-1-phosphate%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2007%26volume%3D18%26spage%3D300%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Marsolais, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=297-307&author=D.+Marsolaisauthor=H.+Rosen&title=Chemical+modulators+of+sphingosine-1-phosphate+receptors+as+barrier-oriented+therapeutic+molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarsolais%26aufirst%3DD.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DChemical%2520modulators%2520of%2520sphingosine-1-phosphate%2520receptors%2520as%2520barrier-oriented%2520therapeutic%2520molecules%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D297%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Okada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahangeer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span> </span><span class="NLM_article-title">Sphingosine kinase/sphingosine 1-phosphate signalling in central nervous system</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.cellsig.2008.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=18694820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVeks7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=7-13&author=T.+Okadaauthor=T.+Kajimotoauthor=S.+Jahangeerauthor=S.+Nakamura&title=Sphingosine+kinase%2Fsphingosine+1-phosphate+signalling+in+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine kinase/sphingosine 1-phosphate signalling in central nervous system</span></div><div class="casAuthors">Okada, Taro; Kajimoto, Taketoshi; Jahangeer, Saleem; Nakamura, Shun-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-13</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids were once regarded as inert structural components of cell membranes.  Now these metabolites are generally believed to be important bioactive mols. that control a wide repertoire of cellular processes such as proliferation and survival of cells.  Along with these ubiquitous cell functions obsd. in many peripheral tissues sphingolipid metabolites, esp. sphingosine 1-phosphate, exert important neuron-specific functions such as regulation of neurotransmitter release.  This review summarizes physiol. and pathol. roles of sphingolipid metabolites emphasizing the role of sphingosine 1-phosphate in the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvd7-soq4atbVg90H21EOLACvtfcHk0lj6I1V_ocE__g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVeks7%252FI&md5=99538d7efb7f9866723a691e4d05f877</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2008.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2008.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DKajimoto%26aufirst%3DT.%26aulast%3DJahangeer%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DS.%26atitle%3DSphingosine%2520kinase%252Fsphingosine%25201-phosphate%2520signalling%2520in%2520central%2520nervous%2520system%26jtitle%3DCell.%2520Signalling%26date%3D2009%26volume%3D21%26spage%3D7%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gude, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate in neural signalling and function</span> <span class="citation_source-journal">Acta Paediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1111%2Fj.1651-2227.2007.00206.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A280%3ADC%252BD2s7ptVCqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=40-43&author=S.+Milstienauthor=D.+Gudeauthor=S.+Spiegel&title=Sphingosine+1-phosphate+in+neural+signalling+and+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate in neural signalling and function</span></div><div class="casAuthors">Milstien Sheldon; Gude David; Spiegel Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Acta paediatrica (Oslo, Norway : 1992). Supplement</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">455</span>),
    <span class="NLM_cas:pages">40-3</span>
        ISSN:<span class="NLM_cas:issn">0803-5326</span>.
    </div><div class="casAbstract">UNLABELLED:  Complex sphingolipids are particularly enriched in the central nervous system.  Although they were long considered to be structural components of membranes, in the last decades it has become apparent that they have other important functions.  More recently, attention has been given to the sphingolipid metabolites ceramide, sphingosine and sphingosine 1-phosphate (S1P), which have been implicated in the regulation of many aspects of neuronal proliferation, differentiation, survival and apoptosis.  Dysregulation of the relative levels of these bioactive sphingolipid metabolites may have implications for a wide array of neurodegenerative disorders and neural malformations.  In this paper, we will focus on studies from our laboratory over the past few years using cultured neurons to examine the roles of the sphingolipid metabolite S1P in neuronal survival and differentiation.  CONCLUSION:  Identification of potential intracellular targets of S1P remains a crucial objective for attaining a better understanding of the potent role this molecule plays in regulating cell fate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRizPA9-bzd8dyzdcP07UmufW6udTcc2eYtUKMFOK_IMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s7ptVCqtg%253D%253D&md5=f85adf9a8590bc956cd2e2e6de2c427a</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1111%2Fj.1651-2227.2007.00206.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1651-2227.2007.00206.x%26sid%3Dliteratum%253Aachs%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DGude%26aufirst%3DD.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine%25201-phosphate%2520in%2520neural%2520signalling%2520and%2520function%26jtitle%3DActa%2520Paediatr.%26date%3D2007%26volume%3D96%26spage%3D40%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Dev, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullershausen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilbe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mir, A.</span><span> </span><span class="NLM_article-title">Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.pharmthera.2007.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=17961662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2008&pages=77-93&author=K.+K.+Devauthor=F.+Mullershausenauthor=H.+Mattesauthor=R.+R.+Kuhnauthor=G.+Bilbeauthor=D.+Hoyerauthor=A.+Mir&title=Brain+sphingosine-1-phosphate+receptors%3A+implication+for+FTY720+in+the+treatment+of+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis</span></div><div class="casAuthors">Dev, Kumlesh K.; Mullershausen, Florian; Mattes, Henri; Kuhn, Rainer R.; Bilbe, Graeme; Hoyer, Daniel; Mir, Anis</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-93</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Multiple sclerosis (MS) is an autoimmune, neurol. disability with unknown etiol.  The current therapies available for MS work by an immunomodulatory action, preventing T-cell- and macrophage-mediated destruction of brain-resident oligodendrocytes and axonal loss.  Recently, FTY720 (fingolimod) was shown to significantly reduce relapse rates in MS patients and is currently in Phase III clin. trials.  This drug attenuates trafficking of harmful T cells entering the brain by regulating sphingosine-1-phosphate (S1P) receptors.  Here, we outline the direct roles that S1P receptors play in the central nervous system (CNS) and discuss addnl. modalities by which FTY720 may provide direct neuroprotection in MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYlyd4S2EeELVg90H21EOLACvtfcHk0lj6I1V_ocE__g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtL3J&md5=d5cf04a35f8bb06f3e094d2e75c698c0</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DDev%26aufirst%3DK.%2BK.%26aulast%3DMullershausen%26aufirst%3DF.%26aulast%3DMattes%26aufirst%3DH.%26aulast%3DKuhn%26aufirst%3DR.%2BR.%26aulast%3DBilbe%26aufirst%3DG.%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DMir%26aufirst%3DA.%26atitle%3DBrain%2520sphingosine-1-phosphate%2520receptors%253A%2520implication%2520for%2520FTY720%2520in%2520the%2520treatment%2520of%2520multiple%2520sclerosis%26jtitle%3DPharmacol.%2520Ther.%26date%3D2008%26volume%3D117%26spage%3D77%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Uhlig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulbins, E.</span><span> </span><span class="NLM_article-title">Sphingolipids in the lungs</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">1100</span><span class="NLM_x">–</span> <span class="NLM_lpage">1114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1164%2Frccm.200804-595SO" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=18755926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvVentA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2008&pages=1100-1114&author=S.+Uhligauthor=E.+Gulbins&title=Sphingolipids+in+the+lungs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipids in the lungs</span></div><div class="casAuthors">Uhlig, Stefan; Gulbins, Erich</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1100-1114</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">A review.  Sphingolipids such as sphingosine-1-phosphate (S1P), ceramide, or sphingomyelin are essential constituents of plasma membranes and regulate many (patho)physiol. cellular responses inducing apoptosis and cell survival, vascular permeability, mast cell activation, and airway smooth muscle functions.  The complexity of sphingolipid biol. is generated by a great variety of compds., diverse receptors, and often antagonistic functions of different sphingolipids.  For instance, apoptosis is promoted by ceramide and prevented by S1P, and pulmonary vascular permeability is increased by S1P2/3 receptors and by ceramide, whereas S1P1 receptors stabilize barrier integrity.  Several enzymes of the sphingolipid metab. respond to external stimuli such as sphingomyelinase isoenzymes that are activated by many stress stimuli and the sphingosine kinase isoenzymes that are activated by allergens.  The past years have provided increasing evidence that these processes contribute to pulmonary disorders including asthma, chronic obstructive pulmonary disease, acute lung injury, and cystic fibrosis.  Sphingolipid metab. offers several novel therapeutic targets for the treatment of lung diseases such as emphysema, asthma, cystic fibrosis, respiratory tract infection, sepsis, and acute lung injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1c1qpC7wtVLVg90H21EOLACvtfcHk0lgcnOGrvfQKtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvVentA%253D%253D&md5=b10c3ec2970d660c9f4acd57657ae380</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1164%2Frccm.200804-595SO&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200804-595SO%26sid%3Dliteratum%253Aachs%26aulast%3DUhlig%26aufirst%3DS.%26aulast%3DGulbins%26aufirst%3DE.%26atitle%3DSphingolipids%2520in%2520the%2520lungs%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2008%26volume%3D178%26spage%3D1100%26epage%3D1114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Augé, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nègre-Salvayre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvayre, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levade, T.</span><span> </span><span class="NLM_article-title">Sphingomyelin metabolites in vascular cell signaling and atherogenesis</span> <span class="citation_source-journal">Prog. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2FS0163-7827%2800%2900007-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=10799716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktlSqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=207-229&author=N.+Aug%C3%A9author=A.+N%C3%A8gre-Salvayreauthor=R.+Salvayreauthor=T.+Levade&title=Sphingomyelin+metabolites+in+vascular+cell+signaling+and+atherogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingomyelin metabolites in vascular cell signaling and atherogenesis</span></div><div class="casAuthors">Auge, Nathalie; Negre-Salvayre, Anne; Salvayre, Robert; Levade, Thierry</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Lipid Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-229</span>CODEN:
                <span class="NLM_cas:coden">PLIRDW</span>;
        ISSN:<span class="NLM_cas:issn">0163-7827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with 186 refs.  The atherosclerotic lesion most probably develops through a no. of cellular events which implicate all vascular cell types and include synthesis of extracellular proteins, cell proliferation, differentiation and death.  Sphingolipids and sphingolipid metabolizing enzymes may play important roles in atherogenesis, not only because of lipoprotein alterations but also by mediating a no. of cellular events which are believed to be crucial in the development of the vascular lesions such as proliferation or cell death.  Exogenous sphingolipids may mediate various biol. effects such as apoptosis, mitogenesis or differentiation depending on the cell type.  Moreover, several mols. present in the atherogenic lesion, such as oxidized LDL, growth factors or cytokines, which activate intracellular signaling pathways leading to vascular cell modifications, can stimulate sphingomyelin hydrolysis and generation of ceramide (and other metabolites as sphingosine-1-phosphate).  Here we review the potential implication of the sphingomyelin/ceramide cycle in vascular cell signaling related to atherosclerosis, and more generally the role of sphingolipids in the events obsd. during the atherosclerotic process as cell differentiation, migration, adhesion, retraction, proliferation and death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR0eHtIWIEnrVg90H21EOLACvtfcHk0lgcnOGrvfQKtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktlSqsbs%253D&md5=bc3809c124061cac95443445af340377</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS0163-7827%2800%2900007-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7827%252800%252900007-2%26sid%3Dliteratum%253Aachs%26aulast%3DAug%25C3%25A9%26aufirst%3DN.%26aulast%3DN%25C3%25A8gre-Salvayre%26aufirst%3DA.%26aulast%3DSalvayre%26aufirst%3DR.%26aulast%3DLevade%26aufirst%3DT.%26atitle%3DSphingomyelin%2520metabolites%2520in%2520vascular%2520cell%2520signaling%2520and%2520atherogenesis%26jtitle%3DProg.%2520Lipid%2520Res.%26date%3D2000%26volume%3D39%26spage%3D207%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Alewijnse, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, S. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, M. C.</span><span> </span><span class="NLM_article-title">Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1038%2Fsj.bjp.0705934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=15504747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOitrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2004&pages=666-684&author=A.+E.+Alewijnseauthor=S.+L.+M.+Petersauthor=M.+C.+Michel&title=Cardiovascular+effects+of+sphingosine-1-phosphate+and+other+sphingomyelin+metabolites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites</span></div><div class="casAuthors">Alewijnse, Astrid E.; Peters, Stephan L. M.; Michel, Martin C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">666-684</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Upon various stimuli, cells metabolize sphingomyelin from the cellular plasma membrane to form sphingosylphosphorylcholine (SPC) or ceramide.  The latter can be further metabolized to sphingosine and then sphingosine-1-phosphate (S1P).  Apart from local formation, S1P and SPC are major constituents of blood plasma.  All four sphingomyelin metabolites (SMM) can act upon intracellular targets, and at least S1P and probably also SPC can addnl. act upon G-protein-coupled receptors.  While the mol. identity of the SPC receptors remains unclear, several subtypes of S1P receptors have been cloned and their distribution in cardiovascular tissues is described.  In the heart SMM can alter intracellular Ca2+ release, particularly via the ryanodine receptor, and conductance of various ion channels in the plasma membrane, particularly IK(Ach).  While the various SMM differ somewhat in their effects, the above alterations of ion homeostasis result in reduced cardiac function in most cases, and ceramide and/or sphingosine may be the mediators of the neg. inotropic effects of tumor necrosis factor.  In the vasculature, SMM mainly act as acute vasoconstrictors in most vessels, but ceramide can be a vasodilator.  SMM-induced vasoconstriction involves mobilization of Ca2+ from intracellular stores, influx of extracellular Ca2+ via L-type channels and activation of a rho-kinase.  Extended exposure to SMM, particularly S1P, promotes several stages of the angiogenic process like endothelial cell activation, migration, proliferation, tube formation and vascular maturation.  The authors propose that SMM are an important class of endogenous modulators of cardiovascular function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm47o1k_ITeLVg90H21EOLACvtfcHk0lgcnOGrvfQKtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOitrrN&md5=b1f804471e653a56ad6794fd5092803f</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0705934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0705934%26sid%3Dliteratum%253Aachs%26aulast%3DAlewijnse%26aufirst%3DA.%2BE.%26aulast%3DPeters%26aufirst%3DS.%2BL.%2BM.%26aulast%3DMichel%26aufirst%3DM.%2BC.%26atitle%3DCardiovascular%2520effects%2520of%2520sphingosine-1-phosphate%2520and%2520other%2520sphingomyelin%2520metabolites%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D143%26spage%3D666%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Yatomi, Y.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular disease</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">575</span><span class="NLM_x">–</span> <span class="NLM_lpage">587</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.2174%2F138161206775474404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=16472149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVGqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=575-587&author=Y.+Yatomi&title=Sphingosine+1-phosphate+in+vascular+biology%3A+possible+therapeutic+strategies+to+control+vascular+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases</span></div><div class="casAuthors">Yatomi, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">575-587</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Blood platelets are very unique in that they store sphingosine 1-phosphate (Sph-1-P) abundantly (possibly due to the existence of highly active sphingosine kinase and a lack of Sph-1-P lyase) and release this bioactive lipid extracellularly upon stimulation.  Vascular endothelial cells (ECs) and smooth muscle cells (SMCs) respond dramatically to this platelet-derived bioactive lipid mainly through a family of G protein-coupled Sph-1-P receptors named S1P1, 2, 3, 4, and 5, originally referred to as EDG-1, 5, 3, 6, and 8, resp.  In fact, the importance of Sph-1-P in platelet-vascular cell interactions has been revealed in a no. of recent reports.  Through interaction with ECs, Sph-1-P can mediate physiol. wound healing processes such as vascular repair, although this important bioactive lipid can become atherogenic and thrombogenic, and cause or aggravate cardiovascular diseases esp. under certain pathol. conditions.  Sph-1-P induces vasoconstriction through interaction with SMCs.  It is likely that regulation of Sph-1-P biol. activities is important for the therapeutical purpose to control vascular disorders.  Particularly, the development of specific S1P receptor agonists or antagonists seems a reasonable strategy to selectively regulate the bioactivity of Sph-1-P, considering that a great diversity of Sph-1-P actions has been reported and that this diversity depends mainly on the S1P receptor subtype involved.  In this review, I will summarize recent findings on possible roles of Sph-1-P in vascular biol. and its therapeutical implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTzHZO1dz1pLVg90H21EOLACvtfcHk0lhvOv0BNfNmOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVGqsrc%253D&md5=8aaf620c15964f6b5a4db05df0f9c042</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.2174%2F138161206775474404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206775474404%26sid%3Dliteratum%253Aachs%26aulast%3DYatomi%26aufirst%3DY.%26atitle%3DSphingosine%25201-phosphate%2520in%2520vascular%2520biology%253A%2520possible%2520therapeutic%2520strategies%2520to%2520control%2520vascular%2520disease%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D575%26epage%3D587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahalan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.</span><span> </span><span class="NLM_article-title">Tipping the gatekeeper: S1P regulation of endothelial barrier function</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.it.2007.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=17276731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1GrtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=102-107&author=H.+Rosenauthor=M.+G.+Sannaauthor=S.+M.+Cahalanauthor=P.+J.+Gonzalez-Cabrera&title=Tipping+the+gatekeeper%3A+S1P+regulation+of+endothelial+barrier+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Tipping the gatekeeper: S1P regulation of endothelial barrier function</span></div><div class="casAuthors">Rosen, Hugh; Sanna, M. Germana; Cahalan, Stuart M.; Gonzalez-Cabrera, Pedro J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">102-107</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The lysophospholipid sphingosine 1-phosphate (S1P) is a pleiotropic signaling lipid present constitutively in plasma, and secreted locally at elevated concns. at sites of inflammation.  S1P maintains essential variable homeostatic functions in addn. to inducing pathophysiol. through the activation of five specific high-affinity G-protein-coupled receptors.  Therefore, S1P can function as an extracellular rheostat regulating tonic and acutely evoked functions.  Although S1P receptors can regulate lymphoid development and lymphocyte trafficking, and different opinions exist on the roles of receptor agonism and functional antagonism in regulating lymphocyte recirculation, this personal perspective highlights the pivotal control points regulated by constitutive and induced S1P receptor tone at vascular endothelial and lymphatic endothelial barriers, through which S1P agonism impacts on both innate and adaptive immunity.  The authors also emphasize how specific, proof-of-concept chem. tools complement genetic approaches by enabling reversible perturbation of the S1P-S1P1 receptor axis and, thus, clarifying in vivo mechanisms in the absence of developmental compensations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR5AFhhSUSlLVg90H21EOLACvtfcHk0lhvOv0BNfNmOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1GrtL4%253D&md5=2ccb920fd60591f904189b7e69597a99</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2007.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2007.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DCahalan%26aufirst%3DS.%2BM.%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26atitle%3DTipping%2520the%2520gatekeeper%253A%2520S1P%2520regulation%2520of%2520endothelial%2520barrier%2520function%26jtitle%3DTrends%2520Immunol.%26date%3D2007%26volume%3D28%26spage%3D102%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Michel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulders, A. C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jongsma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alewijnse, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, S. L. M.</span><span> </span><span class="NLM_article-title">Vascular effects of sphingolipids</span> <span class="citation_source-journal">Acta Paediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1111%2Fj.1651-2227.2007.00036.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=17187602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A280%3ADC%252BD2s7ptVCqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=44-48&author=M.+C.+Michelauthor=A.+C.+M.+Muldersauthor=M.+Jongsmaauthor=A.+E.+Alewijnseauthor=S.+L.+M.+Peters&title=Vascular+effects+of+sphingolipids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular effects of sphingolipids</span></div><div class="casAuthors">Michel Martin C; Mulders Arthur C M; Jongsma Maikel; Alewijnse Astrid E; Peters Stephan L M</div><div class="citationInfo"><span class="NLM_cas:title">Acta paediatrica (Oslo, Norway : 1992). Supplement</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">455</span>),
    <span class="NLM_cas:pages">44-8</span>
        ISSN:<span class="NLM_cas:issn">0803-5326</span>.
    </div><div class="casAbstract">UNLABELLED:  The sphingomyelin metabolites ceramide, sphingosine 1-phosphate (S1P) and sphingosylphosphorylcholine (SPC) are emerging modulators of vascular tone.  While ceramide appears to act primarily intracellularly, S1P and SPC appear to mainly work via specific receptors, although those for SPC have not yet been defined unequivocally.  Each of the sphingomyelin metabolites can induce both vasoconstriction and vasodilatation and, in some cases--ceramide on the one hand, and S1P and SPC on the other hand--have opposite effects on vascular tone.  The differences in effects between vessels may relate to the relative roles of endothelial and smooth muscle cells in mediating them, as well as to the distinct expression patterns of S1P receptors among vascular beds and among endothelial and smooth muscle cells.  Recent evidence suggests that vascular tone is not only modulated by sphingomyelin metabolites which are exogenously added or reach the vessel wall via the bloodstream but also by those formed locally by cells in the vessel wall.  Such local formation can be induced by known vasoactive agents such as angiotensin II and may serve a signalling function.  CONCLUSION:  We conclude that sphingomyelin metabolites are important endogenous modulators of vascular function, which may contribute to the pathophysiology of some diseases and be targets for therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRizPA9-bzd8XthwrmtH4OBfW6udTcc2eaSt2uUp4Ak57ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s7ptVCqtw%253D%253D&md5=a17c857de85079a74c4413b418953097</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1111%2Fj.1651-2227.2007.00036.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1651-2227.2007.00036.x%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DM.%2BC.%26aulast%3DMulders%26aufirst%3DA.%2BC.%2BM.%26aulast%3DJongsma%26aufirst%3DM.%26aulast%3DAlewijnse%26aufirst%3DA.%2BE.%26aulast%3DPeters%26aufirst%3DS.%2BL.%2BM.%26atitle%3DVascular%2520effects%2520of%2520sphingolipids%26jtitle%3DActa%2520Paediatr.%26date%3D2007%26volume%3D96%26spage%3D44%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetzl, E. J.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1038%2Fnri1650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=15999095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsl2itr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=560-570&author=H.+Rosenauthor=E.+J.+Goetzl&title=Sphingosine+1-phosphate+and+its+receptors%3A+an+autocrine+and+paracrine+network"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network</span></div><div class="casAuthors">Rosen, Hugh; Goetzl, Edward J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">560-570</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P) is a biol. active lysophospholipid that transmits signals through a family of G-protein-coupled receptors to control cellular differentiation and survival, as well as the vital functions of several types of immune cell.  In this Review article, the authors discuss recent results that indicate that S1P and its receptors are required for the emigration of thymocytes from the thymus, the trafficking of lymphocytes in secondary lymphoid organs and the migration of B cells into splenic follicles.  In an autocrine manner, through interactions with different G-protein-coupled receptors, S1P also enhances optimal mast-cell migration and release of pro-inflammatory mediators in allergic reactions.  S1P-S1P-receptor regulatory systems might therefore be novel targets for the therapy of diverse immunol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6-Zo0R14YILVg90H21EOLACvtfcHk0lhD9E0haMUNIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsl2itr4%253D&md5=b680f6c9e29d407579ab7f056209d853</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fnri1650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1650%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DGoetzl%26aufirst%3DE.%2BJ.%26atitle%3DSphingosine%25201-phosphate%2520and%2520its%2520receptors%253A%2520an%2520autocrine%2520and%2520paracrine%2520network%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2005%26volume%3D5%26spage%3D560%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Oskeritzian, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate in allergic responses, asthma and anaphylaxis</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.pharmthera.2007.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=17669501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWhsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2007&pages=390-399&author=C.+A.+Oskeritzianauthor=S.+Milstienauthor=S.+Spiegel&title=Sphingosine-1-phosphate+in+allergic+responses%2C+asthma+and+anaphylaxis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate in allergic responses, asthma and anaphylaxis</span></div><div class="casAuthors">Oskeritzian, Carole A.; Milstien, Sheldon; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">390-399</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid metabolite involved in many cellular processes, acting not only as an extracellular ligand to its specific G protein-coupled receptors, but also as a putative intracellular messenger with yet unidentified targets.  Mast cells are tissue-dwelling pivotal early effectors of allergic responses, which produce and secrete S1P that can bind to its receptors present on mast cells to influence their activation and functions.  In this review, we will first discuss the current knowledge of S1P prodn. by two isoenzymes of sphingosine kinase (SphK).  Mechanisms of SphK activation will be discussed, with an emphasis on exptl. approaches developed to study their differential activation and biol. roles in the context of mast cells.  The relevance of mast cells in the etiol. of allergic disorders, asthma and anaphylaxis is well established.  In this review, this concept will be revisited, focusing on the contribution of S1P prodn. and secretion to the symptoms assocd. with dysregulated inflammatory responses.  To conclude, counteracting the proinflammatory effects of S1P could be envisioned as a therapeutic strategy to treat allergic disorders, exacerbated airway inflammation, and anaphylactic reactions, and various options will be discussed, such as the development of pharmacol. tools to inhibit SphKs, S1P neutralizing monoclonal antibody, and S1P receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU658KZB9wzbVg90H21EOLACvtfcHk0lhD9E0haMUNIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWhsLfL&md5=6ca77f4bc8322527e1d6ad3db24b6244</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DOskeritzian%26aufirst%3DC.%2BA.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine-1-phosphate%2520in%2520allergic%2520responses%252C%2520asthma%2520and%2520anaphylaxis%26jtitle%3DPharmacol.%2520Ther.%26date%3D2007%26volume%3D115%26spage%3D390%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Rivera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivera, A.</span><span> </span><span class="NLM_article-title">The alliance of sphingosine-1-phosphate and its receptors in immunity</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">753</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1038%2Fnri2400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=18787560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFKkur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=753-763&author=J.+Riveraauthor=R.+L.+Proiaauthor=A.+Olivera&title=The+alliance+of+sphingosine-1-phosphate+and+its+receptors+in+immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The alliance of sphingosine-1-phosphate and its receptors in immunity</span></div><div class="casAuthors">Rivera, Juan; Proia, Richard L.; Olivera, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">753-763</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Sphingosine-1-phosphate (S1P) is a biol. active metabolite of plasma membrane sphingolipids that is essential for immune cell trafficking.  Its concn. is increased in many inflammatory conditions, such as asthma and autoimmunity.  Much of the immune function of S1P results from the engagement of a family of G-protein-coupled receptors (S1PR1-S1PR5).  Recent findings on the role of S1P in immunosurveillance, the discovery of regulatory mechanisms in S1P-mediated immune-cell trafficking and new advances in understanding the mechanism by which S1P affects immune-cell function indicate that the alliance between S1P and its receptors has a fundamental role in immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogShP9St3JD7Vg90H21EOLACvtfcHk0lgny5cIb-BpiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFKkur%252FI&md5=27e4cbfcd2f91fb1ff9cab462f0e44b7</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1038%2Fnri2400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2400%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DOlivera%26aufirst%3DA.%26atitle%3DThe%2520alliance%2520of%2520sphingosine-1-phosphate%2520and%2520its%2520receptors%2520in%2520immunity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2008%26volume%3D8%26spage%3D753%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Ishii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klauschen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier-Schellersheim, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, R. N.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">458</span><span class="NLM_x">, </span> <span class="NLM_fpage">524</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=524-528&author=M.+Ishiiauthor=J.+G.+Egenauthor=F.+Klauschenauthor=M.+Meier-Schellersheimauthor=Y.+Saekiauthor=J.+Vacherauthor=R.+L.+Proiaauthor=R.+N.+Germain&title=Sphingosine-1-phosphate+mobilizes+osteoclast+precursors+and+regulates+bone+homeostasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshii%26aufirst%3DM.%26aulast%3DEgen%26aufirst%3DJ.%2BG.%26aulast%3DKlauschen%26aufirst%3DF.%26aulast%3DMeier-Schellersheim%26aufirst%3DM.%26aulast%3DSaeki%26aufirst%3DY.%26aulast%3DVacher%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DGermain%26aufirst%3DR.%2BN.%26atitle%3DSphingosine-1-phosphate%2520mobilizes%2520osteoclast%2520precursors%2520and%2520regulates%2520bone%2520homeostasis%26jtitle%3DNature%26date%3D2009%26volume%3D458%26spage%3D524%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Alewijnse, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, S. L. M.</span><span> </span><span class="NLM_article-title">Sphingolipid signalling in the cardiovascular system: good, bad or both?</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">585</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.ejphar.2008.02.089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=18420192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD1cXls1Snt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=585&publication_year=2008&pages=292-302&author=A.+E.+Alewijnseauthor=S.+L.+M.+Peters&title=Sphingolipid+signalling+in+the+cardiovascular+system%3A+good%2C+bad+or+both%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingolipid signalling in the cardiovascular system: Good, bad or both?</span></div><div class="casAuthors">Alewijnse, Astrid E.; Peters, Stephan L. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">585</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">292-302</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Sphingolipids are biol. active lipids that play important roles in various cellular processes and the sphingomyelin metabolites ceramide, sphingosine and sphingosine-1-phosphate can act as signaling mols. in most cell types.  With the recent development of the immunosuppressant drug FTY720 (Fingolimod) which after phosphorylation in vivo acts as a sphingosine-1-phosphate receptor agonist, research on the role of sphingolipids in the immune and other organ systems was triggered enormously.  Since it was reported that FTY720 induced a modest, but significant transient decrease in heart rate in animals and humans, the question was raised which pharmacol. properties of drugs targeting sphingolipid signaling will affect cardiovascular function in vivo.  The answer to this question will most likely also indicate what type of drug could be used to treat cardiovascular disease.  The latter is becoming increasingly important because of the increasing population carrying characteristics of the metabolic syndrome.  This syndrome is, amongst others, characterized by obesity, hypertension, atherosclerosis and diabetes.  As such, individuals with this syndrome are at increased risk of heart disease.  Now numerous studies have investigated sphingolipid effects in the cardiovascular system, can we speculate whether certain sphingolipids under specific conditions are good, bad or maybe both.  In this review we will give a brief overview of the pathophysiol. role of sphingolipids in cardiovascular disease.  In addn., we will try to answer how drugs that target sphingolipid signaling will potentially influence cardiovascular function and whether these drugs would be useful to treat cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCrn1VPopZK7Vg90H21EOLACvtfcHk0lgny5cIb-BpiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXls1Snt74%253D&md5=259b21af9aa684253974c6772861c859</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.02.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.02.089%26sid%3Dliteratum%253Aachs%26aulast%3DAlewijnse%26aufirst%3DA.%2BE.%26aulast%3DPeters%26aufirst%3DS.%2BL.%2BM.%26atitle%3DSphingolipid%2520signalling%2520in%2520the%2520cardiovascular%2520system%253A%2520good%252C%2520bad%2520or%2520both%253F%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D585%26spage%3D292%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Chi, H.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate and immune regulation: trafficking and beyond</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2010&pages=16-24&author=H.+Chi&title=Sphingosine-1-phosphate+and+immune+regulation%3A+trafficking+and+beyond"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChi%26aufirst%3DH.%26atitle%3DSphingosine-1-phosphate%2520and%2520immune%2520regulation%253A%2520trafficking%2520and%2520beyond%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2010%26volume%3D32%26spage%3D16%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Pyne, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate and cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">503</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1038%2Fnrc2875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=20555359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsFKis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=489-503&author=N.+J.+Pyneauthor=S.+Pyne&title=Sphingosine+1-phosphate+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate and cancer</span></div><div class="casAuthors">Pyne, Nigel J.; Pyne, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">489-503</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is substantial evidence that sphingosine 1-phosphate (S1P) is involved in cancer.  S1P regulates processes such as inflammation, which can drive tumorigenesis; neovascularization, which provides cancer cells with nutrients and oxygen; and cell growth and survival.  This occurs at multiple levels and involves S1P receptors, sphingosine kinases, S1P phosphatases and S1P lyase.  This Review summarizes current research findings and examines the potential for new therapeutics designed to alter S1P signalling and function in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopcjXMo4lyC7Vg90H21EOLACvtfcHk0liNjLffHMI66Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsFKis7s%253D&md5=b6963178dfee638d875f652546d009bc</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1038%2Fnrc2875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2875%26sid%3Dliteratum%253Aachs%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DPyne%26aufirst%3DS.%26atitle%3DSphingosine%25201-phosphate%2520and%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D489%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Maceyka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harikumar, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate signaling and its role in disease</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.tcb.2011.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=22001186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Wguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=50-60&author=M.+Maceykaauthor=K.+B.+Harikumarauthor=S.+Milstienauthor=S.+Spiegel&title=Sphingosine-1-phosphate+signaling+and+its+role+in+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate signaling and its role in disease</span></div><div class="casAuthors">Maceyka, Michael; Harikumar, Kuzhuvelil B.; Milstien, Sheldon; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-60</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The bioactive sphingolipid metabolite sphingosine-1-phosphate (S1P) is now recognized as a crit. regulator of many physiol. and pathophysiol. processes, including cancer, atherosclerosis, diabetes and osteoporosis.  S1P is produced in cells by two sphingosine kinase isoenzymes, SphK1 and SphK2.  Many cells secrete S1P, which can then act in an autocrine or paracrine manner.  Most of the known actions of S1P are mediated by a family of five specific G protein-coupled receptors.  More recently, it was shown that S1P also has important intracellular targets involved in inflammation, cancer and Alzheimer's disease.  This suggests that S1P actions are much more complex than previously thought, with important ramifications for development of therapeutics.  This review highlights recent advances in our understanding of the mechanisms of action of S1P and its roles in disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0UHcgnAzcArVg90H21EOLACvtfcHk0liNjLffHMI66Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Wguw%253D%253D&md5=93baaa54059ffec593c9e0092716f02e</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2011.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2011.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DMaceyka%26aufirst%3DM.%26aulast%3DHarikumar%26aufirst%3DK.%2BB.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine-1-phosphate%2520signaling%2520and%2520its%2520role%2520in%2520disease%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2012%26volume%3D22%26spage%3D50%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abo-Elmatty, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jahangeer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.-i.</span><span> </span><span class="NLM_article-title">Roles of extracellular and intracellular sphingosine 1-phosphate in cell migration</span> <span class="citation_source-journal">Genes Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">605</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1111%2Fj.1365-2443.2009.01295.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=19371379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvVCmu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=597-605&author=H.+Yuauthor=T.+Okadaauthor=M.+Kobayashiauthor=D.+M.+Abo-Elmattyauthor=S.+Jahangeerauthor=S.-i.+Nakamura&title=Roles+of+extracellular+and+intracellular+sphingosine+1-phosphate+in+cell+migration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of extracellular and intracellular sphingosine 1-phosphate in cell migration</span></div><div class="casAuthors">Yu, Huan; Okada, Taro; Kobayashi, Masako; Abo-Elmatty, Dina M.; Jahangeer, Saleem; Nakamura, Shun-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">597-605</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1356-9597</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is an important factor for the regulation of cell motility acting both inside and outside the cells.  The precise role of S1P in the control of cell motility, however, remains unclear.  Here, the authors describe the roles of S1P in the regulation of cell motility by dissecting them into intracellular and extracellular actions using a liposomal S1P transfer technique.  In a Boyden chamber assay, free S1P enhanced directional cell movement, whereas liposomal S1P induced nondirectional cell movement.  Furthermore, inhibition of sphingosine kinase (SphK) 1 by several inhibitors or knockdown of enzyme expression by siRNA caused reduced wound-faced cell polarity formation as assessed by wound-healing assay.  Moreover, S1P-induced cell migration was strongly inhibited by SphK inhibitors.  These results indicate that extracellular S1P acting through S1P receptors facilitates the formation of cell polarity, whereas S1P generated inside the cells functions as an intracellular mediator per se to enhance nondirectional cell movement; thus, S1P enhances directional cell movement in a coordinated fashion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCREjEQK0WA7Vg90H21EOLACvtfcHk0liNjLffHMI66Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvVCmu74%253D&md5=dbc65bd3f677f7a8aaee4906a7dd41af</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2443.2009.01295.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2443.2009.01295.x%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DAbo-Elmatty%26aufirst%3DD.%2BM.%26aulast%3DJahangeer%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DS.-i.%26atitle%3DRoles%2520of%2520extracellular%2520and%2520intracellular%2520sphingosine%25201-phosphate%2520in%2520cell%2520migration%26jtitle%3DGenes%2520Cells%26date%3D2009%26volume%3D14%26spage%3D597%26epage%3D605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1205</span><span class="NLM_x">–</span> <span class="NLM_lpage">1213</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.jhep.2010.08.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=21145832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVygsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1205-1213&author=C.+Liauthor=S.+Zhengauthor=H.+Youauthor=X.+Liuauthor=M.+Linauthor=L.+Yangauthor=L.+Li&title=Sphingosine+1-phosphate+%28S1P%29%2FS1P+receptors+are+involved+in+human+liver+fibrosis+by+action+on+hepatic+myofibroblasts+motility"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility</span></div><div class="casAuthors">Li, Changyong; Zheng, Sujun; You, Hong; Liu, Xihong; Lin, Minghua; Yang, Lin; Li, Liying</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1205-1213</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Directed migration of hepatic myofibroblasts (hMFs) contributes to the development of liver fibrosis.  However, the signals regulating the motility of these cells are incompletely understood.  We have recently shown that sphingosine 1-phosphate (S1P) and S1P receptors (S1PRs) are involved in mouse liver fibrogenesis.  Here, we investigated the role of S1P/S1PRs signals in human liver fibrosis involving motility of human hMFs.  S1P level in the liver was examd. by high-performance liq. chromatog.  Expression of S1PRs was characterized, in biopsy specimens of human liver and cultured hMFs, by immunofluorescence and real-time RT-PCR or Western blot anal.  Cell migration was detd. in Boyden chambers, by using the selective S1P receptor agonist or antagonist and silencing of S1PRs expression with small interfering RNA.  S1P level in the human fibrotic liver was increased through up-regulation of sphingosine kinase (SphK), irresp. of the etiol. of fibrosis.  S1P receptors type 1, 2, and 3 (S1P1,2,3) were expressed in human hMFs in vivo and in vitro.  Interestingly, S1P1,3 were strongly induced in human fibrotic samples, whereas expression of S1P2 was massively decreased.  S1P exerted a powerful migratory action on human hMFs.  Furthermore, the effect of S1P was mimicked by SEW2871 (an S1P1 agonist), and blocked by suramin (an S1P3 antagonist) and by silencing S1P1,3 expression.  In contrast, JTE-013 (an S1P2 antagonist) and silencing of S1P2 expression enhanced S1P-induced migration.  SphK/S1P/S1PRs signaling axis plays an important role in human liver fibrosis and is involved in the directed migration of human hMFs into the damaged areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5zOBiC9Y4Q7Vg90H21EOLACvtfcHk0lhX7zDS2r6HSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVygsbw%253D&md5=83e7b15dda5c6a643fa234882cfa060b</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2010.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2010.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DYou%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%26atitle%3DSphingosine%25201-phosphate%2520%2528S1P%2529%252FS1P%2520receptors%2520are%2520involved%2520in%2520human%2520liver%2520fibrosis%2520by%2520action%2520on%2520hepatic%2520myofibroblasts%2520motility%26jtitle%3DJ.%2520Hepatol.%26date%3D2011%26volume%3D54%26spage%3D1205%26epage%3D1213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreier, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">Expression of the sphingosine 1-phosphate receptor, S1P<sub>1</sub>, on T-cells controls thymic emigration</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">15396</span><span class="NLM_x">–</span> <span class="NLM_lpage">15401</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=15396-15401&author=M.+L.+Allendeauthor=J.+L.+Dreierauthor=S.+Mandalaauthor=R.+L.+Proia&title=Expression+of+the+sphingosine+1-phosphate+receptor%2C+S1P1%2C+on+T-cells+controls+thymic+emigration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DDreier%26aufirst%3DJ.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DExpression%2520of%2520the%2520sphingosine%25201-phosphate%2520receptor%252C%2520S1P1%252C%2520on%2520T-cells%2520controls%2520thymic%2520emigration%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D15396%26epage%3D15401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Weigert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruene, B.</span><span> </span><span class="NLM_article-title">Regulation of macrophage function by sphinosine-1-phosphate</span> <span class="citation_source-journal">Immunobiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">214</span><span class="NLM_x">, </span> <span class="NLM_fpage">748</span><span class="NLM_x">–</span> <span class="NLM_lpage">760</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=2009&pages=748-760&author=A.+Weigertauthor=N.+Weisauthor=B.+Bruene&title=Regulation+of+macrophage+function+by+sphinosine-1-phosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeigert%26aufirst%3DA.%26aulast%3DWeis%26aufirst%3DN.%26aulast%3DBruene%26aufirst%3DB.%26atitle%3DRegulation%2520of%2520macrophage%2520function%2520by%2520sphinosine-1-phosphate%26jtitle%3DImmunobiology%26date%3D2009%26volume%3D214%26spage%3D748%26epage%3D760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuymetova, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonifacino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">S1P1 receptor directs the release of immature B cells from bone marrow into blood</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">207</span><span class="NLM_x">, </span> <span class="NLM_fpage">1113</span><span class="NLM_x">–</span> <span class="NLM_lpage">1124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2010&pages=1113-1124&author=M.+L.+Allendeauthor=G.+Tuymetovaauthor=B.+G.+Leeauthor=E.+Bonifacinoauthor=Y.-P.+Wuauthor=R.+L.+Proia&title=S1P1+receptor+directs+the+release+of+immature+B+cells+from+bone+marrow+into+blood"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DTuymetova%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DB.%2BG.%26aulast%3DBonifacino%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DY.-P.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DS1P1%2520receptor%2520directs%2520the%2520release%2520of%2520immature%2520B%2520cells%2520from%2520bone%2520marrow%2520into%2520blood%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2010%26volume%3D207%26spage%3D1113%26epage%3D1124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Rathinasamy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czeloth, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pabst, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Förster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernhardt, G.</span><span> </span><span class="NLM_article-title">The origin and maturity of dendritic cells determine the pattern of sphingosine 1-phosphate receptors expressed and required for efficient migration</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">4072</span><span class="NLM_x">–</span> <span class="NLM_lpage">4081</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2010&pages=4072-4081&author=A.+Rathinasamyauthor=N.+Czelothauthor=O.+Pabstauthor=R.+F%C3%B6rsterauthor=G.+Bernhardt&title=The+origin+and+maturity+of+dendritic+cells+determine+the+pattern+of+sphingosine+1-phosphate+receptors+expressed+and+required+for+efficient+migration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRathinasamy%26aufirst%3DA.%26aulast%3DCzeloth%26aufirst%3DN.%26aulast%3DPabst%26aufirst%3DO.%26aulast%3DF%25C3%25B6rster%26aufirst%3DR.%26aulast%3DBernhardt%26aufirst%3DG.%26atitle%3DThe%2520origin%2520and%2520maturity%2520of%2520dendritic%2520cells%2520determine%2520the%2520pattern%2520of%2520sphingosine%25201-phosphate%2520receptors%2520expressed%2520and%2520required%2520for%2520efficient%2520migration%26jtitle%3DJ.%2520Immunol.%26date%3D2010%26volume%3D185%26spage%3D4072%26epage%3D4081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Cyster, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwab, S. R.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1146%2Fannurev-immunol-020711-075011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=22149932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVKmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=69-94&author=J.+G.+Cysterauthor=S.+R.+Schwab&title=Sphingosine-1-phosphate+and+lymphocyte+egress+from+lymphoid+organs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs</span></div><div class="casAuthors">Cyster, Jason G.; Schwab, Susan R.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">69-94</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Much has been learned about how cells enter lymphoid tissues.  But how do they leave.  Sphingosine-1-phosphate (S1P) has emerged over the past decade as a central mediator of lymphocyte egress.  In this review, we summarize the current understanding of how S1P promotes exit from the secondary lymphoid organs and thymus.  We review what is known about addnl. requirements for emigration and summarize the mostly distinct requirements for exit from the bone marrow.  Egress from lymphoid organs is limited during immune responses, and we examine how this regulation works.  There is accumulating evidence for roles of S1P in directing immune cell behavior within lymphoid tissues.  How such actions can fit together with the egress-promoting role of S1P is discussed.  Finally, we examine current understanding of how FTY720, a drug that targets S1P receptors and is approved for the treatment of multiple sclerosis, causes immune suppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhvMroRvgkZrVg90H21EOLACvtfcHk0lg5_589k4y1BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVKmtLY%253D&md5=c9f9ef63f2248594b0f9ce4d06024bba</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1146%2Fannurev-immunol-020711-075011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-immunol-020711-075011%26sid%3Dliteratum%253Aachs%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26aulast%3DSchwab%26aufirst%3DS.%2BR.%26atitle%3DSphingosine-1-phosphate%2520and%2520lymphocyte%2520egress%2520from%2520lymphoid%2520organs%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2012%26volume%3D30%26spage%3D69%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=346-349&author=S.+Mandalaauthor=R.+Hajduauthor=J.+Bergstromauthor=E.+Quackenbushauthor=J.+Xieauthor=J.+Milliganauthor=R.+Thorntonauthor=G.-J.+Sheiauthor=D.+Cardauthor=C.+A.+Keohaneauthor=M.+Rosenbachauthor=J.+Haleauthor=C.+L.+Lynchauthor=K.+Rupprechtauthor=W.+Parsonsauthor=H.+Rosen&title=Alteration+of+lymphocyte+trafficking+by+sphingosine-1-phosphate+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DRupprecht%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520lymphocyte%2520trafficking%2520by%2520sphingosine-1-phosphate%2520receptor%2520agonists%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D346%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieschl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zollinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">21453</span><span class="NLM_x">–</span> <span class="NLM_lpage">21457</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1074%2Fjbc.C200176200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=11967257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=21453-21457&author=V.+Brinkmannauthor=M.+D.+Davisauthor=C.+E.+Heiseauthor=R.+Albertauthor=S.+Cottensauthor=R.+Hofauthor=C.+Brunsauthor=E.+Prieschlauthor=T.+Baumrukerauthor=P.+Hiestandauthor=C.+A.+Fosterauthor=M.+Zollingerauthor=K.+R.+Lynch&title=The+immune+modulator+FTY720+targets+sphingosine+1-phosphate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span></div><div class="casAuthors">Brinkmann, Volker; Davis, Michael D.; Heise, Christopher E.; Albert, Rainer; Cottens, Sylvain; Hof, Robert; Bruns, Christian; Prieschl, Eva; Baumruker, Thomas; Hiestand, Peter; Foster, Carolyn A.; Zollinger, Markus; Lynch, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21453-21457</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Immunosuppressant drugs such as cyclosporin have allowed widespread organ transplantation, but their utility remains limited by toxicities, and they are ineffective in chronic management of autoimmune diseases such as multiple sclerosis.  In contrast, the immune modulating drug FTY720 is efficacious in a variety of transplant and autoimmune models without inducing a generalized immunosuppressed state and is effective in human kidney transplantation.  FTY720 elicits a lymphopenia resulting from a reversible redistribution of lymphocytes from circulation to secondary lymphoid tissues by unknown mechanisms.  Using FTY720 and several analogs, we show now that FTY720 is phosphorylated by sphingosine kinase; the phosphorylated compd. is a potent agonist at four sphingosine 1-phosphate receptors and represents the therapeutic principle in a rodent model of multiple sclerosis.  Our results suggest that FTY720, after phosphorylation, acts through sphingosine 1-phosphate signaling pathways to modulate chemotactic responses and lymphocyte trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6zyZnHOYNbVg90H21EOLACvtfcHk0lg5_589k4y1BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D&md5=b59856fffa9ebae7fb8182d18daa025f</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200176200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200176200%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DHof%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPrieschl%26aufirst%3DE.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DThe%2520immune%2520modulator%2520FTY720%2520targets%2520sphingosine%25201-phosphate%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D21453%26epage%3D21457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Matloubian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinamon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesneski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">427</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2004&pages=355-360&author=M.+Matloubianauthor=C.+G.+Loauthor=G.+Cinamonauthor=M.+J.+Lesneskiauthor=Y.+Xuauthor=V.+Brinkmannauthor=M.+L.+Allendeauthor=R.+L.+Proiaauthor=J.+G.+Cyster&title=Lymphocyte+egress+from+thymus+and+peripheral+lymphoid+organs+is+dependent+on+S1P+receptor+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatloubian%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DC.%2BG.%26aulast%3DCinamon%26aufirst%3DG.%26aulast%3DLesneski%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DLymphocyte%2520egress%2520from%2520thymus%2520and%2520peripheral%2520lymphoid%2520organs%2520is%2520dependent%2520on%2520S1P%2520receptor%25201%26jtitle%3DNature%26date%3D2004%26volume%3D427%26spage%3D355%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1146%2Fannurev.immunol.23.021704.115628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=15771568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFOjtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=127-159&author=J.+G.+Cyster&title=Chemokines%2C+sphingosine-1-phosphate%2C+and+cell+migration+in+secondary+lymphoid+organs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs</span></div><div class="casAuthors">Cyster, Jason G.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-159</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Secondary lymphoid organs serve as hubs for the adaptive immune system, bringing together antigen, antigen-presenting cells, and lymphocytes.  Two families of G protein-coupled receptors play essential roles in lymphocyte migration through these organs: chemokine receptors and sphingosine-1-phosphate (S1P) receptors.  Chemokines expressed by lymphoid stromal cells guide lymphocyte and dendritic cell movements during antigen surveillance and the initiation of adaptive immune responses.  S1P receptor-1 is required for lymphocyte egress from thymus and secondary lymphoid organs and is downregulated by the immunosuppressive drug FTY720.  Here, the authors review the steps assocd. with the initiation of adaptive immune responses in secondary lymphoid organs, highlighting the roles of chemokines and S1P.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp45ipo25abUbVg90H21EOLACvtfcHk0lirA-l6ai0Viw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFOjtbg%253D&md5=3263792a06b255396daed4eec96e1599</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.23.021704.115628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.23.021704.115628%26sid%3Dliteratum%253Aachs%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DChemokines%252C%2520sphingosine-1-phosphate%252C%2520and%2520cell%2520migration%2520in%2520secondary%2520lymphoid%2520organs%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2005%26volume%3D23%26spage%3D127%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Selecting against S1P<sub>3</sub> enhances the acute cardiovascular tolerability of 3-(<i>N</i>-benzyl)aminopropylphosphonic acid S1P receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3501</span><span class="NLM_x">–</span> <span class="NLM_lpage">3505</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3501-3505&author=J.+J.+Haleauthor=G.+Dohertyauthor=L.+Tothauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+Rosenbachauthor=J.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=M.+Forrestauthor=S.-Y.+Sunauthor=S.+Westauthor=H.+Xieauthor=N.+Nomuraauthor=H.+Rosenauthor=S.+Mandala&title=Selecting+against+S1P3+enhances+the+acute+cardiovascular+tolerability+of+3-%28N-benzyl%29aminopropylphosphonic+acid+S1P+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DToth%26aufirst%3DL.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-Y.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DSelecting%2520against%2520S1P3%2520enhances%2520the%2520acute%2520cardiovascular%2520tolerability%2520of%25203-%2528N-benzyl%2529aminopropylphosphonic%2520acid%2520S1P%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3501%26epage%3D3505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1124%2Fjpet.103.062828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=14747617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=758-768&author=M.+Forrestauthor=S.-Y.+Sunauthor=R.+Hajduauthor=J.+Bergstromauthor=D.+Cardauthor=G.+Dohertyauthor=J.+Haleauthor=C.+Keohaneauthor=C.+Meyersauthor=J.+Milliganauthor=S.+Millsauthor=N.+Nomuraauthor=H.+Rosenauthor=M.+Rosenbachauthor=G.-J.+Sheiauthor=I.+I.+Singerauthor=M.+Tianauthor=S.+Westauthor=V.+Whiteauthor=J.+Xieauthor=R.+L.+Proiaauthor=S.+Mandala&title=Immune+cell+regulation+and+cardiovascular+effects+of+sphingosine+1-phosphate+receptor+agonists+in+rodents+are+mediated+via+distinct+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span></div><div class="casAuthors">Forrest, M.; Sun, S.-Y.; Hajdu, R.; Bergstrom, J.; Card, D.; Doherty, G.; Hale, J.; Keohane, C.; Meyers, C.; Milligan, J.; Mills, S.; Nomura, N.; Rosen, H.; Rosenbach, M.; Shei, G.-J.; Singer, I. I.; Tian, M.; West, S.; White, V.; Xie, J.; Proia, R. L.; Mandala, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">758-768</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a bioactive lysolipid with pleiotropic functions mediated through a family of G protein-coupled receptors, S1P1,2,3,4,5.  Physiol. effects of S1P receptor agonists include regulation of cardiovascular function and immunosuppression via redistribution of lymphocytes from blood to secondary lymphoid organs.  The phosphorylated metabolite of the immunosuppressant agent FTY720 (2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol) and other phosphonate analogs with differential receptor selectivity were investigated.  No significant species differences in compd. potency or rank order of activity on receptors cloned from human, murine, and rat sources were obsd.  All synthetic analogs were high-affinity agonists on S1P1, with IC50 values for ligand binding between 0.3 and 14 nM.  The correlation between S1P1 receptor activation and the ED50 for lymphocyte redn. was highly significant (p < 0.001) and lower for the other receptors.  In contrast to S1P1-mediated effects on lymphocyte recirculation, three lines of evidence link S1P3 receptor activity with acute toxicity and cardiovascular regulation: compd. potency on S1P3 correlated with toxicity and bradycardia; the shift in potency of phosphorylated-FTY720 for inducing lymphopenia vs. bradycardia and hypertension was consistent with affinity for S1P1 relative to S1P3; and toxicity, bradycardia, and hypertension were absent in S1P3-/- mice.  Blood pressure effects of agonists in anesthetized rats were complex, whereas hypertension was the predominant effect in conscious rats and mice.  Immunolocalization of S1P3 in rodent heart revealed abundant expression on myocytes and perivascular smooth muscle cells consistent with regulation of bradycardia and hypertension, whereas S1P1 expression was restricted to the vascular endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKo2vpih4eoLVg90H21EOLACvtfcHk0lgGtAYW9wQfyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D&md5=27183d4991bffbc5d2b88174b1386d5a</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.062828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.062828%26sid%3Dliteratum%253Aachs%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-Y.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DMeyers%26aufirst%3DC.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DMills%26aufirst%3DS.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DSinger%26aufirst%3DI.%2BI.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DImmune%2520cell%2520regulation%2520and%2520cardiovascular%2520effects%2520of%2520sphingosine%25201-phosphate%2520receptor%2520agonists%2520in%2520rodents%2520are%2520mediated%2520via%2520distinct%2520receptor%2520subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D758%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate (S1P) receptor subtypes S1P<sub>1</sub> and S1P<sub>3</sub>, respectively, regulate lymphocyte recirculation and heart rate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">13839</span><span class="NLM_x">–</span> <span class="NLM_lpage">13848</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=13839-13848&author=M.+G.+Sannaauthor=J.+Liaoauthor=E.+Joauthor=C.+Alfonsoauthor=M.-Y.+Ahnauthor=M.+S.+Petersonauthor=B.+Webbauthor=S.+Lefebvreauthor=J.+Chunauthor=N.+Grayauthor=H.+Rosen&title=Sphingosine+1-phosphate+%28S1P%29+receptor+subtypes+S1P1+and+S1P3%2C+respectively%2C+regulate+lymphocyte+recirculation+and+heart+rate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DAlfonso%26aufirst%3DC.%26aulast%3DAhn%26aufirst%3DM.-Y.%26aulast%3DPeterson%26aufirst%3DM.%2BS.%26aulast%3DWebb%26aufirst%3DB.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DSphingosine%25201-phosphate%2520%2528S1P%2529%2520receptor%2520subtypes%2520S1P1%2520and%2520S1P3%252C%2520respectively%252C%2520regulate%2520lymphocyte%2520recirculation%2520and%2520heart%2520rate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D13839%26epage%3D13848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Salomone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyndall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ip, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waeber, C.</span><span> </span><span class="NLM_article-title">Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1038%2Fsj.bjp.0707581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=18026125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitlyntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=140-147&author=S.+Salomoneauthor=E.+M.+Pottsauthor=S.+Tyndallauthor=P.+C.+Ipauthor=J.+Chunauthor=V.+Brinkmannauthor=C.+Waeber&title=Analysis+of+sphingosine+1-phosphate+receptors+involved+in+constriction+of+isolated+cerebral+arteries+with+receptor+null+mice+and+pharmacological+tools"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools</span></div><div class="casAuthors">Salomone, S.; Potts, E. M.; Tyndall, S.; Ip, P. C.; Chun, J.; Brinkmann, V.; Waeber, C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-147</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background and purpose: Sphingosine 1-phosphate (S1P) selectively and potently constricts isolated cerebral arteries, but this response has not been pharmacol. characterized.  Exptl. approach: The receptor subtype(s) involved in S1P-induced cerebrovascular constriction were characterized using genetic (S1P2 and S1P3 receptor null mice) and pharmacol. tools (phospho-FTY720, a S1P1/3/4/5 receptor agonist; SEW2871, a S1P1 receptor agonist, JTE-013, a S1P2 receptor antagonist, VPC23019, a S1P1/3 receptor antagonist).  Isolated basilar or peripheral (femoral, mesenteric resistance) arteries, from either rat or mouse, were studied in a wire myograph.  Key results: S1P concn.-dependently constricted basilar artery in rat, wild-type (WT) and S1P2 null mice, but barely affected vascular tone in S1P3 null mice.  Vasoconstriction to U46619 (a thromboxane analog) or to endothelin-1 did not differ between WT, S1P2 and S1P3 null mice.  JTE-013 inhibited not only S1P-induced vasoconstriction, but also KCl-, U46619- and endothelin-1-induced constriction.  This effect was obsd. in WT as well as in S1P2 null mice.  VPC23019 increased the concn.-dependent vasoconstriction to S1P in both rat and mouse basilar arteries with intact endothelium, but not in rat basilar artery without endothelium.  Phospho-FTY720 concn.-dependently constricted rat basilar arteries, but not femoral or mesenteric resistance arteries, while SEW2871 did not induce any response in the same arteries.  Conclusions and implications: S1P constricts cerebral arteries through S1P3 receptors.  The purported S1P2 receptor antagonist JTE-013 does not appear to be selective, at least in rodents.  Enhancement of S1P-induced contraction by VPC23019 might be related to blockade of S1P1 receptors and NO generation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkx6pcvW_Q37Vg90H21EOLACvtfcHk0liaqLjWby3Y6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitlyntg%253D%253D&md5=1e8bef7d6f2df66b4436300fab09df06</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707581%26sid%3Dliteratum%253Aachs%26aulast%3DSalomone%26aufirst%3DS.%26aulast%3DPotts%26aufirst%3DE.%2BM.%26aulast%3DTyndall%26aufirst%3DS.%26aulast%3DIp%26aufirst%3DP.%2BC.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DWaeber%26aufirst%3DC.%26atitle%3DAnalysis%2520of%2520sphingosine%25201-phosphate%2520receptors%2520involved%2520in%2520constriction%2520of%2520isolated%2520cerebral%2520arteries%2520with%2520receptor%2520null%2520mice%2520and%2520pharmacological%2520tools%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D140%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Murakami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taksugi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnuma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koide, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasamori, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takakura, N.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P<sub>3</sub> receptor: investigation based on a new S1P<sub>3</sub> receptor antagonist</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=704-713&author=A.+Murakamiauthor=H.+Taksugiauthor=S.+Ohnumaauthor=Y.+Koideauthor=A.+Sakuraiauthor=S.+Takedaauthor=T.+Hasegawaauthor=J.+Sasamoriauthor=T.+Konnoauthor=K.+Hayashiauthor=Y.+Watanabeauthor=K.+Moriauthor=Y.+Satoauthor=A.+Takahashiauthor=N.+Mochizukiauthor=N.+Takakura&title=Sphingosine+1-phosphate+%28S1P%29+regulates+vascular+contraction+via+S1P3+receptor%3A+investigation+based+on+a+new+S1P3+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DA.%26aulast%3DTaksugi%26aufirst%3DH.%26aulast%3DOhnuma%26aufirst%3DS.%26aulast%3DKoide%26aufirst%3DY.%26aulast%3DSakurai%26aufirst%3DA.%26aulast%3DTakeda%26aufirst%3DS.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DSasamori%26aufirst%3DJ.%26aulast%3DKonno%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DMochizuki%26aufirst%3DN.%26aulast%3DTakakura%26aufirst%3DN.%26atitle%3DSphingosine%25201-phosphate%2520%2528S1P%2529%2520regulates%2520vascular%2520contraction%2520via%2520S1P3%2520receptor%253A%2520investigation%2520based%2520on%2520a%2520new%2520S1P3%2520receptor%2520antagonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D77%26spage%3D704%26epage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Hamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomatsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugahara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asayama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takagi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, K.</span><span> </span><span class="NLM_article-title">Removal of sphingosine 1-phosphate receptor-3 (S1P<sub>3</sub>) agonism is essential, but inadequate to obtain immunomodulating 2-aminopropane-1,3-diol S1P<sub>1</sub> agonists with reduced effect on heart rate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3154</span><span class="NLM_x">–</span> <span class="NLM_lpage">3168</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901776q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3154-3168&author=M.+Hamadaauthor=M.+Nakamuraauthor=M.+Kiuchiauthor=K.+Marukawaauthor=A.+Tomatsuauthor=K.+Shimanoauthor=N.+Satoauthor=K.+Sugaharaauthor=M.+Asayamaauthor=K.+Takagiauthor=K.+Adachi&title=Removal+of+sphingosine+1-phosphate+receptor-3+%28S1P3%29+agonism+is+essential%2C+but+inadequate+to+obtain+immunomodulating+2-aminopropane-1%2C3-diol+S1P1+agonists+with+reduced+effect+on+heart+rate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Fjm901776q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901776q%26sid%3Dliteratum%253Aachs%26aulast%3DHamada%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DKiuchi%26aufirst%3DM.%26aulast%3DMarukawa%26aufirst%3DK.%26aulast%3DTomatsu%26aufirst%3DA.%26aulast%3DShimano%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DSugahara%26aufirst%3DK.%26aulast%3DAsayama%26aufirst%3DM.%26aulast%3DTakagi%26aufirst%3DK.%26aulast%3DAdachi%26aufirst%3DK.%26atitle%3DRemoval%2520of%2520sphingosine%25201-phosphate%2520receptor-3%2520%2528S1P3%2529%2520agonism%2520is%2520essential%252C%2520but%2520inadequate%2520to%2520obtain%2520immunomodulating%25202-aminopropane-1%252C3-diol%2520S1P1%2520agonists%2520with%2520reduced%2520effect%2520on%2520heart%2520rate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3154%26epage%3D3168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Fryer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muthukumarana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nodop Mazurek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinallo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaude, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modis, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, G. A.</span><span> </span><span class="NLM_article-title">The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P(1)) and hypertension (S1P(3)) in rat</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e52985</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e52985&author=R.+M.+Fryerauthor=A.+Muthukumaranaauthor=P.+C.+Harrisonauthor=S.+Nodop+Mazurekauthor=R.+R.+Chenauthor=K.+E.+Harringtonauthor=R.+M.+Dinalloauthor=J.+C.+Horanauthor=L.+Patnaudeauthor=L.+K.+Modisauthor=G.+A.+Reinhart&title=The+clinically-tested+S1P+receptor+agonists%2C+FTY720+and+BAF312%2C+demonstrate+subtype-specific+bradycardia+%28S1P%281%29%29+and+hypertension+%28S1P%283%29%29+in+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFryer%26aufirst%3DR.%2BM.%26aulast%3DMuthukumarana%26aufirst%3DA.%26aulast%3DHarrison%26aufirst%3DP.%2BC.%26aulast%3DNodop%2BMazurek%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DR.%2BR.%26aulast%3DHarrington%26aufirst%3DK.%2BE.%26aulast%3DDinallo%26aufirst%3DR.%2BM.%26aulast%3DHoran%26aufirst%3DJ.%2BC.%26aulast%3DPatnaude%26aufirst%3DL.%26aulast%3DModis%26aufirst%3DL.%2BK.%26aulast%3DReinhart%26aufirst%3DG.%2BA.%26atitle%3DThe%2520clinically-tested%2520S1P%2520receptor%2520agonists%252C%2520FTY720%2520and%2520BAF312%252C%2520demonstrate%2520subtype-specific%2520bradycardia%2520%2528S1P%25281%2529%2529%2520and%2520hypertension%2520%2528S1P%25283%2529%2529%2520in%2520rat%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De52985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Lucke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levkau, B.</span><span> </span><span class="NLM_article-title">Endothelial functions of sphingosine-1-phosphate</span> <span class="citation_source-journal">Cell. Physiol. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1159%2F000315109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=20502008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsVOms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=87-96&author=S.+Luckeauthor=B.+Levkau&title=Endothelial+functions+of+sphingosine-1-phosphate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Endothelial Functions of Sphingosine-1-phosphate</span></div><div class="casAuthors">Lucke, Susann; Levkau, Bodo</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-96</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  The biol. active sphingolipid sphingosine-1-phosphate (S1P) plays key functions in the immune, inflammatory, and cardiovascular systems.  In the vasculature, S1P and its receptors are involved in vessel morphogenesis and angiogenesis during embryonic development and in the adult organism both under normal and pathol. conditions.  Via its actions on endothelial and smooth muscle cells, S1P regulates arterial tone, vascular permeability, and tissue perfusion.  Elevated local S1P levels during inflammation induce endothelial adhesion mols., recruit inflammatory cells, and activate dendritic cells.  At the same time, S1P activates a neg. feedback loop that consecutively seals endothelial cell-cell contacts, decreases vascular leakage, and inhibits cytokine-induced leukocyte adhesion.  Thus S1P dets. not only the build-up, magnitude, and duration of an inflammatory reaction but also the pace of its resoln.  This review focuses on the role S1P plays in endothelial function, its receptors and signalling pathways, and the role its major carrier high-d. lipoproteins (HDL) play in its bioavailability and transport.  We will also discuss the potential of interfering with S1P-S1P receptor interactions for the treatment of endothelial disorders and vascular pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgsnbdFMWkH7Vg90H21EOLACvtfcHk0lhdC4O1qiEo2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsVOms74%253D&md5=7cb409784dfea08b42abaa924e5b3bff</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1159%2F000315109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000315109%26sid%3Dliteratum%253Aachs%26aulast%3DLucke%26aufirst%3DS.%26aulast%3DLevkau%26aufirst%3DB.%26atitle%3DEndothelial%2520functions%2520of%2520sphingosine-1-phosphate%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2010%26volume%3D26%26spage%3D87%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Takuwa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizugishi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanuma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satouchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitumori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takuwa, Y.</span><span> </span><span class="NLM_article-title">S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species</span> <span class="citation_source-journal">Cardiovasc. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">484</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2009&pages=484-493&author=N.+Takuwaauthor=S.+Ohkuraauthor=S.+Takashimaauthor=K.+Ohtaniauthor=Y.+Okamotoauthor=T.+Tanakaauthor=K.+Hiranoauthor=S.+Usuiauthor=F.+Wangauthor=W.+Duauthor=K.+Yoshiokaauthor=Y.+Bannoauthor=M.+Sasakiauthor=I.+Ichiauthor=M.+Okamuraauthor=N.+Sugimotoauthor=K.+Mizugishiauthor=Y.+Nakanumaauthor=I.+Ishiiauthor=M.+Takamuraauthor=S.+Kanekoauthor=S.+Kojoauthor=K.+Satouchiauthor=K.+Mitumoriauthor=J.+Chunauthor=Y.+Takuwa&title=S1P3-mediated+cardiac+fibrosis+in+sphingosine+kinase+1+transgenic+mice+involves+reactive+oxygen+species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakuwa%26aufirst%3DN.%26aulast%3DOhkura%26aufirst%3DS.%26aulast%3DTakashima%26aufirst%3DS.%26aulast%3DOhtani%26aufirst%3DK.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DHirano%26aufirst%3DK.%26aulast%3DUsui%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DDu%26aufirst%3DW.%26aulast%3DYoshioka%26aufirst%3DK.%26aulast%3DBanno%26aufirst%3DY.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DIchi%26aufirst%3DI.%26aulast%3DOkamura%26aufirst%3DM.%26aulast%3DSugimoto%26aufirst%3DN.%26aulast%3DMizugishi%26aufirst%3DK.%26aulast%3DNakanuma%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DI.%26aulast%3DTakamura%26aufirst%3DM.%26aulast%3DKaneko%26aufirst%3DS.%26aulast%3DKojo%26aufirst%3DS.%26aulast%3DSatouchi%26aufirst%3DK.%26aulast%3DMitumori%26aufirst%3DK.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DTakuwa%26aufirst%3DY.%26atitle%3DS1P3-mediated%2520cardiac%2520fibrosis%2520in%2520sphingosine%2520kinase%25201%2520transgenic%2520mice%2520involves%2520reactive%2520oxygen%2520species%26jtitle%3DCardiovasc.%2520Res.%26date%3D2009%26volume%3D85%26spage%3D484%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Sobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menyhart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Killer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renault, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Studer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P<sub>2</sub> and S1P<sub>3</sub> receptors and Smad-independent signaling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">14839</span><span class="NLM_x">–</span> <span class="NLM_lpage">14851</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=14839-14851&author=K.+Sobelauthor=K.+Menyhartauthor=N.+Killerauthor=B.+Renaultauthor=Y.+Bauerauthor=R.+Studerauthor=B.+Steinerauthor=M.+H.+Bolliauthor=O.+Naylerauthor=J.+Gatfield&title=Sphingosine-1-phosphate+%28S1P%29+receptor+agonists+mediate+pro-fibrotic+responses+in+normal+human+lung+fibroblasts+via+S1P2+and+S1P3+receptors+and+Smad-independent+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSobel%26aufirst%3DK.%26aulast%3DMenyhart%26aufirst%3DK.%26aulast%3DKiller%26aufirst%3DN.%26aulast%3DRenault%26aufirst%3DB.%26aulast%3DBauer%26aufirst%3DY.%26aulast%3DStuder%26aufirst%3DR.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DGatfield%26aufirst%3DJ.%26atitle%3DSphingosine-1-phosphate%2520%2528S1P%2529%2520receptor%2520agonists%2520mediate%2520pro-fibrotic%2520responses%2520in%2520normal%2520human%2520lung%2520fibroblasts%2520via%2520S1P2%2520and%2520S1P3%2520receptors%2520and%2520Smad-independent%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D14839%26epage%3D14851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Pyne, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span> </span><span class="NLM_article-title">Role of sphingosine 1-phosphate and lysophosphatidic acid in fibrosis</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1831</span><span class="NLM_x">, </span> <span class="NLM_fpage">228</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1831&publication_year=2013&pages=228-38&author=N.+J.+Pyneauthor=G.+Duboisauthor=S.+Pyne&title=Role+of+sphingosine+1-phosphate+and+lysophosphatidic+acid+in+fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DDubois%26aufirst%3DG.%26aulast%3DPyne%26aufirst%3DS.%26atitle%3DRole%2520of%2520sphingosine%25201-phosphate%2520and%2520lysophosphatidic%2520acid%2520in%2520fibrosis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2013%26volume%3D1831%26spage%3D228%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Foster, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweitzer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persohn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balatoni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuschel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span> </span><span class="NLM_article-title">Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1124%2Fjpet.107.127183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=17682127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ynsLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2007&pages=469-476&author=C.+A.+Fosterauthor=L.+M.+Howardauthor=A.+Schweitzerauthor=E.+Persohnauthor=P.+C.+Hiestandauthor=B.+Balatoniauthor=R.+Reuschelauthor=C.+Beerliauthor=M.+Schwartzauthor=A.+Billich&title=Brain+penetration+of+the+oral+immunomodulatory+drug+FTY720+and+its+phosphorylation+in+the+central+nervous+system+during+experimental+autoimmune+encephalomyelitis%3A+consequences+for+mode+of+action+in+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis</span></div><div class="casAuthors">Foster, Carolyn A.; Howard, Laurence M.; Schweitzer, Alain; Persohn, Elke; Hiestand, Peter C.; Balatoni, Balazs; Reuschel, Roland; Beerli, Christian; Schwartz, Manuela; Billich, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">469-476</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">FTY720 [2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride] is an oral sphingosine-1-phosphate receptor modulator under development for the treatment of multiple sclerosis (MS).  The drug is phosphorylated in vivo by sphingosine kinase 2 to its bioactive form, FTY720-P.  Although treatment with FTY720 is accompanied by a redn. of the peripheral lymphocyte count, its efficacy in MS and exptl. autoimmune encephalomyelitis (EAE) may be due to addnl., direct effects in the central nervous system (CNS).  We now show that FTY720 localizes to the CNS white matter, preferentially along myelin sheaths.  Brain trough levels of FTY720 and FTY720-P in rat EAE are of the same magnitude and dose dependently increase; they are in the range of 40 to 540 ng/g in the brain tissue at efficacious doses and exceed blood concns. severalfold.  In a rat model of chronic EAE, prolonged treatment with 0.03 mg/kg was efficacious, but limiting the dosing period failed to prevent EAE despite a significant decrease in blood lymphocytes.  FTY720 effectiveness is likely due to a culmination of mechanisms involving redn. of autoreactive T cells, neuroprotective influence of FTY720-P in the CNS, and inhibition of inflammatory mediators in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq37e2tpDlreLVg90H21EOLACvtfcHk0liTeedu2skLsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ynsLfP&md5=a4f414517a4b567e8d8905f0da2b4706</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.127183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.127183%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DHoward%26aufirst%3DL.%2BM.%26aulast%3DSchweitzer%26aufirst%3DA.%26aulast%3DPersohn%26aufirst%3DE.%26aulast%3DHiestand%26aufirst%3DP.%2BC.%26aulast%3DBalatoni%26aufirst%3DB.%26aulast%3DReuschel%26aufirst%3DR.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DSchwartz%26aufirst%3DM.%26aulast%3DBillich%26aufirst%3DA.%26atitle%3DBrain%2520penetration%2520of%2520the%2520oral%2520immunomodulatory%2520drug%2520FTY720%2520and%2520its%2520phosphorylation%2520in%2520the%2520central%2520nervous%2520system%2520during%2520experimental%2520autoimmune%2520encephalomyelitis%253A%2520consequences%2520for%2520mode%2520of%2520action%2520in%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D323%26spage%3D469%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Balatoni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storch, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swoboda, E.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schönborn, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koziel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambrou, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C. A.</span><span> </span><span class="NLM_article-title">FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis</span> <span class="citation_source-journal">Brain Res. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">316</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.brainresbull.2007.06.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=17845905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVWhs7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2007&pages=307-316&author=B.+Balatoniauthor=M.+K.+Storchauthor=E.-M.+Swobodaauthor=V.+Sch%C3%B6nbornauthor=A.+Kozielauthor=G.+N.+Lambrouauthor=P.+C.+Hiestandauthor=R.+Weissertauthor=C.+A.+Foster&title=FTY720+sustains+and+restores+neuronal+function+in+the+DA+rat+model+of+MOG-induced+experimental+autoimmune+encephalomyelitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis</span></div><div class="casAuthors">Balatoni, Balazs; Storch, Maria K.; Swoboda, Eva-M.; Schoenborn, Vinzenz; Koziel, Agnieszka; Lambrou, George N.; Hiestand, Peter C.; Weissert, Robert; Foster, Carolyn A.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">307-316</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">FTY720 (fingolimod) is an oral sphingosine 1-phosphate (S1P) receptor modulator under development for the treatment of multiple sclerosis (MS).  To elucidate its effects in the central nervous system (CNS), we compared functional parameters of nerve conductance in the DA rat model of myelin oligodendrocyte glycoprotein (MOG)-induced exptl. autoimmune encephalomyelitis (EAE) after preventive and therapeutic treatment.  We demonstrate that prophylactic therapy protected against the emergence of EAE symptoms, neuropathol., and disturbances to visual and somatosensory evoked potentials (VEP, SEP).  Moreover, therapeutic treatment from day 25 to 45 markedly reversed paralysis in established EAE and normalized the electrophysiol. responses, correlating with decreased demyelination in the brain and spinal cord.  The effectiveness of FTY720 in this model is likely due to several contributing factors.  Evidence thus far supports its role in the redn. of inflammation and preservation of blood-brain-barrier integrity.  FTY720 may also act via S1P receptors in glial cells to promote endogenous repair mechanisms that complement its immunomodulatory action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFwogDXcfLFrVg90H21EOLACvtfcHk0liTeedu2skLsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVWhs7jL&md5=5fb8cec643e3ca6d7b35eaf3b020b873</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresbull.2007.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresbull.2007.06.023%26sid%3Dliteratum%253Aachs%26aulast%3DBalatoni%26aufirst%3DB.%26aulast%3DStorch%26aufirst%3DM.%2BK.%26aulast%3DSwoboda%26aufirst%3DE.-M.%26aulast%3DSch%25C3%25B6nborn%26aufirst%3DV.%26aulast%3DKoziel%26aufirst%3DA.%26aulast%3DLambrou%26aufirst%3DG.%2BN.%26aulast%3DHiestand%26aufirst%3DP.%2BC.%26aulast%3DWeissert%26aufirst%3DR.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26atitle%3DFTY720%2520sustains%2520and%2520restores%2520neuronal%2520function%2520in%2520the%2520DA%2520rat%2520model%2520of%2520MOG-induced%2520experimental%2520autoimmune%2520encephalomyelitis%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2007%26volume%3D74%26spage%3D307%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span> </span><span class="NLM_article-title">FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and central nervous system</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">1173</span><span class="NLM_x">–</span> <span class="NLM_lpage">1182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1111%2Fj.1476-5381.2009.00451.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=19814729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSks7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=1173-1182&author=V.+Brinkmann&title=FTY720+%28fingolimod%29+in+multiple+sclerosis%3A+therapeutic+effects+in+the+immune+and+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system</span></div><div class="casAuthors">Brinkmann, Volker</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1173-1182</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  FTY720 (fingolimod) is a first-in-class sphingosine 1-phosphate (S1P) receptor modulator that was highly effective in Phase II clin. trials for Multiple Sclerosis (MS).  FTY720 is phosphorylated in vivo by sphingosine kinase-2 to form the active moiety FTY720-phosphate that binds to four of the five G protein-coupled S1P receptor subtypes.  Studies using conditional S1P1 receptor-deficient and sphingosine kinase-deficient mice showed that the egress of lymphocytes from lymph nodes requires signaling of lymphocytic S1P1 receptors by the endogenous ligand S1P.  The S1P mimetic FTY720-phosphate causes internalization and degrdn. of cell membrane-expressed S1P1, thereby antagonizing S1P action at the receptor.  In models of human MS and demyelinating polyneuropathies, functional antagonism of lymphocytic S1P1 slows S1P-driven egress of lymphocytes from lymph nodes, thereby reducing the nos. of autoaggressive TH17 cells that recirculate via lymph and blood to the central nervous system and the sciatic/ischiatic nerves.  Based on its lipophilic nature, FTY720 crosses the blood-brain barrier, and ongoing expts. suggest that the drug also down-modulates S1P1 in neural cells/astrocytes to reduce astrogliosis, a phenomenon assocd. with neurodegeneration in MS.  This may help restore gap-junctional communication of astrocytes with neurons and cells of the blood-brain barrier.  Addnl. effects may result from (down-) modulation of S1P3 in astrocytes and of S1P1 and S1P5 in oligodendrocytes.  In conclusion, FTY720 may act through immune-based and central mechanisms to reduce inflammation and support structural restoration of the central nervous system parenchyma.  Beyond the autoimmune indications, very recent studies suggest that short-term, low-dose administration of FTY720 could help treat chronic (viral) infections.  Differential effects of the drug on the trafficking of naive, central memory and effector memory T cell subsets are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOQw7bGw9977Vg90H21EOLACvtfcHk0lhuXKexcb_5xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSks7fO&md5=33c85af3e092990c4c43fbeae5512de4</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00451.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00451.x%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26atitle%3DFTY720%2520%2528fingolimod%2529%2520in%2520multiple%2520sclerosis%253A%2520therapeutic%2520effects%2520in%2520the%2520immune%2520and%2520central%2520nervous%2520system%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D158%26spage%3D1173%26epage%3D1182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Coelho, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saini, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato-Bigbee, C.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate and oligodendrocytes: from cell development to the treatment of multiple sclerosis</span> <span class="citation_source-journal">Prostaglandins Other Lipid Mediators</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.prostaglandins.2009.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=19808013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslSiu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2010&pages=139-144&author=R.+P.+Coelhoauthor=H.+S.+Sainiauthor=C.+Sato-Bigbee&title=Sphingosine-1-phosphate+and+oligodendrocytes%3A+from+cell+development+to+the+treatment+of+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate and oligodendrocytes: From cell development to the treatment of multiple sclerosis</span></div><div class="casAuthors">Coelho, Rochelle P.; Saini, Harsimran S.; Sato-Bigbee, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">139-144</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid that mediates a wide variety of biol. effects in different cells and tissues.  This review discusses the effects of S1P signaling in oligodendrocytes, the myelin making cells of the central nervous system (CNS).  Results from different labs. have uncovered direct actions of S1P at different maturational stages along the oligodendroglial lineage.  There is also evidence for the existence in oligodendrocytes of interactions between S1P and signaling by factors which, like neurotrophin-3 (NT-3) and platelet-derived growth factor (PDGF), have profound effects on oligodendrocyte development and myelination.  Moreover, S1P signaling in oligodendrocytes may not only play an important role during normal CNS development but also offer new therapeutic avenues to stimulate remyelination in demyelinating diseases like multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXpUozYYh8nbVg90H21EOLACvtfcHk0lhuXKexcb_5xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslSiu7c%253D&md5=2eebef84125efc6e433a29f47adc1d5c</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2009.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2009.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DCoelho%26aufirst%3DR.%2BP.%26aulast%3DSaini%26aufirst%3DH.%2BS.%26aulast%3DSato-Bigbee%26aufirst%3DC.%26atitle%3DSphingosine-1-phosphate%2520and%2520oligodendrocytes%253A%2520from%2520cell%2520development%2520to%2520the%2520treatment%2520of%2520multiple%2520sclerosis%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2010%26volume%3D91%26spage%3D139%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Miron, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwin, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarjour, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soliven, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antel, J. P.</span><span> </span><span class="NLM_article-title">Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">2682</span><span class="NLM_x">–</span> <span class="NLM_lpage">2694</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.2353%2Fajpath.2010.091234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=20413685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptFKrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2010&pages=2682-2694&author=V.+E.+Mironauthor=S.+K.+Ludwinauthor=P.+J.+Darlingtonauthor=A.+A.+Jarjourauthor=B.+Solivenauthor=T.+E.+Kennedyauthor=J.+P.+Antel&title=Fingolimod+%28FTY720%29+enhances+remyelination+following+demyelination+of+organotypic+cerebellar+slices"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices</span></div><div class="casAuthors">Miron, Veronique E.; Ludwin, Samuel K.; Darlington, Peter J.; Jarjour, Andrew A.; Soliven, Betty; Kennedy, Timothy E.; Antel, Jack P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2682-2694</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Remyelination, which occurs subsequent to demyelination, contributes to functional recovery and is mediated by oligodendrocyte progenitor cells (OPCs) that have differentiated into myelinating cells.  Therapeutics that impact remyelination in the CNS could be crit. determinants of long-term functional outcome in multiple sclerosis (MS).  Fingolimod is a S1P receptor modulator in MS clin. trials due to systemic anti-inflammatory properties, yet may impact cells within the CNS by crossing the blood-brain barrier.  Previous studies using isolated dissocd. cultures indicate that neural cells express S1P receptors and respond to receptor engagement.  Our objective was to assess the effects of fingolimod on myelinrelated processes within a multicellular environment that maintains physiol. cell-cell interactions, using organotypic cerebellar slice cultures.  Fingolimod treatment had no impact on myelin under basal conditions.  Fingolimod treatment subsequent to lysolecithin-induced demyelination enhanced remyelination and process extension by OPCs and mature oligodendrocytes, while increasing microglia nos. and immunoreactivity for the astrocytic marker glial fibrillary acidic protein.  The no. of phagocytosing microglia was not increased by fingolimod.  Using S1P receptor specific agonists and antagonists, we detd. that fingolimod-induced effects on remyelination and astrogliosis were mediated primarily through S1P3 and S1P5, whereas enhanced microgliosis was mediated through S1P1 and S1P5.  Taken together, these data demonstrate that fingolimod modulates multiple neuroglial cell responses, resulting in enhanced remyelination in organotypic slice cultures that maintain the complex cellular interactions of the mammalian brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGradvge9335h7Vg90H21EOLACvtfcHk0lgQVuN55WMtjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptFKrs7c%253D&md5=6e7efa55ed7482a64dad66c6ec384de8</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2010.091234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2010.091234%26sid%3Dliteratum%253Aachs%26aulast%3DMiron%26aufirst%3DV.%2BE.%26aulast%3DLudwin%26aufirst%3DS.%2BK.%26aulast%3DDarlington%26aufirst%3DP.%2BJ.%26aulast%3DJarjour%26aufirst%3DA.%2BA.%26aulast%3DSoliven%26aufirst%3DB.%26aulast%3DKennedy%26aufirst%3DT.%2BE.%26aulast%3DAntel%26aufirst%3DJ.%2BP.%26atitle%3DFingolimod%2520%2528FTY720%2529%2520enhances%2520remyelination%2520following%2520demyelination%2520of%2520organotypic%2520cerebellar%2520slices%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2010%26volume%3D176%26spage%3D2682%26epage%3D2694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Choi, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardell, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teo, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yung, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P<sub>1</sub>) modulation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">751</span><span class="NLM_x">–</span> <span class="NLM_lpage">756</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=751-756&author=J.+W.+Choiauthor=S.+E.+Gardellauthor=D.+R.+Herrauthor=R.+Riveraauthor=C.-W.+Leeauthor=K.+Noguchiauthor=S.+T.+Teoauthor=Y.+C.+Yungauthor=M.+Luauthor=G.+Kennedyauthor=J.+Chun&title=FTY720+%28fingolimod%29+efficacy+in+an+animal+model+of+multiple+sclerosis+requires+astrocyte+sphingosine+1-phosphate+receptor+1+%28S1P1%29+modulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DGardell%26aufirst%3DS.%2BE.%26aulast%3DHerr%26aufirst%3DD.%2BR.%26aulast%3DRivera%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.-W.%26aulast%3DNoguchi%26aufirst%3DK.%26aulast%3DTeo%26aufirst%3DS.%2BT.%26aulast%3DYung%26aufirst%3DY.%2BC.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DKennedy%26aufirst%3DG.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DFTY720%2520%2528fingolimod%2529%2520efficacy%2520in%2520an%2520animal%2520model%2520of%2520multiple%2520sclerosis%2520requires%2520astrocyte%2520sphingosine%25201-phosphate%2520receptor%25201%2520%2528S1P1%2529%2520modulation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D751%26epage%3D756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Groves, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy</span> <span class="citation_source-journal">J Neurol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">328</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.jns.2013.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=23518370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlGit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=328&publication_year=2013&pages=9-18&author=A.+Grovesauthor=Y.+Kiharaauthor=J.+Chun&title=Fingolimod%3A+direct+CNS+effects+of+sphingosine+1-phosphate+%28S1P%29+receptor+modulation+and+implications+in+multiple+sclerosis+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy</span></div><div class="casAuthors">Groves, Aran; Kihara, Yasuyuki; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Neurological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">328</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">9-18</span>CODEN:
                <span class="NLM_cas:coden">JNSCAG</span>;
        ISSN:<span class="NLM_cas:issn">0022-510X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Fingolimod is the first oral disease-modifying therapy approved for relapsing forms of multiple sclerosis (MS).  Following phosphorylation in vivo, the active agent, fingolimod phosphate (fingolimod-P), acts as a sphingosine 1-phosphate (S1P) receptor modulator, binding with high affinity to four of the five known S1P receptors (S1P1, S1P3, S1P4 and S1P5).  The mechanism of action of fingolimod in MS has primarily been considered as immunomodulatory, whereby fingolimod-P modulates S1P1 on lymphocytes, selectively retaining autoreactive lymphocytes in lymph nodes to reduce damaging infiltration into the central nervous system (CNS).  However, emerging evidence indicates that fingolimod has direct effects in the CNS in MS.  For example, in the MS animal model of exptl. autoimmune encephalomyelitis (EAE), fingolimod is highly efficacious in both a prophylactic and therapeutic setting, yet becomes ineffective in animals selectively deficient for S1P1 on astrocytes, despite maintained normal immunol. receptor expression and functions, and S1P-mediated immune activities.  Here we review S1P signaling effects relevant to MS in neural cell types expressing S1P receptors, including astrocytes, oligodendrocytes, neurons, microglia and dendritic cells.  The direct effects of fingolimod on these CNS cells obsd. in preclin. studies are discussed in view of the functional consequences of reducing neurodegenerative processes and promoting myelin preservation and repair.  The therapeutic implications of S1P modulation in the CNS are considered in terms of the clin. outcomes of MS, such as reducing MS-related brain atrophy, and other CNS disorders.  Addnl., we briefly outline other existing and investigational MS therapies that may also have effects in the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru2tvngjfbNrVg90H21EOLACvtfcHk0lgQVuN55WMtjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlGit78%253D&md5=22b2eb7c069d299a36b9dbbb1a40208c</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.jns.2013.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jns.2013.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DGroves%26aufirst%3DA.%26aulast%3DKihara%26aufirst%3DY.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DFingolimod%253A%2520direct%2520CNS%2520effects%2520of%2520sphingosine%25201-phosphate%2520%2528S1P%2529%2520receptor%2520modulation%2520and%2520implications%2520in%2520multiple%2520sclerosis%2520therapy%26jtitle%3DJ%2520Neurol.%2520Sci.%26date%3D2013%26volume%3D328%26spage%3D9%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kanter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span> </span><span class="NLM_article-title">Novel S1P<sub>1</sub> receptor agonists - Part 2: From bicyclo[3.1.0]hexane fused thiophenes to isobutyl substituted thiophenes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1021/jm401456d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401456d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=M.+H.+Bolliauthor=J.+Velkerauthor=C.+M%C3%BCllerauthor=B.+Mathysauthor=M.+Birkerauthor=R.+Bravoauthor=D.+Burauthor=R.+de+Kanterauthor=P.+Hessauthor=C.+Kohlauthor=D.+Lehmannauthor=S.+Meyerauthor=O.+Naylerauthor=M.+Reyauthor=M.+Scherzauthor=B.+Steiner&title=Novel+S1P1+receptor+agonists+-+Part+2%3A+From+bicyclo%5B3.1.0%5Dhexane+fused+thiophenes+to+isobutyl+substituted+thiophenes&doi=10.1021%2Fjm401456d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fjm401456d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401456d%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DVelker%26aufirst%3DJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DBirker%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBur%26aufirst%3DD.%26aulast%3Dde%2BKanter%26aufirst%3DR.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DLehmann%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DRey%26aufirst%3DM.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSteiner%26aufirst%3DB.%26atitle%3DNovel%2520S1P1%2520receptor%2520agonists%2520-%2520Part%25202%253A%2520From%2520bicyclo%255B3.1.0%255Dhexane%2520fused%2520thiophenes%2520to%2520isobutyl%2520substituted%2520thiophenes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26doi%3D10.1021%2Fjm401456d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and developement settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+developement+settings"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520developement%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Hann, M. M.</span><span> </span><span class="NLM_article-title">Molecular obesity, potency and other addictions in drug discovery</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1039%2FC1MD00017A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1Kht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=349-355&author=M.+M.+Hann&title=Molecular+obesity%2C+potency+and+other+addictions+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular obesity, potency and other addictions in drug discovery</span></div><div class="casAuthors">Hann, Michael M.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">349-355</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Despite the increase in global biol. and chem. knowledge the discovery of effective and safe new drugs seems to become harder rather than easier.  Some of this challenge is due to increasing demands for safety and novelty, but some of the risk involved in this should be controllable if we had more effectively learned from our failures.  This perspective reflects on some of the learnings of recent years in relation to the causes of attrition.  The term Mol. Obesity is introduced to describe our tendency to build potency into mols. by the inappropriate use of lipophilicity which leads to the premature demise of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSlF7TPy6fHLVg90H21EOLACvtfcHk0ljk_gv2YdnTWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1Kht7g%253D&md5=954870db4b1d9e846612c3bb256582f7</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1039%2FC1MD00017A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC1MD00017A%26sid%3Dliteratum%253Aachs%26aulast%3DHann%26aufirst%3DM.%2BM.%26atitle%3DMolecular%2520obesity%252C%2520potency%2520and%2520other%2520addictions%2520in%2520drug%2520discovery%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D349%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Waring, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, C.</span><span> </span><span class="NLM_article-title">A quantitative assessment of hERG liability as a function of lipophilicity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1759</span><span class="NLM_x">–</span> <span class="NLM_lpage">1764</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2Fj.bmcl.2006.12.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=17239590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1yrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1759-1764&author=M.+J.+Waringauthor=C.+Johnstone&title=A+quantitative+assessment+of+hERG+liability+as+a+function+of+lipophilicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative assessment of hERG liability as a function of lipophilicity</span></div><div class="casAuthors">Waring, Michael J.; Johnstone, Craig</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1759-1764</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The impact of lipophilicity as a factor contributing to hERG potency is assessed for a large dataset of compds. of differing ionization type.  This dataset is derived from compds. tested in the Ionworks-based in vitro electrophysiol. hERG assay at AstraZeneca.  Using logistic regression, a quantification of the risk assocd. with increasing lipophilicity is presented.  The anticipated differences between acidic, basic and neutral compds. are apparent in the data but lipophilicity is shown to be a stronger driver for hERG potency than might have been expected.  Simple rules defining target lipophilicity values for minimizing hERG liability are derived.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlCr9mVGL2-LVg90H21EOLACvtfcHk0ljk_gv2YdnTWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1yrtb8%253D&md5=3819e045d7b773f129773f1ff567b980</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.061%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DC.%26atitle%3DA%2520quantitative%2520assessment%2520of%2520hERG%2520liability%2520as%2520a%2520function%2520of%2520lipophilicity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1759%26epage%3D1764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span> </span><span class="NLM_article-title">Role of physicochemical properties and ligand lipophilicity efficiency in addressing drug safety risks</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1016%2FS0065-7743%2810%2945023-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=380-391&author=M.+P.+Edwardsauthor=D.+A.+Price&title=Role+of+physicochemical+properties+and+ligand+lipophilicity+efficiency+in+addressing+drug+safety+risks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2FS0065-7743%2810%2945023-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-7743%252810%252945023-X%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26atitle%3DRole%2520of%2520physicochemical%2520properties%2520and%2520ligand%2520lipophilicity%2520efficiency%2520in%2520addressing%2520drug%2520safety%2520risks%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D380%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Walters, W. P.</span><span> </span><span class="NLM_article-title">Going further than Lipinski’s rule in drug design</span> <span class="citation_source-journal">Expert Opin. Drug. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=99-107&author=W.+P.+Walters&title=Going+further+than+Lipinski%E2%80%99s+rule+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalters%26aufirst%3DW.%2BP.%26atitle%3DGoing%2520further%2520than%2520Lipinski%25E2%2580%2599s%2520rule%2520in%2520drug%2520design%26jtitle%3DExpert%2520Opin.%2520Drug.%2520Discovery%26date%3D2012%26volume%3D7%26spage%3D99%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Miyaura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, A.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed cross-coupling reactions of organoboron compounds</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2457</span><span class="NLM_x">–</span> <span class="NLM_lpage">2483</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00039a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=2457-2483&author=N.+Miyauraauthor=A.+Suzuki&title=Palladium-catalyzed+cross-coupling+reactions+of+organoboron+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span></div><div class="casAuthors">Miyaura, Norio; Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2457-83</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with >250 refs. including title reactions and their mechanisms, prepn. of organoboron reagents, alkoxycarbonylation and dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHwupBJT1UCbVg90H21EOLACvtfcHk0lilBVnj1VWUWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D&md5=d127b414a75161652876eebc3ed0c486</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1021%2Fcr00039a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00039a007%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DPalladium-catalyzed%2520cross-coupling%2520reactions%2520of%2520organoboron%2520compounds%26jtitle%3DChem.%2520Rev.%26date%3D1995%26volume%3D95%26spage%3D2457%26epage%3D2483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Doucet, H.</span><span> </span><span class="NLM_article-title">Suzuki–Miyaura cross-coupling reactions of alkylboronic acid derivatives or alkyltrifluoroborates with aryl, alkenyl or alkyl halides and triflates</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">2013</span><span class="NLM_x">–</span> <span class="NLM_lpage">2030</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2008&publication_year=2008&pages=2013-2030&author=H.+Doucet&title=Suzuki%E2%80%93Miyaura+cross-coupling+reactions+of+alkylboronic+acid+derivatives+or+alkyltrifluoroborates+with+aryl%2C+alkenyl+or+alkyl+halides+and+triflates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoucet%26aufirst%3DH.%26atitle%3DSuzuki%25E2%2580%2593Miyaura%2520cross-coupling%2520reactions%2520of%2520alkylboronic%2520acid%2520derivatives%2520or%2520alkyltrifluoroborates%2520with%2520aryl%252C%2520alkenyl%2520or%2520alkyl%2520halides%2520and%2520triflates%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2008%26volume%3D2008%26spage%3D2013%26epage%3D2030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Jana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathak, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigman, M. S.</span><span> </span><span class="NLM_article-title">Advances in transition metal (Pd,Ni,Fe)-catalyzed cross-coupling reactions using alkyl-organometallics as reaction partners</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1492</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr100327p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFeisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=1417-1492&author=R.+Janaauthor=T.+P.+Pathakauthor=M.+S.+Sigman&title=Advances+in+transition+metal+%28Pd%2CNi%2CFe%29-catalyzed+cross-coupling+reactions+using+alkyl-organometallics+as+reaction+partners"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in Transition Metal (Pd, Ni, Fe)-Catalyzed Cross-Coupling Reactions Using Alkyl-organometallics as Reaction Partners</span></div><div class="casAuthors">Jana, Ranjan; Pathak, Tejas P.; Sigman, Matthew S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1417-1492</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review was given discussing the synthesis, stability, and transition metal-catalyzed(Pd, Ni, Fe) cross-coupling of sp3-organonetallics possessing β-H(s) using alkylzinc (Negishi), allylboron (Suzuki-Miyaura), alkylmagnesium (Kumada), alkyltin (Stille), alkylsilicon (Hiyama), and alkylindium.  Besides their detailed development and mechanistic investigations, extension to asym. catalysis and applications in total synthesis were described.  Organometallic reagents that cannot undergo β-H- elimination were not reviewed comprehensively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz1NzFql_8krVg90H21EOLACvtfcHk0lilBVnj1VWUWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFeisbk%253D&md5=30863f277ba20b5aec43f14125260cd4</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1021%2Fcr100327p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr100327p%26sid%3Dliteratum%253Aachs%26aulast%3DJana%26aufirst%3DR.%26aulast%3DPathak%26aufirst%3DT.%2BP.%26aulast%3DSigman%26aufirst%3DM.%2BS.%26atitle%3DAdvances%2520in%2520transition%2520metal%2520%2528Pd%252CNi%252CFe%2529-catalyzed%2520cross-coupling%2520reactions%2520using%2520alkyl-organometallics%2520as%2520reaction%2520partners%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D1417%26epage%3D1492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Fürstner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitner, A.</span><span> </span><span class="NLM_article-title">Iron-catalyzed cross-coupling reactions of alkyl-Grignard reagents with aryl chloride, tosylates and triflates</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=609-612&author=A.+F%C3%BCrstnerauthor=A.+Leitner&title=Iron-catalyzed+cross-coupling+reactions+of+alkyl-Grignard+reagents+with+aryl+chloride%2C+tosylates+and+triflates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25BCrstner%26aufirst%3DA.%26aulast%3DLeitner%26aufirst%3DA.%26atitle%3DIron-catalyzed%2520cross-coupling%2520reactions%2520of%2520alkyl-Grignard%2520reagents%2520with%2520aryl%2520chloride%252C%2520tosylates%2520and%2520triflates%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2002%26volume%3D41%26spage%3D609%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Fürstner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krause, H.</span><span> </span><span class="NLM_article-title">Iron-catalyzed cross coupling reactions</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">13856</span><span class="NLM_x">–</span> <span class="NLM_lpage">13863</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja027190t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=13856-13863&author=A.+F%C3%BCrstnerauthor=A.+Leitnerauthor=M.+M%C3%A9ndezauthor=H.+Krause&title=Iron-catalyzed+cross+coupling+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Fja027190t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja027190t%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25BCrstner%26aufirst%3DA.%26aulast%3DLeitner%26aufirst%3DA.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DM.%26aulast%3DKrause%26aufirst%3DH.%26atitle%3DIron-catalyzed%2520cross%2520coupling%2520reactions%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26spage%3D13856%26epage%3D13863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Hartwig, J. F.</span><span> </span><span class="NLM_article-title">Transition metal catalyzed synthesis of arylamines and aryl ethers from aryl halides and triflates: scope and mechanism</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2046</span><span class="NLM_x">–</span> <span class="NLM_lpage">2067</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1002%2F%28SICI%291521-3773%2819980817%2937%3A15%3C2046%3A%3AAID-ANIE2046%3E3.0.CO%3B2-L" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADyaK1cXls12lsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=2046-2067&author=J.+F.+Hartwig&title=Transition+metal+catalyzed+synthesis+of+arylamines+and+aryl+ethers+from+aryl+halides+and+triflates%3A+scope+and+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Transition metal catalyzed synthesis of arylamines and aryl ethers from aryl halides and triflates: scope and mechanism</span></div><div class="casAuthors">Hartwig, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2046-2067</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">The transition metal catalyzed synthesis of arylamines by the reaction of aryl halides or triflates (triflate = trifluoromethanesulfonyl) with primary or secondary amines has rapidly become a valuable synthetic tool for a variety of applications.  This process can form monoalkyl- or dialkylanilines as well as mixed diaryl- or triarylamines.  The chem. can be extended to the formation of aryl ethers from aryl halides, although this process is currently less general than the synthesis of arylamines.  The mechanism of this reaction involves several novel organometallic reactions.  For example, the C-N or C-O bond is formed by reductive elimination of amines or ethers, and the metal-amido complexes that undergo reductive elimination can be formed in the catalytic cycle by N-H activation.  Side products are formed by β-H elimination from amides, examples of which have recently been obsd. directly.  This synthetic methods to form arylamines by this Pd-catalyzed chem.  In addn. to information on syntheses, a description of the pertinent mechanistic data on the overall catalytic cycle, on each elementary reaction in the catalytic cycle, and on competing side reactions is presented.  This review, with 185 refs., covers manuscripts that appeared in press before July 1, 1997 as well as those submitted by the author and co-workers before this date.  A brief discussion of papers that appeared between July 1, 1997 and Mar. 1, 1998 is included as an appendix.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN62JEgQmn5rVg90H21EOLACvtfcHk0liXcqnVj5TgVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXls12lsbY%253D&md5=8e5c153e91706b01c8fc99f622a484a9</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819980817%2937%3A15%3C2046%3A%3AAID-ANIE2046%3E3.0.CO%3B2-L&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819980817%252937%253A15%253C2046%253A%253AAID-ANIE2046%253E3.0.CO%253B2-L%26sid%3Dliteratum%253Aachs%26aulast%3DHartwig%26aufirst%3DJ.%2BF.%26atitle%3DTransition%2520metal%2520catalyzed%2520synthesis%2520of%2520arylamines%2520and%2520aryl%2520ethers%2520from%2520aryl%2520halides%2520and%2520triflates%253A%2520scope%2520and%2520mechanism%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1998%26volume%3D37%26spage%3D2046%26epage%3D2067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Kerins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, D. F.</span><span> </span><span class="NLM_article-title">Generation of substituted styrenes via Suzuki cross-coupling of aryl halides with 2,4,6-trivinylcyclotriboroxane</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">4968</span><span class="NLM_x">–</span> <span class="NLM_lpage">4971</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo020074o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvVaisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=4968-4971&author=F.+Kerinsauthor=D.+F.+O%E2%80%99Shea&title=Generation+of+substituted+styrenes+via+Suzuki+cross-coupling+of+aryl+halides+with+2%2C4%2C6-trivinylcyclotriboroxane"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of Substituted Styrenes via Suzuki Cross-Coupling of Aryl Halides with 2,4,6-Trivinylcyclotriboroxane</span></div><div class="casAuthors">Kerins, Fergal; O'Shea, Donal F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4968-4971</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of functionalized styrene derivs. can be readily achieved utilizing a Suzuki cross-coupling protocol between aryl halides and 2,4,6-trivinylcyclotriboroxane-pyridine complex.  The scope and limitations of the procedure were demonstrated by investigation of an array of ortho-substituted aryl halides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphXIT69_FaBLVg90H21EOLACvtfcHk0liXcqnVj5TgVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvVaisbY%253D&md5=00265b1ba9a6f0dc782c062ed3e85827</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Fjo020074o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo020074o%26sid%3Dliteratum%253Aachs%26aulast%3DKerins%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DD.%2BF.%26atitle%3DGeneration%2520of%2520substituted%2520styrenes%2520via%2520Suzuki%2520cross-coupling%2520of%2520aryl%2520halides%2520with%25202%252C4%252C6-trivinylcyclotriboroxane%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2002%26volume%3D67%26spage%3D4968%26epage%3D4971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Beck, G.; Heitzer, H.</span><span> </span><span class="NLM_article-title">Verfahren zur Herstellung von 2-Halogenpyridinaldehyden und Neue 2-Halogenpyridinaldehyde</span>. EP0702003, Mar 20,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=G.+Beck&author=H.+Heitzer&title=Verfahren+zur+Herstellung+von+2-Halogenpyridinaldehyden+und+Neue+2-Halogenpyridinaldehyde"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DG.%26atitle%3DVerfahren%2520zur%2520Herstellung%2520von%25202-Halogenpyridinaldehyden%2520und%2520Neue%25202-Halogenpyridinaldehyde%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Buratti, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardini, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minisci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perchinunno, M.</span><span> </span><span class="NLM_article-title">Nucleophilic character of alkyl radicals. V: Selective homolytic α-oxyalkylation of heteroaromatic bases</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3655</span><span class="NLM_x">–</span> <span class="NLM_lpage">3668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1971&pages=3655-3668&author=W.+Burattiauthor=G.+P.+Gardiniauthor=F.+Minisciauthor=F.+Bertiniauthor=R.+Galliauthor=M.+Perchinunno&title=Nucleophilic+character+of+alkyl+radicals.+V%3A+Selective+homolytic+%CE%B1-oxyalkylation+of+heteroaromatic+bases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuratti%26aufirst%3DW.%26aulast%3DGardini%26aufirst%3DG.%2BP.%26aulast%3DMinisci%26aufirst%3DF.%26aulast%3DBertini%26aufirst%3DF.%26aulast%3DGalli%26aufirst%3DR.%26aulast%3DPerchinunno%26aufirst%3DM.%26atitle%3DNucleophilic%2520character%2520of%2520alkyl%2520radicals.%2520V%253A%2520Selective%2520homolytic%2520%25CE%25B1-oxyalkylation%2520of%2520heteroaromatic%2520bases%26jtitle%3DTetrahedron%26date%3D1971%26volume%3D27%26spage%3D3655%26epage%3D3668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Minisci, F.</span><span> </span><span class="NLM_article-title">Novel applications of free-radical reactions in preparative organic chemistry</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">1973</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1055%2Fs-1973-22123" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1973&publication_year=1973&pages=1-24&author=F.+Minisci&title=Novel+applications+of+free-radical+reactions+in+preparative+organic+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1055%2Fs-1973-22123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1973-22123%26sid%3Dliteratum%253Aachs%26aulast%3DMinisci%26aufirst%3DF.%26atitle%3DNovel%2520applications%2520of%2520free-radical%2520reactions%2520in%2520preparative%2520organic%2520chemistry%26jtitle%3DSynthesis%26date%3D1973%26volume%3D1973%26spage%3D1%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Duncton, M. A. J.</span><span> </span><span class="NLM_article-title">Minisci reactions: versatile CH-functionalizations for medicinal chemists</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1135</span><span class="NLM_x">–</span> <span class="NLM_lpage">1161</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1039%2Fc1md00134e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFeju77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=1135-1161&author=M.+A.+J.+Duncton&title=Minisci+reactions%3A+versatile+CH-functionalizations+for+medicinal+chemists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Minisci reactions. Versatile CH-functionalizations for medicinal chemists</span></div><div class="casAuthors">Duncton, Matthew A. J.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1135-1161</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The addn. of a radical to a heteroarom. base is commonly referred to as a Minsici reaction.  Such reactions constitute a broad-set of selective CH-functionalization processes.  This review described some of the major applications of Minisci reactions and related processes to medicinal or biol. chem., and highlights some potential developments within this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4rms5MglIuLVg90H21EOLACvtfcHk0lhM8xYF6rbKhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFeju77E&md5=49d9076c79e5caf19d21b8fbd74ff0c2</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1039%2Fc1md00134e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00134e%26sid%3Dliteratum%253Aachs%26aulast%3DDuncton%26aufirst%3DM.%2BA.%2BJ.%26atitle%3DMinisci%2520reactions%253A%2520versatile%2520CH-functionalizations%2520for%2520medicinal%2520chemists%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D1135%26epage%3D1161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">Novel S1P<sub>1</sub> receptor agonists—Part 1: From pyrazoles to thiophenes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9737</span><span class="NLM_x">–</span> <span class="NLM_lpage">9755</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4014373" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9737-9755&author=M.+H.+Bolliauthor=C.+M%C3%BCllerauthor=B.+Mathysauthor=S.+Abeleauthor=M.+Birkerauthor=R.+Bravoauthor=D.+Burauthor=P.+Hessauthor=C.+Kohlauthor=D.+Lehmannauthor=O.+Naylerauthor=M.+Reyauthor=S.+Meyerauthor=M.+Scherzauthor=G.+Schmidtauthor=B.+Steinerauthor=A.+Treiberauthor=J.+Velkerauthor=T.+Weller&title=Novel+S1P1+receptor+agonists%E2%80%94Part+1%3A+From+pyrazoles+to+thiophenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fjm4014373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4014373%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DBirker%26aufirst%3DM.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DLehmann%26aufirst%3DD.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DRey%26aufirst%3DM.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DVelker%26aufirst%3DJ.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3DNovel%2520S1P1%2520receptor%2520agonists%25E2%2580%2594Part%25201%253A%2520From%2520pyrazoles%2520to%2520thiophenes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9737%26epage%3D9755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Brossard, P.; D’Ambrosio, D.; Ipek, M.; Dingemanse, J.</span><span> </span><span class="NLM_article-title">Effects on Heart Rate of Three Different Up-Titration Regimens of Ponesimod, a Selective S1P<sub>1</sub> Receptor Modulator, and of Re-Initiation of Treatment in Healthy Male and Female Subjects</span>. Presented at the 28th Congress of the European Commitee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2012), Lyon, France, Oct 10–13,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span>P468.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=P.+Brossard&author=D.+D%E2%80%99Ambrosio&author=M.+Ipek&author=J.+Dingemanse&title=Effects+on+Heart+Rate+of+Three+Different+Up-Titration+Regimens+of+Ponesimod%2C+a+Selective+S1P1+Receptor+Modulator%2C+and+of+Re-Initiation+of+Treatment+in+Healthy+Male+and+Female+Subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBrossard%26aufirst%3DP.%26atitle%3DEffects%2520on%2520Heart%2520Rate%2520of%2520Three%2520Different%2520Up-Titration%2520Regimens%2520of%2520Ponesimod%252C%2520a%2520Selective%2520S1P1%2520Receptor%2520Modulator%252C%2520and%2520of%2520Re-Initiation%2520of%2520Treatment%2520in%2520Healthy%2520Male%2520and%2520Female%2520Subjects%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Gergely, P.; Wallström, E.; Nuesslein-Hildesheim, B.; Bruns, C.; Zécri, F. J.; Cooke, N. G.; Traebert, M.; Tuntland, T.; Rosenberg, M.; Saltzman, M.</span><span> </span><span class="NLM_article-title">Phase I Study with the Selective S1P1/S1P5 Receptor Modulator BAF312 Indicates That S1P1 Rather Than S1P3 Mediates Transient Heart Rate Reduction in Humans</span>. Presented at the 25th Congress of the European Committe for Treatment and Research in Multiple Sclerosis (ECTRIMS), Düsseldorf, Germany, Sep 9–12,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>P437.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=P.+Gergely&author=E.+Wallstr%C3%B6m&author=B.+Nuesslein-Hildesheim&author=C.+Bruns&author=F.+J.+Z%C3%A9cri&author=N.+G.+Cooke&author=M.+Traebert&author=T.+Tuntland&author=M.+Rosenberg&author=M.+Saltzman&title=Phase+I+Study+with+the+Selective+S1P1%2FS1P5+Receptor+Modulator+BAF312+Indicates+That+S1P1+Rather+Than+S1P3+Mediates+Transient+Heart+Rate+Reduction+in+Humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DP.%26atitle%3DPhase%2520I%2520Study%2520with%2520the%2520Selective%2520S1P1%252FS1P5%2520Receptor%2520Modulator%2520BAF312%2520Indicates%2520That%2520S1P1%2520Rather%2520Than%2520S1P3%2520Mediates%2520Transient%2520Heart%2520Rate%2520Reduction%2520in%2520Humans%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Wallström, E.; Gergely, P.; Nuesslein-Hildesheim, B.; Zécri, F. J.; Cooke, N. G.; Bruns, C.; Luttringer, O.; Sing, T.; Groenewegen, A.; Rosenberg, M.; Saltzman, M.</span><span> </span><span class="NLM_article-title">BAF312, a Selective S1P1/S1P5 Receptor Modulator, Effectively Reduces Absolute Lymphocyte Counts in Human Volunteers and Demonstrates the Relevance of S1P1 in Mediating a Transient Heart Rate Reduction</span>. Presented at the 62nd Annual Meeting of the American Academy of Neurology, Toronto, Ontario, Canada, Apr 10–17,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>PO5.052.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=E.+Wallstr%C3%B6m&author=P.+Gergely&author=B.+Nuesslein-Hildesheim&author=F.+J.+Z%C3%A9cri&author=N.+G.+Cooke&author=C.+Bruns&author=O.+Luttringer&author=T.+Sing&author=A.+Groenewegen&author=M.+Rosenberg&author=M.+Saltzman&title=BAF312%2C+a+Selective+S1P1%2FS1P5+Receptor+Modulator%2C+Effectively+Reduces+Absolute+Lymphocyte+Counts+in+Human+Volunteers+and+Demonstrates+the+Relevance+of+S1P1+in+Mediating+a+Transient+Heart+Rate+Reduction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DWallstr%25C3%25B6m%26aufirst%3DE.%26atitle%3DBAF312%252C%2520a%2520Selective%2520S1P1%252FS1P5%2520Receptor%2520Modulator%252C%2520Effectively%2520Reduces%2520Absolute%2520Lymphocyte%2520Counts%2520in%2520Human%2520Volunteers%2520and%2520Demonstrates%2520the%2520Relevance%2520of%2520S1P1%2520in%2520Mediating%2520a%2520Transient%2520Heart%2520Rate%2520Reduction%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Rey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delahaye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span> </span><span class="NLM_article-title">Desensitization by progressive up-titration prevents first-dose effects on the heart: guinea pig study with ponesimod, a selective S1P1 receptor modulator</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e74285</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e74285&author=M.+Reyauthor=P.+Hessauthor=M.+Clozelauthor=S.+Delahayeauthor=J.+Gatfieldauthor=O.+Naylerauthor=B.+Steiner&title=Desensitization+by+progressive+up-titration+prevents+first-dose+effects+on+the+heart%3A+guinea+pig+study+with+ponesimod%2C+a+selective+S1P1+receptor+modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRey%26aufirst%3DM.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DClozel%26aufirst%3DM.%26aulast%3DDelahaye%26aufirst%3DS.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DSteiner%26aufirst%3DB.%26atitle%3DDesensitization%2520by%2520progressive%2520up-titration%2520prevents%2520first-dose%2520effects%2520on%2520the%2520heart%253A%2520guinea%2520pig%2520study%2520with%2520ponesimod%252C%2520a%2520selective%2520S1P1%2520receptor%2520modulator%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De74285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottschlich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seelig, A.</span><span> </span><span class="NLM_article-title">Blood–brain barrier permeation: molecular parameters governing passive diffusion</span> <span class="citation_source-journal">J. Membr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1007%2Fs002329900434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=9767674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADyaK1cXmsFOlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=1998&pages=201-211&author=H.+Fischerauthor=R.+Gottschlichauthor=A.+Seelig&title=Blood%E2%80%93brain+barrier+permeation%3A+molecular+parameters+governing+passive+diffusion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier permeation: molecular parameters governing passive diffusion</span></div><div class="casAuthors">Fischer, H.; Gottschlich, R.; Seelig, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Membrane Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">201-211</span>CODEN:
                <span class="NLM_cas:coden">JMBBBO</span>;
        ISSN:<span class="NLM_cas:issn">0022-2631</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag New York Inc.</span>)
        </div><div class="casAbstract">Fifty-three compds. with clin. established ability to cross or not to cross the blood-brain barrier by passive diffusion were characterized by means of surface activity measurements in terms of three parameters, i.e., the air-water partition coeff., Kaw, the crit. micelle concn., CMCD, and the cross-sectional area, AD.  A three-dimensional plot in which the surface area, AD, is plotted as a function of Kaw-1 and CMCD shows essentially three groups of compds.: (i) very hydrophobic compds. with large air-water partition coeffs. and large cross-sectional areas, AD > 80 Å2, which do not cross the blood-brain barrier, (ii) compds. with lower air-water partition coeffs. and an av. cross-sectional area, AD ≃ 50 Å2, which easily cross the blood-brain barrier, and (iii) hydrophilic compds. with low air-water partition coeffs. (AD < 50 Å2) which cross the blood-brain barrier only if applied at high concns.  It was shown that the lipid membrane-water partition coeff., Klw, measured previously, can be correlated with the air-water partition coeff. if the addnl. work against the internal lateral bilayer pressure, πbi = 34 ± 4 mN/m, is taken into account.  The partitioning into anisotropic lipid membranes decreases exponentially with increasing cross-sectional areas, AD, according to Klw = const. Kaw exp(-ADπbi/kT), where kT is the thermal energy.  The cross-sectional area of the mol. oriented at a hydrophilic-hydrophobic interface is thus the main determinant for membrane permeation provided the mol. is surface active and has a pKa > 4 for acids and a pKa < 10 for bases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvYrDWv9GpI7Vg90H21EOLACvtfcHk0lhnMPPJdGfmhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmsFOlsL4%253D&md5=a549eaf6f7ce81af291868899e3d0ab0</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1007%2Fs002329900434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002329900434%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DGottschlich%26aufirst%3DR.%26aulast%3DSeelig%26aufirst%3DA.%26atitle%3DBlood%25E2%2580%2593brain%2520barrier%2520permeation%253A%2520molecular%2520parameters%2520governing%2520passive%2520diffusion%26jtitle%3DJ.%2520Membr.%2520Biol.%26date%3D1998%26volume%3D165%26spage%3D201%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Van De Waterbeemd, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camenisch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chretien, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raevsky, O. A.</span><span> </span><span class="NLM_article-title">Estimation of blood–brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors</span> <span class="citation_source-journal">J. Drug Targeting</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.3109%2F10611869808997889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=9886238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADyaK1MXkvFKmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=151-165&author=H.+Van+De+Waterbeemdauthor=G.+Camenischauthor=G.+Folkersauthor=J.+R.+Chretienauthor=O.+A.+Raevsky&title=Estimation+of+blood%E2%80%93brain+barrier+crossing+of+drugs+using+molecular+size+and+shape%2C+and+H-bonding+descriptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors</span></div><div class="casAuthors">Van de Waterbeemd, Han; Camenisch, Gian; Folkers, Gerd; Chretien, Jacques R.; Raevsky, Oleg A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-165</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1061-186X</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">The influence of physicochem. properties, including lipophilicity, H-bonding capacity and mol. size and shape descriptors on brain uptake has been investigated using a selection of marketed CNS and CNS-inactive drugs.  It is demonstrated that the polar surface area of a drug can be used as a suitable descriptor for the drugs' H-bonding potential.  A combination of a H-bonding and a mol. size descriptor, i.e., the major components of lipophilicity and permeability, avoiding knowledge of distribution coeffs., is proposed to est. brain penetration potential of new drug candidates.  Previously reported exptl. surface activity data appear to be strongly correlated to mol. size of the drug compds.  Present anal. offers a modern basis for property-based design and targeting of CNS drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0yCKmlzsa37Vg90H21EOLACvtfcHk0lgqe3-hKms47g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvFKmtg%253D%253D&md5=9106ff6aa0755ff76fd0634822857d4a</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.3109%2F10611869808997889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10611869808997889%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDe%2BWaterbeemd%26aufirst%3DH.%26aulast%3DCamenisch%26aufirst%3DG.%26aulast%3DFolkers%26aufirst%3DG.%26aulast%3DChretien%26aufirst%3DJ.%2BR.%26aulast%3DRaevsky%26aufirst%3DO.%2BA.%26atitle%3DEstimation%2520of%2520blood%25E2%2580%2593brain%2520barrier%2520crossing%2520of%2520drugs%2520using%2520molecular%2520size%2520and%2520shape%252C%2520and%2520H-bonding%2520descriptors%26jtitle%3DJ.%2520Drug%2520Targeting%26date%3D1998%26volume%3D6%26spage%3D151%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Clark, D. E.</span><span> </span><span class="NLM_article-title">Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood–brain barrier penetration</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">815</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1999&pages=815-821&author=D.+E.+Clark&title=Rapid+calculation+of+polar+molecular+surface+area+and+its+application+to+the+prediction+of+transport+phenomena.+2.+Prediction+of+blood%E2%80%93brain+barrier+penetration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DD.%2BE.%26atitle%3DRapid%2520calculation%2520of%2520polar%2520molecular%2520surface%2520area%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520transport%2520phenomena.%25202.%2520Prediction%2520of%2520blood%25E2%2580%2593brain%2520barrier%2520penetration%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1999%26volume%3D88%26spage%3D815%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Norinder, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haeberlein, M.</span><span> </span><span class="NLM_article-title">Computational approaches to the prediction of the blood–brain distribution</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=291-313&author=U.+Norinderauthor=M.+Haeberlein&title=Computational+approaches+to+the+prediction+of+the+blood%E2%80%93brain+distribution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNorinder%26aufirst%3DU.%26aulast%3DHaeberlein%26aufirst%3DM.%26atitle%3DComputational%2520approaches%2520to%2520the%2520prediction%2520of%2520the%2520blood%25E2%2580%2593brain%2520distribution%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D291%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Abbott, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolman, D. E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patabendige, A. K.</span><span> </span><span class="NLM_article-title">Assays to predict drug permeation across the blood–brain barrier, and distribution to brain</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">901</span><span class="NLM_x">–</span> <span class="NLM_lpage">910</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.2174%2F138920008786485182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Fjm4014696&amp;key=18991587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivF2nsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=901-910&author=N.+J.+Abbottauthor=D.+E.+M.+Dolmanauthor=A.+K.+Patabendige&title=Assays+to+predict+drug+permeation+across+the+blood%E2%80%93brain+barrier%2C+and+distribution+to+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Assays to predict drug permeation across the blood-brain barrier, and distribution to brain</span></div><div class="casAuthors">Abbott, N. J.; Dolman, D. E. M.; Patabendige, A. K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">901-910</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug discovery programs to target or avoid the brain need to take into account the properties of the blood-brain barrier (BBB).  The importance to CNS PK of the free drug concn. in brain is increasingly recognized, and assays for drug discovery programs are being adjusted accordingly.  In vitro models of the BBB continue to play an important role in this process.  Good cell-based models using brain endothelium have been developed and validated for mechanistic studies, and some are suitable for medium to high throughput permeability screening and toxicol.  Brain homogenate and brain slice methods allow estn. of drug partition into brain.  In combination with in silico and in vivo models, the portfolio of methods establishing and predicting CNS drug PK is now very powerful, allowing much more accurate iterative feedback to chemists to optimize compd. profiles through the drug discovery and development program.  The advantage of using models based on real BBB cellular anatomy and physiol. is that they have the power to reveal and incorporate previously undiscovered properties, such as new transporters, metabolic enzymes and modulation, to form the basis for models mimicking neurol. disorders as well as normal function, and to allow physiol.-based pharmacokinetic (PBPK) extrapolation from animal models to humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvzxDfnsvLpLVg90H21EOLACvtfcHk0ljW8wmfSvFg0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivF2nsbo%253D&md5=8b5559e705ceb125855d64bceccea68d</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.2174%2F138920008786485182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008786485182%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DN.%2BJ.%26aulast%3DDolman%26aufirst%3DD.%2BE.%2BM.%26aulast%3DPatabendige%26aufirst%3DA.%2BK.%26atitle%3DAssays%2520to%2520predict%2520drug%2520permeation%2520across%2520the%2520blood%25E2%2580%2593brain%2520barrier%252C%2520and%2520distribution%2520to%2520brain%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D901%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span> </span><span class="NLM_article-title">Strategies to optimize the brain availability of central nervous system drug candidates</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=371-381&author=T.+T.+Wagerauthor=A.+Villalobosauthor=P.+R.+Verhoestauthor=X.+Houauthor=C.+L.+Shaffer&title=Strategies+to+optimize+the+brain+availability+of+central+nervous+system+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26atitle%3DStrategies%2520to%2520optimize%2520the%2520brain%2520availability%2520of%2520central%2520nervous%2520system%2520drug%2520candidates%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D371%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0ljW8wmfSvFg0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+desirable+central+nervous+system+drug+space+through+the+alignment+of+molecular+properties%2C+in+vitro+ADME%2C+and+safety+attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0lj1Rhf_UlYAsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520desirable%2520central%2520nervous%2520system%2520drug%2520space%2520through%2520the%2520alignment%2520of%2520molecular%2520properties%252C%2520in%2520vitro%2520ADME%252C%2520and%2520safety%2520attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Gerebtzoff, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seelig, A.</span><span> </span><span class="NLM_article-title">In silico prediction of blood–brain barrier permeation using the calculated molecular cross-sectional area as main parameter</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2638</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci0600814" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVakurbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=2638-50&author=G.+Gerebtzoffauthor=A.+Seelig&title=In+silico+prediction+of+blood%E2%80%93brain+barrier+permeation+using+the+calculated+molecular+cross-sectional+area+as+main+parameter"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">In silico prediction of blood-brain barrier permeation using the calculated molecular cross-sectional area as main parameter</span></div><div class="casAuthors">Gerebtzoff, Gregori; Seelig, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2638-2650</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cross-sectional area, AD, of a compd. oriented in an amphiphilic gradient such as the air-water or lipid-water interface has previously been shown to be crucial for membrane partitioning and permeation, resp.  Here, the authors developed an algorithm that dets. the mol. axis of amphiphilicity and the cross-sectional area, ADcalc, perpendicular to this axis.  Starting from the conformational ensemble of each mol., the three-dimensional conformation selected as the membrane-binding conformation was the one with the smallest cross-sectional area, ADcalcM, and the strongest amphiphilicity.  The calcd., ADcalcM, and the measured, AD, cross-sectional areas correlated linearly (n = 55, slope, m = 1.04, detn. coeff., r2 = 0.95).  The calcd. cross-sectional areas, ADcalcM, were then used together with the calcd. octanol-water distribution coeffs., log D7.4, of the 55 compds. (with a known ability to permeate the blood-brain barrier) to establish a calibration diagram for the prediction of blood-brain barrier permeation.  It yielded a limiting cross-sectional area (ADcalcM = 70 Å2) and an optimal range of octanol-water distribution coeffs. (-1.4 ≤ log D7.4 < 7.0).  The calibration diagram was validated with an independent set of 43 compds. with the known ability to permeate the blood-brain barrier, yielding a prediction accuracy of 86%.  The incorrectly predicted compds. exhibited log D7.4 values comprised between -0.6 and -1.4, suggesting that the limitation for log D7.4 is less rigorous than the limitation for AD.  An accuracy of 83% has been obtained for a second validation set of 42 compds. which were previously shown to be difficult to predict.  The calcd. parameters, ADcalcM and log D7.4, thus allow for a fast and accurate prediction of blood-brain barrier permeation.  Analogous calibration diagrams can be established for other membrane barriers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozSE1BCDh_XbVg90H21EOLACvtfcHk0lj1Rhf_UlYAsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVakurbL&md5=f27ce493f0560331674f9a7e9b11cb30</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fci0600814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci0600814%26sid%3Dliteratum%253Aachs%26aulast%3DGerebtzoff%26aufirst%3DG.%26aulast%3DSeelig%26aufirst%3DA.%26atitle%3DIn%2520silico%2520prediction%2520of%2520blood%25E2%2580%2593brain%2520barrier%2520permeation%2520using%2520the%2520calculated%2520molecular%2520cross-sectional%2520area%2520as%2520main%2520parameter%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2006%26volume%3D46%26spage%3D2638%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Boström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plowright, A. T.</span><span> </span><span class="NLM_article-title">Oxadiazoles in medicinal chemsitry</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1817</span><span class="NLM_x">–</span> <span class="NLM_lpage">1830</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2013248" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1817-1830&author=J.+Bostr%C3%B6mauthor=A.+Hognerauthor=A.+Llin%C3%A0sauthor=E.+Wellnerauthor=A.+T.+Plowright&title=Oxadiazoles+in+medicinal+chemsitry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fjm2013248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2013248%26sid%3Dliteratum%253Aachs%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DHogner%26aufirst%3DA.%26aulast%3DLlin%25C3%25A0s%26aufirst%3DA.%26aulast%3DWellner%26aufirst%3DE.%26aulast%3DPlowright%26aufirst%3DA.%2BT.%26atitle%3DOxadiazoles%2520in%2520medicinal%2520chemsitry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1817%26epage%3D1830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Grimont, J.; Le Goff, F.; Bourquin, G.; Silva, J.</span><span> </span><span class="NLM_article-title">Quality Assessment and Concentration Determination of Actelion’s Compound Solutions by Automated LCMS and Quantitative NMR</span>. Presented at MipTec 2010—The Leading European Event for Drug Discovery, Basel, Switzerland, Sep 20–24,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+Grimont&author=F.+Le+Goff&author=G.+Bourquin&author=J.+Silva&title=Quality+Assessment+and+Concentration+Determination+of+Actelion%E2%80%99s+Compound+Solutions+by+Automated+LCMS+and+Quantitative+NMR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGrimont%26aufirst%3DJ.%26atitle%3DQuality%2520Assessment%2520and%2520Concentration%2520Determination%2520of%2520Actelion%25E2%2580%2599s%2520Compound%2520Solutions%2520by%2520Automated%2520LCMS%2520and%2520Quantitative%2520NMR%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span>openmolecules.org. Property Explorer Applet. <a href="http://www.openmolecules.org/propertyexplorer/applet" class="extLink">http://www.openmolecules.org/propertyexplorer/applet</a> (accessed October<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=openmolecules.org.+Property+Explorer+Applet.+http%3A%2F%2Fwww.openmolecules.org%2Fpropertyexplorer%2Fapplet+%28accessed+October+2013%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed-Hagen, A. E.</span><span> </span><span class="NLM_article-title">Measurement of Michaelis constants for cytochrome P450-mediated biotransformation reactions using a substrate depletion approach</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=831-837&author=R.+S.+Obachauthor=A.+E.+Reed-Hagen&title=Measurement+of+Michaelis+constants+for+cytochrome+P450-mediated+biotransformation+reactions+using+a+substrate+depletion+approach"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DReed-Hagen%26aufirst%3DA.%2BE.%26atitle%3DMeasurement%2520of%2520Michaelis%2520constants%2520for%2520cytochrome%2520P450-mediated%2520biotransformation%2520reactions%2520using%2520a%2520substrate%2520depletion%2520approach%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2002%26volume%3D30%26spage%3D831%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Chakraborti, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, G.</span><span> </span><span class="NLM_article-title">One-pot synthesis of nitriles from aldehydes under microwave irradiation: influence of the medium and mode of microwave irradiation on product formation</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">13265</span><span class="NLM_x">–</span> <span class="NLM_lpage">13268</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=13265-13268&author=A.+K.+Chakrabortiauthor=G.+Kaur&title=One-pot+synthesis+of+nitriles+from+aldehydes+under+microwave+irradiation%3A+influence+of+the+medium+and+mode+of+microwave+irradiation+on+product+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChakraborti%26aufirst%3DA.%2BK.%26aulast%3DKaur%26aufirst%3DG.%26atitle%3DOne-pot%2520synthesis%2520of%2520nitriles%2520from%2520aldehydes%2520under%2520microwave%2520irradiation%253A%2520influence%2520of%2520the%2520medium%2520and%2520mode%2520of%2520microwave%2520irradiation%2520on%2520product%2520formation%26jtitle%3DTetrahedron%26date%3D1999%26volume%3D55%26spage%3D13265%26epage%3D13268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Meyer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joussef, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallardo, H.</span><span> </span><span class="NLM_article-title">Synthesis of new 1,2,4- and 1,3,4-oxadiazole derivatives</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2003</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">905</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Fjm4014696&amp;key=10.1055%2Fs-2003-38681" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2003&publication_year=2003&pages=899-905&author=E.+Meyerauthor=A.+C.+Joussefauthor=H.+Gallardo&title=Synthesis+of+new+1%2C2%2C4-+and+1%2C3%2C4-oxadiazole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1055%2Fs-2003-38681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2003-38681%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DE.%26aulast%3DJoussef%26aufirst%3DA.%2BC.%26aulast%3DGallardo%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520new%25201%252C2%252C4-%2520and%25201%252C3%252C4-oxadiazole%2520derivatives%26jtitle%3DSynthesis%26date%3D2003%26volume%3D2003%26spage%3D899%26epage%3D905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span> </span><span class="NLM_article-title">Practical and scalable synthesis of S1P<sub>1</sub> receptor agonist ACT-209905</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">604</span></span><div class="citationLinks">[<a href="/doi/10.1021/op200326s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm4014696&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Oisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=595-604&author=G.+Schmidtauthor=S.+Reberauthor=M.+H.+Bolliauthor=S.+Abele&title=Practical+and+scalable+synthesis+of+S1P1+receptor+agonist+ACT-209905"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Practical and scalable synthesis of S1P1 receptor agonist ACT-209905</span></div><div class="casAuthors">Schmidt, Gunther; Reber, Stefan; Bolli, Martin H.; Abele, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">595-604</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A practical and scalable route for the fast delivery of 12 kg of S1P1 agonist (ACT-209905) has been developed.  ACT-209905 is composed of an amino pyridine group, an oxadiazole spacer, a 2-ethyl-5-methylphenol moiety and a chiral 1-amino-2-propanol side chain.  The convergent synthesis consists of 16 steps with 9 isolated intermediates and is chromatog.-free.  Key building blocks are accessed from low-cost starting materials, such as acetone, di-Et oxalate, cyanoacetamide, and 2-ethyl-5-Me aniline.  A Negishi coupling that was troubled by the use of metal reagents and concomitant metal waste streams has been replaced by a less expensive Guareschi-Thorpe reaction to build up an amino isonicotinic acid.  The chiral 1-amino-2-propanol moiety was secured by selective ring-opening of an epoxide with lithium hexamethyldisilazide as an ammonia surrogate, thus omitting the notorious double alkylated byproduct.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqRMtjnTWGN7Vg90H21EOLACvtfcHk0ljZ6cqRazPeVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Oisrc%253D&md5=455e2fb1f56ce5cd9601d141392877c6</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Fop200326s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop200326s%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DReber%26aufirst%3DS.%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DAbele%26aufirst%3DS.%26atitle%3DPractical%2520and%2520scalable%2520synthesis%2520of%2520S1P1%2520receptor%2520agonist%2520ACT-209905%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2012%26volume%3D16%26spage%3D595%26epage%3D604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i40"><a href="/doi/suppl/10.1021/jm4014696">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_85224"></div></div></div></div></div><hr /></hr><p class="last">Additional experimental details on the synthesis and characterization of all target compounds and all intermediates not given above as well as data and a brief comment on mean arterial blood pressure and heart rate effects of compound <b>53</b> in spontaneously hypertensive rats are given. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm4014696/suppl_file/jm4014696_si_001.pdf">jm4014696_si_001.pdf (687.27 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm4014696&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-1%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm4014696%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm4014696" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799bf7d7cb41923","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
